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Atopic eczema and its relation to the skin barrier
 Atopic eczema (ae) is a multifactorial, chronic 
relapsing, pruritic, inflammatory skin disease. The 
disease is characterized by eczematous lesions as 
well as a broad spectrum of clinical manifestations, 
like xerosis (dry skin), erythema (red skin), and 
pruritus (itch) (Figure 1)1. These symptoms affect 
the quality of life substantially, and patients often 
show difficulties in their social life2. The incidence 
of ae in developed countries is rapidly increasing 
over the last two decennia to a current prevalence of 
5-10% in adults and around 20% in children, making 
it one of the most common skin diseases3-8. The 
diagnosis of ae is based on a constellation of clinical 
findings, as there is no pathognomonic biomarker 
for diagnosis. Formerly, ae was considered as a solely 
inflammatory disease and therefore often referred 
to as atopic dermatitis (but also neurodermatitis and 
endogenous eczema). Patients show an increased 
reaction to antigens, thereby inducing a dominant 
T-cell response that upregulates the production of 
cytokines. Although the disease is called ‘atopic’, up 
Figure 1: An example of a child with ae. In general, patients show the 
presence of lesional areas (affected, presence of erythema) as well as 






to 60% of patients with the clinical phenotype of ae do not have elevation of total or 
allergen-specific IgE levels in serum.  As only a subpopulation show increased levels of 
IgE antibodies and eosinophils (white blood cells associated with allergy), there is still a 
controversy in terminology9-11.
 However, a strong association between ae and loss-of-function mutations in the filaggrin 
gene (flg) was observed in 200612-16. Filaggrin is not directly related to the primary 
inflammatory response in ae, but is crucial for a proper formation of the outermost layer 
of the skin, the stratum corneum (sc), and sc hydration. The sc functions as the primary 
barrier of the skin17-19. Often referred to as a ‘brick and mortar’ structure, both the 
corneocytes (bricks) and lipids (mortar) are essential for the skin barrier. This finding 
created a paradigm shift in the understanding of the disease away from the inflammatory 
aspects towards ae as an epidermal barrier disorder11,20,21. One of the current hypotheses 
is that defects in the barrier function of the sc may facilitate the transport of pathogens, 
allergens, and irritants across the skin, thereby provoking dysfunctional innate and 
adaptive immune responses (Figure 2)11. This inflammation exacerbates the barrier 
defects, which allows successive pathogens to penetrate the skin, initiating a vicious 
circle. Recent studies corroborate this theory that a skin barrier dysfunction is causative 
for the risk of developing ae21-26.
Human epidermis
 Mammalian skin is divided into two layers, the dermis and epidermis (Figure 2). The 


















Figure 2: Schematic overview of the skin. a) Illustration resembling a cross-section of the skin showing the epidermis, 
dermis, and the subcutaneous tissue. A magnification of the epidermis is provided in. b) Under healthy conditions (left), 
the stratum corneum functions as the main barrier. However, a reduced barrier in ae patients (right) facilitates the 
transport of exogenous compounds into the deeper layers of the epidermis, thereby provoking an immune response. The 
reduced skin barrier function also leads to increased transepidermal water loss (tewl).
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the lymph vessels crucial for lymphocyte distribution in the dermis27. Lymphocytes act 
as a second line of defense, and may induce a T-cell response when arrest of exogenous 
compounds occurs. In ae, lymphocyte activation leads to an inflammatory response 
resulting in skin lesions11. The fact that exogenous compounds can reach the second line 
of defense means that it has already surpassed the epidermis. 
 The human epidermis can be divided into 4 layers (strata). The stratum basale is the 
deepest located layer that contains the epidermal stem cells. In this layer, proliferation 
of keratinocytes the major cell type takes place28. Keratinocytes migrate upwards, and 
differentiate during this migration. This differentiation is a sequential process crucial for 
formation of the barrier function of the skin29,30. First, keratinocytes are migrating to 
the stratum spinosum where the formation of lamellar bodies (LBs) is initiated31. LBs 
are secretory organelles that contain the precursors of the lipids essential for a proper 
skin barrier as well as many enzymes necessary to convert the lipids into their final 
structure in human sc32. The corneocytes are gradually differentiating and migrating 
towards the stratum granulosum, where numerous processes take place in a very short 
time period30,33,34: Keratin filaments aggregate after interaction with filaggrin, and 
enzymes will start to degrade cell components like the nucleus and cell organelles. In 
addition, desmosomes that keep the keratinocytes together are transformed into 
corneodesmosomes, and a cornified envelope is formed around the plasma membrane of 
the keratinocytes34. Lipids and enzymes of the LBs are extruded at the interface between 
the stratum granulosum and the uppermost layer of the skin, the sc35-37.
The stratum corneum as the primary skin barrier 
 The sc acts as the primary barrier against penetration of pathogens, allergens and 
other exogenous substances into the lower layers of the skin (the so-called outside-in 
barrier), and also prevent excessive transepidermal water loss (tewl, Figure 2), the so-
called inside-out barrier38,39. The sc has a ‘brick-and-mortar’ like structure. The ‘bricks’ 
are corneocytes: flattened, terminally differentiated keratinocytes40,41. The sc contains 
around 20 layers of corneocytes and is around 15-20 μm thick42,43. The corneocytes are 
embedded in a lipid matrix that is the ‘mortar’ of the sc barrier. The mortar is formed 
at the interface of the stratum granulosum and sc: The lipid disks stored in the LBs are 
extruded into the intercellular space between the stratum granulosum and sc. These lipid 
disks fuse together and create the highly ordered lipid lamellae. Metabolism, transport 
and extrusion of the sc lipids will be discussed below.
 The sc is constantly renewed. In human skin this occurs in approximately 2 to 4 weeks. 
At the surface, continuous shedding of the sc takes place at a rate of approximately 5·108 
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cells/day, a process called desquamation44. It is an active process that depends on pH, 
enzyme activity, and also on sc water levels in which kallikreins (KLKs) and cathepsins 
degrade the strong cohesive links between the corneocytes, the corneodesmosomes45-49. 
Friction or sheer stress with the environment enhances the shedding of corneocytes at 
the skin surface.
 The major penetration pathway of most molecules through the sc is along the intercellular 
pathway (i.e. penetration via the extracellular lipid matrix)50,51. This emphasizes the 
importance of the sc lipids as the primary barrier components of the skin.
Extracellular lipid matrix in human stratum corneum
 The lipids located in the extracellular matrix of the sc consist primarily of three 
lipid classes: ceramides (cers), free fatty acids (ffas), and cholesterol (chol), in 
approximately equimolar amounts52-55. The former two consist of carbon chains that 
are exceptionally heterogeneous in their molecular structure and are therefore classified 
into subclasses. Under healthy conditions, human sc ffas are predominantly saturated, 
but mono-unsaturated ffas (MUFAs) and trace amounts of poly-unsaturated ffas 
(PUFAs) are present as well53,56,57. Ffas with an additional hydroxyl-group (OH-ffas) are 
occasionally reported too57. Moreover, ffas show an extensive variation in their carbon 
chain length. The most predominant ffas have a chain length around 24 carbon atoms, 
but the full chain length distribution varies between 16 and 36 carbon atoms56,57. The 
second lipid class, cers, show even more structural diversity: They consist of a sphingoid 
base linked via an amide bond to a fatty acid (acyl) chain and are classified according 
to the different functional groups they have in both chains (Figure 3)58: The sphingoid 
moiety can either be a sphingosine [S], dihydrosphingosine [dS], phytosphingosine [P] or 
6-hydroxysphingosine [H]. The acyl chain is either non-hydroxylated [N], α-hydroxylated 
[A], or can even be ω-hydroxylated and successively linked to another fatty acid resulting 
in an esterified ω-hydroxylated [EO] acyl chain. The latter [EO] subclass (also named 
acyl-cer subclass) has an exceptionally long carbon chain which is unique for sc lipids. 
Different combinations in both carbon chains lead to the possibility of 12 different cer 
subclasses which have all been observed in human sc except for cer [EOdS]59. In addition 
to their variation in subclasses, cers show a wide distribution in their total chain length 
(that is, the chain length of both the sphingosine base and the acyl chain together). cer 
chain lengths between 34 carbon atoms and 72 carbon atoms have been reported in 
healthy human subjects59,60. 
 The sc lipid matrix is not only distinctive in its composition, but also shows a unique three-
dimensional ordering (Figure 4)61. Lipids are organized in stacked layers, lamellae62,63. 
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The structures formed by these layers have a repeat distance (d) of approximately 6 nm 
or 13 nm, referred to as the short periodicity phase (SPP) and long periodicity phase 
(LPP), respectively64-66. In particular the LPP is considered to be important for the barrier 
function of the skin, as is demonstrated from in vitro studies using lipid membranes67-69. 
Approximately perpendicular to the lamellar organization, lipids are packed with certain 
density. This lateral lipid packing is also of high importance for a proper sc barrier 
function70. At physiological temperature, human sc lipids are mainly present in a very dense 
orthorhombic organization. However, some lipid domains may be arranged in a less dense, 
hexagonal organization or even liquid organization, making the sc more permeable71-75.
Epidermal lipid metabolism
 Sc lipids (viz. ffas, cers and chol) are either generated in viable keratinocytes by several 






















































































Figure 3: Molecular structure and nomenclature of cers. Containing a polar head group and two apolar tails, cers 
are composed of a sphingoid base (depicted in blue) linked via an amide bond to an acyl chain (gray). Both chains can 
vary in their structure at the carbon positions indicated by the red arrows. In human sc, 4 different sphingoid bases 
(dihydrosphingosine [ds], sphingosine [s], phytosphingosine [p], 6-hydroxy sphingosine [h]) and 3 different acyl chains 
(non-hydroxy fatty acid [n], α-hydroxy fatty acid [a] and esterified ω-hydroxy fatty acid [eo]) are present. Together, this 
results in the presence of 12 subclasses of which all but cer [eods] have been identified in human sc.
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sources, such as the dietary lipids (e.g. essential ffas) or lipids synthesized in other 
organs like the liver76. Several enzymatic reactions are required for lipids synthesis and 
the subsequent lipid transport from the keratinocytes into the extracellular matrix of the 
sc, which will be discussed briefly (Figure 5).
 Fatty acid synthase synthesizes ffas to a chain length of 16 carbon atoms (palmitic 
acid) using acetyl-CoA and malonyl-CoA. Successively, ffas can be elongated over 
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Figure 4: Descriptive illustration explaining the lamellar and lateral organization in human stratum corneum. 1) The 
uppermost layer of the skin, the stratum corneum (sc), is composed of a ‘brick’ and ‘mortar’ structure of corneocytes and 
a highly ordered lipid matrix 2). 3) The lipids are arranged in stacked layers (lamellae), with two coexisting lamellar 
phases. These lamellar phases have a repeat distance of either 6 nm (spp) or 13 nm (lpp). The lateral organization is the 
plane perpendicular to the direction of the lamellar organization. Three possible arrangements of the lipids are possible: 
a very dense, ordered orthorhombic organization, a less dense, ordered hexagonal organization, or a disordered liquid 
organization. The former is predominantly present in healthy human sc.
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length distribution of ffas. In addition to elongation, ffas can be converted to mono-
unsaturated ffas (MUFAs) and poly-unsaturated ffas (PUFAs) catalyzed by stearoyl-CoA 
desaturases (scDs)80. Subsequently, the synthesized ffas can either be used for synthesis 
of cers (described below) or transformed to phospholipids and stored into LBs. 
 cer synthesis occurs in the endoplasmatic reticulum81-83. The first step involves the 
enzyme serine palmitoyl transferase that catalyzes the condensation of serine and 
palmitoyl-CoA to form 3-keto-dihydrosphingosine, which is successively reduced to form 
dihydrosphingosine. The next enzymatic step acylates a ffa to dihydrosphingosine. In 
this step, 6 cer synthases are involved84-86. Each of the different cer synthases are more 
specific to certain ffa chain length and degree of unsaturation. The final step involves 
the conversion of the dihydrosphingosine into one of the several sphingoid subclasses 
Figure 5: Schematic overview 
of main enzymatic processes 
involved in the formation 
of sc lipid lamellae. Arrows 
indicate the transport or 
conversion of lipids that are 
catalyzed by enzymes denoted 
by the abbreviations in blue. 
Abbreviations are as follows:  
fas = fatty acid synthase; elovl 
= elongation of very long chain 
fatty acids family (1 to 7); scd 
= stearoyl-coa desaturase; spt = 
serine palmitoyltransferase; ksr 
= 3-ketosphinganine reductase; 
(a)gpat = (acyl)glycerol-3-
phosphate acyltransferase; cers 
= ceramide synthase family (1 
to 6); des = dihydroceramide 
desaturase (1 and 2); gcs = 
glucosylceramide synthase; sms 
= sphingomyelin synthase; sult 
= cholesterol sulfotransferase 
type 2b isoform 1b; csase = 
cholesterol sulfatase; pla-2 
= phospholipase; β-gcase = 
β-glucocerebrosidase; asmase = 
acid sphingomyelinase.
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catalyzed by dihydroceramide desaturase (DES) enzymes. These subclasses of sphingoid 
bases are either sphingosine [S], dihydrosphingosine [dS], phytosphingosine [P], or 
6-hydroxysphingosine [H]59,87. The different cers are then transported to the Golgi 
complex and converted to glucosyl-cers and sphingomyelin, before transported into 
LBs86,88.
 Chol is the third main component of the sc lipid matrix and needs no conversion 
for storage into the LBs. It can also be converted to oxysterol or chol-sulfate, which 
stimulates keratinocyte differentiation and plays a crucial role in the desquamation 
process by inhibiting the activity of proteases that promote the degradation of the 
desmosomes89-91. Moreover, chol-sulfate is highly amphiphillic and can therefore cross 
the keratinocyte membrane and directly enter the stratum corneum where it will be 
partially converted back to chol by cholesterol sulfatase to be incorporated into the lipid 
lamellae76,92.
 The LBs generated in the stratum spinosum and stratum granulosum contain both the 
lipid precursors (chol, phospholipids, glucocylceramides and sphingomyelin) as well as 
the enzymes that convert the precursor-lipids into the final extracellular barrier lipids31. 
At the interface of the stratum granulosum and sc, secretion of the lipids from the LBs 
into the stratum corneum occurs. This process is called lamellar body extrusion, and is 
triggered by changes in the local calcium concentration76. The lipids are then converted 
to their final substituents by enzymes that are cosecreted in the LBs32,93,94: The 
phospholipids are converted back to ffas (and glycerol) by phospholipases95, whereas 
β-glucocerebrosidase and acidic sphingomyelinase convert respectively glucosylceramides 
and sphingomyelin back into cers96-99.
 Crucial for an optimal lipid synthesis and successive LB formation is a proper 
differentiation of keratinocytes. Important regulators of keratinocyte proliferation 
and differentiation are the nuclear hormone receptors like peroxisome proliferator-
activated receptors (ppars) and liver X receptor (LXR)92,100. These transcription factors 
are designated as ‘liposensors’, as they can sense cellular lipid levels and adjust gene 
expression accordingly. Ppars are primarily activated by ffas and their metabolic 
products, while LXR is activated by oxysterol metabolites101. Activation of ppars and LXR 
stimulate expression of keratinocyte differentiation markers, such as loricrin, involucrin 
and filaggrin102-106. Consequently, as the amount of ffas and chol necessary for LB 
formation increases, ppar and LXR activation is also increased which stimulate corneocyte 
formation76,100. In addition to their role in the formation of the sc ‘bricks’, ppars and 
LXR also act directly on the sc lipids: They stimulate lipid synthesis, facilitates both LB 
formation and LB secretion, and promote extracellular lipid processing107-110.
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Stratum corneum hydration
 The permeability, flexibility, and enzymatic activity of the sc is highly dependent on 
its water content. Proper sc hydration is regulated by (derivatives of) amino acids and 
specific salts, commonly referred to as the ‘natural moisturizing factor’ (NMF)111,112. 
Reduced NMF levels in the sc may negatively affect the hydration level, but is also 
suggested to increase the local pH, as NMF are derived from amino acids. Sub-optimal sc 
hydration levels or pH can have an effect on hydrolytic enzymes and the aforementioned 
permeability and flexibility. This may thereby induce a negative effect on many processes 
like desquamation, keratinocyte differentiation, lipid synthesis, cornified envelope 
formation, and the sc barrier function111,113-119. Most of the amino acid derived NMF 
are breakdown products of filaggrin. flg mutations lead to reduced NMF levels which is 
associated with dry skin120,121. This may explain the relation between ae, dry skin and 
flg mutations122. Although loss-of-function mutations in the flg gene are the foremost 
genetic risk factor for developing ae, a relatively large percentage of ae patients around 
50-80% do not carry such a mutation123,124. Besides, there is no convincing data that 
shows a clear relation between flg mutations and a reduced skin barrier function in ae 
patients as measured by transepidermal water loss.  Therefore, the role of filaggrin for an 
impaired sc barrier function remains indistinct, suggesting that other components of the 
epidermis and the skin barrier are likely to be involved as well125-127.
 
The cutaneous immune response in ae
 The primary cause for inflammation in ae is related to penetration of antigens through 
the disrupted sc barrier. This leads to an acute Th2-driven inflammatory response in the 
early stage of ae, but can develop in a Th1-driven response when the disease becomes 
chronic11,20,128,129. In addition, lesional epidermis (affected skin sites, Figure 1) in ae 
is characterized by infiltration of dermal dendritic cells, memory T cells, eosinophils, 
mast cells, lymphocytes and (IgE coated) macrophages11,130-134. The Th2-response leads 
to increased expression of cytokines which play a crucial role in the cutaneous immune 
response. Among these are the pro-inflammatory interleukins (ILs), like IL-4, IL-5, IL-13, 
IL-17, IL-22 as well as IL-31, the initiator of the itch-response. These cytokines reduce 
the expression of filaggrin, thereby exaggerating ae11,135,136. The production of these 
cytokines occurs in the T-cells, except for thymic stromal lymphopoietin (TSLP), which is 
produced by the keratinocytes. TSLP enhances the production of Th-2 cytokines by mast 
cells and mediates the dendritic cells towards a Th2-response137,138. 
 The hydration of the skin is also of importance for the immune response. It is 
known that an increase in local pH induces the activity of serine proteases, leading to 
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the generation of primary cytokines, interleukin (IL)-1α and IL-1β139-141. These are 
considered to be important for triggering the cytokine cascade and are related to the skin 
barrier dysfunction142-144.
Studies on the sc barrier lipids in ae
 The specific role of the lipid composition and organization with respect to ae has yet to 
be elucidated, though several studies show the importance of these aspects regarding ae. 
Concerning the lipid composition, there is conflicting information reported: some studies 
notice no change in the cer composition, whereas others demonstrate a decrease in total 
cer level as well as a decrease of cer subclasses [eos], [eoh] and/or [np], and increase 
in cer [as]54,145-152. A study by Ishikawa et al. tended to show differences in the chain 
length of some cer subclass in lesional skin only. In addition, they show that the levels 
of individual cer subclasses were altered even in non-lesional ae skin153. With respect to 
ffas, little is known on the changes in sc of ae compared to that in sc of control subjects. 
Results on the ffa lipid class in ae are scarce, but two studies report a decrease in sc 
ffas longer than 24 or 26 carbon atoms in ae patients154,155. With respect to the lipid 
organization in ae patients, almost no information is available. Pilgram et al. performed a 
limited study in 3 ae subjects in which they observe a significant increase in hexagonally 
ordered lipids compared to controls, as studied by electron diffraction. Fartasch et al. 
show that LB extrusion is delayed in ae, resulting in diminished delivery of the lipids into 
the intercellular regions156. The metabolic enzymes involved in lipid synthesis have been 
studied as well, since these are involved in the underlying causes for possible changes in 
the sc lipids of ae patients. However, the data are scarce. For example: two studies report 
no changes in enzyme activity of sphingomyelinase and β-glucocerebrosidase in skin of 
ae patients compared to healthy controls157,158. However, this is contradictory to a study 
published by Jensen et al., who reported a reduced activity of sphingomyelinase in both 
lesional and non-lesional skin of ae patients159. Hara et al. report that ceramide deficiency 
is related to another enzyme, sphingomyelin deacylase, which converts sphingomyelin 
into sphingosylphosphorylcholine and ffas instead of cers160,161. Another example of 
important sc lipid modulators which are modified in ae are the ppars. Lesional skin of ae 
patients showed an increased expression of pparβ/δ, while the expression of pparα and 
pparγ was decreased162,163. As discussed before, ppars stimulate keratinocyte expression 
and have a direct effect on lipid synthesis, LB formation and its secretion, and promote 
extracellular lipid processing. Changes in these nuclear receptor proteins are therefore 
suggested to affect the sc lipid barrier. However, the changes in differentiation in relation 
to lipid biosynthesis and lipid composition are not fully established. One of the important 
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pieces in the puzzle is a comprehesive analysis of the barrier lipids, in which not only the 
lipid classes, but also the chain length distribution of the lipids is studied. 
Analysis of the sc lipid composition
 Analyzing the three main sc lipid classes (chol, ffa, cers) can be challenging, as these 
lipids are very non-polar and show a large diversity164. ffas are most commonly analyzed 
by gas chromatography (gc) or gas liquid chromatography (glc). Although the lipid 
composition can be examined in detail, the main draw-back of these methods is related 
to the labor intensive derivatization of the sample prior to analysis165,166. Despite all 
technological improvements, identification and quantification of sc ffas has only been 
reported twice by Ansari and Norlen in healthy human skin56,57. 
 The structural variation is the main challenge for analysis of cers. Usually, thin layer 
chromatography (tlc) is used to separate some of the cer subclasses, and quantification or 
additional structural information can be obtained by successive densitometry or nuclear 
magnetic resonance (nmr) spectroscopy58,150,167-170. Main drawbacks are that tlc is 
usually cumbersome, cannot separate all subclasses at once, and has a low linear dynamic 
range in terms of quantification58,164. Better separation of lipids can usually be achieved 
by gc, but cers are non-volatile and unstable in the gas-phase, making gc only compatible 
for analysis of cers when derivatized171-174. Liquid chromatography (lc) in combination 
with light-scattering detection (lsd) has proven its potential for proper sc cer separation 
and analysis, but the inability for quantification is a major disadvantage175-179. Mass 
spectrometry (ms) is currently the most sensitive and powerful tool for identification of 
cers, and although quantification is relatively difficult, technological developments over 
the last decennia have led to improvements on this major issue. In combination with lc, 
it allows for analysis of all cer subclasses and can distinguish between different chain 
lengths as well. Whereas tlc in combination with nmr demonstrates the presence of 9 
cer subclasses, the introduction of lc/ms has led to the discovery and identification of 
2 additional subclasses. Ms can be a powerful tool as it gives information on the mass of a 
compound, a unique feature very useful for identification. However, the aforementioned 
quantification issue is a major drawback. Proper quantification is usually difficult as ms 
needs extensive validation, multiple internal standards per sample and quality controls. 
Nevertheless, reported data on sc cers by lc/ms has proven its potential and its high 
sensitivity makes lc/ms the preferred method when small quantities of material are 
used59,60,180-185.
 The analysis of all lipid classes at once is currently limited to tlc only. This method 
has led to enormous advancements in the understanding of lipids in the sc, and is still 
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frequently used for sc lipid analysis. However, the aforementioned disadvantages makes 
this method not appropriate for detailed analysis, especially when focusing on the lipid 
chain length distribution or when using small lipid amounts. There is currently no method 
for detailed analysis of all sc lipids, in which chain lengths of individual ffas and cers 
as well as all their subclasses can be studied at once. One of the primary challenges that 
will be addressed in this thesis is regarding development of a robust and high-throughput 
method, using straightforward sample preparation that enables detailed analysis 
of all main sc lipid classes in a single setup using very limited sample amounts. Lc in 
combination with ms seems most promising, as it can both separate lipid classes based on 
polarity (like tlc), and in addition on a second dimension: molecular mass.
 The analytical methods reported in literature have also been used to study the sc 
lipids in ae, although the results remain inconclusive. For example, two (relatively 
recently) developed methods report contradictory information regarding ae. Farwanah 
et al. developed a high performance tlc method to compare the cer composition in 
non-lesional skin of 7 ae patients with 7 healthy control subjects146. However, they 
observed no differences in any of the cer subclasses between the two groups. In contrast, 
Masukawa et al. developed an lc/ms method to study 8 ae patients and 7 control 
subjects153. In contrast to Farwanah et al., they observed significant changes in some of 
the cer subclasses of both lesional skin and non-lesional skin. They suggest that besides 
cer subclasses, cer chain length may be of importance for a proper sc lipid composition. 
These contradictory results show that more information is required to fully elucidate the 
lipid composition in these patients. To achieve this, there is a need for proper analytical 
methods enabling the analysis of all lipid classes in sc as well as the lipid chain length.
Analyzing the sc lipid organization
 The sc lipids are organized in a highly ordered 3D-structure (Figure 4). The lamellar 
lipid organization can be studied by means of small angle X-ray diffraction (saxd). The 
principle of saxd is that X-rays are scattered by a sample (i.e. sc sheets). The scattered 
X-rays are recorded as a function of its scattering vector (q), defined as q = 2π·sin θ/λ, in 
which λ is the wavelength of the X-rays and θ the angle of the scattered X-rays (Figure 6a). 
As the lamellar lipid organization is characterized by repeating lipid layers (periodicity 
phase), a typical saxd profile of human sc (see Figure 6b) shows sequential maxima from 
which the repeat distance (d) of the lpp and spp can be determined, according to the 
equation d = n·2π/qn (n = order of diffraction peak)64-66.
 The lateral lipid organization can be studied by Fourier transform infrared spectroscopy 
(ftir). An infrared beam is emitted on a sample (i.e. sc sheet), and the amount of ir 
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radiation that is absorbed due to resonating atom bond vibrations is recorded. 
Analyzing specific vibrations in different wavelength regions provide information on the 
3-dimensional sc lipid organization. These are e.g. CH2 symmetric stretching vibrations 
(2848-2053 cm-1) and the CH2 scissoring vibrations (1460-1480 cm-1; Figure 7)71-75. 
The former provides information on the conformational ordering of the lipids, and peak 
positions at a lower frequency (~2848 cm-1) contribute to a higher degree of conformational 
ordering than peak positions located at a higher wavenumber (2853 cm-1). The bandwidth 
of the CH2 scissoring vibrations is indicative for the amount of orthorhombic domains 



















































Figure 7: The lateral organization can be 
measured by ftir. a) ch2 stretching vibra-
tions: At a lower frequency (~2848 cm-1), 
ch2 stretching vibrations indicate a high 
degree of conformational ordering of the 
lipids, whereas a high wavenumber (2853 
cm-1) is indicative for a liquid organization 
(low degree of conformational ordering). b) 
ch2 scissoring vibrations (1460-1480 cm-1): 
An orthorhombic organization results in a 
splitting of the scissoring vibrations, while a 
























Figure 6: a) Principle of saxd. An x-ray beam is scattered at a certain angle (θ) by the sc sheet, resulting in a 2d-saxd 
image, which can be transformed into a typical saxd plot shown in b): A representative saxd profile of human sc. The 
scattering intensity is plotted as a function of q, which is defined by q = 2πsin θ/λ. The x-ray diffraction graph of human 
sc is characterized by a high intensity at low q values due to keratin in the corneocytes and a series of peaks. The peaks 
indicated by I (weak peak), II (strong peak) and III (weak peak) are attributed to the lpp. Peak II is also attributed to the 
spp. The peak indicated by # is due to chol.
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present in human sc. A small, single peak with a limited bandwidth is indicative for the 
presence of a hexagonal organization, whereas an increased bandwidth of the scissoring 
vibrations is indicative for an increased fraction of lipids present as orthorhombic lipid 
domains.
This thesis
 The rapid increase in prevalence of ae urges for novel treatments, also with respect to sc 
barrier repair. However, the exact role of the sc lipids for the impaired skin barrier function 
in ae is inconclusive. This lack of knowledge hampers the development for restoring the sc 
barrier by e.g. topical treatments. The studies described in this thesis aim in providing detailed 
information on the sc lipid composition, the lipid organization, and the role of sc lipids for the 
skin barrier function. In other words: we want to study the role of the lipids in the impaired 
skin barrier in ae. To study these three basal parameters in a combined study is unique, but 
needs several scientific barriers to be breached before this can be realized. The next chapter 
will describe the objectives and aims that facilitate in realizing the main goal of the study. 
part i chapter 1 
24
References
1 Leung DY, Bieber T. Atopic dermatitis. 
 Lancet 2003; 361: 151-60.
2 Kiebert G, Sorensen SV, Revicki D et al. Atopic dermatitis is 
associated with a decrement in health-related quality of  life. 
International Journal of Dermatology 2002; 41: 151-8.
3 Alanne S, Nermes M, Soderlund R et al. Quality of life in 
infants with atopic dermatitis and healthy infants: a follow-
up from birth to 24 months. 
 Acta Paediatrica 2011; 100: e65-70.
4 Alvarenga TM, Caldeira AP. Quality of life in pediatric 
patients with atopic dermatitis. 
 J Pediatr (Rio J) 2009; 85: 415-20.
5 Misery L, Finlay AY, Martin N et al. Atopic dermatitis: impact 
on the quality of life of patients and their partners.   
Dermatology 2007; 215: 123-9.
6 Mozaffari H, Pourpak Z, Pourseyed S et al. Quality of life in 
atopic dermatitis patients. Journal of microbiology,
 immunology, and infection = Wei mian yu gan ran za zhi 2007; 
40: 260-4.
7 Slattery MJ, Essex MJ, Paletz EM et al. Depression, anxiety, 
and dermatologic quality of life in adolescents with atopic  
dermatitis. The Journal of allergy and clinical immunology 2011; 
128: 668-71.
8 van Valburg RW, Willemsen MG, Dirven-Meijer PC et al. 
Quality of life measurement and its relationship to   
disease severity in children with atopic dermatitis in general 
practice. Acta Dermato-Venereologica 2011; 91: 147-51.
9 Flohr C, Johansson SG, Wahlgren CF et al. How atopic 
is atopic dermatitis? The Journal of allergy and clinical 
immunology 2004; 114: 150-8.
10 Wollenberg A, Rawer HC, Schauber J. Innate immunity in 
atopic dermatitis. Clin Rev Allergy Immunol 2011; 41: 272-81.
11 Oyoshi MK, He R, Kumar L et al. Cellular and molecular 
mechanisms in atopic dermatitis. Adv Immunol 2009;   
102: 135-226.
12 Palmer CN, Irvine AD, Terron-Kwiatkowski A et al. Common 
loss-of-function variants of the epidermal barrier protein 
filaggrin are a major predisposing factor for atopic  
dermatitis. Nature Genetics 2006; 38: 441-6.
13 Brown SJ, McLean WH. One remarkable molecule: filaggrin. 
The Journal of investigative dermatology 2012; 
 132: 751-62.
14 Irvine AD, McLean WH, Leung DY. Filaggrin mutations 
associated with skin and allergic diseases. The New England  
journal of medicine 2011; 365: 1315-27.
15 McLean WH, Irvine AD. Heritable filaggrin disorders: the 
paradigm of atopi dermatitis. The Journal of investigative   
dermatology 2012; 132: E20-1.
16 O'Regan GM, Sandilands A, McLean WH et al. Filaggrin 
in atopic dermatitis. The Journal of allergy and clinical 
immunology 2008; 122: 689-93.
17 Elias PM, Choi EH. Interactions among stratum corneum 
defensive functions. Experimental Dermatology 2005;  
14: 719-26.
18 Elias PM. Stratum corneum defensive functions: an inte-
grated view. The Journal of investigative dermatology 2005; 
 
 125: 183-200.
19 Irvine AD, McLean WH. Breaking the (un)sound barrier: 
filaggrin is a major gene for atopic dermatitis. The Journal of 
investigative dermatology 2006; 126: 1200-2.
20 Elias PM, Hatano Y, Williams ML. Basis for the barrier 
abnormality in atopic dermatitis: outside-inside-outside 
pathogenic mechanisms. The Journal of allergy and clinical 
immunology 2008; 121: 1337-43.
21 Elias PM, Steinhoff M. "Outside-to-inside" (and now back to 
"outside") pathogenic mechanisms in atopic dermatitis. The 
Journal of investigative dermatology 2008; 128: 1067-70.
22 Elias PM. Barrier repair trumps immunology in the 
pathogenesis and therapy of atopic dermatitis. Drug Discov 
Today Dis Mech 2008; 5: e33-e8.
23 Seidenari S, Giusti G. Objective assessment of the skin 
of children affected by atopic dermatitis: A study of pH, 
capacitance and tewl in eczematous and clinically uninvolved 
skin. Acta Dermato-Venereologica 1995; 75: 429-33.
24 Elias PM, Schmuth M. Abnormal skin barrier in the 
etiopathogenesis of atopic dermatitis. Current Opinion in 
Allergy and Clinical Immunology 2009; 9: 437-46.
25 Werner Y, Lindberg M. Transepidermal water loss in dry and 
clinically normal skin in patients with atopic dermatitis. Acta 
Derm Venereol 1985; 65: 102-5.
26 Yoshiike T, Aikawa Y, Sindhvananda J et al. Skin barrier 
defect in atopic dermatitis: increased permeability of the 
stratum corneum using dimethyl sulfoxide and theophylline. 
J Dermatol Sci 1993; 5: 92-6.
27 Kielty CM, Shuttleworth CA. Microfibrillar elements of the 
dermal matrix. Microsc Res Tech 1997; 38: 413-27.
28 Barthel R, Aberdam D. Epidermal stem cells. Journal of the 
European Academy of Dermatology and Venereology : JEADV 
2005; 19: 405-13.
29 Eckert RL. Structure, function, and differentiation of the 
keratinocyte. Physiol Rev 1989; 69: 1316-46.
30 Fuchs E. Epidermal differentiation: the bare essentials. The 
Journal of cell biology 1990; 111: 2807-14.
31 Feingold KR. Lamellar bodies: the key to cutaneous barrier 
function. The Journal of investigative dermatology 2012; 132: 
1951-3.
32 Elias PM, Feingold KR. Epidermal lamellar body as a 
multifunctional secretory organelle. In: Skin barrier (Elias P, 
Feingold K, eds). New York: Taylor & Francis. 2006; 261–72.
33 Eckert RL, Rorke EA. Molecular biology of keratinocyte 
differentiation. Environmental health perspectives 1989; 80: 
109-16.
34 Steven AC, Bisher ME, Roop DR et al. Biosynthetic pathways 
of filaggrin and loricrin--two major proteins expressed by 
terminally differentiated epidermal keratinocytes. J Struct 
Biol 1990; 104: 150-62.
35 Fartasch M, Bassukas ID, Diepgen TL. Structural relationship 
between epidermal lipid lamellae, lamellar bodies and 
desmosomes in human epidermis: an ultrastructural study. 
The British journal of dermatology 1993; 128: 1-9.
36 Menon GK, Ghadially R, Williams ML et al. Lamellar bodies 
as delivery systems of hydrolytic enzymes: implications for 
25
normal and abnormal desquamation. The British journal of 
dermatology 1992; 126: 337-45.
37 Menon GK, Feingold KR, Elias PM. Lamellar body secretory 
response to barrier disruption. The Journal of investigative 
dermatology 1992; 98: 279-89.
38 Madison KC. Barrier function of the skin: "la raison d'etre" of 
the epidermis. The Journal of investigative dermatology 2003; 
121: 231-41.
39 Scheuplein RJ, Blank IH. Permeability of the skin. Physiol Rev 
1971; 51: 702-47.
40 Elias PM. Epidermal lipids, barrier function, and 
desquamation. The Journal of investigative dermatology 1983; 
80 Suppl: 44s-9s.
41 Elias PM. Epidermal lipids, membranes, and keratinization. 
International Journal of Dermatology 1981; 20: 1-19.
42 Blair C. Morphology and thickness of the human stratum 
corneum. The British journal of dermatology 1968; 80: 430-6.
43 Holbrook KA, Odland GF. Regional differences in the 
thickness (cell layers) of the human stratum corneum: 
an ultrastructural analysis. The Journal of investigative 
dermatology 1974; 62: 415-22.
44 Milstone LM. Epidermal desquamation. Journal of 
dermatological science 2004; 36: 131-40.
45 Egelrud T. Desquamation in the stratum corneum. Acta 
dermato-venereologica. Supplementum 2000; 208: 44-5.
46 Emami N, Diamandis EP. Human tissue kallikreins: a road 
under construction. Clinica chimica acta; international journal 
of clinical chemistry 2007; 381: 78-84.
47 Ishida-Yamamoto A, Kishibe M. Involvement of 
corneodesmosome degradation and lamellar granule 
transportation in the desquamation process. Medical 
Molecular Morphology 2011; 44: 1-6.
48 Ishida-Yamamoto A, Igawa S, Kishibe M. Order and disorder 
in corneocyte adhesion. The Journal of dermatology 2011; 38: 
645-54.
49 Bouwstra JA, Groenink HW, Kempenaar JA et al. Water 
distribution and natural moisturizer factor content in human 
skin equivalents are regulated by environmental relative 
humidity. The Journal of investigative dermatology 2008; 128: 
378-88.
50 Williams ML, Elias PM. The extracellular matrix of stratum 
corneum: role of lipids in normal and pathological function. 
Crit Rev Ther Drug Carrier Syst 1987; 3: 95-122.
51 Johnson ME, Blankschtein D, Langer R. Evaluation of solute 
permeation through the stratum corneum: lateral bilayer 
diffusion as the primary transport mechanism. Journal of 
Pharmaceutical Sciences 1997; 86: 1162-72.
52 Wertz PW, Downing DT. Epidermal lipids. In: Physiology, 
biochemistry, and molecular biology of the skin (Goldsmith 
LA, ed), 2nd edn. New York: Oxford University Press. 1991; 
205–36.
53 Bouwstra JA, Gooris GS, Cheng K et al. Phase behavior of 
isolated skin lipids. Journal of lipid research 1996; 37: 999-
1011.
54 Holleran WM, Takagi Y, Uchida Y. Epidermal sphingolipids: 
metabolism, function, and roles in skin disorders. Febs 
Letters 2006; 580: 5456-66.
55 Man MM, Feingold KR, Thornfeldt CR et al. Optimization of 
physiological lipid mixtures for barrier repair. The Journal of 
investigative dermatology 1996; 106: 1096-101.
56 Norlen L, Nicander I, Lundsjo A et al. A new HPlc-based 
method for the quantitative analysis of inner stratum 
corneum lipids with special reference to the free fatty acid 
fraction. Archives of Dermatological Research 1998; 290: 508-
16.
57 Ansari MN, Nicolaides N, Fu HC. Fatty acid composition of 
the living layer and stratum corneum lipids of human sole 
skin epidermis. Lipids 1970; 5: 838-45.
58 Motta S, Monti M, Sesana S et al. Ceramide composition of 
the psoriatic scale. Biochim Biophys Acta 1993; 1182: 147-51.
59 Masukawa Y, Narita H, Shimizu E et al. Characterization of 
overall ceramide species in human stratum corneum. J Lipid 
Res 2008; 49: 1466-76.
60 Farwanah H, Wohlrab J, Neubert RH et al. Profiling of human 
stratum corneum ceramides by means of normal phase lc/
Apci-ms. Anal Bioanal Chem 2005; 383: 632-7.
61 Bouwstra JA, Dubbelaar FE, Gooris GS et al. The lipid 
organisation in the skin barrier. Acta dermato-venereologica. 
Supplementum 2000; 208: 23-30.
62 Madison KC, Swartzendruber DC, Wertz PW et al. Presence 
of intact intercellular lipid lamellae in the upper layers of the 
stratum corneum. The Journal of investigative dermatology 
1987; 88: 714-8.
63 Bouwstra JA, Gooris GS, van der Spek JA et al. Structural 
investigations of human stratum corneum by small-angle 
X-ray scattering. The Journal of investigative dermatology 
1991; 97: 1005-12.
64 Groen D, Gooris GS, Bouwstra JA. New insights into the 
stratum corneum lipid organization by X-ray diffraction 
analysis. Biophysical Journal 2009; 97: 2242-9.
65 McIntosh TJ, Stewart ME, Downing DT. X-ray diffraction 
analysis of isolated skin lipids: reconstitution of intercellular 
lipid domains. Biochemistry 1996; 35: 3649-53.
66 Bouwstra J, Pilgram G, Gooris G et al. New aspects of the 
skin barrier organization. Skin Pharmacology and Applied Skin 
Physiology 2001; 14 Suppl 1: 52-62.
67 Groen D, Poole DS, Gooris GS et al. Is an orthorhombic 
lateral packing and a proper lamellar organization important 
for the skin barrier function? Biochimica Et Biophysica Acta 
2011; 1808: 1529-37.
68 de Jager M, Groenink W, Bielsa i Guivernau R et al. A novel 
in vitro percutaneous penetration model: evaluation of 
barrier properties with p-aminobenzoic acid and two of its 
derivatives. Pharm Res 2006; 23: 951-60.
69 Grubauer G, Feingold KR, Harris RM et al. Lipid content and 
lipid type as determinants of the epidermal permeability 
barrier. Journal of lipid research 1989; 30: 89-96.
70 Bommannan D, Potts RO, Guy RH. Examination of stratum 
corneum barrier function in vivo by infrared spectroscopy. 
The Journal of investigative dermatology 1990; 95: 403-8.
71 Pilgram GS, Engelsma-van Pelt AM, Bouwstra JA et al. 
Electron diffraction provides new information on human 
stratum corneum lipid organization studied in relation 
to depth and temperature. The Journal of investigative 
dermatology 1999; 113: 403-9.
72 Damien F, Boncheva M. The extent of orthorhombic lipid 
part i chapter 1 
26
phases in the stratum corneum determines the barrier 
efficiency of human skin in vivo. The Journal of investigative 
dermatology 2010; 130: 611-4.
73 Goldsmith LA, Baden HP. Uniquely oriented epidermal lipid. 
Nature 1970; 225: 1052-3.
74 de Jager MW, Gooris GS, Dolbnya IP et al. The phase 
behaviour of skin lipid mixtures based on synthetic 
ceramides. Chemistry and physics of lipids 2003; 124: 123-34.
75 Bouwstra JA, Gooris GS, Dubbelaar FE et al. Phase behavior 
of lipid mixtures based on human ceramides: coexistence of 
crystalline and liquid phases. Journal of lipid research 2001; 
42: 1759-70.
76 Feingold KR. Thematic review series: skin lipids. The role 
of epidermal lipids in cutaneous permeability barrier 
homeostasis. Journal of lipid research 2007; 48: 2531-46.
77 Uchida Y. The role of fatty acid elongation in epidermal 
structure and function. Dermato-endocrinology 2011; 3: 65-9.
78 Kihara A. Very long-chain fatty acids: elongation, physiology 
and related disorders. Journal of Biochemistry 2012; 152: 387-
95.
79 Ohno Y, Suto S, Yamanaka M et al. ELOVL1 production of 
C24 acyl-CoAs is linked to C24 sphingolipid synthesis. Proc 
Natl Acad Sci U S A 2010; 107: 18439-44.
80 Miyazaki M, Ntambi JM. Chapter 7 - Fatty acid desaturation 
and chain elongation in mammals. In: Biochemistry of Lipids, 
Lipoproteins and Membranes (Fifth Edition) (Dennis EV, Jean 
EV, eds). San Diego: Elsevier. 2008; 191-V.
81 Merrill AH, Jr. De novo sphingolipid biosynthesis: a 
necessary, but dangerous, pathway. The Journal of biological 
chemistry 2002; 277: 25843-6.
82 Futerman AH, Riezman H. The ins and outs of sphingolipid 
synthesis. Trends Cell Biol 2005; 15: 312-8.
83 Fagone P, Jackowski S. Membrane phospholipid synthesis 
and endoplasmic reticulum function. Journal of lipid research 
2009; 50 Suppl: S311-6.
84 Levy M, Futerman AH. Mammalian ceramide synthases. 
IUBMB Life 2010; 62: 347-56.
85 Mizutani Y, Mitsutake S, Tsuji K et al. Ceramide biosynthesis 
in keratinocyte and its role in skin function. Biochimie 2009; 
91: 784-90.
86 Sandhoff R. Very long chain sphingolipids: tissue expression, 
function and synthesis. Febs Letters 2010; 584: 1907-13.
87 Robson KJ, Stewart ME, Michelsen S et al. 6-Hydroxy-4-
sphingenine in human epidermal ceramides. Journal of lipid 
research 1994; 35: 2060-8.
88 Hannun YA, Obeid LM. Principles of bioactive lipid 
signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 
2008; 9: 139-50.
89 Denning MF, Kazanietz MG, Blumberg PM et al. Cholesterol 
sulfate activates multiple protein kinase C isoenzymes and 
induces granular cell differentiation in cultured murine 
keratinocytes. Cell Growth Differ 1995; 6: 1619-26.
90 Hanley K, Wood L, Ng DC et al. Cholesterol sulfate stimulates 
involucrin transcription in keratinocytes by increasing Fra-1, 
Fra-2, and Jun D. Journal of lipid research 2001; 42: 390-8.
91 Sato J, Denda M, Nakanishi J et al. Cholesterol sulfate 
inhibits proteases that are involved in desquamation of 
stratum corneum. The Journal of investigative dermatology 
1998; 111: 189-93.
92 Feingold KR, Jiang YJ. The mechanisms by which lipids 
coordinately regulate the formation of the protein and 
lipid domains of the stratum corneum: Role of fatty acids, 
oxysterols, cholesterol sulfate and ceramides as signaling 
molecules. Dermato-endocrinology 2011; 3: 113-8.
93 Wertz PW, Downing DT, Freinkel RK et al. Sphingolipids 
of the stratum corneum and lamellar granules of fetal rat 
epidermis. The Journal of investigative dermatology 1984; 83: 
193-5.
94 Freinkel RK, Traczyk TN. Lipid composition and acid 
hydrolase content of lamellar granules of fetal rat epidermis. 
The Journal of investigative dermatology 1985; 85: 295-8.
95 Mao-Qiang M, Feingold KR, Jain M et al. Extracellular 
processing of phospholipids is required for permeability 
barrier homeostasis. Journal of lipid research 1995; 36: 1925-
35.
96 Holleran WM, Ginns EI, Menon GK et al. Consequences 
of beta-glucocerebrosidase deficiency in epidermis. 
Ultrastructure and permeability barrier alterations in 
Gaucher disease. The Journal of clinical investigation 1994; 93: 
1756-64.
97 Holleran WM, Takagi Y, Menon GK et al. Processing of 
epidermal glucosymseramides is required for optimal 
mammalian cutaneous permeability barrier function. The 
Journal of clinical investigation 1993; 91: 1656-64.
98 Jensen JM, Schutze S, Forl M et al. Roles for tumor necrosis 
factor receptor p55 and sphingomyelinase in repairing 
the cutaneous permeability barrier. The Journal of clinical 
investigation 1999; 104: 1761-70.
99 Schmuth M, Man MQ, Weber F et al. Permeability barrier 
disorder in Niemann-Pick disease: sphingomyelin-ceramide 
processing required for normal barrier homeostasis. The 
Journal of investigative dermatology 2000; 115: 459-66.
100 Schmuth M, Jiang YJ, Dubrac S et al. Thematic review series: 
skin lipids. Peroxisome proliferator-activated receptors and 
liver X receptors in epidermal biology. Journal of lipid research 
2008; 49: 499-509.
101 Chawla A, Repa JJ, Evans RM et al. Nuclear receptors and 
lipid physiology: opening the X-files. Science 2001; 294: 
1866-70.
102 Komuves LG, Hanley K, Lefebvre AM et al. Stimulation of 
PPARalpha promotes epidermal keratinocyte differentiation 
in vivo. The Journal of investigative dermatology 2000; 115: 
353-60.
103 Hanley K, Jiang Y, He SS et al. Keratinocyte differentiation 
is stimulated by activators of the nuclear hormone receptor 
PPARalpha. The Journal of investigative dermatology 1998; 
110: 368-75.
104 Hanley K, Ng DC, He SS et al. Oxysterols induce 
differentiation in human keratinocytes and increase 
Ap-1-dependent involucrin transcription. The Journal of 
investigative dermatology 2000; 114: 545-53.
105 Mao-Qiang M, Fowler AJ, Schmuth M et al. Peroxisome-
proliferator-activated receptor (PPAR)-gamma activation 
stimulates keratinocyte differentiation. The Journal of 
investigative dermatology 2004; 123: 305-12.
106 Schmuth M, Haqq CM, Cairns WJ et al. Peroxisome 
27
proliferator-activated receptor (PPAR)-beta/delta stimulates 
differentiation and lipid accumulation in keratinocytes. The 
Journal of investigative dermatology 2004; 122: 971-83.
107 Jiang YJ, Lu B, Kim P et al. PPAR and LXR activators regulate 
ABCA12 expression in human keratinocytes. The Journal of 
investigative dermatology 2008; 128: 104-9.
108 Jiang YJ, Lu B, Tarling EJ et al. Regulation of ABCG1 
expression in human keratinocytes and murine epidermis. 
Journal of lipid research 2010; 51: 3185-95.
109 Man MQ, Choi EH, Schmuth M et al. Basis for improved 
permeability barrier homeostasis induced by PPAR and LXR 
activators: liposensors stimulate lipid synthesis, lamellar body 
secretion, and post-secretory lipid processing. The Journal of 
investigative dermatology 2006; 126: 386-92.
110 Rivier M, Castiel I, Safonova I et al. Peroxisome proliferator-
activated receptor-alpha enhances lipid metabolism in a skin 
equivalent model. The Journal of investigative dermatology 
2000; 114: 681-7.
111 Rawlings AV, Matts PJ. Stratum corneum moisturization 
at the molecular level: an update in relation to the dry skin 
cycle. J Invest Dermatol 2005; 124: 1099-110.
112 Tabachnick J, LaBadie JH. Studies on the biochemistry 
of epidermis. IV. The free amino acids, ammonia, urea, 
and pyrrolidone carboxylic acid content of conventional 
and germ-free albino guina pig epidermia. The Journal of 
investigative dermatology 1970; 54: 24-31.
113 Harding CR. The stratum corneum: structure and function in 
health and disease. Dermatol Ther 2004; 17 Suppl 1: 6-15.
114 Elias PM. The epidermal permeability barrier: from Saran 
Wrap to biosensor. In: Skin Barrier (Elias PM, Feingold KR, 
eds). New York: Taylor & Francis. 2005; 25–32.
115 Del Rosso JQ. Moisturizers: function, formulation, and 
clinical applications. In: Cosmeceuticals (Draelos ZD, ed). 
Oxford: Elsevier. 2005; 97-102.
116 Bouwstra JA, de Graaff A, Gooris GS et al. Water distribution 
and related morphology in human stratum corneum at 
different hydration levels. The Journal of investigative 
dermatology 2003; 120: 750-8.
117 Del Rosso JQ, Levin J. The clinical relevance of maintaining 
the functional integrity of the stratum corneum in both 
healthy and disease-affected skin. J Clin Aesthet Dermatol 
2011; 4: 22-42.
118 Tetsuji H. Cornified envelope. In: Skin moisturization 
(Rawlings AV, Leyden JJ, eds). New York: Informa 
Healthcare. 2009; 83-97.
119 Hachem JP, Man MQ, Crumrine D et al. Sustained serine 
proteases activity by prolonged increase in pH leads to 
degradation of lipid processing enzymes and profound 
alterations of barrier function and stratum corneum 
integrity. The Journal of investigative dermatology 2005; 125: 
510-20.
120 Voegeli D. The role of emollients in the care of patients with 
dry skin. Nursing standard 2007; 22: 62, 4-8.
121 Takahashi M, Tezuka T. The content of free amino acids in 
the stratum corneum is increased in senile xerosis. Archives of 
Dermatological Research 2004; 295: 448-52.
122 Sandilands A, O'Regan GM, Liao H et al. Prevalent and rare 
mutations in the gene encoding filaggrin cause ichthyosis 
vulgaris and predispose individuals to atopic dermatitis. The 
Journal of investigative dermatology 2006; 126: 
 1770-5.
123 Irvine AD. Fleshing out filaggrin phenotypes. The Journal of 
investigative dermatology 2007; 127: 504-7.
124 Morar N, Cookson WO, Harper JI et al. Filaggrin mutations 
in children with severe atopic dermatitis. The Journal of 
investigative dermatology 2007; 127: 
 1667-72.
125 Jakasa I, Koster ES, Calkoen F et al. Skin barrier function 
in healthy subjects and patients with atopic dermatitis in 
relation to filaggrin loss-of-function mutations. J Invest 
Dermatol 2011; 131: 540-2.
126 Akiyama M. FLG mutations in ichthyosis vulgaris and atopic 
eczema: spectrum of mutations and population genetics. The 
British journal of dermatology 2010; 162: 472-7.
127 Proksch E, Jensen JM, Elias PM. Skin lipids and epidermal 
differentiation in atopic dermatitis. Clin Dermatol 2003; 21: 
134-44.
128 Grewe M, Bruijnzeel-Koomen CA, Schopf E et al. A role for 
Th1 and Th2 cells in the immunopathogenesis of atopic 
dermatitis. Immunol Today 1998; 19: 359-61.
129 Scharschmidt TC, Segre JA. Modeling atopic dermatitis 
with increasingly complex mouse models. The Journal of 
investigative dermatology 2008; 128: 1061-4.
130 Leung DY, Bhan AK, Schneeberger EE et al. Characterization 
of the mononuclear cell infiltrate in atopic dermatitis using 
monoclonal antibodies. The Journal of allergy and clinical 
immunology 1983; 71: 47-56.
131 Bieber T. Atopic dermatitis. The New England journal of 
medicine 2008; 358: 1483-94.
132 Leung DY, Schneeberger EE, Siraganian Rp et al. The presence 
of IgE on macrophages and dendritic cells infiltrating into the 
skin lesion of atopic dermatitis. Clin Immunol Immunopathol 
1987; 42: 328-37.
133 Zachary CB, Allen MH, MacDonald DM. In situ 
quantification of T-lymphocyte subsets and Langerhans cells 
in the inflammatory infiltrate of atopic eczema. The British 
journal of dermatology 1985; 112: 149-56.
134 Trautmann A, Akdis M, Schmid-Grendelmeier P et al. 
Targeting keratinocyte apoptosis in the treatment of atopic 
dermatitis and allergic contact dermatitis. The Journal of 
allergy and clinical immunology 2001; 108: 839-46.
135 Koga C, Kabashima K, Shiraishi N et al. Possible pathogenic 
role of Th17 cells for atopic dermatitis. The Journal of 
investigative dermatology 2008; 128: 2625-30.
136 Toda M, Leung DY, Molet S et al. Polarized in vivo expression 
of IL-11 and IL-17 between acute and chronic skin lesions. 
The Journal of allergy and clinical immunology 2003; 111: 875-
81.
137 Allakhverdi Z, Comeau MR, Jessup HK et al. Thymic stromal 
lymphopoietin is released by human epithelial cells in 
response to microbes, trauma, or inflammation and potently 
activates mast cells. The Journal of experimental medicine 
2007; 204: 253-8.
138 Bogiatzi SI, Fernandez I, Bichet JC et al. Cutting Edge: 
Proinflammatory and Th2 cytokines synergize to induce 
thymic stromal lymphopoietin production by human skin 
part i chapter 1 
28
keratinocytes. Journal of Immunology 2007; 178: 3373-
7.139 Nylander-Lundqvist E, Back O, Egelrud T. IL-1 beta 
activation in human epidermis. Journal of Immunology 1996; 
157: 1699-704.
140 Elias PM. Stratum corneum defensive functions: An 
integrated view. Journal of Investigative Dermatology 2005; 
125: 183-200.
141 Elias PM, Schmuth M. Abnormal skin barrier in the 
etiopathogenesis of atopic dermatitis. Current Allergy and 
Asthma Reports 2009; 9: 265-72.
142 Elias PM, Wood lc, Feingold KR. Epidermal pathogenesis of 
inflammatory dermatoses. Am J Contact Dermat 1999; 10: 
119-26.
143 Elias PM, Feingold KR. Does the tail wag the dog? Role of the 
barrier in the pathogenesis of inflammatory dermatoses and 
therapeutic implications. Archives of dermatology 2001; 137: 
1079-81.
144 Badertscher K, Bronnimann M, Karlen S et al. Mast cell 
chymase is increased in chronic atopic dermatitis but not in 
psoriasis. Archives of Dermatological Research 2005; 296: 503-
6.
145 Bleck O, Abeck D, Ring J et al. Two ceramide subfractions 
detectable in Cer(AS) position by HPTlc in skin surface lipids 
of non-lesional skin of atopic eczema. J Invest Dermatol 1999; 
113: 894-900.
146 Farwanah H, Raith K, Neubert RH et al. Ceramide profiles 
of the uninvolved skin in atopic dermatitis and psoriasis are 
comparable to those of healthy skin. Arch Dermatol Res 2005; 
296: 514-21.
147 Angelova-Fischer I, Mannheimer AC, Hinder A et al. 
Distinct barrier integrity phenotypes in filaggrin-related 
atopic eczema following sequential tape stripping and lipid 
profiling. Exp Dermatol 2011; 20: 351-6.
148 Ishibashi M, Arikawa J, Okamoto R et al. Abnormal 
expression of the novel epidermal enzyme, 
glucosymseramide deacylase, and the accumulation of its 
enzymatic reaction product, glucosylsphingosine, in the skin 
of patients with atopic dermatitis. Laboratory investigation; a 
journal of technical methods and pathology 2003; 83: 397-408.
149 Matsumoto M, Umemoto N, Sugiura H et al. Difference in 
ceramide composition between "dry" and "normal" skin in 
patients with atopic dermatitis. Acta Dermato-Venereologica 
1999; 79: 246-7.
150 Di Nardo A, Wertz P, Giannetti A et al. Ceramide and 
cholesterol composition of the skin of patients with atopic 
dermatitis. Acta Derm Venereol 1998; 78: 27-30.
151 Jungersted JM, Scheer H, Mempel M et al. Stratum corneum 
lipids, skin barrier function and filaggrin mutations in 
patients with atopic eczema. Allergy 2010; 65: 911-8.
152 Imokawa G, Abe A, Jin K et al. Decreased level of ceramides 
in stratum corneum of atopic dermatitis: an etiologic factor 
in atopic dry skin? J Invest Dermatol 1991; 96: 523-6.
153 Ishikawa J, Narita H, Kondo N et al. Changes in the ceramide 
profile of atopic dermatitis patients. J Invest Dermatol 2010; 
130: 2511-4.
154 Macheleidt O, Kaiser HW, Sandhoff K. Deficiency of 
epidermal protein-bound omega-hydroxyceramides in atopic 
dermatitis. J Invest Dermatol 2002; 119: 166-73.
155 Takigawa H, Nakagawa H, Kuzukawa M et al. Deficient 
production of hexadecenoic acid in the skin is associated in 
part with the vulnerability of atopic dermatitis patients to 
colonization by Staphylococcus aureus. Dermatology 2005; 
211: 240-8.
156 Fartasch M, Bassukas ID, Diepgen TL. Disturbed extruding 
mechanism of lamellar bodies in dry non-eczematous skin of 
atopics. Br J Dermatol 1992; 127: 221-7.
157 Jin K, Higaki Y, Takagi Y et al. Analysis of beta-
glucocerebrosidase and ceramidase activities in atopic and 
aged dry skin. Acta Dermato-Venereologica 1994; 74: 337-40.
158 Kusuda S, Cui CY, Takahashi M et al. Localization of 
sphingomyelinase in lesional skin of atopic dermatitis 
patients. The Journal of investigative dermatology 1998; 111: 
733-8.
159 Jensen JM, Folster-Holst R, Baranowsky A et al. Impaired 
sphingomyelinase activity and epidermal differentiation in 
atopic dermatitis. The Journal of investigative dermatology 
2004; 122: 1423-31.
160 Hara J, Higuchi K, Okamoto R et al. High-expression of 
sphingomyelin deacylase is an important determinant of 
ceramide deficiency leading to barrier disruption in atopic 
dermatitis. The Journal of investigative dermatology 2000; 115: 
406-13.
161 Higuchi K, Hara J, Okamoto R et al. The skin of 
atopic dermatitis patients contains a novel enzyme, 
glucosymseramide sphingomyelin deacylase, which cleaves 
the N-acyl linkage of sphingomyelin and glucosymseramide. 
The Biochemical journal 2000; 350 Pt 3: 747-56.
162 Westergaard M, Henningsen J, Johansen C et al. Expression 
and localization of peroxisome proliferator-activated 
receptors and nuclear factor kappaB in normal and lesional 
psoriatic skin. The Journal of investigative dermatology 2003; 
121: 1104-17.
163 Plager DA, Leontovich AA, Henke SA et al. Early cutaneous 
gene transcription changes in adult atopic dermatitis and 
potential clinical implications. Experimental Dermatology 
2007; 16: 28-36.
164 Cremesti ae, Fischl AS. Current methods for the 
identification and quantitation of ceramides: an overview. 
Lipids 2000; 35: 937-45.
165 Blau K, Halket JM. Handbook of derivatives for 
chromatography, 2nd edn. Chichester ; New York: Wiley. 
1993.
166 Gutnikov G. Fatty acid profiles of lipid samples. J Chromatogr 
B Biomed Appl 1995; 671: 71-89.
167 Robson KJ, Stewart ME, Michelsen S et al. 6-Hydroxy-4-
sphingenine in human epidermal ceramides. J Lipid Res 
1994; 35: 2060-8.
168 Stewart ME, Downing DT. A new 6-hydroxy-4-sphingenine-
containing ceramide in human skin. J Lipid Res 1999; 40: 
1434-9.
169 Wertz PW, Miethke MC, Long SA et al. The composition 
of the ceramides from human stratum corneum and from 
comedones. J Invest Dermatol 1985; 84: 410-2.
170 Bose R, Chen P, Loconti A et al. Ceramide generation by the 
Reaper protein is not blocked by the caspase inhibitor, p35. J 
Biol Chem 1998; 273: 28852-9.
29
171 Gaver RC, Sweeley CC. Methods for Methanolysis of 
Sphingolipids and Direct Determination of Long-Chain Bases 
by Gas Chromatography. J Am Oil Chem Soc 1965; 42: 294-8.
172 Murphy RC, Fiedler J, Hevko J. Analysis of nonvolatile lipids 
by mass spectrometry. Chem Rev 2001; 101: 479-526.
173 Raith K, Darius J, Neubert RH. Ceramide analysis utilizing 
gas chromatography-mass spectrometry. J Chromatogr A 
2000; 876: 229-33.
174 Bleton J, Gaudin K, Chaminade P et al. Structural analysis 
of commercial ceramides by gas chromatography-mass 
spectrometry. J Chromatogr A 2001; 917: 251-60.
175 Christie WW, Urwin RA. Separation of Lipid Classes from 
Plant-Tissues by High-Performance Liquid-Chromatography 
on Chemically Bonded Stationary Phases. Hrc-J High Res 
Chrom 1995; 18: 97-100.
176 Christie WW. Rapid Separation and Quantification of Lipid 
Classes by High-Performance Liquid-Chromatography and 
Mass (Light-Scattering) Detection. Journal of Lipid Research 
1985; 26: 507-12.
177 Gildenast T, Lasch J. Isolation of ceramide fractions from 
human stratum corneum lipid extracts by high-performance 
liquid chromatography. Biochim Biophys Acta 1997; 1346: 
69-74.
178 Gaudin K, Chaminade P, Ferrier D et al. Analysis of 
commercial ceramides by non-aqueous reversed-phase liquid 
chromatography with evaporative light-scattering detection. 
Chromatographia 1999; 49: 241-8.
179 Gaudin K, Chaminade P, Baillet A et al. Contribution to liquid 
chromatographic analysis of cutaneous ceramides. J Liq 
Chromatogr R T 1999; 22: 379-400.
180 Farwanah H, Wirtz J, Kolter T et al. Normal phase liquid 
chromatography coupled to quadrupole time of flight 
atmospheric pressure chemical ionization mass spectrometry 
for separation, detection and mass spectrometric profiling of 
neutral sphingolipids and cholesterol. J Chromatogr B Analyt 
Technol Biomed Life Sci 2009; 877: 2976-82.
181 Farwanah H, Pierstorff B, Schmelzer CE et al. Separation and 
mass spectrometric characterization of covalently bound 
skin ceramides using lc/Apci-ms and Nano-ESI-ms/ms. J 
Chromatogr B Analyt Technol Biomed Life Sci 2007; 852: 562-
70.
182 Masukawa Y, Narita H, Sato H et al. Comprehensive 
quantification of ceramide species in human stratum 
corneum. J Lipid Res 2009; 50: 1708-19.
183 Vietzke JP, Brandt O, Abeck D et al. Comparative 
investigation of human stratum corneum ceramides. Lipids 
2001; 36: 299-304.
184 Raith K, Neubert RHH. Liquid chromatography-electrospray 
mass spectrometry and tandem mass spectrometry of 
ceramides. Analytica Chimica Acta 2000; 403: 295-303.
185 Hinder A, Schmelzer CEH, Rawlings AV et al. Investigation 
of the Molecular Structure of the Human Stratum Corneum 
Ceramides [NP] and [EOS] by Mass Spectrometry. Skin 
Pharmacology and Physiology 2011; 24: 127-35.
Figure 1 was used with permission from Rachmat Tubagus, doktermudatrader.blogspot.nl (2012)
Figure 2a was purchased from iStockphoto
Figure 2b was purchased from Shutterstock




aim and outline of 
this thesis
Background
 Human skin forms a protective barrier against 
penetration of exogenous compounds into the body 
and prevents excessive transepidermal water loss 
(tewl)1-3. This skin barrier function is primarily 
located in the uppermost layer of the skin, the stra-
tum corneum (sc). Human sc consists of corneocytes 
embedded in a highly structured lipid matrix. The sc 
lipid matrix is comprised of ceramides (cers), free 
fatty acids (ffas) and cholesterol (chol)4,5. The 
lipids are crucial for the skin barrier function. In 
atopic eczema (ae), the skin barrier is impaired, and 
allergens and irritants can penetrate through the sc 
into the lower epidermal layers thereby provoking an 
immune response6-8. Previous studies demonstrated 
that sc lipid composition in ae patients is changed, 
although the role of the lipids is not fully understood. 
Objectives
 The primary aim of this thesis is to study in detail 
the sc lipid composition and organization as well as 
their role in the skin barrier function in eczematous 
patients. This is achieved by pursuing the following 
challenges:
1. Developing robust methods that enables 
  quantitative analysis of all main sc lipid classes
  in detail.
2. Determine the comprehensive sc lipid 
  composition of both lesional and non-lesional  
  skin in ae patients and compare the lipid profile  
  to healthy controls.
3. Establish how changes in the sc lipid 
  composition of ae patients are related to   
  changes observed in the lipid organization, and  
  how those affect the skin barrier function.
4. Determine the relationship between sc lipid 
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composition and organization with respect to other sc sources that show a reduced skin 
barrier function, i.e. Netherton syndrome (nts) and human skin equivalents (hses).
Outline
This thesis is divided into three parts that will address the aforementioned objectives:
-  Part II (Chapters 3-4) covers the development of a novel method for analysis of chol, 
  cers and ffas, by means of liquid chromatography coupled to mass spectrometry   
  (lc/ms). 
-  Part III (Chapters 5-8) describes the use of the developed lc/ms methods to examine
  the sc lipid composition in ae patients and control subjects. The observed changes   
  in the sc lipid composition in skin of ae patients will be related to changes in the lipid
  organization and reduced skin barrier function. 
-  Part IV (Chapters 9-10) focuses on the relationship between lipid composition and
  lipid organization of two different skin sources: sc from nts patients and sc from
  hses. 
Chapter overview
 Chapter 3 describes the development of a normal phase lc/ms method for analysis of 
all cer subclasses and their chain length distribution in human sc. A short validation 
assay is presented and comparisons are made between ex-vivo human sc and sc harvested 
from tape strips. It also reports on the identification of a new cer subclass by means of 
fragmentation studies (ms/ms) and high mass accuracy ms. 
 Lc/ms method development continues in Chapter 4, in which the analysis of ffas is 
described. Reverse phase lc/ms in negative ion mode is used. Method validation shows 
the robustness, linearity, and sensitivity of the method, and demonstrates the use of 
chloride adducts for increased ionization efficiency. The ffa method was successively 
coupled to the method for cer analysis explained in the previous chapter, which was 
improved to enable analysis of chol as well. The combined method was then applied on 
sc samples from different skin sources: human sc from ex vivo skin, human sc harvested 
by tape stripping, porcine skin, and skin obtained from hses.
 Part II focuses on the application of the developed lc/ms methods for analysis of the 
sc lipid in ae patients. Chapter 5 describes a short study in 6 ae patients and 6 healthy 
subjects. The cer composition is examined and related to the lamellar lipid organization 
studied by small-angle X-ray diffraction (saxd).
 In Chapter 6, data are presented on the cer composition of non-lesional sc of 28 
ae patients and healthy subjects. The cer composition is related to the lamellar lipid 
part i chapter 2
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organization (saxd studies) and lateral lipid organization (Fourier transform infrared 
spectroscopy (ftir) studies). In addition, changes in the cer composition and lipid 
organization were associated to changes in skin barrier function (monitored by tewl) 
and disease severity (scORAD). Finally, the influence of loss-of-function mutations in the 
filaggrin gene as well as the level of natural moisturizing factor is studied in relation to 
the sc lipids and skin barrier function.
 Chapter 7 reports the continuation on examining the sc in ae, in which both the ffa 
and cer composition was determined and compared to healthy subjects. In addition, the 
effect of inflammation on the lipid parameters is discussed, as both lesional and non-
lesional skin sites are examined. Changes observed in the sc ffas and cers are discussed 
in relation to the lipid organization and skin barrier function, and finally linked to 
epidermal lipid metabolism.
 In contrast to the previous three chapters, which report on the relative levels of the 
various lipids in sc lipid in ae patients, Chapter 8 demonstrates the importance of the 
lipid/protein ratio with respect to the sc barrier function. This is examined by Raman 
spectroscopy, whereas the barrier is monitored by tewl.
 Part III reports on sc lipid studies from two different skin sources. Chapter 9 focuses 
on the sc lipids in patients with NTS, a severe skin disease in which a mutation in the 
SPINK5 gene leads to hyperactivity of epidermal proteases resulting in sc detachment. 
The observed changes in lipid composition are compared to changes in lipid organization. 
These changes are also discussed in view of the results obtained from ae patients described 
in the previous chapters.
 In Chapter 10, data are shown on the lipid composition of sc obtained from hses. The 
lipid composition, examined by the newly developed lc/ms method, is compared to the 
lipid composition using thin layer chromatography. In addition, the lipid organization 
and the activity of several enzymes involved in epidermal lipid synthesis are determined 
and discussed with respect to the lipid composition.
 Chapter 11 summarizes the results, presents overall conclusions, and elaborates on the 
perspectives.
 An overview of the main parameters described in this thesis as well as the respective 
analytical methods used to collect these data are presented in Figure 1: The sc lipid 
composition, lipid organization, and (to a less extend) lipid amount are the most 
prominently discussed parameters in relation to the sc barrier function. In addition, the 
disease severity and filaggrin content are also related to the sc barrier function in several 
chapters.
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Figure 1: Schematic overview, illustrating the primary focus of the studies described throughout this thesis (in black); the 
main studied parameters (in blue); and the analytical methods used to examine these parameters (in red).
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 Ceramides (CERs) in the upper layer of the skin, 
the stratum corneum (Sc), play a key role in the 
skin barrier function. In human Sc, the literature 
currently reports 11 CER subclasses that have 
been identified. In this paper, a novel quick and 
robust liquid chromatography coupled to mass-
spectrometry (Lc/Ms) method is presented that 
allows the separation and analysis of all known 
human Sc CER subclasses using only limited sample 
preparation. Besides all 11 known and identified 
subclasses, a 3D multi-mass chromatogram shows 
the presence of other lipid subclasses. Using Lc/
Ms/Ms with both an ion trap (It) system, a Fourier 
transform-ion cyclotron resonance (Ft-ICR) system, 
and a triple quadruple (Tq) system, we were able to 
identify one of these lipid subclasses as a new CER 
subclass: the ester-linked ω-hydroxy fatty acid with 
a dihydrosphingosine base (CER [EOdS]). Besides 
the identification of a new CER subclass, this paper 
also describes the applicability and robustness of 
the developed Lc/Ms method by analyzing three 
(biological) Sc samples: Sc from human dermatomed 
skin, human Sc obtained by tape stripping, and Sc 
from full-thickness skin explants. All three biological 
samples showed all known CER subclasses and slight 
differences were observed in CER profile.
Introduction
 The outermost layer of mammalian skin, the 
stratum corneum (Sc), consists of corneocytes 
embedded in a lipid matrix. This layer serves as 
the main barrier for diffusion of substances across 
the skin. As the lipid matrix is the only continuous 
pathway in the Sc, the composition and organization 
of these lipids are of major importance for a 
chapter 
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competent skin barrier function1-4. The major lipid classes in human Sc are cholesterol, 
free fatty acids, and ceramides (CERs). In particular the CERs have drawn much attention 
and several reported studies demonstrate that changes in CER composition may play a 
role in an impaired skin barrier5-11. The various CERs consist of a sphingoid base linked 
via an amide bond to a fatty acid. Both variations in the fatty acid carbon chain and 
the sphingoid base architecture results in a large number of CER subclasses with a wide 
variation in chain length distribution. The molecular architecture of these subclasses is 
depicted in Figure 1. Over the years, important information about CER composition in 
human Sc has been obtained using high performance thin layer chromatography (HptLc) 
in conjunction with nuclear magnetic resonance (Nmr). This resulted in a gradual increase 
in the number of identified subclasses. By use of these methods, 9 different human CER 
subclasses have been identified in the Sc of healthy human skin12-16. As HptLc is easily 
accessible, it is still frequently used in various fields with respect to skin lipid research to 
determine the CER subclasses in human Sc11,17,18. However, these approaches are very 
time consuming and a high quantity of material is required, which is not always available. 
The application of liquid chromatography coupled to mass spectrometry (Lc/Ms) results 
in a much more detailed profile of each individual subclass using only small quantities of 
material19-28. Besides their important role in human skin, CERs are also key molecules 
with respect to cell signaling, growth, differentiation, and apoptosis29-38. Also in these 
research areas, the introduction of Ms has shown a tremendous boost in the identification 






























Figure 1: Ceramide structures: Four possible sphingosine related chains (s: sphingosine; ds: dihydrosphingosine; 
h: 6-hydroxy-sphingosine; p: phyto-sphingosine) are linked via an amide bond to either of three different fatty acid 
components (n: non-hydroxy fatty acid; a: α-hydroxy fatty acid; eo: esterified ω-hydroxy fatty acid) resulting in 
theoretically 12 different cer subclasses. Literature has reported the presence of all but cer [eods] in human sc. 
Note: r represents one of the three different fatty acid chains.
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of CERs in biological matrices.
 With respect to human Sc, two novel CER subclasses were reported recently39, showing 
that the number of subclasses in human Sc is still expanding. However, several of the 
Lc/Ms methods currently reported cannot analyze all CER subclasses in a single run. 
Also, almost all Lc/Ms methods reported so far are time consuming; multiple sample 
preparation steps are necessary and many methods require a solid phase extraction 
step beforehand. Moreover, the total analysis time of a single sample always exceeds 20 
minutes and often more than one hour, which is less attractive for analysis of a large 
number of samples. Therefore, the aims of our study were to i) minimize analysis time 
to allow quick sampling and analysis of total CER content; ii) use a minimal number of 
sample preparation steps to keep the method accessible while minimizing degradation 
during these steps, and iii) maintain a high CER sensitivity. To achieve these goals, we 
decided to use a normal phase Lc (NpLc) setup in combination with an atmospheric 
pressure chemical ionization (Apci) source. Regarding CER analysis, this choice offers 
some advantages over the commonly used reversed phase Lc (RpLc) combined with 
electrospray ionization (Esi) Ms, such as i) considerably lower ion suppression40-42; ii) 
Apci experiments are usually performed at higher flow rates compared with Esi, allowing 
for a shorter analysis time43, and iii) Apci permits the use of a nonpolar mobile phase, 
enhancing the ionization efficiency for non-polar compounds, i.e. CERs (in particular the 
higher mass subclasses)21,44.
 Analysis of human Sc CERs using this developed method resulted in the appearance of 
new lipid classes in a 3D-chromatogram. To obtain structural information about some 
of these new species, we performed fragmentation (Ms/Ms) on relevant ions (see Table 
III), which led to the identification of one new CER subclass. The robustness of the Lc/
Ms method was also demonstrated by measuring CERs from three different biological 
matrices: extracted lipids of isolated Sc from native human skin, Sc harvested with tape-
strips, or Sc obtained from the outgrowth of full-thickness human skin explants, referred 
to as the human skin explant model45. We chose these three different biological matrices 
to demonstrate the applicability of this methodology for future studies.
Materials and Methods 
CeR classification
 In this paper, we use the most recently introduced CER classification system according 
to Motta et al.46, which was extended by Masukawa et al.39. The CERs consist of 
either a sphingosine (S), a phyto-sphingosine (P), a 6-hydroxy sphingosine (H) or a 
dihydrosphingosine (dS) base. This base is chemically linked to either a non-hydroxy 
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fatty acid (N), α-hydroxy fatty acid (A), or an esterified ω-hydroxy fatty acid (EO). Current 
literature reports 11 different CER subclasses, viz. CERs denoted by [NS], [NdS], [Np], [NH], 
[AS], [AdS], [AP], [AH], [EOS], [EOP], and [EOH]. Figure 1 gives an overview of the molecular 
structures of all known CER subclasses. With respect to the fragmentation studies of 
CER species in this report, a more detailed nomenclature is used and shows as well, in 
parentheses, the number of carbon atoms for the specific ester, fatty acid, or carbon 
chain. For example, CER [E(18:2)O(30)S(18)] corresponds to a CER species containing a 
C18 sphingosine carbon backbone linked via an amide bond to a ω-hydroxy triacontanoic 
acid, which is ester-linked to a linoleic moiety.
Chemicals
 Ethanol (EtOH), isopropyl alcohol (IPA), methanol (MeOH), and n-heptane of HPLc 
grade or higher were purchased from Biosolve (Valkenswaard, The Netherlands). HPLc 
grade chloroform was obtained from Lab-Scan (Dublin, Ireland). Ultra purified water 
was prepared using a Purelab Ultra purification system (Elga Labwater, High Wycombe, 
UK). Trypsin and trypsin inhibitor were purchased from Sigma-Aldrich Chemie Gmbh 
(Steinheim, Germany). Synthetic CER [N(24)dS(18)] was purchased from Avanti Polar 
Lipids (Alabaster, AL). All other synthetic CERs were kindly provided by Cosmoferm 
(Delft, The Netherlands): CER [EOS] (E(18:2)O(30)S(18)), CER [NS] (N(24)S(18)), CER [Np] 
(N(24)P(18)), CER [AS] (A(24)S(18)), CER [AP] (A(24)P(18)), and CER [EOP] (E(18:2)O(30)
P(18)).
Isolation of Sc from human skin, tape stripping and cultured full-thickness 
explants
 Within 24 hours after surgery, residual subcutaneous fat was removed from the skin. The 
preparation of human Sc was performed according to the procedure described by Nugroho 
et al.47. In short, skin was stretched on Styrofoam and dermatomed to a thickness of 
around 300 µm (Deca Dermatome, DePuy Healthcare, Leeds, UK). Then, the skin was put 
on Whatman filters soaked in a solution of 0.1 % trypsin in 150 mM Phosphate Buffered 
Saline (PBS) solution pH 7.4 (8 g/L NaCl, 2.86 g/L Na2HPO4, 0.2 g/L KH2PO4, 0.19 g/L KCl). 
After overnight storage at 4°C, the skin was incubated for 1 h at 37°C followed by peeling 
off the Sc from the epidermis. The Sc was washed once in a 0.1% trypsin inhibitor in PBS 
pH 7.4 solution, twice in water, and stored in a dry, argon gas containing environment to 
inhibit oxidation of the Sc lipids. Lipids from the full-thickness skin explants model were 
also collected: Six cultured samples were combined into two pools of three samples and 
treated analogous to the samples obtained from surgical skin described above, excluding 
part i i chapter 3
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the dermatome step. Lipids obtained from tape stripping were harvested according to 
the following procedure: tape stripping (area 4.5 cm2) was performed on the ventral 
forearm of a healthy volunteer (male, age 33). Ten consecutive Poly(phenylene sulfide) 
tape strips (Nichiban, Tokyo, Japan) were taken at the same spot. All tapes were pressed 
to the targeted skin (450 g/cm2) and peeled off with tweezers in one fluid stroke using 
alternating directions for each tape strip. The 5th to 8th tape strips were selected for lipid 
extraction. The tapes were punched to an area of 2 cm2, and each punched area was put 
separately in a glass vial filled with 1 mL chloroform/methanol/water (1:2:½). All vials 
were stored at -20°C under argon atmosphere.
Lipid extraction
 Lipids from tape strips, Sc isolated from dermatomed human skin, and cultured full-
thickness skin explants were all extracted according to the method of Bligh and Dyer48 
with some small modifications described by Thakoersing et al49. Briefly, liquid-liquid 
extraction of the lipids from either human Sc or tape strips was performed sequentially 
using 3 different ratios of solvent mixtures chloroform/MeOH/water (1:2:½ ; 1:1:0 ; 2:1:0). 
A solution of 0.25 M KCl was added to extract polar lipids. After drying to N2 gas, lipids 
were dissolved in a solution of heptane/chloroform/MeOH (95:2½:2½): Regarding the 
lipids isolated from Sc of dermatomed skin, 1 mL of solvent was appropriate to obtain a 
proper sample concentration for optimal Lc/Ms analysis. Sc lipid samples obtained from 
the 4 tape strips were pooled prior to drying, and afterwards reconstituted in 0.1 mL to 
concentrate the lipids. Lipids extracted from cultured full-thickness skin explants were 
also reconstituted to a final volume of 0.1 ml.
CeR analysis by Lc/Ms
 NpLc was performed using a binary gradient solvent system of heptane (solvent A) 
and heptane/IPA/EtOH (2:1:1, solvent B) using a flow rate of 0.8 mL/min (see Table I for 
Table I: Applied lc gradient setup of a single run. Solvent a corresponds to 






0.00 93 / 7
2.50 93 / 7
2.55 90 / 10
5.00 90 / 10
10.00 50 / 50
10.50 93 / 7
12.00 93 / 7
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detailed gradient description). Separation was performed using a polyvinyl alcohol (PVA)-
Sil column (PVA-bonded column; 5 µm particle size, 100 × 2.1 mm i.d.) purchased from 
YMC (Kyoto, Japan). The HPLc (Alliance 2695, Waters Corp., Milford, MA) was coupled 
to one of several mass spectrometers, depending on the aim of the study. Additional 
details on the individual studies are described below. In general all mass spectrometers 
were equipped with an Apci source set to 450°C. Synthetic CERs had a final concentration 
ranging from nanomolar up to micromolar, depending on the experiment. Biological 
samples were concentrated to a final total lipid concentration around 0.1 mg/mL, 
determined by weighing. The injection volume of all samples was set to 10 µl. The analysis 
was performed using Thermo Finnigan Xcalibur software (version 2.0). 
Profiling of ceRs in synthetic and biological mixtures
 Profiling of CERs in synthetic mixtures as well as in samples from dermatomed skin, 
tape strips, and full-thickness skin explants was performed with the Lc system described 
above coupled to a triple quadrupole (Tq) mass spectrometer (TSQ Quantum, Thermo 
Finnigan, San Jose, CA) equipped with an Apci source operated in the positive ion mode. 
The temperature of the source heater was set to 450°C and the heated capillary was set to 
250°C. The capillary voltage was maintained at 3 kV, and the discharge current was set to 
5 µA. The flow rates of the nitrogen sheath and auxiliary gas were set to 0.4 and 2.4 L/min, 
respectively. To obtain a full CER profile including all CER chain lengths, the scan range was 
set from 600-1200 atomic mass units (amu). The resolution full width at half maximum 
(FWHM) was set to 0.7 amu. The analysis time was set to 8 minutes with an addition of 4 
minutes of column washing and equilibration afterwards, leading to a total run time of 
12 minutes. Synthetic CERs were used for development of the method, fragment analysis 
(see below), and limit-of-detection/limit of quantification (LOD/LOQ) determination. 
Regarding the development of the method, an equimolar synthetic mixture of 250 fmol/
CER was prepared and analyzed. For LOD/LOQ determination, a range from micromolar to 
nanomolar was used, resulting in amounts on-column ranging from picomol to femtomol 
levels. 
Identification of ceR using (Lc/)Ms/Ms
 Fragmentation spectra (Ms/Ms) of synthetic CERs and human Sc CERs were obtained 
using an ion trap (IT) system (LcQ Deca, Thermo Finnigan) combined with a Surveyor Lc 
system (Thermo Finnigan). Synthetic CERs were infused (in chloroform-MeOH 2:1) using a 
postcolumn low dead volume T-piece at a rate of 5 µL/min while maintaining a continuous 
flow of solvent A:B (93:7), as described above, at 0.8 ml/min. The normalized collision 
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energy for Ms/Ms was set between 40% and 70%, depending on the specific fragments 
which appeared to be indicative of a specific CER structure (more detail below). The sheath 
gas and auxiliary gas were set to consecutively 50 and 5 AU, which were slightly different 
settings compared with the setup used for general profiling of CERs described earlier but 
showed better results with respect to fragmentation of CERs. The scan time was set to 
50 ms. All other parameters were similar to the setup of the Tq system described above. 
A drawback of ms/Ms using an IT system is the limitation of the scan range that can be 
selected once the parent ion is set: in our studies, species over 1020 amu were fragmented. 
Using the it system described above, the product scan range resulted in a low-mass cut-
off at m/z 285 amu. Because we also wanted to acquire information on fragments in the 
range between 250 and 280 amu, Ms/Ms was performed on the Tq system, analyzing in 
the product scan mode while the collision energy was set to 40V. All other parameters 
were identical to the setup described for the Tq system.
High mass accuracy analysis
 Accurate mass analysis of all synthetic CERs as well as the unidentified species observed 
in the lipid mixture isolated from native human Sc was performed using a Fourier 
transform-ion cyclotron resonance system (LTq FT Ultra, Thermo Electron) interfaced 
with a Surveyor Lc pump and injector system equivalent to the one used for Ms/Ms 
analysis described above. The analysis time was set to 100 ms for mass accuracy up to 
4 digits (deviation <1ppm) and the resolution was set at 100.000. All other parameters 
were comparable to the setup used for fragment analysis described above.
Results and Discussion
Analysis and optimization of HPLc/aPci-Ms
 Prior to analysis of biological samples, the method was developed and optimized for all 
6 synthetic CERs, resulting in applied parameters which were described in the Materials 
and Methods section (Profiling of CERs in synthetic and biological mixtures). To analyze 
each individual synthetic CER with uniform chain length, NpLc was chosen over reverse 
phase Lc because this mode allows for separation of individual CER subclasses. We chose 
to use a PVA column as it has advantages in terms of separation and peak shape compared 
with commonly used silica and diol columns50,51. Although Esi is mainly used for the 
analysis of CERs, the Apci mode is also used frequently. The latter permits a higher flow 
rate (in our studies 0.8 mL/min) that results in a significantly shorter elution time of the 
CERs43, thereby decreasing the overall Lc/Ms analysis time. The total ion chromatogram 
of the synthetic CERs is provided in Figure 2a and shows that with this high flow rate, the 
43
CER subclasses are excellently separated. Because Apci was used, only single positively 
charged ions were present and could under our conditions be identified as either [M+H]+ 
or [M+H-H2O]+ ions. The LOD and LOQ of all six synthetic CERs were determined and are 
listed in Table II. These were calculated from ion extracted chromatograms (IECs) obtained 
from full scan Ms (m/z 600-1200 amu). The LOD and LOQ were defined by the signal-to-
noise ratio (S/N), being 3 and 10, respectively.
 This Lc/Ms method shows several advantages over others with regard to analysis time, 
sample preparation and sensitivity. Qualitative analysis as well as relative comparability 
studies may be carried out easily. However, complete quantitative analysis of CERs is only 
possible when the effect of different ionization efficiencies between CER subclasses and 
chain lengths has been studied. Moreover, ion suppression effects (although they are 
expected to be of limited effect during Apci-Ms) as well as sample preparation effects 
should also be taken into account. Ideally, each analyte should have its own isotopically 
labeled internal standards (13C, 15N and 2D isotopes) added at different stages of the 
sample preparation and the analysis. This should allow for correction of the mentioned 
effects resulting in quantitative data of these CERs. However, such internal standards 
are not, or very limitedly, available. Therefore, a practical approach is to use a limited 
number of such standards that correct for these effects per CER subclass. Future studies 
will include several of these standards to make this assay (semi-)quantitative. The use 
of several nonisotopically labeled internal standards to correct for chain length and CER 
subclass regarding human Sc is described in the literature only once23.
CeR analysis of human sc 
 To separate and analyze the CER subclasses from isolated human Sc, a crude human Sc 
lipid mixture was injected using an identical setup as was used for synthetic CERs. The 
CER total ion chromatogram of the human Sc sample is shown in Figure 2b and shows 
elution and group separation of all CER subclasses within 8 minutes. The chromatographic 
resolution of the peaks was considerably lower compared with the synthetic CER mixture. 
This, however, can be fully explained by the presence of a wide range of both fatty acid 
and sphingosine chain lengths in each CER subclass, resulting in a relatively broad 
chromatographic peak per class: the total carbon chain length of the CER has a small effect 
on the polarity of the species thereby changing the retention time slightly. For example, 
both synthetic [N(18)P(24)] and its human Sc counterpart elutes at 4.10 minutes and 
show similar peak shapes (Figure 2a and Supplementary Figure 1). However, human 
CER [Np] with a total chain length of 54 carbon atoms elutes at 3.72 minutes, whereas a 
total chain length of 40 shows a retention time at 4.18 minutes. This illustrates that the 
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Figure 2: NPLC/APCI-MS total ion current of a) equimolar (250 fmol/CER) synthetic human CER mixture containing 
CER [EOS], [NS], [EOP], [NP], [AS] and [AP]; b) crude lipid extract of human SC (abbreviations as in Figure 1). Peaks 
noted with a * contain other SC lipid classes (e.g. triglycerides, cholesterol) and do not interfere with the CER analysis.
Table II: Accurate mass lc-ms analysis and lod/loq values of 6 synthetic ceramides.
Amu: atomic mass unit; lod: limit of detection, defined as s/n=3; loq: Limit of quantification, defined as s/n=10. 
a: measured with ft-icr ms, resolution 100.000. b: measured with tq ms: resolution fwhm (Full Width at Half 
Maximum) = 0.7 amu.








+  994.953 9  29
E(18:2)O(30)P(18) [M+H]+  1030.974 1  5
N(24)S(18) 632.634 13  45
N(24)P(18) [M+H]+  668.655 18  60
A(24)S(18) 648.629 28  94
A(24)P(18) [M+H]+  684.650 19  64






distribution in total number of carbon atoms results in the broadening of the total ion 
current peak as depicted in Figure 2b. Nevertheless, this apparent ‘loss in resolution’ can 
be fully overcome by adding the mass/charge (m/z) axis as a third dimension. The peaks 
that did show overlap in the human CERs total ion current chromatogram can therefore 
easily be distinguished in the 3D multi-mass chromatogram as shown in Figure 3. This plot 
shows each separated CER class with multiple peaks from which each total carbon chain 
length could be derived. From this 3D plot the variation in chain lengths and therefore 
the slight difference in polarity (i.e. retention time) can be seen clearly. An overview of 
the total carbon chain lengths of all CER subclasses is listed in the inset of Figure 3. The 
calculated total chain length distribution is in line with those reported by Masukawa et 
al39. However, due to the high sensitivity of our method and the specific tuning for high 
mass CERs, it shows an even broader range of chain lengths for, in particular, the [EO] 
subclasses. This results in the detection of CER subclasses with molecular masses over 
1100 amu corresponding to very long total carbon chain lengths up to 76 carbon atoms.



























































Figure 3: 3D multi-mass chromatogram of dermatomed human SC. Positive ions of CER species using NPLC/APCI-MS. 
X-axis shows the retention time. Y-axis represents the m/z ratio (in amu). Z-axis depicts the relative intensity of the CER 
species. Classes noted by either an A, B, or * are unknown species. The inset in the upper right corner shows the range in 
which the various chain lengths of every CER class were observed.
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Ms/Ms of the unknown ceR class
 Besides 11 CER subclasses known to be present in human Sc, Figure 3 also shows the 
presence of other lipid subclasses, marked as *, A, and B, which are unidentified so far. 
Currently, four sphingoid base chains and three acyl chain variations have been indentified 
in CERs isolated from human Sc, which results in theoretically 12 different CER subclasses 
(Figure 1)23,39. CER [EOdS] has been previously observed by gas-liquid chromatography 
in pig skin and epidermal cysts as a variant of CER [EOS]16,52. However, its presence in 
human Sc as a separate subclass has never been confirmed and recent literature on human 
Sc only mentions 11 different subclasses, not pointing out CER [EOdS]. Therefore, our aim 
was to seek for the presence of this CER subclass [EOdS] in the 3D mass chromatogram. 
Because this CER bears an esterified fatty acid, its m/z-value should be in the range of 
other [EO] subclasses (i.e. over 900 amu). Figure 3 depicts two unidentified lipid classes 
located in this high m/z range: A and B. To obtain more information about the unknown 
classes, Lc/Ft-ICR Ms was used to determine the m/z of all peaks of both unidentified 
classes with high mass accuracy. From the high mass accuracy data it was concluded that 
the masses of the unidentified group labeled B in Figure 3 correspond to the theoretical 
masses of the CER subclass [EOdS], and a combined mass spectrum of this unknown 
lipid class is shown in Figure 4, including the accurate masses and the total number of 
C-atoms the species should bear. Another indication that this unidentified lipid class may 










































Figure 4: Average mass spectrum 
(retention time range: 2.1-2.7 min; 
positive ion mode) of unidentified 
lipid class, performed by high mass 
accuracy FT-ICR-MS. C-numbers 
correspond to the theoretical total 
number of carbon atoms the species 
should bear, i.e. the chain length of 
the proposed CER [EOdS].
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expected that CER [EOdS] elutes prior to the [EOS] subclass, as [NdS] and [AdS] both elute 
prior to their unsaturated non-hydroxy and ω-hydroxy sphingosine analogs, [NS] and [AS] 
respectively. This expectation is in accordance to the elution sequence of the unknown 
CER class and CER [EOS]. Therefore, both on the basis of the close agreement between the 
theoretical mass of the expected compound and the observed exact mass with matching 
elemental formulae as well as their relative retention times there is a strong indication 
that this unknown subclass is indeed the CER [EOdS].
 To confirm the hypothesis that this unknown CER subclass is indeed the proposed CER 
[EOdS], Ms/Ms experiments were performed to obtain structural information on the 
fragments of both known as well as the unknown CERs. Because no synthetic variant of 
CER [EOdS] is commercially available, synthetic CERs, viz. [N(24)S(18)], [N(24)dS(18)], and 
[E(18:2)O(30)S(18)] were fragmented to obtain product ions that could be characteristic 
for their structure. This data was compared with that reported before39,53-58. Following 
the synthetic CERs, CER fragment-ions of relevant human Sc were analyzed. Subsequently, 
the above derived fragmentation reactions were used to identify fragments of the 
unknown Sc CER subclass. The results of these fragmentation studies are shown in Figure 
5a-e and Table III, and will be explained below. (It is not in the scope of this publication 
to fully interpret the observed spectra and identify all observed (fragment-)ions, as this 
requires additional studies.)
 When focusing on the synthetic CER [N(24)S(18)] (Figure 5a), very characteristic 
fragments were observed for both the sphingosine base as well as the fatty acid chain, 
which have also been reported in earlier studies39,54,56,58. In particular fragments 
at m/z 252.3, 264.3, and 282.2 amu corresponding to [(M+H)-(FA chain)-CH3OH]+, 
[(M+H)-(FA chain)-H2O]+ and [(M+H)-(FA chain)]+ respectively, are descriptive for a 
sphingosine base of 18 carbon atoms. Also, a fatty acid chain of 24 carbon atoms 
shows typical fragments at m/z 368.3 and 392.4 amu, which can be recognized as 
[(M+H)-(sphingosine chain)]+ and [(M+H)-(C16H31OH)]+ respectively. Also fragments 
without individual chain length information were observed: ions at m/z 602.4 and 614.6 
amu, matching respectively [(M+H)-H2O-CH3OH]+ and [(M+H)-H2O]+ ions, are also present 
in Figure 5a. Subsequently, Ms/Ms experiments were conducted on CER [N(24)dS(18)], 
resulting in the mass spectrum shown in Figure 5b. Again, fragments corresponding to 
the fatty acid chain and the sphingosine base were observed54,56,58: the fatty acid related 
fragments of CER [NdS] are similar to their CER [NS] counterparts (m/z 368.3 and 392.4 
amu). This is expected because both structures contain a non-hydroxy fatty acid and are 
therefore identical. Fragments related to the sphingosine base are shifted +2 amu (m/z 
254.3, 266.3 and 284.2 amu). This is also in agreement as CER [dS] contains one degree of 
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CER [N(24)S(18)] CER [N(24)dS(18)]
CER [E(18:2)O(30)S(18)]
Human SC CER [EOS] C70 (parent mass = 1050.9)





Figure 5: MS/MS spectra of synthetic CERs using an Ion Trap (IT) system: a) CER [N(18)S(24)]; b) CER [N(18)dS(24)]; 
c) CER [E(18:2)O(30)S(18)]; d) human SC CER subclass [EOS] C70, parent m/z 1050.9 amu; e) unknown human SC 
CER, parent m/z 1052.9 amu. Because of the low m/z cut off and range limitations of MS/MS using an IT system (see 
text), a triple quad (TQ) MS was used to obtain fragment ion spectra in the low mass range (250-300 amu) of human 
SC CER [EOS] (d) and the unknown CER (e).
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saturation less, i.e. two hydrogen atoms more. Hereafter, the more complicated CER [EOS] 
– consisting of a sphingosine base 18 carbon atoms long and a fatty acid chain 30 carbon 
atoms long, with a linoleic acid moiety esterified to it – was studied. Fragmentation of 
this CER resulted in a mass spectrum present in Figure 5c. Since this CER also bears a 
sphingosine base, fragments with respect to the sphingosine chain are similar to CER [NS] 
and CER [NdS] (viz. ions at m/z 252.3, 264.3, 282.2 amu). The fragments at m/z 450.5, 
730.7 and 964.9 amu correspond to fragments related to the fatty acid chain. The Ms/
Ms spectrum of CER [EOS] contains additional fragments compared with CER [NS] and 
[NdS] because the esterified linoleic acid may fragment as well. Fragments at m/z 696.7 
and 714.7 amu indicate the loss of a linoleic moiety with and without the loss of a water 
molecule, respectively. 
 Subsequently, Ms/Ms spectra of the human Sc variant of CER [EOS] were studied to 
confirm that their fragmentation is in agreement with these observations. The precursor 
ion of CER [E(18:2)O(34)S(18)] at m/z 1050.9 amu was fragmented and the result is 
shown in Figure 5d. Indeed, fragments corresponding to the loss of the fatty acid chain, 
the sphingosine chain, as well as fragments without the ester chain were observed (see 
Table III). In addition, fragments showed individual chain lengths of either the fatty 
acid or sphingosine chain. The characteristic sphingosine fragment of m/z 264.3 amu 
for example (C18 sphingosine), also showed fragments of m/z 292.3 and 320.3 amu 
(respectively C20 and C22). The same phenomenon was observed for esterified fatty 
acid fragments like 730.7 and 758.7 (C48 and C50). Finally, we performed Ms/Ms on the 
hypothesized CER [EOdS] observed in human Sc. Because human CERs contain various 
chain lengths in a single subclass, the precursor ion of the proposed CER [E(18:2)O(34)
dS(18)], at m/z 1052.9 was selected for fragmentation studies. This precursor ion should, 
following observations described above, lead to fragments best comparable to the CER 
[E(18:2)O(34)S(18)] counterpart. Figure 5e shows the Ms/Ms spectrum obtained from 
this precursor ion. Very indicative fragments, which were observed in both CER [EOS] 
as well as in CER [NdS], also appear in this spectrum, indicating that this unidentified 
species indeed contains an esterified ω-hydroxy fatty acid moiety and also bears a 
dihydrosphingosine chain (i.e. 266.3, 450.5, 730.7, 772.7, 790.8). This strongly supports 
the hypothesis that the unknown CER class is indeed CER [EOdS]. From Figure 4 it can 
be concluded that the mass range of this newly identified CER [EOdS] ranges from m/z 
1015.0 to 1181.1 amu and corresponds exactly with a CER [EOdS] having a total chain 
length ranging from 66 to 78 carbon atoms long. Besides, it is known from literature that 
the CERs containing an even number of carbon atoms are more abundantly present than 
odd chain length CERs21,23, which is also the case in our mass spectrum of Figure 4, again 


































































































   











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































confirming that the unknown CER subclass is CER [EOdS].
 Finally, we also hypothesized on the possible molecular structure of the unknown lipid 
class noted as ‘A’ in Figure 3. Although we cannot make any firm conclusion because no 
extensive Ms/Ms studies were performed, it can be pointed out that this lipid species bears 
a mass in similar ranges as the CER [EO] subclasses. Moreover, from the early elution time 
it can be concluded that this lipid class is more apolar than all known CERs subclasses. 
Figure 6 shows the mass spectrum result of high mass accuracy analysis performed on 
these species by Ft-ICR-Ms, including the respective molecular formulae for every peak 
observed. These molecular formulae are quite conclusive, as the difference between the 
observed and theoretical mass is low: between -0.17 and 1.06 parts per million. Although 
it is highly speculative what the molecular structure of this lipid class is, the arguments 
mentioned above, in combination with the exact mass data, may point to a lipid structure 
comparable to CER [EOdS], but with one OH-group less. More extensive research and 
repeated measurements will address this lipid in future studies.
Human skin ceR analysis harvested by using tape strips
 Our aim was to develop a method for CER analysis that could also provide a CER 
profile when harvesting in vivo Sc using tape strips. Because tape strips usually contain 












































































m/z (amu) Composition Delta (ppm)
900.876 C59 H114 O4 N 0.92
914.891 C60 H116 O4 N 0.24
928.906 C61 H118 O4 N -0.04
942.922 C62 H120 O4 N 0.15
956.938 C63 H122 O4 N 0.45
970.953 C64 H124 O4 N 0.32
984.969 C65 H126 O4 N 0.32
998.985 C66 H128 O4 N 0.95
1013.001 C67 H130 O4 N 0.65
1027.016 C68 H132 O4 N 0.30
1041.031 C69 H134 O4 N -0.17
1055.048 C70 H136 O4 N 0.94
1069.064 C71 H138 O4 N 1.06
1083.079 C72 H140 O4 N 0.62
1097.095 C73 H142 O4 N 0.89
Figure 6: Average mass spectrum 
(retention time range: 1.8-2.4 min; 
positive ion mode) of unidentified 
lipid class, performed by high mass 
accuracy FT-ICR-MS, including mass 
table with the differences (delta) of 
the observed and theoretical mass 
of the proposed molecular formulae 
in parts per million (ppm).
part i i chapter 3
52
Figure 7: 3D multi-mass chromatogram of a) tape strips from human SC; b) cultured full-thickness skin explants. 
“a” respresent the same unknown lipid mass as was shown in human SC from dermatomed skin (Figure 3). Compared 
to human SC from dermatomed skin, some lipid species in cultured full-thickness skin explants show either higher 
abundance (noted by ↑), or did not show up in dermatomed skin at all and might therefore possibly be different CER 
species (noted by *). Probable contamination caused by the tape strip is depicted as **.
Lc/Ms. To circumvent these issues, we decided to use poly(phenylene sulfide) tape strips 
obtained from Nichiban. These tape strips were also used in studies for CER analysis by 
Masukawa et al.23,39. After lipid extraction and the additional concentration step (see 
Material and Methods), samples were injected and the 3D CER profile is shown in Figure 
7. All the CER subclasses with varying chain length distributions could be identified and 
possible contaminants from the tape did not interfere with the results. All known CER 
classes can be observed in tape strip harvested Sc and only minor deviations from the 
profile were observed. The nature of these differences remains to be investigated in future 
studies.
CeR analysis of a human skin explant model
 The extracted lipids from a cultured full-thickness skin explants model were analyzed 
using the same method as used for dermatomed skin and skin harvested from tape strips. 
53
The results of the two individual pools were comparable and one of these 3D multi-mass 
chromatograms is presented in Figure 7b. Although it is not the purpose of this study to 
thoroughly investigate the exact differences between human skin and the cultured full-
thickness skin explant model, from Figure 7b it can be concluded that this model contains 
several differences, including additional lipid subclasses compared with native human 
skin, possibly CERs.
Conclusion
 In this paper, we describe a new method for effectively profiling Sc CERs with high 
sensitivity and only a very limited number of sample preparation steps, making this 
method very approachable for the analysis of different sorts of Sc samples. The high 
sensitivity of our method – in particular for CERs with a higher mass range – resulted in 
the detection of additional lipid classes of which one could be identified as CER [EOdS]. 
This is the fourth CER linoleic moiety esterified to a very long fatty acid chain confirmed 
to be present in human skin by Lc/Ms. We also successfully applied this method to CERs 
extracted from human Sc harvested using tape strips. Because low quantities of lipids 
are obtained by tape stripping, an Lc/Ms method with high sensitivity is required. Also 
regarding these tape strip samples, the developed method was robust enough to detect 
all CERs. Finally, samples from a cultured full-thickness skin explant model could also be 
analyzed using this developed method and sensitivity seems no issue. Future research 
on CER analysis may benefit from this new method, showing an easy, robust, quick, and 
sensitive method for analysis of these lipid species.
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Supplemental data
Supplementary Figure 1: a) Stacked chromatograms (iec) of the human stratum corneum cer subclass [ns]. The wide 
distribution in chain lengths of a single ceramide subclass (40 to 54 carbon atoms) causes the wide total ion current 
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 Ceramides (CERs), cholesterol (Chol), and free 
fatty acids (Ffas) are the main lipid classes in 
human stratum corneum (Sc, outermost layer of 
the skin), but there are no studies that report on the 
detailed analysis of these classes in a single setup. 
The primary aims of this present study were to 1) 
develop a Lc/ms method for quantitative analysis of 
Ffas; and 2) combine this method with the analysis 
of Chol and with our recently reported method 
for Cer analysis. This combined method detects 
all major Sc lipids in a single setup using NPLc and 
positive ion mode Apci-ms for detection of Cers and 
Chol, and RpLc using negative ion mode Apci-ms to 
analyze Ffas. Validation showed this method to be 
robust, reproducible, sensitive, and fast. It is, to our 
knowledge, the first study that permits the analysis 
of Sc Ffas by Lc/ms. The method was successfully 
applied on ex vivo human Sc, human Sc obtained from 
tape stripping and human skin substitutes (porcine 
Sc and human skin equivalents). In conjunction with 
Cer profiles, clear differences in Ffa profiles were 
observed between these different Sc sources. For 
future research, this provides an excellent method 
for quantitative, ‘high-throughput’ profiling of Sc 
lipids with more than adequate sensitivity.
Introduction
 Lipid analysis is currently of main interest in many 
research areas, as these compounds are crucial to 
unveil biological mechanisms in e.g. cell signaling, 
energy storage, enzyme activation, apoptosis, 
metabolism and functioning of cell membranes1-7. 
Particularly in dermatological research, lipidomics 
has had increased attention since its importance 
regarding human dermatological disorders has 
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recently been demonstrated8-13. The lipids located in the uppermost layer of the skin 
– the stratum corneum (Sc) – fulfill a primary role in the skin barrier function9,14-17. 
Human Sc lipids consist of mainly 3 classes: free fatty acids (Ffas), ceramides (Cers) and 
cholesterol (Chol)18-24. Based on their variations in chemical structure, Cers are divided 
into subclasses25 (in Supplementary Figure 1 the Cer subclasses are provided), which are 
important for a proper barrier function26-29.
 The recent increment in more detailed knowledge about Sc lipid composition can, to 
a large extent, be attributed to the upcoming use of liquid chromatography coupled to 
mass spectrometry (Lc/ms). Lc/ms provides both information on lipid subclasses as well 
as the chain length distribution in each of the subclasses, which is not possible using the 
common technique of thin layer chromatography (TLc)30-32. However, no study reports 
on Lc/ms analysis of all three Sc lipid classes in a single setup. One of the main reasons 
is the lack of a proper Lc/ms method for analyzing Sc Ffas. The most frequently used 
method to analyze this particular lipid class is gas chromatography (GC). This method, 
however, is labor intensive as derivatization of the Ffas is required prior to analysis33-35. 
Moreover, GC is rarely used for analysis of the Cers simultaneously, as these non-volatile 
compounds are unstable in the gas-phase (if not derivatized, which is cumbersome as 
well)36-38. On the contrary, Lc/ms has the potential to analyze the Cers, Ffas, and Chol 
in a single setup.
 Therefore, the first aim of the study was to develop and validate an Lc/ms method that 
enables quantitative analysis of Ffas present in human Sc. Once validated, the second 
aim was to combine this method with our recently reported Lc/ms method for analysis of 
Cers (see previous chapter)39, and to improve this method to enable the analysis of Chol 
as well. The two combined methods would permit the analysis of all main Sc lipid classes. 
Sample collection and preparation should be kept to a minimum to prevent degradation 
and allow for high-throughput analysis40. Analysis of underivatized lipids is therefore 
preferable.
 After the development of the Lc/ms method, we validated and successively tested the 
method on Sc from ex vivo human Sc and compared it to three scientifically relevant 
samples: 1) analysis of human Sc obtained from tape stripping (tape stripping is a non-
invasive way to obtain Sc from which the lipids can be extracted) and 2) Sc from two 
human skin substitutes, i.e. porcine skin and human skin equivalent (hse). The latter is 
generated from keratinocytes and fibroblasts, the most abundant cell types in the skin.




 HPLc grade (or higher) methanol (MeOH), n-heptane, isopropanol (IPA), acetonitrile 
(ACN), ethanol (EtOH), and acetic acid (HAc) were purchased from Biosolve (Valkenswaard, 
The Netherlands). Chloroform (CHCl3) was attained from Lab-Scan (Dublin, Ireland). Ultra 
purified water was prepared using a Purelab Ultra purification system (Elga Labwater, 
High Wycombe, UK). Potassium chloride was obtained from Merck (Darlctadt, Germany). 
Ffa 22:0-OH and deuterated Chol-D7 were obtained from Larodan AB (Malmö, Sweden). 
Trypsin, trypsin inhibitor, Chol as well as Ffas 16:0, 16:1, 18:0, 18:1, 18:2, 20:0, 22:0, 
22:1, 24:0, 24:1 and 28:0 were obtained from Sigma-Aldrich GmbH (Steinheim, Germany). 
Deuterated Ffas 18:0-D35 and 24:0-D47 acids were purchased from Cambridge Isotope 
Laboratories (Andover, MA). Synthetic Cer [NdS] was purchased from Avanti Polar Lipids 
(Alabaster, AL). All other synthetic Cers, viz. [EOS], [NS], [NP], [AS], [AP], [EOP], deuterated 
[EOS]-D31, and deuterated [NS]-D47, were kindly provided by Evonik (Essen, Germany). 
A more specified description of the chemicals is located in the Supplementary Materials 
and Methods.
Sc sample collection and lipid extraction
 Synthetic lipids as well as Sc lipids from human ex vivo surgical skin were used to develop 
and validate the Lc/ms method. To study the applicability of the developed method, 3 
different skin sources (viz. human Sc obtained from tape stripping, Sc from HSEs, and 
Sc from porcine skin) were analyzed and compared to human ex vivo Sc. The collection 
and processing of skin samples is in accordance to the Declaration of Helsinki and all 
human subjects gave written informed consent. The whole sample collection (by means 
of tape stripping)39,41,42 and lipid extraction procedures (extended Bligh and Dyer)43,44 
are described previously, and also added to the supporting Materials and Methods. 
Afterwards, samples were reconstituted in heptane/CHCl3/MeOH (95:2½:2½) to a final 
concentration of ~1.0 mg/ml. When sample storage was necessary, samples were stored 
under argon atmosphere, at -20°C, in a dark environment. The heptane/CHCl3/MeOH 
solution is stable at 21°C, but phase separation occurs over time at lower temperatures 
(e.g. <7°C). Heating the solution for 1 hour at 34°C results in a single phase. The solution 
can be used afterwards at room temperature. This single solution was suitable for lipid 
analysis of both Ffas as well as Cers and Chol. 
Lipid analysis by Lc/Ms
 All Sc lipids were analyzed using a single setup of an HPLc (either an Alliance 2695, 
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Waters Corp., Milford, MA; or Surveyor Thermo Finnigan, San Jose, CA) coupled to an Apci 
source equipped on a triple quadrupole (TQ) mass spectrometer (TSQ Quantum, Thermo 
Finnigan) operating in full scan mode. Separation of Ffas by chain length and degree of 
unsaturation can be achieved on a reverse phase column. Using Apci-ms, underivatized 
Ffas are most effectively analyzed in negative ion mode45,46, whereas Cers and Chol are 
best separated on a normal phase column and result in abundant protonated species in 
the positive ion mode47,48. Therefore, we use two injections of 10 µl to analyze all Sc lipids: 
one injection for the separation of Ffas on a RpLc column (Purospher Star LiChroCART, 
Merck) and another injection for the analysis of both Cers and Chol by separation on a 
NPLc column (PVA-Sil, YMC, Kyoto, Japan). A switching valve (Rheodyne MXP9900-000, 
IDEX Corporation, Rohnert Park, CA) was used to change the flow to either the NPLc- or 
RpLc-column. Another switching valve directed the flow to either the Apci-ms or to the 
waste to prevent ionization effects caused by excessive contamination originating from 
e.g. tape strips. A schematic illustration of the setup is shown in Supplementary Figure 2.
 Regarding the Ffa analysis, the vaporizer and capillary temperature were set to 450 
and 250°C, respectively. Ionization was performed in negative ion mode, scanning 
from 200-600 amu using a nitrogen flow of 3 and 0.8 L/min for auxiliary and sheath 
gas, respectively. The discharge current was set at 6 µa while the capillary voltage was 
maintained at 2kV. The peak width at nominal resolution, determined by full width at 
half maximum, was set to 0.7 amu. Chromatographic separation of all Ffas (C14-C36) was 
achieved within 7 minutes at a flow rate of 0.5 mL/min using a binary gradient from ACN/
H2O (90:10) to MeOH/heptane (90:10). 1% CHCl3 and 0.1% HAc were added to both mobile 
phases to greatly enhance the ionization efficiency and boost the formation of the [M+Cl]- 
adduct, which appeared to be the main ion present for all Ffa(-related) compounds (see 
‘Ffa method development’ in results and discussion section). For the analysis of Cers 
and Chol, the method published previously was used with some small adaptations to the 
gradient, sheath gas flow rate, and scan range (360-1200 amu), to permit analysis of Chol. 
The full method development and explanation of Cer analysis is described elsewhere39. A 
summary of all Lc and ms parameters is presented in Supplementary Table I. 
Data processing
 Automated peak detection and area integration was performed using Quan Browser 
software version 2.0.7 (Thermo Fisher Scientific, Bremen, Germany), but all data were 
manually inspected and corrected when necessary. Peak areas were corrected for their 
appropriate internal standard (ISTD).
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Method validation.
 An in-house protocol was used to determine the linear dynamic range, limit of detection 
and quantification (LOD and LOQ), and inter-day and inter-batch reproducibility. The 
linear dynamic range of each analyte was determined from calibration curves prepared as 
an academic sample as well as in human Sc matrix. Standards were prepared in duplicate 
and injected in triplicate. Linear regression on the calibration curves was performed (on 
data points >LOQ), except for Chol, where a non-linear fit was more appropriate since 
ion suppression played a significant role at higher concentration ranges. LODs and LOQs 
of each Ffa ([M+Cl]-) were determined by the signal to noise ratio (S/N) of 3 and 10, 
respectively. Matrix effects (e.g. ion suppression) were studied by calibration curves of 
deuterated internal standards (Ffa 18:0-D35 and 24:0-D47) which were prepared with and 
without spiked lipids from pooled (n=6) human ex vivo Sc. Regarding the Ffas, 8 different 
Ffas in 7 different concentrations ranging between 0.01 µM up to 900 µM (corresponding 
to levels of 0.1 pmol to 9 nmol) per Ffa were assessed. For Chol, deuterated and non-
deuterated Chol in 12 different concentrations ranging between 25 pmol and 25 nmol 
were analyzed. Regarding the Cers, adaptations to the original method did only influence 
the retention time, not the LOD/LOQ values. As a consequence, the latter is adapted from 
the previously reported values and listed in Supplementary Table II39. Regarding the 
reproducibility, both the inter-day variation and inter-batch variation were examined. 
The former was calculated from a triplicate measurement over 3 different days (intra-




 No Lc/ms method is available for Ffa analysis of Sc, but several reports exist for Ffa 
analysis from other lipid sources. However, Lc puts some limitations on the choice of the 
mobile phase49,50. Apci may in our case be appreciated over other ionization techniques 
as we also use Apci in our setup to detect Cers and Chol, and it is desirable to use a single 
setup for the detection of all Sc lipid classes at once. Besides, it shows less dependency 
on ion suppression51-56. For the reasons mentioned above – and the expectation of the 
presence of very long carbon chains (>30 carbon atoms) in Sc Ffas – we used the analytical 
method of Nagy et al. as a starting point, since that method focused on analyzing long 
chain Ffas from dried blood spots and plant oils45. We modified and optimized the 
method, as it was not able to detect and separate most Sc Ffas. The first challenge was 
to enhance ionization efficiency, because signal to noise ratios were too low for real-life 
63
applications. Post-column addition of CHCl3/MeOH (2:1, 20µl/min) resulted in a drastic 
increase in signal intensity of around 2900% (see Supplementary Figure 3) for every Ffa 
with mass [M+35]-. This chloride adduct, being reported in various applications based 
on Lc/ms analysis57-59, originated from the CHCl3 which was subsequently added to the 
mobile phase (1% v/v proved optimal). Also a small amount of acetic acid (0.1% v/v) was 
added to assure that all Ffas are fully non-dissociated60, allowing proper chromatography 
and chloride adduct formation ([M+Cl]-). This favored the ionization towards a consistent 
chloride adduct which accounted for >99% of the total signal for all observed Ffas (see 
Supplementary Table III).
 A second challenge was to increase the separation between different Ffas. The initial 
method separated Ffas based on their chain length. However, Ffas differing in degree of 
unsaturation (e.g. 18:0 vs. 18:1 vs. 18:2) were not separated. Seperation by retention time 
was necessary since the chloride isotope peaks [M+37Cl]- of C18:1 and C18:2 overlapped 
with the base peaks [M+35Cl]- of C18:0 and C18:1, respectively. Replacing MeOH/H2O by 
MeOH/ACN resulted in an additional separation between different degrees of unsaturation, 
as is illustrated in Figure 1. For example, the resolution between C18:0 and C18:1 – as 
defined by R = 2(tR18:0 – tR18:1) ⁄ (wC18:0 + wC18:1) – increased from 0.12 to 1.36. However, 




















































































































































315.2 amu 315.2 amu
317.2 amu 317.2 amu
319.2 amu 319.2 amu
**
*
Time (min) m/z (amu)
Figure 1: a) lc/ms chromatogram 
of a mixture of synthetic ffas 
c18:0, c18:1, and c18:2 using 
either meoh/h20 (left) or meoh/
acn (right) as the mobile phase. 
Numbers correspond to the mass 
and retention time of that ion. * and 
** indicate the chloride isotope peak 
that corresponds to an ffa with one 
degree of unsaturation more, shown 
in the mass spectra of b). These peaks 
that are overlapping in mass (due to 
the chloride isotope) and significantly 
interfere (>5%) with the results (if 
not separated by their retention 
time) are shown in red, while non-
interfering peaks are shown in black.
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since 100% ACN was immiscible with heptane, phase separation occurred and no proper 
analysis could be performed. Therefore a gradient of ACN/H2O (90:10) to MeOH/heptane 
(90:10) was used that proved to be optimal and resulted in the proper separation of all 
Ffas. 
 After optimization, the method was validated. All quantitative parameters will be 
discussed below, primarily focusing on Ffas. Individual chromatograms of saturated 
and unsaturated Ffas detected in human Sc are provided in Figure 2. All Ffas that are 
predominantly present in human skin (Ffa C24-C28) appear as clear, well separated 
peaks. However, early eluting Ffas which are less abundant in human Sc (C14:0-C17:0, 
C19:0, C16:1-C18:2) show less defined peak shapes. This could be improved by increasing 








































































































































































Figure 2: Chromatograms of [m+cl]- ions of ffas observed in human sc (range c14:0-c36:1). Left two columns show 
ffas with short to medium chain length that elute at an early stage from the column (<3 minutes), while the right two 
columns show medium and long chain length ffas. Values above the respective ffa peaks correspond to the retention 
time. * indicates the 37cl isotope peak that correspond to an ffa with one degree of unsaturation more than the peak of 
interest. # indicate peaks which belong to either cers or are unknown.
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primary aim to enable high-throughput screening for Ffas. Besides, we focused on the 
most abundant Ffas, in which we did not encounter these problems.
Ffa method validation.
 Validation measurements were performed according to an in-house developed protocol, 
and the chromatographic robustness, linearity, sensitivity (LOD/LOQ), reproducibility 
and matrix effects were determined and described in more detail below (Table I).
 Chromatographic robustness. The variation of the retention time of each analyte was 
investigated. In general, the average RSD of the retention time was 4.7%, but differed 
among the various Ffas. Ffas with less than 20 carbon atoms showed more variation 
(RSD=~7-8%), while later eluting Ffas, having more than 20 carbon atoms (which are most 
abundant in human Sc), showed a more robust retention time (RSD= ~2%). All analytes 
showed acceptable capacity factors (k’>1.5) ranging between 1.7-10.0 for the earliest and 
latest eluting synthetic Ffa (C18:2 / C28:0), respectively. Additional information on the 
robustness was obtained by transferring the method to a different HPLc system (Alliance 
2695, Waters): No significant changes in any of the parameters was observed.
 Sensitivity and linear dynamic range. LOD/LOQ values of each synthetic reference 
compound were determined using both academic solutions (CHCl3/MeOH/heptane, 
95:2½:2½) and ex vivo Sc matrix solution (academic solution plus 1 mg/ml isolated Sc). 
The linearity (R2) of all analytes ranged from 0.990–0.999 over the range of 0.1-9000 
pmol (7 data points, Table I and Supplementary Figure 4). Regarding the LOD and LOQ, a 
log-linear relationship was observed between the chain length (i.e. mass) of the Ffa and 
the response factor (Figure 3). To cross-validate this relationship, we used synthetic Ffas 
FFA 















C18:0 319.3 1.62 ± 0.11 3.8 100 335 1.5 - 16.3 4.2 - 7.6 0.992 
C18:1 317.3 1.27 ± 0.11 2.8 73 242 5.8 - 15.0 2.8 - 8.0 0.990 
C18:2 315.2 0.91 ± 0.07 1.7 60 201 6.6 - 14.5 3.5 - 9.6 0.991 
C22:0 375.3 2.28 ± 0.06 5.8 21 68 3.2 - 10.0 2.3 - 7.8 0.991 
C24:0 403.4 2.70 ± 0.06 7.0 12 41 3.3 - 7.6 2.6 - 3.3 0.997 
C28:0 459.4 3.71 ± 0.07 10.0 7 23 2.1 - 4.1 1.6 - 4.0 0.996 
C18:0D35 354.4 1.38 ± 0.07  3.1 51 169 ND ND 0.997 
C24:0D47 450.6 2.57 ± 0.06 6.6 17 58 ND ND 0.999 
CERs 









E(18:2)O(30)S(18)  995.0 5.0 12.2 9 29 
E(18:2)O(30)P(18)  1031.0  5.7 13.9 1 5 
N(24)S(18) 632.6 5.2 12.7 13 45 
N(24)dS(18) 652.7 4.9 11.9 6 21 
N(24)P(18) 668.7 5.9 14.5 18 60 
A(24)S(18) 648.6 6.4 15.7 28 94 
A(24)P(18) 684.7 7.5 18.6 19 64 
CHOL       
CHOL  369.4 1.87 ± 0.06  3.9 280 940 
CHOL - D7  376.4 1.93 ± 0.05  4.1 150 490 
 
The capacity factor (k’) was calculated using Tinjection peak = 0.34 minutes *: rsd% presented here are those measured over 
the full range of concentrations. Nd means not determined. **: calculated from all combined data points of 3 days, 3 
batches.
Table I: Validation results of synthetic ffas, measured in full scan mode. Capacity factors (k’), linearity (r2), sensitivity 
(lod/loq), precision (rsds) and inter batch and inter day variations are shown.
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(16:0, 16:1, 20:0, 22:1, 24:1) and calculated their response factors. The values fit very well 
in between the other data points. Thus, Ffas with a higher chain length showed lower LOD 
and LOQ values. Both higher noise and lower response levels at lower mass ranges as well 
as short retention times contribute to this change in LOD/LOQ phenomenon. LOD and 
LOQ values were determined by S/N 3 and 10, respectively for the individual ion traces 
[M+Cl]- for each lipid by using full scan ms acquisition. LODs ranges from 100 to 7 nM 
(1 to 0.07 pmol) for C18:0 to C28:0, respectively. LOQ values of C18:0 to C28:0 ranges 
from 335 to 23 nM (3.4 to 0.23 pmol). These LODs and LOQs are suitable for the analysis 
of all common Sc samples (e.g. ex vivo Sc, tape stripped Sc, etcetera) and this makes the 
method very competitive with time-consuming GC or GC/ms procedures.
 Reproducibility. The reproducibility was examined by determining inter-day and inter-
batch variability for all synthetic analytes (Table I). Batch to batch variation among the 
various Ffas and their concentrations was on average 4.5%, ranging between 1.6 and 9.6%. 
The inter-day variability varied depending on the Ffa chain length and the concentration 
used. An average variability of 7.7% was achieved, but higher mass Ffas and high 
concentrations generally reduced the variability to 4% or lower. For instance, the inter-day 
variability of C24:0 was ~3% at a concentrations ≥3 nmol. In contrast, Ffa 18:0 showed an 
inter-day RSD of 1.5% at a concentration of 900 µM, but this value was increased to 16.3% 
at concentrations just above the LOQ. The variation in chromatographic robustness is a 
second reason for the increase in RSD: lower mass Ffas show more variation in elution 
time, thereby affecting the peak area to some extent.
 Matrix effects. By comparing calibration curves between an academic solution and a 
Sc matrix solution, we observed only very small differences for our internal standards: 



















Figure 3: Dot plot showing the relation 
between the chain length of ffas and the 
response factor (10log scale), defined as 
the auc/concentration. Blue and red dots 
represent saturated and unsaturated ffa s, 
respectively. Closed dots correspond to the 
values calculated from the validation protocol 
(c18:0, c18:1, c18:2, c22:0, c24:0 and 
c28:0), while open dots represent samples 
that were analyzed on a different day to cross-
validate the protocol (c16:0, c16:1, c20:0, 
c22:1 and c24:1). The exponential fit of this 
curve showed r2=0.984.
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Compound  Tape  HSE  Porcine  
FFAs   
Saturated      
C14:0 × × × × 
C16:0 × ×* × × 
C16:1 × ×* × × 
C18:0 × ×* × × 
C18:1 × ×* × × 
C18:2 × × × × 
C20:0 × × × × 
C21:0 × × -  × 
C22:0 × × × × 
C23:0 × × -  × 
C24:0 × × × × 
C25:0 × × × × 
C26:0 × × × × 
C27:0 × × -  × 
C28:0 × × × × 
C29:0 × × -  × 
C30:0 × × × × 
C31:0 × × -  × 
C32:0 × × -  × 
C33:0 × -  -  -  
C34:0 × -  -  -  
Unsaturated      
C16:1 × × × × 
C18:1 × × × × 
C18:2 × × × × 
C18:3 -  -  -  × 
C20:1 -  -  × × 
C22:1 -  -  × × 
C24:1 -  -  × × 
C26:1 -  -  × × 
C28:1 -  -  × × 
C30:1 × × × × 
C32:1 × × × × 
C34:1 × × × × 
C36:1 × -  × × 
C38:1 -  -  × × 
Hydroxy      
C22:0-OH × × -  -  
C23:0-OH × × -  -  
C24:0-OH × × × × 
C25:0-OH × × -  -  
C26:0-OH × × × × 
C27:0-OH × × -  -  
C28:0-OH × × -  -  
CERs   
[EOS]  64 - 76 65 - 76 66 - 76 60 - 74
[EOP]  63 - 76 64 - 76 64 - 76 64 - 70
[EOH]  63 - 72 64 - 72 66 - 72 -
[EOdS]  66 - 78 66 - 78 66 - 78 62 - 72
[NS]  34 - 56 34 - 54 34 - 54 32 - 52
[NP]  34 - 54 34 - 54 34 - 54 33 - 52
[NH]  34 - 52 34 - 52 32 - 48 -
[NdS]  34 - 58 34 - 56 34 - 56 33 - 52
[AS]  34 - 52 33 - 52 32 - 50 31 - 52
[AP]  34 - 51 34 - 52 34 - 50 36 - 52
[AH]  32 - 51 34 - 50 32 - 48 -
[AdS]  34 - 52 33 - 52 34 - 50 32 - 46
CHOL   
CHOL × × ××
Human
SC
× = Detected. - = Not detected. * = Present in blank tape strips. Numbers in the cer section correspond to the range in 
carbon chain length (i.e. total number of carbon atoms from the sphingosine chain and fatty acid chain).
Table II: Lipids present in ex vivo human sc, human sc harvested by tape stripping, hses and porcine skin.
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compared to academic solutions, matrix samples showed 99.6% and 100.7% response 
for the C18:0-D35 and C24:0-D47 internal standards. As we observed a higher variation 
between inter-batch samples, we neglect this relatively small error.
Detection of ffas in human sc samples.
 Human ex vivo Sc shows roughly 30 known Ffas, both saturated (odd and even chain 
lengths ranging from C14:0-C34:0) and unsaturated (even chain lengths ranging from 
C16:1-C18:1, C30:1-C36:1, C18:2). Overall, C24:0 and C26:0 are the most abundantly 
present Ffas in human Sc, accounting for >50% to the total Ffa content, whereas the 
presence of unsaturated Ffas was low (Figure 4a-c). Ffas with even chain length account 
for ~80% to the total Ffa level present in human skin. The results are in excellent 
agreement to the results obtained by GC analysis published by Ponec et al. and Norlen et 
al.32,61 As a result of the increased sensitivity of the newly developed method (largely due 
to the use of CHCl3 as an ionization enhancer), the carbon chain length range in which 
we were able to observe Ffas is similar or even broader than reported so far32,61-65, as 
chain lengths over 32 carbon atoms could be detected (Figure 5a and Table II). Also the 
total analysis time is noticeably reduced from >50 minutes using the GC/ms method to 8 
minutes for the new Lc/ms method. Besides the unsaturated and saturated Ffas observed 
in human Sc, we were also interested in hydroxy-Ffas that are rarely taken into account 
































































Figure 4: Barplots (mean±sd, n=13) of the relative abundances of a) human sc ffas and b) all 12 cer subclasses. 
With respect to the ffas, predominantly saturated ffas are present (black bars). However, monounsaturated ffas (gray 
bars) and diunsaturated ffas (white bars) are observed as well – for ffa c18 primarily – as is shown from the inset.
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but have shown to be present in human Sc62. Identification by Lc/ms did not reveal 
any informative ions and could therefore not be used to obtain structural information. 
Therefore, synthetic C22:0-OH was analyzed and showed a retention time (2.0 min), m/z 
(391.3 amu), and chloride-adduct pattern which is similar to one of the unknown peaks in 
human Sc (Figure 5a, labeled ‘+’). These three parameters indicate that this unknown peak 
is indeed C22:0-OH. In fact, more unidentified peaks (noted by *) are observed in human 
Sc. It is highly probable that these are hydroxy-Ffas as they differ exactly 14 amu in mass 
(one CH2 group) from each other, elute at retention times similar to the extrapolated 
synthetic C22:0-OH Ffa, and show a chloride-adduct pattern (Supplementary Figure 5). 
As is the case for saturated Ffas, even chain length OH-Ffas are much more abundant 
than odd chain length OH-Ffas, C24:0-OH and C26:0-OH being the most prominent ions 
observed.
CeR and cHoL analysis and its detection in human sc samples
 Small adaptations to the previously reported method for Cer analysis (provided in 
Supplementary Table I) enabled the analysis of Chol, eluting as a very intense peak prior 
to all Cer subclasses at 1.9 min (Figure 5b and Supplementary Table II) at m/z of 369 amu, 
corresponding to the [M+H-H2O]+ ion. The LOD for Chol and deuterated Chol was 280 







































































Figure 5: 3d multi-mass chromatograms of a) rplc-ms on human sc ffas. Saturated and unsaturated ffas are marked 
in blue and yellow respectively. Ions shown in red and labeled */+ are unknown ffas hypothesized as hydroxy-ffas. 
These lipids ranged from 22 carbon atoms (labeled +) to 28 carbon atoms (see Supplementary Figure 5). Other lipid 
(related) peaks are shown in grey. b) Nplc-ms on human sc chol and cers. All 12 cer subclasses present in human sc 
are detected, all with variation in chain length. red lines and gray dotted lines indicate the chain length distribution for 
identified and unidentified cer subclasses, respectively.
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and 150 nM (2.8 pmol and 1.5 pmol, injected on column), respectively. A linear dynamic 
range was achieved below 300 µM (3 nmol, injected on column), but above this amount 
the linear dynamic range was lost (Supplementary Figure 4) due to limited ionization 
capability. This resulted in a reduction of effective voltage for the corona discharge and 
hence a lower electric field strength. We note that this dynamic range of Chol is reduced 
after analysis of large series (>150 human Sc samples of 1 mg/mL): the upper limit will be 
restricted due to limited ionization efficiency as a result of carbonaceous deposit on the 
tip of the discharge needle limiting the electric field strength. When continuing analysis 
on an unclean Apci needle, sensitivity is lost for subsequently Chol, Ffas, and finally 
Cers. As this effect starts off with a reduction in dynamic range of Chol, it can be used as 
a marker for corona discharge needle condition (i.e. system performance).
 Regarding Cers, separation and sensitivity was similar as published previously39. 
In fact, extending the mass range below 600 amu revealed additional Cer species (see 
Applications section). The Cer profile depicted in Figure 4b closely resembles that of 
the earlier quantitative publication by Masukawa et al.66, in which various synthesized 
internal standards were used to correct every Cer subclass for their relative ionization 
efficiency. The Lc/Apci-ms method described in this manuscript makes use of 2 internal 
standards which are commercially available. Nevertheless, the results of both methods 
are very similar, indicating that our Apci-ms method is not biased towards certain cer 
subclasses, and by the addition of 2 internal standards, one can correct successfully for 
differences in e.g. ionization efficiencies between high mass and low mass Cers.
Applications on the combined Lc/Ms method for analysis of ffas, ceRs and cHoL
 Besides the already discussed human ex vivo Sc lipid profile, the applicability of the 
developed Lc/ms method is illustrated by applying this method to obtain a lipid profile 
from three different biological samples, e.g. 1) tape stripped human Sc, 2) HSEs and 3) 
porcine skin. The 3D multi-mass chromatograms and identified Sc lipids in the respective 
samples are shown in Figure 6 and Table II respectively. The main advantage of plotting 
3D multi-mass chromatograms is that it is easy to show full lipid profiles in a single 
picture, thereby comparing various samples on a relative scale. A disadvantage is that 
no conclusion can be drawn on an absolute quantitative level. For the purpose of this 
study, a relative comparison of lipid profiles by these 3D plots is sufficient, and Figure 
6 illustrates the applicability of the developed method. Pictures are for comparison 
purposes normalized towards the most prominent endogenic Ffa or Cer peak (marked in 
purple). Key differences will be discussed below.
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Figure 6: representative, normalized 3d multi-mass chromatograms for both ffa analysis (left) and cer analysis 
(right) of a) Tape stripped sc; b) Hse sc; c) Porcine sc. Chromatograms are normalized to the peak marked in purple 
(the most abundant endogenic ffa or cer in their respective plots). Saturated, unsaturated and hydroxy-ffas are 
marked in blue, yellow and red, respectively. Unidentified peaks or peaks belonging the cer lipid class are shown in gray. 
Ions shown in green and labeled ‘+’ are unknown ffas specific for the skin substitutes. * indicate contamination from 
tape strips. Internal standards are labeled ‘is’. # and × note the increased abundance of the very short cers in hse and 
porcine skin, respectively.
compared to ex vivo Sc: It takes between 20-50 Nichiban PPS tape strips to fully remove 
the Sc, thus 1 tape strip removes about 2-5% of the total Sc amount (unpublished data, 
J. van Smeden 2010). Nevertheless, almost all Ffas and Cers are still detectable (Figure 
6a and Table II) and show comparable lipid profiles: The Cer profile closely resembles 
the ex vivo Sc pattern, and all 12 subclasses and chain lengths are observed. Also the Ffa 
profile shows great similarities to the ex vivo Sc lipid profile, except for short chain Ffas 
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C16 and C18. The increased abundance of these particular Ffas by using tape stripping 
as sampling method, was caused by the presence of high levels of these Ffas in the tape 
itself (marked as *), as was confirmed by analysis of blank tape strips (not shown). This 
‘contamination’ of lipids from tape is a very common problem, and of all investigated 
tapes, this Nichiban PPS tape showed the least amount of lipid content.
 HSEs: There are many similarities between ex vivo Sc (Figure 5 and Table II) and the 
HSEs (Figure 6b and Table II): All 12 Cer classes are present and saturated, unsaturated 
and hydroxy-Ffas are observed. However, there are also some major differences: First of 
all, the Ffa lipid profile (left picture Figure 6b) of HSEs shows the increased appearance 
of unsaturated Ffas, covering a broader range than present in human Sc, ranging from 
C16:1 up to C38:1. Second, very few hydroxy-Ffas are observed (labeled in red). Third, the 
Ffa chain length distribution is shifted to shorter chain length, as Ffas longer than C30:0 
are reduced and short chain Ffas (C16:0, C16:1, C18:0 and C18:1) are increased. Fourth, 
there are multiple additional (unknown) lipids observed, of which the ones marked by 
a ‘+’ are noteworthy to mention: These have a mass of 2 amu less than the slightly later 
eluting OH-Ffas. As there is an increase in monounsaturated Ffas (MUFAs) compared to ex 
vivo Sc, it may be that these lipids are MUFA OH-Ffas. Indeed, the shorter retention times 
as well as the masses of these lipids may suggest the presence of MUFA OH-Ffas, although 
more studies are necessary to confirm this. At last, the 3D multi-mass chromatogram 
indicates a reduced presence of odd chain Ffas compared to ex vivo Sc. 
 With respect to the Cer profile (right picture in Figure 6b), additional unidentified 
subclasses are observed which are marked by ‘+’. There is a relative increase in the presence 
of hydrophilic lipids, in particular Cer [AH] and some unidentified compounds that elute 
near Cer [AH]. In addition, low mass Cers (marked by #) are increased which is in line 
with the Ffa profile: as previously stated, a higher abundance of shorter chain length 
Ffas are observed in HSEs compared to ex vivo Sc. Finally, Cer [NP] and [NS] are largely 
reduced, which is in line with previous HPTLc research. The nature and possible biological 
causes for these differences are discussed in detail elsewhere by Thakoersing et al.67, but 
it was concluded that biological pathways in which Ffa elongation and desaturation are 
involved, may likely be altered.
 Porcine skin: Regarding Ffas, almost no hydroxy-Ffas or odd chain length Ffas are 
observed (Figure 6c and Table II). For the Cer profile, non-polar Cers (i.e. Cer [NdS] 
and [NS]) are relatively much more abundant than the most hydrophilic Cer subclasses 
compared to human Sc. Some of these hydrophilic Cers are strongly reduced (i.e. Cer [AP] 
and [EOP]) and some subclasses are fully absent (CER [AH], [NH] and [EOH]), which is in 
agreement to literature68-70. This is in contrast to the HSE profile, which shows increased 
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abundance of polar Cers. In addition, there is a shift to a shorter Cer chain length, which 
can be observed from the drastic increase in Cers with a shorter chain length (mass <600 
amu), in particular 3 extraordinary high peaks (marked by ×): Cer [AdS] C34 and both Cer 
[AS] C33 and C34.
 In summary, our results show that tape stripping is an appropriate method to be used 
for Lc/ms analysis of in vivo Sc lipids, and the obtained lipid profile closely resembles the 
lipid profile from full-thickness ex vivo Sc. The skin substitutes show drastic changes in the 
Ffa composition, which also affected the Cer composition. HSEs show a lipid profile which 
is more comparable to human skin than porcine skin, in particular for the Cer profile. This 
could be relevant for near-future studies, as animal testing for cosmetic purposes is banned 
throughout the European Union by 2013 and proper skin substitutes are necessary71. 
Although the HSEs do not fully mimic the lipid composition in human Sc, changes in culture 
conditions may improve the lipid composition, as recently reported by Thakoersing et al.41
Conclusions
 An Lc/ms method was developed that is able to detect and quantify Chol, Cers and 
Ffas using a single setup with two injections. This method is fast, allowing for high 
throughput analysis, and requires no derivatization steps. It is sensitive enough to 
analyze small sample amounts (i.e. tape stripping), but also permits analysis of samples 
with much higher sample concentration (e.g. ex vivo Sc) due to its high linear dynamic 
range. Regarding the analysis of Ffas, this is – to the best of our knowledge – the first 
time that Lc/ms enables the analysis of underivatized Ffas from Sc. The addition of 
chloroform as an ionization agent resulted in the formation of [M+Cl]- adducts which 
enabled analysis of saturated, unsaturated and hydroxy Ffas in Sc with a wide chain length 
range (14-38 carbon atoms). The method proved to be robust, as can be deduced from the 
validation parameters. The method was successfully applied on human ex vivo Sc, human 
Sc obtained from tape stripping, and Sc obtained from 2 human skin substitutes. In these 
skin substitutes, all 3 lipid classes are present, but its lipid profile differs substantially 
from that in human Sc when analyzed in detail by Lc/ms. In addition to the identified 
Ffas and Cers which were profiled for the different Sc sources, many unknown lipids 
were observed as well. Upcoming studies will surely focus on the identification of these 
compounds. This Lc/ms method can be used to obtain lipid profiles of numerous different 
Sc samples. In particular lipidomics on skin diseases is currently of high interest, and 
future studies will exploit the detailed Sc lipid analysis by Lc/ms presented here.
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Supplementary Materials and Methods
Chemicals
 HPLC grade (or higher) methanol (MeOH), n-heptane, isopropanol (IPA), acetonitrile 
(ACN), ethanol (EtOH) and acetic acid (HAc) were purchased from Biosolve (Valkenswaard, 
The Netherlands). HPLC grade chloroform (CHCl3) was attained from Lab-Scan (Dublin, 
Ireland). Ultra purified water was prepared using a Purelab Ultra purification system 
(Elga Labwater, High Wycombe, UK). Potassium chloride was obtained from Merck 
(Darmstadt, Germany). 2-Hydroxydocosanoic (C22:0-OH) and deuterated CHOL-D7 
and were obtained from Larodan AB (Malmö, Sweden). Trypsin and trypsin inhibitor 
as well as CHOL, hexadecanoic (C16:0), 9-hexadecenoic (C16:1), octadecanoic (C18:0), 
9-octadecenoic (C18:1), 9,12-octadecadienoic (C18:2), eicosanoic (20:0), docosanoic 
(C22:0), 13-docosenoic (C22:1), tetracosanoic (C24:0), 15-tetracosenoic (C24:1) and 
octacosanoic (C28:0) acids were obtained from Sigma-Aldrich GmbH (Steinheim, 
Germany). Deuterated octadecanoic (C18:0-D35) and deuterated tetracosanoic 
(C24:0-D47) acids were purchased from Cambridge Isotope Laboratories (Andover, MA, 
USA). Synthetic CER [N(24)dS(18)] was purchased from Avanti Polar Lipids (Alabaster, 
AL). All other synthetic CERs were kindly provided by Evonik (Essen, Germany): CER [EOS] 
(E(18:2)O(30)S(18)), CER [NS] (N(24)S(18)), CER [NP] (N(24)P(18)), CER [AS] (A(24)S(18)), 
CER[AP] (A(24)P(18)), CER [EOP] (E(18:2)O(30)P(18)), deuterated CER [E(18:2)O(30)
S(18)]-D31 and deuterated CER [N(24)S(18)]-D47. 
Sc sample collection 
 Synthetic lipids as well as SC lipids from human ex vivo surgical skin were used to develop 
and validate the LC/MS method. To study the applicability of the developed method, 3 
different sources were analyzed and compared to human ex vivo SC. The collection and 
processing of skin samples is in accordance to the Declaration of Helsinki. SC of healthy 
human volunteers was obtained by tape stripping using poly(phenylene sulfide) tape 
strips (Nichiban, Tokyo, Japan)1: 9 Tapes were successively applied on a single area (4½ 
cm2) of the ventral forearm, and afterwards peeled off with tweezers. Tape strips 1 to 5 
were discarded to avoid contamination of superficial substances (e.g. sebum). Tapes 6 to 
9 were punched to an area of 2 cm2 and put separately in a glass vial containing 1 ml of 
lipid extraction solution chloroform/methanol/water (CHCl3/MeOH/H2O, 1:2:½, v/v); In 
addition to the tape-strip samples, 3 other epidermal skin sources were harvested: HSEs, 
human ex vivo skin and porcine skin. HSEs were cultured as described previously2. Freshly 
excised ex vivo skin was obtained from surgeries performed at local hospitals and porcine 
skin was obtained from an accredited abattoir. Both skin samples were dermatomed to 
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obtain an epidermal sheet with 0.6 mm thickness. 
 Successively, SC from all epidermal skin sources was isolated by trypsin digestion 
according to the procedure described in detail elsewhere3. Briefly, the skin was put in a 
Petri dish on Whatman filter soaked in a 0.1% trypsin in PBS solution pH 7.4 (8 g/L NaCl, 
2.86 g/L Na2HPO4, 0.2 g/L KH2PO4, 0.19 g/L KCl) and stored overnight at 4°C. The skin 
was then incubated at 37°C for 1 hour and subsequently the SC layer was peeled off. The 
SC was washed once in 0.1% trypsin inhibitor in PBS solution, twice in demi water and 
stored in a dark, dry argon containing atmosphere to avoid lipid oxidation. To human SC 
samples, an internal standard solution was added containing equimolar concentrations 
of the deuterated lipids (FFA C18-D35, FFA C24-D47, CER [EOS]-D31, CER [NS]-D47).
Lipid extraction
 All sources of SC were then treated similarly according to the following procedure: 
Lipids were extracted according to an extended method of Bligh and Dyer4, described 
by Thakoersing et al.4,5: Basically, a three step liquid-liquid extraction was performed 
using (sequentially) 3 different ratios of CHCl3/MeOH/H2O (1:2:½ ; 1:1:0 ; 2:1:0). The 
combined organic fractions were evaporated under N2 gas at 40°C and reconstituted in 
heptane/CHCl3/MeOH (95:2½:2½) to a final concentration of ~1.0 mg/ml (determined 
by weighing). This single solution was suitable for lipid analysis by both reverse phase 
chromatography (RPLC) regarding FFAs, and normal phase chromatography (NPLC) for 
analysis of CERs and CHOL. When sample storage was necessary, samples were stored 
























































































Supplementary Figure 1: Molecular structure of all cer subclasses and nomenclature according to Motta et al.6 
All cers bear a polar head group and two long carbon chains. Both chains may vary in molecular architecture (at the 
carbon positions marked in red) and each cer subclass is denoted by its sphingoid base (blue) and fatty acid chain (gray) 
resulting in the 12 cer subclasses in human sc. In addition, all cer subclasses show a varying carbon chain lengths 
(marked by red arrows). The number of total carbon atoms in the cers is the number of carbon atoms in the fatty acid 










Supplementary Figure 2: Schematic setup of the lc/ms to analyze all 3 main lipid classes by either nplc (cers and 
chol) or rplc (ffas).
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Supplementary Figure 3: Log-scaled bar plot of the response of various ffas with and without post column addition of 
chloroform (20 µl/min), in dark blue and light blue, respectively. Numbers above the bars indicate the relative increase 
in peak area when chloroform is added, which is on average ~2900%. Peak integration was performed on the main 
peaks, being the [m+cl]- and [m-h]- for analysis with and without chloroform addition, respectively.
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Supplementary Figure 4: Calibration curves of a) Synthetic ffas and b) Chol and deuterated chol (chol-d7). The 
inset shows a magnification from the range where a linear fit could be applied. Depicted r2 values correspond to a linear 
fit, except for the full range chol and chol-d7 curves.
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Supplementary Figure 5: a) 3D multi-mass chromatogram of the unknown lipid species marked in red and labeled 
1-7, corresponding to the hypothesized oh-ffas with a carbon chain length range between 22 and 28 carbon atoms. The 
individual mass spectra of each labeled peak is shown in b), showing the main ion mass [m+cl]- and its 37cl isotope peak 
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 Supplementary Tables






























Flow rate   
Injection volume  
Mobile phase 








Mobile phase ratio 
( : , %)  
0.0 97:3  
0.5 97:3  
1.5 20:80  
3.5 0:100  
6.5 0:100  
9.5 97:3  
13.0 97:3   
Time 
(min) 
Mobile phase ratio 
( : , %)**
0.0 98:2  
2.5 96:4  
2.6 93:7  
6.0 88:12  
11.0 50:50  
12.5 98:2  
19.0 98:2   
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*: the final method is displayed here. An explanation of the choices made from the initial method to this final method is 
reported in the ‘ffa method development’ section. **: adaptations made to the method described previously1.
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CERs/CHOL 








E(18:2)O(30)S(18) 995.0 5.0 12.2 9 29 
E(18:2)O(30)P(18) 1031.0  5.7 13.9 1 5 
N(24)S(18) 632.6 5.2 12.7 13 45 
N(24)dS(18) 652.7 4.9 11.9 6 21 
N(24)P(18) 668.7 5.9 14.5 18 60 
A(24)S(18) 648.6 6.4 15.7 28 94 
A(24)P(18) 684.7 7.5 18.6 19 64 
CHOL 369.4 1.87 ± 0.06  3.9 280 940 
CHOL-D7 376.4 1.93 ± 0.05  4.1 150 490 
FFA
chain length
Relative abundance (%) - No CHCl3 addition Relative abundance (%) - 1% CHCl3 addition
[M-H]- [M+Cl]-  [M+HAc-H]-
C18:0 33 ± 12  52 ± 13  15 ± 1  <1  >99 ± 1  <1  
C20:0 46 ± 12  37 ± 12  17 ± 1 <1  >99 ± 0  <1  
C22:0 56 ± 9  26 ± 11  18 ± 3  <1  >99 ± 0 <1  
C24:0 66 ± 9  18 ± 8  16 ± 1  <1  >99 ± 0 <1  
C26:0 71 ± 9  14 ± 7  15 ± 2  <1  >99 ± 0 <1  
C28:0 75 ± 6  9 ± 3  17 ± 4  <1  >99 ± 0  <1  
[M-H]- [M+Cl]- [M+HAc-H]-
Supplementary Table II: Basic parameters of chol and cer analysis. Lod and loq values 
are adapted from the previous report1.
Values are calculated by the auc of each ion. Addition of chcl3 greatly favors the [m+cl]- adduct formation (≥99%), 
resulting in increased peak intensities (Supplementary Figure III).
Supplementary Table III: relative abundance of the 3 main ions observed (viz. [m-h]-, [m+cl]- and [m+hac-h]- when 
either 0% or 1% chcl3 (v/v) was added to the mobile phase, illustrated for 6 ffas.
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dermatology. 2011. 131:2136-2138.
 The existence of an impaired skin barrier function 
in atopic eczema (AE, also referred to as atopic 
dermatitis) has been demonstrated previously, 
revealing the importance of the skin barrier in the 
pathophysiology of AE1. Loss-of-function mutations 
in the filaggrin gene (FLG) are known to be major risk 
factors for developing AE2. However, recent findings 
report a reduced skin barrier function irrespective 
of filaggrin genotype, suggesting the importance of 
additional factors for an impaired skin barrier in AE1. 
 The skin barrier is primarily provided by the 
stratum corneum (SC), consisting of enucleated cells 
surrounded by lipid regions. SC lipids (primarily 
ceramides (CERs), cholesterol, and free fatty acids) 
form two lamellar phases: the short- and long 
periodicity phase (respectively SPP and LPP) with 
periodicities of ~6 nm and ~13 nm, respectively. 
These periodicities were determined by small angle 
X-ray diffraction (SAXD)3. Barrier properties of the 
skin may also depend on the lipid organization of 
the SC lipids and an altered lipid composition or 
organization may cause a reduced skin barrier in AE. 
Several studies have reported on the CER composition 
in AE patients4,5. In the present study, the CER 
composition and lamellar lipid organization in the 
SC of AE skin have been simultaneously examined. 
For AE patients, we observe drastic changes in lipid 
organization which correlate with changes in CER 
composition, as compared with control subjects.
 The study was conducted in accordance with the 
Declaration of Helsinki Principles and approved 
by the Ethical Committee of the Leiden University 
Medical Center. Subjects gave written informed 
consent. 6 Caucasian ae patients (23.3 ± 5.2 years; 2 
males) and 6 Caucasian subjects without (history of) 
dermatological disorders (24.7 ± 7.6 years; 1 male) 
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were included. The subjects did not apply any dermatological products to their forearms 
for at least one week before the studies. To study the lipid properties irrespective of flg 
mutations, we excluded subjects with any of the four most prevalent mutations found in 
European Caucasians: 2282del4, R501X, S3247X, and R2447X, analyzed by genotyping6.
 The lamellar lipid organization was studied using 4 mm biopsies harvested from the 
ventral forearm of non-lesional skin. The local severity of non-lesional ae skin was 
evaluated by local SCORing Atopic Dermatitis (SCORAD)7, and was 0 for all patients. SC was 
isolated by trypsin digestion8 and analyzed by SAXD using a microfocus beam (European 
Synchrotron Radiation Facility, Grenoble, France) similarly as described elsewhere9. 
The CER composition was examined in SC harvested by tape stripping non-lesional 
regions from the ventral forearm (PPS tape, Nichiban, Tokyo, Japan) close to the region 
of the biopsy. Tape strip numbers 6-9 were extracted, pooled and analyzed by liquid-
chromatography (LC) (Alliance 2695, Waters Milford, MA) coupled to mass spectrometry 





















































Figure 1: Diffraction patterns of a) control subjects, b) ae patients and c) boxplots showing the variance of the main 
peak position in both groups. The inset in the upper right corner of a) schematically represents the lipid organization and 
shows the periodicity of the lpp (d ~ 12.6 nm). 1 And 2 indicate patients with an altered saxd profile (indicated by * 
and **). # Indicates phase separated cholesterol. From the positions of the peaks (q) the repeat distance of the lpp was 
calculated using the equation d = n·2π/qn (n = order of diffraction peak). The main peak is also caused by the 1
st order 
diffraction peak of the spp located at a slightly higher q-value than the 2nd order of the lpp.
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CERs is described previously12. Briefly, CERs contain a fatty acid chain (either an esterified 
ω-hydroxy (EO), α-hydroxy (A), or non-hydroxy (N) fatty acid) linked via an amide to a 
sphingosine chain (either a sphingosine (S), dihydrosphingosine (dS) phytosphingosine 
(P), or 6-hydroxysphingosine (H)), resulting in 12 CER subclasses.
 Figure 1a shows three SC diffraction patterns representative for control subjects. The 
periodicity of the LPP was obtained from the peak positions3. All control subjects show 
three LPP peak positions (1st, 2nd and 3rd order) at scattering vector values (q) 0.50, 1.00 
(main peak) and 1.45 nm-1 respectively, corresponding to a periodicity of 12.6 nm. The 
1st order peak of the SPP also contributes to the main peak, which is located at a slightly 
higher q-value. Figure 1b shows diffraction patterns of AE patients. The top diffraction 
pattern closely resembles those of control subjects and is representative for 4 patients. 
However, two patients (marked 1 and 2) show a different pattern: the central curve shows 
a shift in the main diffraction peak to a q-value of 1.06 nm-1 (labeled *). The lower curve 
shows only a single reflection at q = 1.20 nm-1 (labeled **). Increased q-values of the peak 
positions signify shorter periodicities of the lamellar phases in the SC of those patients. 
The boxplots (Figure 1c) show a small variance between the 6 control subjects, but a large 
variance within the group of patients.

































































Figure 2: Lc/ms analysis on human stratum corneum ceramides obtained from tape strips taken from the ventral forearm. 
To permit semi-quantitative analysis, two deuterated ceramides (cer [e(18:2)o(30)s(18)] and cer [n(24)s(18)]) were 
used as internal standards. a) Bar graph of the relative ceramide abundance (in percentages) of every ceramide subclass 
of control subjects (black bars) and ae patients (grey bars) (mean ± sd, n=12). An unpaired student’s t-test showed a 
significant difference in cer [np] content between control and ae subjects (p<0.005). b) Boxplot of the relative ceramide 
abundance (in percentages) of the ceramide [eo] subclasses, as well showing the individual data points (n=12). White 
and grey boxes represent respectively control subjects and ae patients. Anova showed a significant difference in the total 
cer [eo] content ([eods] + [eos] + [eop] + [eoh]): p<0.05). Individual ae patients marked as 1 and 2 correspond to 
the same patients labeled in Figure 1. 
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 Figure 2a shows the CER composition analyzed by LC/MS. All 12 CER subclasses were 
observed, including the newly identified CER [EOdS]11. The observed CER profile is very similar 
to that observed in previous studies using a fully quantitative method4,13. AE skin showed 
a significant decrease in the abundance of CER [NP] content (P<0.005, student’s t-test) and 
in the content of long chain CERs (i.e. subclass [EO], Figure 2b, p<0.05, two-way ANOVA), 
which is in accordance to recent findings4. The highest reduction in abundance of CER 
[EO]-subclasses was observed in patients showing an altered X-ray diffraction pattern: 1 
and in particular 2 (Figures 1 and 2). Previous studies have shown that the LPP may be 
important for the skin barrier function14: isolated human CERs with a decreased CER [EO] 
level showed a strong reduction in formation of the LPP15. This variation in structure 
results in a more dominant influence of the 1st order SAXD peak of the SPP on the main 
SAXD peak, which explains the shift in peak position in the diffraction patterns of the two 
AE patients.
 To our knowledge, our studies demonstrate for the first time that a change in CER 
composition can be associated with a change in the lamellar lipid organization in AE patients 
compared with control subjects. This association may lead to a better understanding of 
the altered SC lipid barrier in AE.
Acknowledgements
 This research is supported by the Dutch Technology Foundation STW, which is part of 
the Netherlands Organisation for Scientific Research (NWO), and which is partly funded 
by the Ministry of Economic Affairs.
chapter 5part i i i
90
References
1 Jakasa I, Koster ES, Calkoen F et al. Skin barrier function 
in healthy subjects and patients with atopic dermatitis in 
relation to filaggrin loss-of-function mutations. 
 J Invest Dermatol 2011; 131: 540-2.
2 Palmer CN, Irvine AD, Terron-Kwiatkowski A et al. 
Common loss-of-function variants of the epidermal barrier 
protein filaggrin are a major predisposing factor for atopic 
dermatitis. Nature Genetics 2006; 38: 441-6.
3 Bouwstra JA, Gooris GS, van der Spek JA et al. Structural 
investigations of human stratum corneum by small-angle 
X-ray scattering. The Journal of investigative dermatology 
1991; 97: 1005-12.
4 Ishikawa J, Narita H, Kondo N et al. Changes in the ceramide 
profile of atopic dermatitis patients. 
 J Invest Dermatol 2010; 130: 2511-4.
5 Jungersted JM, Scheer H, Mempel M et al. Stratum corneum 
lipids, skin barrier function and filaggrin mutations in 
patients with atopic eczema. Allergy 2010; 65: 911-8.
6 Sandilands A, Terron-Kwiatkowski A, Hull PR et al. 
Comprehensive analysis of the gene encoding filaggrin 
uncovers prevalent and rare mutations in ichthyosis vulgaris 
and atopic eczema. Nature Genetics 2007; 39: 650-4.
7 Stalder JF, Taieb A. Severity scoring of atopic dermatitis: the 
scorad index. Consensus Report of the European Task Force 
on Atopic Dermatitis. Dermatology 1993; 186: 23-31.
8 Tanojo H, Bouwstra JA, Junginger HE et al. In vitro human 
skin barrier modulation by fatty acids: Skin permeation and 
thermal analysis studies. 
 Pharmaceutical Research 1997; 14: 42-9.
9 Bras W, Dolbnya IP, Detollenaere D et al. Recent experiments 
on a combined small-angle/wide-angle X-ray scattering beam 
line at the ESRF. Journal of Applied Crystallography 2003; 36: 
791-4.
10 Thakoersing VS, Ponec M, Bouwstra JA. Generation of 
human skin equivalents under submerged conditions-
mimicking the in utero environment. Tissue Eng Part A 2010; 
16: 1433-41.
11 van Smeden J, Hoppel L, van der Heijden R et al. LC/MS 
analysis of stratum corneum lipids: ceramide profiling and 
discovery. J Lipid Res 2011; 52: 1211-21.
12 Motta S, Monti M, Sesana S et al. Ceramide composition of 
the psoriatic scale. Biochim Biophys Acta 1993; 1182: 147-51.
13 Masukawa Y, Narita H, Sato H et al. Comprehensive 
quantification of ceramide species in human stratum 
corneum. J Lipid Res 2009; 50: 1708-19.
14 de Jager MW, Gooris GS, Ponec M et al. Lipid mixtures 
prepared with well-defined synthetic ceramides closely mimic 
the unique stratum corneum lipid phase behavior. J Lipid Res 
2005; 46: 2649-56.
15 Bouwstra JA, Gooris GS, Dubbelaar FE et al. Phase behavior 
of lipid mixtures based on human ceramides: coexistence of 
crystalline and liquid phases. Journal of lipid research 2001; 
42: 1759-70.
91







an altered lipid 
organization and 
decreased barrier 
function in atopic 
eczema patients
Jeroen van Smeden1,*, Michelle Janssens1,*, 
Gert S. Gooris1, Wim Bras2,  
Guiseppe Portale2, Peter J. caspers3,4,  
rob J. Vreeken5,6, Thomas hankemeier5,6, 
Sanja Kezic7, ron Wolterbeek8, Adriana 
P.M. Lavrijsen9, and Joke A. Bouwstra1
1 division of drug delivery Technology,  
 Leiden Academic centre for drug research,  
 Leiden University, Leiden, The Netherlands. 
2 Netherlands Organization for Scientific 
 research, dUBBLe crG/eSrF, Grenoble,  
 France. 
3 center for Optical diagnostics and Therapy, 
 department of dermatology, erasmus Mc,  
 rotterdam, The Netherlands.
4 river diagnostics BV, rotterdam, 
 The Netherlands.
5 division of Analytical Biosciences, Leiden 
 Academic centre for drug research, Leiden  
 University, Leiden, The Netherlands.
6 Netherlands Metabolomics centre, Leiden 
 Academic centre for drug research, Leiden  
 University, Leiden, The Netherlands.
7 coronel institute of Occupational health, 
 Academic Medical center, University of  
 Amsterdam, Amsterdam, The Netherlands.
8 department of Medical Statistics and  
 Bioinformatics, Leiden University Medical  
 center, Leiden, The Netherlands.
9 department of dermatology, Leiden   
 University Medical center, Leiden, The  
 Netherlands.
*Both authors contributed equally to this work
Adapted from Journal of Lipid research. 
2012. 53:2755-2766. 
Abstract
 A hallmark of atopic eczema (Ae) is skin barrier 
dysfunction. Lipids in the stratum corneum (SC), 
primarily ceramides, free fatty acids and cholesterol, 
are crucial for the barrier function, but their 
role in relation to AE is indistinct. Filaggrin is an 
epithelial barrier protein with a central role in the 
pathogenesis of AE. Nevertheless, the precise causes 
of AE-associated barrier dysfunction are largely 
unknown. In this study, a comprehensive analysis of 
ceramide composition and lipid organization in non-
lesional SC of AE patients and control subjects was 
performed by means of mass spectrometry, infrared 
spectroscopy, and X-ray diffraction. In addition, the 
skin barrier and clinical state of the disease were 
examined. The level of ceramides with an extreme 
short chain length is drastically increased in SC 
of AE patients, which leads to an aberrant lipid 
organization and a decreased skin barrier function. 
Changes in SC lipid properties correlate with disease 
severity but are independent of filaggrin mutations. 
We demonstrate for the first time that changes in 
ceramide chain length and lipid organization are 
directly correlated with the skin barrier defects in 
non-lesional skin of AE patients. We envisage that 
these insights will provide a new therapeutic entry 
in therapy and prevention of AE. 
Introduction
 The skin offers a protective barrier against aller-
gens, irritants, and microorganisms and prevents 
excessive transepidermal water loss (TEWL). The 
barrier function strongly relies on the outermost 
layer of the skin, the stratum corneum (SC), which 
consists of corneocytes embedded in a highly 
organized lipid matrix1,2. This lipid matrix is 
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considered to be important for a proper skin barrier function.
 Ceramides (CERs), cholesterol, and free fatty acids are the main lipid classes in SC. 
To date, 12 CER subclasses in human SC have been identified with a wide chain length 
distribution3,4. An explanation of the Cer nomenclature is given in Figure 1. The aim of 
the present study was to determine the chain lengths of each Cer subclass in non-lesional 
skin of atopic eczema (Ae) patients and to correlate these with lipid organization, skin 
barrier function and disease severity, see Figure 2.
 Ae is a chronic relapsing inflammatory skin disease characterized by a broad spectrum 
of clinical manifestations, such as erythema, dryness, and intense pruritus5,6. Ae affects 
over 15% of Caucasian children and 2-10% of adults, and its prevalence is increasing 






















































































Figure 1: Structure and nomenclature of cers. All cers bear a polar head group and two long carbon chains. The 
polar head group may vary in molecular architecture (at the carbon positions marked in red), resulting in 12 different 
subclasses in human sc. Both chains in every cer subclass show varying carbon chain lengths (marked by red arrows). 
Each cer subclass is denoted by its sphingoid base (blue) and fatty acid chain (gray), resulting in the 12 cer subclasses. 
The abbreviations are as follows: For the sphingoid base: dihydrosphingosine (ds), sphingosine (s), phytosphingosine (p), 
6-hydroxy sphingosine (h). The various acyl chains are denoted by: Non-hydroxy fatty acid (n), α-hydroxy fatty acid (a) 
and esterified ω-hydroxy fatty acid (eo). This results in the 12 cer subclass notations: [nds], [ads], [eods], [ns], [as], 
[eos], [np], [ap], [eop], [nh], [ah], [eoh]. The number of total carbon atoms in the cers (e.g. c34 cers) is the number 
of carbon atoms in the fatty acid chain plus the number of carbon atoms in the sphingoid base.
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function in lesional and non-lesional skin12-16. 
 In previous studies, it has been shown that Ae is strongly associated with mutations in 
the filaggrin gene (Flg)17-19, but the role of Flg mutations for the barrier dysfunction is 
yet inconclusive20-25. Other factors, such as aberrations in the Sc lipids, may play a role 
in the decreased skin barrier in Ae12,26,27. In healthy Sc, lipids form two lamellar phases 
with repeat distances of approximately 6 and 13 nm. These are referred to as the short 
periodicity phase (SPP) and long periodicity phase (LPP), respectively28,29. A schematic 
presentation of the lipid organization is provided in Figure 3. Within the lipid lamellae, 
the lipids have a dense (orthorhombic) lateral organization, although a subpopulation of 
the lipids can be less densely packed in a hexagonal organization30-32. 
 Cers play a crucial role in the lipid organization33, and they have a characteristic 
molecular architecture. Several studies have reported significant changes in Cer subclasses 
in non-lesional Sc of Ae patients: reduced Cer [NP], increased Cer [AS], and reduced long 
chain Cers [EOH] and [EOS]12,23,34-36. Some of these changes could be correlated with 
changes in skin barrier function. However, no information was reported on the effect 
of chain length distribution of Cers on the skin barrier until recently: Ishikawa et al. 
showed that lesional skin has a significantly increased level of short-chain Cers (with 
a total chain length of 34 carbon atoms) in one specific Cer subclass, which correlates 
with the impaired skin barrier function37. These results suggest that Cer chain length 
may be an important factor in skin barrier dysfunction of Ae patients. These findings 
were the starting point of the present study, in which we performed a detailed analysis 
on Cer composition, focusing in particular on the Cer chain length distribution in non-
lesional Sc of Ae patients in relation to lipid organization and skin barrier dysfunction. 
We studied Sc of non-lesional skin, as we aimed to monitor the changes in lipid properties 
in the absence of inflammation. We have identified several Cer subclasses that exhibit an 
increased level of extremely short C34 chains in Ae, and we demonstrate that the overall 
level of C34 is increased in Ae. The changes in Cer chain length distribution correlated 














Figure 2: Schematic overview of the sc 
lipid parameters, clinical parameters, 
and the determinants of the filaggrin 
content discussed in this article. These 
different parameters may all affect 
the skin barrier and are therefore 
investigated in this study. Arrows 
indicate possible correlations that are 
studied throughout the manuscript.
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of natural moisturizing factor (NMF, composed of filaggrin-derived amino acids, their 
metabolites, specific sugars, and salts). Changes in Cer chain length distribution did not 
correlate with Flg genotype. These results demonstrate for the first time that Cer chain 















z = 13 nm
(LPP)
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(SPP)
Figure 3: Lamellar and lateral organization in human stratum corneum. a) The outermost layer of the epidermis, 
the stratum corneum (sc), consists of dead cells (corneocytes) embedded in a lipid matrix, also referred to as the 
brick (corneocytes) and mortar (lipids) structure b). The intercellular lipids are arranged in layers (lamellae) c), 
with two coexisting lamellar phases. These lamellar phases have a repeat distance of 6 nm (referred to as the short 
periodicity phase (spp)) or 13 nm (referred to as the long periodicity phase (lpp)). The lateral organization is the 
plane perpendicular to the direction of the lamellar organization. There are three possible arrangements of the lipids: a 
very dense, ordered, orthorhombic organization; a less dense, ordered, hexagonal organization; or a disordered, liquid 
organization. 
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Material and Methods
Study population and general study setup 
 The study was conducted in accordance with the Declaration of Helsinki Principles, 
and was approved by the Ethical Committee of the Leiden University Medical Center. 
All subjects gave written informed consent. 15 Caucasian subjects without (history 
of) dermatological disorders (25.0 ± 5.2 years; 5 males) and 28 Caucasian Ae patients 
(25.6 ± 5.6 years; 11 males) were included. The group of Ae patients consists of 14 patients 
with and 14 patients without the presence of common Flg genotype mutations (see Flg 
mutation analysis below). Subjects did not apply any dermatological products to their 
forearms for at least one week prior to the study. The study itself was performed in a 
temperature and humidity controlled room, and subjects were acclimatized for 45 min 
prior to the measurements. Per subject, all measurements were performed on a single day 
on one of the ventral forearms, which was observed by a dermatologist at the start of the 
study to carefully depict an area of non-lesional skin, which was marked accordingly. At 
this area, NMF levels were determined with Raman spectroscopy, followed by subsequent 
tape stripping, TEWL, and Fourier transform infrared spectroscopy (FTIR) measurements, 
as described below. At the end of the study day, buccal mucosa cells were collected with a 
cotton swab, and SCORing Atopic Dermatitis (SCORAD) was performed by a dermatologist 
to determine the severity of the disease. Finally, a 4 mm biopsy was harvested close to the 
area where all measurements were performed.
Flg mutation analysis
 The influence of Flg mutations on lipid properties was studied. We screened all subjects 
on the four most prevalent mutations found in European Caucasians (2282del4, R501X, 
S3247X and R2447X), covering around 93% of all Flg mutations known to date38. Buccal 
mucosa cells were collected by rubbing the inside of the cheeks with a cotton swab 
on a plastic stick after rinsing the mouth with water. Mutations were determined by 
genotyping after DNA extraction39.
Skin barrier function assessment by tewL
 A Tewameter 210 (Courage+Khazaka, Köln, Germany) was used to measure TEWL on 
the marked area on the ventral forearm of the subject. The forearm was placed in an 
open chamber, and TEWL values were recorded for 2 minutes, after which an average 
reading during the last 10 seconds of the measurement was calculated. This procedure 
was performed before tape stripping (baseline TEWL) and after every two tape strips to 
have an indication of the amount of removed Sc.
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ScoRaD
 SCORAD was performed by the dermatologist to determine the severity of the disease40.
Determination of NMf levels in sc
 Confocal Raman microspectroscopy (3510 Skin Composition Analyzer, River 
Diagnostics, Rotterdam, The Netherlands) was used to measure NMF in the Sc of the 
ventral forearm. The principles and experimental details of this method and the procedure 
have been described elsewhere41,42. Depth profiles of Raman spectra were measured at 
2 µm intervals from the skin surface to 20 µm below the skin surface. In each subject, 15 
profiles were measured at different spots within the marked area on the ventral forearm. 
Raman spectra were recorded between 400 and 1800 cm-1 with a 785 nm laser. Laser 
power on the skin was 25 mW. NMF levels relative to keratin were determined from the 
Raman spectra measured between 4 and 8 µm by means of classical least-squares fitting. 
Relative NMF to keratin levels were calculated from the recorded Raman spectra by using 
SkinTools 2.0 (River Diagnostics, Rotterdam, The Netherlands).
Tape stripping procedure
 To harvest Sc lipids, the following tape stripping procedure was performed on both 
control subjects and non-lesional regions of Ae patients: multiple poly(phenylene sulfide) 
tape strips (Nichiban, Tokyo, Japan) were successively applied at the same area (4.5 cm2) 
on the ventral forearm. All tapes were pressed to the targeted skin with a pressure of 
450 g/cm2 using a D-Squame pressure instrument (Cuderm Corp., Dallas, TX). Tweezers 
were used to remove the tape in a fluent stroke, using alternating directions for each 
successive tape strip. The Squamescan 850A (Heiland Electronic, Wetzlar, Germany) was 
used to determine the amount of Sc removed to obtain a good indication of the depth of 
each tape strip taken43,44. Calibration was performed by a bicinchoninic acid (BCA) assay 
using bovine serum albumin (BSA). The predicted total amount of protein in the Sc was 
calculated by plotting 1/TEWL against the cumulative amount of protein removed. The 
intercept with the x-axis is indicative for the total amount of protein in the Sc according 
to Kalia et al.43. Tapes 6 to 9 were selected for lipid composition analysis, as these tapes do 
not show surface contamination (observed when analyzing tape strips from the surface 
of the Sc). All tapes were punched to a circular area of 2 cm2, put individually into glass 
vials containing 1 mL chloroform/methanol/water (1:2:½) and stored at -20°C under 
argon atmosphere prior to lipid extraction.
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Lipid extraction and ceramide analysis by Lc/Ms
 Lipid extraction was performed on 4 tape strips (numbers 6 to 9) of each subject. Before 
lipids were extracted from tape strips by liquid-liquid extraction, 2 deuterated internal 
ceramide standards (Cer [NS] C24 and, Cer [EOS] C30 linoleate) were added to compare 
Cer levels between control group and non-lesional skin of Ae patients. Then, a slightly 
enhanced extraction procedure of the commonly used Bligh and Dyer method was 
performed on all 4 selected tape strips individually: 3 different ratios of solvent mixtures 
chloroform/methanol/water (1:2:½; 1:1:0; 2:1:0) were used sequentially to extract 
all lipids. A detailed procedure is described elsewhere45,46. Afterwards, lipid extracts 
from all 4 individual tapes were pooled, dried under N2 gas and reconstituted in 100 µl 
chloroform/methanol/heptane (2½:2½:95) to obtain a total lipid concentration around 
1.0 mg/mL. Samples were stored at -20°C until use. The analysis was performed by LC/
MS using a recently developed LC/MS method described in detail elsewhere4. Briefly, 10 µl 
of each lipid sample was automatically injected and separated onto an analytical normal 
phase column (pva-bonded column; 100 × 2.1 mm i.d., 5 µm particle size, YMC (Kyoto, 
Japan)) by a gradient solvent system from heptane to heptane/IPA/ethanol at a flow 
rate of 0.8 mL/min using an Alliance 2695 HPLC system (Waters Milford, MA). The HPLC 
was coupled to a mass spectrometer (TSQ Quantum, Thermo Finnigan, San Jose, CA) in 
atmospheric pressure chemical ionization (APCI), positive scan mode with a scan range 
set at 360-1200 amu. The temperature of the source heater and heated capillary were set 
to 450°C and 250°C, respectively, and the discharge current was set to 5 µA. The ceramide 
analysis was performed using Xcalibur software version 2.0, and its nomenclature used 
throughout this article is according to Motta et al.47 in which ceramide subclasses are 
classified by letter abbreviations according to their two individual chains: the sphingoid 
base (either dihydrosphingosine (dS), sphingosine (S), 6-hydroxy sphingosine (H) or 
phyto-sphingosine (P)), chemically linked to the fatty acid chain (either an α-hydroxy 
fatty acid (A), an esterified ω-hydroxy fatty acid (EO) or a non-hydroxy fatty acid (N)). This 
results in 12 different Cer subclasses, namely [AdS], [AS], [AH], [AP], [EOdS], [EOS], [EOH], 
[EOP], [NdS], [NS], [NH], and [NP]. The Cer nomenclature and its molecular structure are 
explained in Figure 1.
Lateral organization and conformational ordering of the lipids
 To obtain information on the lateral organization and conformational ordering of the 
lipids, FTIR spectra were recorded in the same skin region also used for lipid analysis. 
FTIR spectra of the Sc were collected after each 2 tape strips using a Varian 670-IR 
spectrometer (Varian Inc., Santa Clara, CA) equipped with a broad band mercury-
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cadmium-telluride (mct) detector and an external sample compartment containing a 
Gladiatr (Pike, Madison, WI) attenuated total reflection (ATR) accessory with a single 
reflection diamond. The spectral resolution was 2 cm-1. The instrument was continuously 
purged with dry N2. Each spectrum was an average of 150 scans. For data treatment the 
instrument software Resolutions Pro 4.1 (Varian Inc.) was used. We calculated positions 
of the CH2 symmetric stretching vibration and second derivatives of the scissoring 
bandwidth as described previously48,49. Shortly, the second derivative was calculated and 
it was baseline-corrected between the endpoints of the scissoring region (~1460-1480 
cm-1). We calculated the bandwidth at 50% of the peak height (full width half maximum, 
FWHM) and determined CH2 symmetric stretching vibration positions of spectra recorded 
between the removal of 2 to 10 tape strips.
Biopsy and small angle x-ray diffraction measurements
 After tape stripping, 4 mm biopsies were taken from the ventral forearm close to the 
region of the tape stripping. Sc was isolated by trypsin digestion as described earlier50. 
This procedure does not affect the lipid organization in Sc51. The Sc sheets were measured 
by small angle X-ray diffraction (SAXD) performed at the European Synchrotron Radiation 
Facility (ESRF, Grenoble, France) using station BM26B. Prior to the measurements, Sc was 
hydrated over a 27% NaBr solution during 24h. To obtain high quality diffraction patterns Sc 
was carefully oriented parallel to the primary X-ray beam. SAXD patterns were detected with 
a Frelon 2000 charge-coupled device (CCD) detector at room temperature for a period of 10 
minutes using a microfocus beam, similarly as described elsewhere52. Samples were checked 
for evidence of radiation damage, and exposure time to X-rays was kept to a minimum. 
From the scattering angle, the scattering vector (q) was calculated by q = 4π sin θ/λ, in which 
λ is the wavelength of the X-rays at the sample position and θ the scattering angle. 
Statistical analysis
 Statistical analysis was performed using SPSS Statistics. Non-parametric Mann-Whitney 
tests were performed when comparing 2 groups and stated significant when P<0.05. 
When the effect of Flg was taken into account and trends were observed, Kruskall-Wallis 
tests, and eventually, additional Mann-Whitney tests were performed. Bivariate analysis 
was performed to analyze which parameters showed a significant correlation, and their 
respective Spearman’s ρ correlation coefficients were calculated. Univariate general linear 
model analysis was performed to correlate the biologically and clinically relevant parameters 
to 2 independent lipid parameters, as well as to the predicted and the observed average 
chain length. 
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Results
Description of study population
 Fourteen out of 28 Ae patients were carriers of at least one of the four most common Flg 
mutations (details in Supplementary Table I). Patient and control subject characteristics 
are provided in Supplementary Table II. Two control subjects were heterozygous for Flg 
mutations. Severity of the disease was scored by an experienced dermatologist using 
SCORAD (Figure 4a). Ae patients showed an elevated TEWL in non-lesional skin compared 
with control subjects (12.2 ± 6.5 g/m2/h and 6.5 ± 1.7 g/m2/h, respectively; P<0.0005, 
Figure 4b) and lower NMF levels compared with control subjects (0.66 ± 0.39 and 1.05 ± 
0.20, respectively; P<0.01, Figure 4c).
 
Reduced ceR chain length correlates with a decreased barrier function
 From the LC/MS data, lipid profiles were constructed and examples are shown in 
Supplementary Figure 1. From manual integration of these lipid profiles, the relative 
abundance of all Cer subclasses could be calculated (Supplementary Figure 2). Statistical 
differences between control subjects and Ae patients were observed in 7 subclasses: Cers 
[EOP], [EOH], [NS], [NP], [NH], [AS] and [AH] (P<0.05). No difference was observed between 
carriers and non-carriers of Flg mutations. The total Cer level in the control group and in 
non-lesional skin of Ae patients was not significantly different 37.0 ± 3.6 and 38.5.4 ± 2.4 


















































a) b) c)SCORAD TEWL NMF
p < 0.0005 p = 0.0013
Figure 4: scorad, tewl and nmf levels in control subjects and ae patients. Dot plots showing individual control 
subjects (  and ) and ae patients (  and ) of the measured parameters (a) scorad, (b) tewl and (c) nmf levels. 
Open and filled data points indicate carriers and non-carriers of nmf mutations, respectively. Means are indicated 
by gray horizontal lines and their corresponding values (±sd). Significant differences were observed between control 
subjects and ae patients for both tewl and nmf. Flg mutations were associated with reduced nmf levels in ae patients 


































































































































































































































Average CER chain length
Figure 5: cer composition in control subjects and ae patients. a) Dot plot showing the average chain length of all cers 
in total; the relative abundance of total c34 cers; and the relative abundance of total [eo] cers. b) Dot plots indicating 
the relative abundance of c34 cer species for each subclass. c) Scatter plot of univariate analysis of the predicted 
average chain length (by the abundance of c34 cers and [eo] cers) versus the observed average chain length. Gray 
dotted lines represents the optimal fit (r=0.94). d) Scatter plot of univariate analysis of c34 cer and cer [eo] versus 
the tewl. Insets show the residuals of the respective plots. Gray dotted lines represents the optimal fit (r=0.77). Control 
subjects are indicated by  and . AE patients with are indicated by  and . Open and filled data points indicate 
carriers and non-carriers of flg mutations, respectively. 
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 The average Cer chain length was significantly decreased by 0.64 ± 0.23 total carbon 
atoms in Ae patients (mean±SEM; P=0.012, Figure 5a). No difference was observed 
between carriers and non-carriers of Flg mutations (P>0.1). Figure 5a shows that in non-
lesional skin of Ae patients, extremely short C34 Cers were increased within several Cer 
subclasses. This was primarily observed in Cer subclasses [AS], [AH], [NS] and [NH] (Figure 
5b, P<0.05). The increase in total C34 Cers in Ae (P<0.0001) contributes to a reduction in 
overall chain length. In addition, the very long chain Cers belonging to the [EO] subclass 
are significantly reduced, which is primarily caused by significantly decreased levels of 
Cer [EOH] and [EOP] (P=0.019 and P=0.040, respectively, Figure 5a and Supplementary 
Figure 2b). Univariate analysis shows that an increased level of C34 Cers and decreased 
level of Cers [EO] largely contribute to a reduction in average Cer chain length, as can be 
observed from Figure 5c. The influence of Flg mutations on any of the Cer chain length 
parameters was not significant (P>0.1; detailed overview in Supplementary Tables III-V).
 The observed changes in Cer chain length were compared with changes in barrier 
function as assessed by TEWL. The results in Figure 5d show a strong correlation between 
TEWL and the levels of C34 Cers and Cer [EO]: univariate analysis of TEWL versus the total 
C34 Cers and total Cer [EO] levels shows a correlation coefficient of 0.77 (P<0.0001). 
Correlations between the relative abundances of the various Cer subclasses with TEWL 
are shown in Table I. Cer [EOH] and Cer [AS] are the two subclasses which are most 
significantly associated with TEWL. This again indicates the importance of the chain 
length for the skin barrier in Ae: the exceptional long Cer [EOH] is decreased, whereas 
CER [AS] (the Cer subclass with the highest abundance of exceptionally short C34 Cers) 
is increased. The changes in Cer composition are irrespective of Flg mutation status 
(P=0.58). 
Table I: Correlation coefficients of the various cer subclasses versus 
tewl. The table contains all 12 cer subclasses as well as the cers that 
strongly influence the chain length (i.e. total cer [eo] and total c34 
cers).
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Figure 6: Lipid organization in control subjects and ae patients. a) The upper saxd curve of a control subject shows 
the 1st (I), 2nd (II) and 3rd (III) order peak positions of the lpp. # indicates phase separated cholesterol. The middle 
diffraction curve is from an ae patient and resembles the pattern of sc of the control subject. The bottom curve of an ae 
patient shows only the presence of peak II. b) Position of peak II in saxd curves. c) Position of the stretching vibrations 
in the ftir spectrum. d) Scissoring bandwidth in the ftir spectrum. e) Correlation between lipid organization and 
tewl. Scatter plot of univariate analysis of saxd peak II position + bandwidth of scissoring vibrations versus the tewl. 
The inset shows the residuals of this plot. The gray dotted line represents the optimal fit (r=0.76). Control subjects are 
indicated by  and . Ae patients with are indicated by  and . Open and filled data points indicate carriers and 
non-carriers of flg mutations, respectively.
Altered lamellar and lateral lipid organization correlates with a decreased barrier 
function
 SAXD gives information about the lamellar organization of intercellular lipids in Sc28 
(explanation in Supplementary Figure 3). The lipids form two lamellar phases, the SPP 
and LPP. Figure 6a shows three examples of SAXD curves from Sc. The upper curve is a 
typical example of a control subject. The central curve is typical for Ae. The bottom curve 
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is representative for a subgroup of Ae patients with an aberrant SAXD profile. The upper 
two curves show lipid-based features as two weak diffraction peaks (labeled I and III) 
and a strong peak (labeled II). The LPP contributes to all three peaks, whereas the SPP 
contributes only to peak II (Supplementary Figure 3). In the bottom curve, both peaks 
I and III are absent, and peak II is shifted to higher q-values. Peaks I and III were not 
present in 5 out of 28 patients. As peak I and peak III are attributed to the LPP, this 
indicates that there is a drastic reduction in the presence of the LPP in those patients.
 Figure 6b shows the position of the strong peak (II) in the SAXD curves from control 
subjects (left) and Ae patients (right). The peak position shows a larger variance within the 
group of Ae patients compared with the group of control subjects. The average position of 
the strong peak is located at significantly higher q-values for Ae patients compared with 
control subjects (1.03 nm-1 and 1.00 nm-1, respectively, P=0.046). The position of peak 
II showed no difference between Ae patients with and patients without Flg mutations 
(P=0.76). 
 FTIR was used to obtain information on the lateral lipid organization. Two types of 
vibrations were monitored, the CH2 symmetric stretching vibrations and the CH2 
scissoring vibrations (Supplementary Figure 4). A low (~2848 cm-1) wavenumber of 
the CH2 symmetric stretching vibrations indicates the presence of a highly ordered lipid 
organization (either hexagonal or orthorhombic), whereas a high (2853 cm-1) wavenumber 
indicates a liquid disordered phase53. The mean value of the position of the CH2 symmetric 
stretching vibrations of Ae patients shows a small but significant shift to higher values 
compared with control subjects (2849.2 cm-1 versus 2848.8 cm-1, respectively, P=0.0013, 
Figure 6c). In addition, the variance in the group of Ae patients is larger than in control 
subjects. To distinguish between an orthorhombic (dense) or hexagonal (less dense) 
lateral organization, the bandwidth of the CH2 scissoring vibrations was monitored. A 
narrow bandwidth (typically 8 cm-1) indicates the presence of only a hexagonal lipid 
organization, whereas a large bandwidth of typically 11 cm-1 is indicative for the presence 
of mainly an orthorhombic organization49. The average bandwidth of the scissoring 
vibrations was significantly lower in Ae patients compared with control subjects (10.6 
cm-1 versus 11.6 cm-1, respectively, P=0.010, Figure 6d), demonstrating a reduction 
of lipids in an orthorhombic organization and thus a less dense lipid organization. No 
significant influence of Flg mutations on the lipid organization in Ae patients was found 
(P>0.05, Figures 6b-d).
 Univariate analysis was performed between TEWL and two independent lipid 
organization parameters: a lamellar organization component (SAXD peak II position) and 
a lateral organization component (FTIR scissoring bandwidth). The correlation coefficient 
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was r=0.76 (P<0.0001, Figure 6e), which demonstrates that skin barrier function as 
measured by TEWL is significantly influenced by lipid organization.
Altered ceR composition correlates with aberrant lipid organization. 
 As the Cer composition and lipid organization both show a relationship with a reduced 
skin barrier (TEWL), the relation between the lipid parameters is summarized in Table II. The 
levels of C34 Cers and Cer [EO] associate with both the lamellar organization (SAXD) and 
lateral lipid organization (FTIR scissoring bandwidth and stretching vibrations position). A 
powerful correlation of 0.71 was observed when both the lamellar and lateral organization 
components (SAXD and CH2 scissoring) were plotted versus the two components of the Cer 
composition ([EO] Cers and C34 Cers). Supplementary Figure 5 illustrates this correlation.
Table II: Correlation coefficients 
of lipid composition and lipid 
organization parameters.
Lipid organization / CER composition parameters Correlation coefficients (r)
SAXD peak II position vs total C34 CER content 0.432**
SAXD peak II position vs total CER [EO] content -0.393**
SAXD peak II position vs average CER chain length -0.370*
FTIR scissoring bandwidth vs total C34 CER content -0.669***
FTIR scissoring bandwidth vs total CER [EO] content 0.267
FTIR scissoring bandwidth vs average CER chain length 0.386*
FTIR stretching vs total C34 CER content 0.607***
FTIR stretching vs total CER [EO] content -0.399*
FTIR stretching vs average CER chain length -0.471**
Correlated parameters Correlation coefficients (r) 
TEWL vs SCORAD
TEWL vs SAXD peak II position
TEWL vs FTIR scissoring bandwidth
TEWL vs FTIR stretching
TEWL vs total C34 CER content
TEWL vs total CER [EO] content










SCORAD vs SAXD peak II position
SCORAD vs FTIR scissoring bandwidth
SCORAD vs FTIR stretching
SCORAD vs total C34 CER content
SCORAD vs total CER [EO] content 









NMF vs SAXD peak II position
NMF vs FTIR scissoring bandwidth
NMF vs FTIR stretching 
NMF vs total C34 CER content
NMF vs total CER [EO] content







Table III: Correlations between the various 
parameters.
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Altered ceR composition and aberrant lipid organization correlate with NMf levels 
and scoRaD
 A detailed overview of correlation coefficients between different parameters is 
presented in Table III. NMF levels correlate (r>0.4, P<0.01) with both lamellar and lateral 
lipid organization as well as with chain length of the Cers. SCORAD (disease severity) was 
associated with Cer composition (i.e. total C34 Cers and total Cer [EO] content) and lipid 
organization (i.e. SAXD peak II position and FTIR scissoring bandwidth), with correlation 
coefficients of 0.56 (P<0.01) and 0.58 (P<0.01), respectively. 
Flg mutations correlate with NMf levels, but not with scoRaD and tewL levels.
 NMF levels were significantly lower in Flg carriers than in non-carriers (0.45 ± 0.19 and 
0.87 ± 0.43, respectively, P<0.005). Both SCORAD and TEWL values were independent of 
Flg genotype (P=0.34 and P=0.23), respectively.
Discussion
 We performed an integral analysis of Cer composition, focusing on the chain length 
distribution of each of the Cer subclasses in relation to lipid organization and their 
correlation with skin barrier function (TEWL), disease severity (SCORAD), Flg mutations 
and NMF levels. This study provides detailed information about the role of lipids in the 
impaired skin barrier function of non-lesional Ae skin. 
 The results show a reduced average Cer chain length in non-lesional skin of Ae patients. 
This reduction in chain length can be attributed to an increase in extremely short C34 
Cers as well as a reduction in very long Cer [EO] subclasses. The increment in C34 Cers has 
recently been reported by Ishikawa et al. for a single subclass (Cer [NS]) in lesional skin of 
Ae patients37. Here we show in non-lesional skin a largely increased level of C34 Cers in 
four Cer subclasses: Cer [NS], [NH], [AS] and [AH]. In addition, the results show changed 
levels in some of the Cer subclasses consistent with previous reports: a decrease in Cer 
[NP] level and an increase in Cer [AS] level12,34-37,54,55. We did not observe a change in 
Cer/protein levels between Ae patients and controls. Interestingly, the reduction in Cer 
chain length found in the present study had a much stronger impact on the skin barrier 
function than did the changes in Cer subclass levels: the TEWL increases proportionally 
with decreasing chain length. These findings are in excellent agreement with earlier in 
vitro studies showing that a reduction in chain length of Cers has a stronger impact on 
the lipid organization and permeability than a change in the ratio between Cer subclasses 
keeping the chain length approximately equal56-58, unpublished results M. Oguri, G.S. 
Gooris, J.A. Bouwstra). Di Nardo et al. observed a reduction in Cer/CHOL ratio in non-
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lesional skin of Ae patients, whereas other studies do not report a decrease in Cer content 
in non-lesional Ae skin20,35-37,54.  Groen et al.58 observed that when increasing the Cer 
or FFA level  while keeping the level of the other two main lipid classes equal, did not 
affect the permeability in vitro. Therefore these studies suggest that the Cer composition 
and chain length rather than the ratio between lipid classes does play a major role in 
the increased TEWL in non-lesional skin in patients with Ae. The increment in C34 
Cers and decrement in Cer [EO] suggest that elongation of the acyl chains is reduced. 
As the elongase family plays an important role in the elongation of fatty acids in the 
viable epidermis, we hypothesize that the higher abundance of C34 Cers may be due to a 
misbalance in the activity of some of the members of the elongase family59,60.  
 Several publications report on the lipid organization in Ae patients: Pilgram et al. 
reported changes in the lateral packing when comparing three Ae patients with three 
controls32. In a very recent study, we reported the first results on a very limited number of 
subjects focusing on the lamellar phases and ceramide subclasses without examining the 
Cer chain lengths61. In addition, several studies focused on the (delayed or incomplete) 
lamellar body extrusion process in Ae62-64, possibly caused by a reduced peroxisome 
proliferator-activated receptor activation65.  In the present study we were particularly 
interested in the influence of Cer chain length on the lipid organization in Ae patients. 
 With respect to the lamellar lipid organization, we observed a shift in the peak II 
position of SAXD curves of Sc in Ae patients. This observation indicates a reduced value 
of the repeat distances of the lamellar phases and/or a reduced formation of the LPP28. 
The correlation between SAXD peak II position with Cer [EO] and C34 Cer levels indicates 
that changes in these Cer levels affect the lamellar organization. When focusing on the 
lateral organization, Ae patients show a less dense lipid packing compared with controls 
that correlates strongly with a higher level of C34 Cers. This finding shows that Cer chain 
length is also an important determinant of the lateral lipid organization in Sc. The observed 
changes in lamellar and lateral organization correlate with the increased TEWL levels and 
thus with an abnormal skin barrier function in patients with Ae. The findings in this study 
strongly support the hypothesis that in Ae patients a reduction in Cer chain length leads 
to a change in lipid organization, which in turn leads to an impaired barrier function. In 
addition, the present study shows that this impaired barrier function is correlated with 
the disease severity as determined by SCORAD, which is supported by literature66,67. This 
may indicate that as a result of inflammation, lipid synthesis is influenced (even at non-
lesional sites), and subsequently the barrier function is decreased. 
 As Flg mutations are known to be predisposing factors for Ae17, an interesting 
question is whether lipid changes are associated with the presence of Flg mutations. We 
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screened our subjects for four of the most prevalent Flg mutations accounting for 93% 
of the European Flg mutation spectrum38. In our study cohort, there is no evidence that 
Flg mutations have an effect on Cer composition and lipid organization. In contrast, 
in a recent study in ichtyosis vulgaris patients68, changes in the lamellar organization 
were observed between the patients and controls. In that investigation, however, the 
majority of the patients were homozygote or compound heterozygote with respect to Flg 
mutations, and no inflammation was observed in these patients. 
 In previous studies, as well as in the current study, Ae patients with Flg mutations 
showed significantly reduced NMF levels22,69. Remarkably, in this study changes in lipids 
correlated with NMF levels but not with the presence or absence of Flg mutations. This 
suggests that between Flg gene (genotype) and NMF (phenotype), other (translational and 
environmental) factors may also influence NMF levels. These factors may include Flg copy 
numbers (repeat alleles on the Flg gene)70 and interleukin levels, which can downregulate 
filaggrin expression71. Changes in NMF levels are suggested to lead to a change in pH, and 
together with altered interleukin levels and protease activity this may affect enzymes 
involved in Cer biosynthesis5,68,72-74 and therefore change the Cer composition and lipid 
organization. Thus, despite the fact that we did not find a correlation between the lipids 
and Flg mutation status, filaggrin might play an indirect role in the decreased barrier 
function of Ae patients, although the underlying mechanism remains unclear. Besides, 
other barrier proteins may be involved. This will be subject of future studies by our group.
In conclusion, in this study we have shown that the Cer chain length is altered in Ae 
patients by elevated C34 Cers levels and reduced Cer [EO] levels. These changes correlate 
with an altered lipid organization and a decreased barrier function in Ae patients. In 
addition, a significant correlation was observed between disease severity and change in 
lipid composition and organization. Our results suggest a novel therapeutic entry to repair 
skin barrier defects in Ae patients, aimed at normalizing Cer chain length distribution. 
Such a treatment could improve the Sc lipid organization and restore the skin barrier 
function of Ae patients.
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Supplementary Figure 1: representative 3d multi-mass chromatograms of sc ceramides of a healthy subject (left) 
and an ae patient (right). All subclasses are indicated by their abbreviation. Is indicates one of the deuterated internal 
standards (cer classes [eos] and [ns]) which were added to every sample to enable semi-quantitative analysis.
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Supplementary Figure 2: Bar plot showing the relative abundances of all cer subclasses (a) and only the very long 
[eo] cer subclasses (b) (Mean ± sem). Green bars correspond to the control group, while orange and red bars correspond 
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Supplementary Figure 3: Lamellar organization in human stratum corneum. The right graph shows a typical saxd 
profile of human sc. The scattering intensity (i) is plotted as a function of q, which is defined by q = 2πsin θ/λ, in which 
λ is the wavelength of the x-rays and θ the angle of the scattered x-rays. The x-ray diffraction graph of human stratum 
corneum is characterized by a high intensity at low q values due to keratin in the corneocytes and a series of peaks. The 
peaks indicated by I (weak peak), II (strong peak) and III (weak peak) are attributed to the lpp. Peak II is also attributed 
to the spp. The peak indicated by # is due to cholesterol. A schematic drawing of the x-ray curves of the keratin, lpp and 
spp is also shown on the left. The 1st, 2nd, 3rd, 4th, 5th and 6th order of the lpp (indicated by 1l-6l) and 1st and 2nd order 
of the spp (indicated by 1s and 2s) . From the positions of the peaks (q) the repeat distance of the lpp and spp can be 
calculated using the equation d = n·2π/qn (n = order of diffraction peak). When comparing the positions of the lpp and 
spp to that in the diffraction pattern of the sc, peak I and III are only attributed to the lpp, while II is attributed to the 
lpp (2l) and spp (1s). Higher order reflections cannot be detected due to the low intensities of these peaks.
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Supplementary Figure 4: The lateral organization can be measured by Fourier transform infrared spectroscopy (ftir) 
by focusing on the ch2 scissoring vibrations (1460-1480 cm-1) and the ch2 symmetric stretching vibrations (2848-
2053 cm-1). a) An orthorhombic organization results in a splitting of the scissoring vibrations, while a hexagonal 
packing results in a single vibration. Therefore, an increased bandwidth of the scissoring vibrations is indicative for an 
increased fraction of lipids forming orthorhombic lipid domains. In addition, the ch2 symmetric stretching vibration 
provides information about the conformational ordering of the lipids b); a lower frequency (~2848 cm-1) indicates a 
fully extended chains (high degree of conformational ordering) of the lipids, whereas a high wavenumber (2853 cm-1) is 
indicative for a liquid organization (low degree of conformational ordering).
chapter 6part i i i
114
Supplementary Figure 5: Scatter plot of univariate analysis of the predicted correlation between the cer organization 
(lamellar organization (saxd) and lateral organization (ch2 scissoring) versus the cer organization (the abundance of 
[eo] cers and c34 cers). Gray dotted line represents the optimal fit (r=0.713). Control subjects are indicated by / . 
Non-lesional skin and lesional skin of ae patients are indicated by /  and  / .Open and filled data points indicate 
carriers and non-carriers of flg mutations, respectively.


















Loss-of-function mutation  2282del4  R501X  R2447X  S3247X  
Heterozygous:10  4 4 1 1 
Homozygous: 3  2 1 -  -  
Compound heterozygous: 1 1 1 -  -  
Supplementary Table I. Mutations in the cohort of ae patients.
Supplementary Table II. Characteristics of the subjects
Parameter  Control (n=15)  AE (n=28)  
Age (years)  25.0 ± 5.2 25.6 ± 5.6 
Female gender  10 17 
Total SCORAD  - 28.0 ± 16.1 
TEWL (g/m2/h)  6.5 ± 1.7 12.2 ± 6.5 
NMF (AU)  1.05 ± 0.2 0.66 ± 0.39 



























(P - value) 
 
[EOS] 3.76 ± 0.59  3.43 ± 1.52  0.191  3.66 ± 1.79  3.19 ± 1.22  0.550  
[EOP] 1.43 ± 0.36  1.21 ± 0.36  0.040  1.13 ± 0.33  1.29 ± 0.38  0.270  
[EOH] 4.06 ± 0.87  3.21 ± 0.97  0.019  3.17 ± 1.01  3.25 ± 0.97  0.783  
[EOdS] 0.37 ± 0.26  0.29 ± 0.23  0.286  0.30 ± 0.28  0.28 ± 0.17  0.713  
[NS] 6.88 ± 2.57  9.67 ± 3.44  0.003  9.84 ± 4.20  9.51 ± 2.64  0.646  
[NP] 26.5 ± 2.57  19.85 ± 5.16  <0.001  18.49 ± 4.99  21.21 ± 5.14 0.183  
[NH] 14.01 ± 1.94  12.54 ± 2.63  0.033  12.94 ± 2.83  12.14 ± 2.45  0.462  
[NdS] 9.48 ± 3.75  7.86 ± 2.92  0.063  7.80 ± 2.59  7.92 ± 3.32  0.783  
[AS] 4.57 ± 0.68  8.67 ± 3.48  <0.001  8.95 ± 4.24  8.39 ± 2.65  0.963  
[AP] 14.79 ± 4.96  16.73 ± 4.94  0.308  16.95 ± 5.05  16.52 ± 5.02  0.890  
[AH] 13.07 ± 3.46  15.21 ± 3.66  0.028  15.47 ± 3.59  14.96 ± 3.84  0.462  
[AdS] 1.09 ± 0.32  1.32 ± 0.66  0.272  1.30 ± 0.88  1.35 ± 0.36  0.141  
Supplementary Table III. Statistical data of the relative abundance of the 12 cer subclasses in control subjects versus 
ae patients and ae patients that carry and do not carry flg mutations.
CER  
Control























(P - value) 
 
[AS] C34  0.32 ± 0.11 0.78 ± 0.44 <0.001 0.68 ± 0.48  0.89 ± 0.38 0.089  
[AP] C34  0.10 ± 0.02 0.13 ± 0.06 0.058 0.13 ± 0.07  0.13 ± 0.05 0.232  
[AH] C34  0.16 ± 0.06 0.34 ± 0.14 <0.001 0.30 ± 0.14  0.39 ± 0.13 0.089  
[AdS] C34 0.06 ± 0.04 0.08 ± 0.07 0.337 0.07 ± 0.08  0.09 ± 0.05 0.251  
[NS] C34  0.08 ± 0.04 0.25 ± 0.18 0.002 0.22 ± 0.20  0.28 ± 0.17 0.198  
[NP] C34  0.06 ± 0.05 0.07 ± 0.06 0.936 0.07 ± 0.04  0.06 ± 0.08 0.141  
[NH] C34 0.10 ± 0.04 0.17 ± 0.14 0.045 0.14 ± 0.14  0.20 ± 0.14 0.118  
Supplementary Table IV. Data of the relative abundance of all c34 cers between control versus ae and ae patients 


























(P - value) 
 
CER [EO] (%)  9.62 ± 2.62  8.13 ± 2.47  0.079*  8.26 ± 2.94 8.00 ± 2.00 0.788*
CERs C34 (%)  0.87 ± 0.26  1.83 ± 0.83  0.00017* 1.62 ± 0.95 2.04 ± 0.68 0.185*
Mean chain length (CA) 47.0 ± 0.72 46.4 ± 0.72  0.012** 46.7 ± 0.78 46.4 ± 0.74 0.277**
Supplementary Table V. Statistical overview of the relative abundance regarding cer [eo] and cers c34 for control 
subjects and ae patients. The effect of flg mutations in patients is shown as well.
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Abstract
 One of the features of atopic eczema (Ae) is 
a decreased skin barrier function. The stratum 
corneum (Sc) lipids – comprised of ceramides (Cers), 
free fatty acids (Ffas), and cholesterol – form a highly 
ordered lipid organization that fulfill a predominant 
role in this barrier function. Recently, the detailed 
Cer composition in non-lesional skin has been 
investigated in Ae patients. In the present study, we 
report for the first time i) the extracellular Sc Ffa 
composition, including chain length and degree of 
unsaturation, in both lesional and non-lesional skin; 
and ii) how these factors associate with the examined 
Cer composition and the impaired skin barrier in Ae. 
 The results show a clearly distinguishable lipid 
profile between control skin, non-lesional and 
lesional Ae skin. In particular the Ffa chain lengths 
are clearly reduced in Ae Sc, and the changes are 
much more pronounced in lesional skin than in 
non-lesional skin. The Cer composition and lipid 
organization were also examined in lesional skin and 
compared to data on non-lesional skin, previously 
reported. We noticed a strong reduction in Cer chain 
length and a reduced density in the lipid organization. 
Changes in the chain length distribution of Ffas 
and Cers were strongly associated. In addition, 
we encountered a strong association between a 
reduction in chain length of both lipid classes and the 
increased presence of a less dense lipid organization. 
The changes in lipid organization did also associate 
with a reduced skin barrier function and were more 
pronounced in lesional skin.
 These changes in composition, organization and 
barrier function were strongly observed in lesional 
skin, but already present in non-lesional skin, and 
demonstrate the importance of the Ffas and the 
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lipid chain length for a proper lipid organization and skin barrier function.
Introduction
 Atopic eczema (Ae) is a very common skin disease with a current prevalence of 10-15% in 
developed countries1-5. Ae has multiple manifestations, such as erythema, skin dryness, 
and pruritic skin lesions. The etiology of Ae is complex: it is an multifactorial disease 
in which genetics, environmental factors, and an immune dysregulation all interplay. 
Although the immunological dysregulation is characteristic for Ae patients, the skin 
barrier dysfunction also plays an important role6-10. A reduced skin barrier may result 
in an increased penetration of allergens and irritants, thereby provoking an immune 
response11. A commonly used parameter to indicate a (reduced) skin barrier function is 
transepidermal water loss (TEWL). Patients show increased TEWL values at both lesional 
and non-lesional sites, indicating that the skin barrier is affected in both inflamed and 
non-inflamed regions8,12,13. 
 In 2006 it was reported – and since then replicated in many studies – that loss-of-
function mutations in the filaggrin gene (flg) are a major predisposing factor for 
developing Ae14-17. Filaggrin is a well-known skin barrier protein responsible for proper 
keratin filament alignment18. In addition, filaggrin degradation products – i.e. the natural 
moisturizing factor (NMF) – are important to retain the moist and acidic nature of the 
stratum corneum (Sc), which is the uppermost layer of the skin where the main barrier of 
the skin is located19. However, the reduced skin barrier in Ae cannot fully be explained by 
flg mutations, as i) 50-70% of all Ae patients are non-carriers of such a mutation19 and ii) 
in a number of studies no relation was observed between flg mutations and the impaired 
skin barrier in Ae20-23. 
 Because the lipids play an important role in the skin barrier – also with respect to 
Ae7,24-27 – the aim of this study is to determine the lipid chain length distribution and 
in particular free fatty acid composition in Ae, and their relation with the skin barrier 
function. The Sc consists of corneocytes with a lipid matrix in the intercellular regions. 
The lipids are composed of an approximately equimolar ratio of cholesterol, free fatty 
acids (Ffas) and ceramides (Cers, molecular architecture is explained in Figure 1)28-
31. These lipids are organized in regularly stacked lipid layers24,25,32,33. Within these 
layers, the lipids form a very dense, highly ordered packing – the so-called orthorhombic 
organization – but a subpopulation is also present in a less dense – hexagonal – or even 
liquid organization (Figure 2)34-36. In a recent study we examined the Cer composition 
and lipid organization in non-lesional skin of Ae patients, from which it was concluded 
that a reduction in the average chain length of Sc Cers coincided with an increase in 































































































Figure 1: Explanation of cer subclasses and cer chain length. Cers are composed of a fatty acid chain linked to a 
sphingosine base. Both chains show a wide distribution in their carbon chains length (indicated by the arrows, the 
numbers represent the general distribution). This results in a wide range of the total carbon chain length of cers, that is, 
the carbon atoms of the two chains combined. In addition, cers can have an additional functional group at the carbon 
positions labeled in red, which results in the presence of 12 subclasses, denoted as: [nds], [ads], [eods], [ns], [as], [eos], 
[np], [ap], [eop], [nh], [ah], [eoh].
the hexagonal organization. These changes in Cer composition and lipid organization 
strongly correlated to the degree of skin barrier dysfunction, suggesting that Cer chain 
length may be a key factor for a proper lipid organization and impaired skin barrier 
function in non-lesional Ae skin37. 
 Building on these recent findings in non-lesional skin, this study presents for the first 
time a detailed analysis of the Ffas chain length distribution in lesional as well as in non-
lesional Ae skin. We focused on the chain length distribution as well as on the presence of 
mono-unsaturated Ffas (MUFAs) and the very sparsely studied hydroxy-Ffas. Previously, 
a wide chain length distribution has been observed in healthy subjects ranging from 
mainly 16 to 36 carbon atoms38-40. To the best of our knowledge, only one study reports 
on the Ffa chain length in Ae patients, mentioning the very long chain fatty acids only. 
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They observed a decreased presence of Ffas longer than 24 carbon atoms41. Based on our 
detailed Ffa analysis, we studied the association of changes in chain length distribution 
of the Ffas with the chain length distribution of the Cers, as literature reports a common 
synthetic pathway for both lipid classes42,43. It was found that the average Ffa chain 
length in Ae patients is shortened, which is in conjunction with a reduced Cer chain 
length. In addition, we examined possible correlations between changes in chain length 
profiles of the Ffas (and Cers) versus i) a modulation in lipid organization, ii) a reduction 
in skin barrier function monitored by tewl and iii) flg mutations. 
Materials and Methods
General study setup
 The study is in accordance to declaration of Helsinki and consists of 15 Caucasian 
control subjects (25.0±5.2 years; 5 males) and 28 Caucasian Ae patients (25.6±5.6 years; 
11 males), of which 11 did show lesional skin sites at the day in which all measurements 
were performed. Patients were screened by the four most prevalent mutations found 
in the European population (2282del4, R501X, S3247X and R2447X): 14 patients and 2 
control subjects appeared as carriers for a flg mutation. No dermatologic products were 
Figure 2: Lateral organization 
in human stratum corneum. 
(1) The outermost layer of 
the epidermis, the stratum 
corneum (sc), consists of dead 
cells (corneocytes) embedded 
in a lipid matrix, also referred 
to as the brick (corneocytes) 
and mortar (lipids) structure 
(2). The intercellular lipids are 
arranged in layers (lamellae). 
The lateral organization is 
the plane perpendicular to 
the direction of the lamellar 
organization. There are three 
possible arrangements of the 
lipids: a very dense, ordered, 
orthorhombic organization; a 
less dense, ordered, hexagonal 
organization; or a disordered, 
liquid organization.
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applied on the forearms of any of the subjects at least one week prior to the study. Various 
techniques to study the lipid composition and organization are described in more detail 
below. All measurements were performed on both non-lesional skin and lesional skin (if 
present) of the ventral forearms. A dermatologist marked an area of 4.5 cm2 on the ventral 
forearm of the control subjects and Ae patients. On this area, the TEWL was measured 
using an open chamber Tewameter TM 210 (Courage+Khazaka, Köln, Germany) device. 
Values were recorded for a period of two minutes after which an average reading during 
the last 10 seconds of the measurement was calculated. This procedure was performed 
before tape stripping (baseline TEWL) and after each two tape strips.
 Sc lipids were obtained by tape stripping. In between each 2 tape strips, FTIR 
measurements were performed to study the lipid organization. In order to determine 
flg mutations, buccal mucosa cells were collected by rubbing the inside of the cheeks 
with a cotton swab on a plastic stick after rinsing the mouth with water. Mutations were 
determined by genotyping after DNA extraction15.
Tape stripping procedure and Lc/Ms analysis
 Sc lipids were harvested using multiple poly(phenylene sulfide) tape strips (Nichiban, 
Tokyo, Japan). Successive tapes were pressed on the marked area using a pressure device, 
and were removed in one fluent stroke using tweezers. To avoid contamination of surface 
lipids (e.g. sebum), tape strips 1-5 were discarded and only tapes 6 to 9 were used for 
lipid analysis of non-lesional skin and – if possible – from lesional skin. The tapes were 
punched to an area of 2 cm2 and stored in chloroform/methanol/water (1:2:½) at a dark, 
cold (-20°C), and dry environment, under argon atmosphere. Afterwards, lipid extraction 
of all samples was performed using an adapted procedure of the Bligh and Dyer method 
described by Thakoersing et al.44 Lipids were reconstituted in chloroform/methanol/
heptane (2½:2½:95) and ready for analysis by LC/MS using a recently developed method 
for analysis of both Cers and Ffas45,46 (van Smeden, unpublished data). Figure 1 explains 
the nomenclature (according to Motta et al.47) and variation in chemical structure for 
these Cer subclasses.
 Prior to the analysis of the Ffa composition, a particular problem for the quantification 
of Ffa C16:0, C17:0, C18:0 and C18:1 was encountered. These endogenous lipids are also 
present in the tape-strips used to harvest the Sc, thereby interfering with the analysis 
of Sc Ffas (van Smeden, unpublished data). However, it was possible to correct for the 
amount of these lipids on the tape. This procedure is explained in detail in the supplement 
(Supplementary Figure 1 and Supplementary Table I). 
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Lateral lipid organization by ftiR and its principles
 Fourier transform infrared spectroscopy (FTIR) spectra were recorded after each two 
tape-strips in order to obtain information on the lateral organization and conformational 
ordering of the lipids. A Varian 670-IR spectrometer (Varian Inc., Santa Clara, CA) equipped 
with a broad band mercury-cadmium-telluride (MCT) detector and an external sample 
compartment containing a Gladiatr (Pike, Madison, WI) attenuated total reflection (ATR) 
accessory with a single reflection diamond was used. The spectral resolution was 2 cm-1. 
The instrument was continuously purged with dry N2. Each spectrum was an average of 
150 scans. For data treatment, the instrument software Resolutions Pro 4.1 (Varian Inc.) 
was used. Positions of the CH2 symmetric stretching vibrations and scissoring bandwidth 
were calculated as described previously48,49. Shortly, the second derivative was calculated 
and it was baseline-corrected between the endpoints of the scissoring region (~1460-1480 
cm-1). We calculated the bandwidth at 50% of the peak height (full width half maximum, 
FWHM) and determined CH2 symmetric stretching vibration positions of spectra recorded 
between the removal of 2 to 10 tape strips. The width of the peak is indicative for the 
size and amount of orthorhombic lipid domains50. The stretching peak position indicates 
whether lipids are present in either a highly ordered organization (low peak position at 
~2848 cm-1) or a disordered/liquid phase (high peak position ~2853 cm-1). 
Data analysis
 All statistical outcomes were determined using SPSS Statistics 17.0. In general, data was 
not Gaussian distributed and therefore non-parametric Mann-Whitney tests are more 
appropriate when 2 groups were compared, and Spearman’s ρ correlation coefficients are 
shown. Jonckheere trend tests were performed to assess significance of trends between 
control, non-lesional and lesional Sc. Differences were considered significant when 
P<0.05. For some subjects in some of the parameters, data could not be determined and 
therefore missing. These data points were not replaced but are left blank. For lesional 
skin it was in a few cases not possible to obtain 4 tape strips. In that case we used merely 
2 or 3 tapes. This is one of the reasons why we do not report absolute data on the lipid 
composition, but rather relative values. Another important reason for presenting relative 
data is because the lipid composition is compared to the lipid organization. The latter 
is depending on the relative amounts of the former, rather than absolute amounts. We 
therefore chose for presenting relative data.
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Figure 3: Ffa data on controls, non-lesional ae and 
lesional ae (labeled as green, orange, or red bars, 
respectively). The total amount of all ffas was set to 
100%. a) Bar plots showing the relative abundance 
of the ffa subclasses (saturated, mufa, hydroxy-ffa) 
in control sc, non-lesional, and lesional ae skin. There 
is a significant increase and decrease in trend for the 
abundance of mufa ffas (mufas), and hydroxy-ffas, 
respectively, for controls, non-lesional, and lesional 
ae sc (p<0.03). b-d) Chain length distribution 
of saturated ffas, mufas, and hydroxy-ffas, 
respectively, in control sc, non-lesional, and lesional 
ae sc. There is a significant trend of increasing 
abundance of saturated ffas with chain lengths of 16 
and 18 carbon atoms between controls, non-lesional, 
and lesional ae sc (p<0.001). There is a significant 
trend of decreasing abundance of saturated ffas with 
chain lengths of 22 and 30 carbon atoms (except 
c23) between controls, non-lesional, and lesional ae 
sc (p<0.04). There is a significant trend of increasing 
abundance of mufas with chain lengths of 16 and 
18 carbon atoms between controls, non-lesional, and 
lesional ae sc (p<0.04). There is a significant trend 
of decreasing abundance of mufas with chain lengths 
of 20 and 30 carbon atoms (except c22, c23, c24) 
between controls, non-lesional, and lesional ae sc 
(p<0.05). There is a significant trend of decreasing 
abundance of all hydroxy-ffas except c16 between 
controls, non-lesional, and lesional ae sc (p<0.04). 
The total relative amount of these three ffa classes is 
100%. Controls, non-lesional ae skin, and lesional ae 
skin are shown in green, orange and red, respectively. 
Error bars represent the sd. The scatter dot plot in 
e) shows the average ffa chain length. Horizontal 
lines indicate the mean value ±sd. Non-carriers and 
carriers of a flg mutation are represented by filled 
and open data points, respectively. Control subjects 
are indicated by / . Non-lesional skin and lesional 
skin of ae patients are indicated by /  and  / ,
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Results
Altered ffa composition in sc of ae patients
 Ae patients showed – in both lesional and non-lesional skin – an increase in MUFAs at the 
expense of hydroxy-Ffas (Figure 3a), whereas the total level of saturated (non-hydroxy) 
Ffas was unchanged. In lesional skin, changes in levels of the various Ffa subclasses are 
more pronounced than in non-lesional skin. For the saturated Ffas, the chain length 
distribution is notably changed: very long chain Ffas (≥24 carbon atoms) were strongly 
reduced whereas shorter Ffas – in particular C16:0 and C18:0 – were increased (Figure 
3b). These changes in Ffa chain length distribution were more pronounced in lesional 
Sc, but already of significance in non-lesional skin. The MUFAs showed higher levels of 
short Ffas C16:1 and C18:1 in non-lesional and lesional skin compared to the control 
(Figure 3c). Hydroxy-Ffas ≥18 carbon atoms were decreased, predominantly in lesional 
skin (Figure 3d). All these changes resulted in a significantly decrease in average Ffa chain 
length in non-lesional as well as lesional Ae skin compared to controls (20.3±0.9, 18.2±0.6 
and 21.4±0.4 carbon atoms, respectively, P<0.001, Figure 3e). Ffa profiles of Ae patients 
from both lesional and non-lesional skin were compared per subject (pairing), and the 
Table I: Influence of loss-of-function flg 
mutations on several parameters related 






FLG mutation  
(n=2)  P-value
TEWL  6.5±1.7 6.5±1.6 0.933 
FTIR Scissoring Bandwidth  11.6±0.9 11.4±0.2 0.410 
FTIR Stretching peak position  2848.8±0.2 2848.6±0.1 0.305 
NMF levels  1.064±0.217 0.98±0.042 0.800 
Average CER chain length  47.0±0.7 47.4±1.0 0.549 
Average FFA chain length  22.6±0.9 22.6±0.3 0.933 
Abundance of MUFAs  0.129±0.081 0.123±0.055 0.933 
Acyl- CERs total  9.3±2.6 11.6±2.6 0.361 
C34 CERs total  0.87±0.16 0.90±0.76 >0.99 
Parameters








FLG mutation  
(n=5)  P-value  
TEWL  11.4±6.8 13.1±6.2 0.246 25.7±12.1 29.8±12.0 0.662 
FTIR Scissoring Bandwidth 11.1±1.1 10.1±1.4 0.089 10.5±0.8 7.8±1.8 0.016 
FTIR Stretching peak position 2849.0±0.5 2849.3±0.4 0.052 2849.2±0.3 2849.8±0.6 0.151 
NMF levels   0.451±0.195 0.008 0.454±0.18 0.37±0.168 0.662 
Average CER chain length  46.5±0.8 46.3±0.6 0.603 45.0±2.1 43.4±2.4 0.413 
Average FFA chain length  21.2±1.1 21.2±1.7 0.701 19.2±1.7 19.3±2.2 0.841 
Abundance of MUFAs   0.203±0.081 0.329 0.205±0.087 0.225±0.144 0.841 
Acyl- CERs total  8.3±2.9 8.0±2.0 0.713 4.0±0.9 5.8±3.4 0.556 
C34 CERs total  1.62±0.95 2.04±0.68 0.066 6.38±2.55 7.11±1.82 >0.99 
Parameters
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average Ffa chain length was always lower in lesional skin compared to non-lesional skin 
(Supplementary Figure 2). No effects were observed of flg mutation status on the Ffa 
composition, neither in the Ffa chain length, nor in the abundance of hydroxy-Ffas or 
MUFAs (P>>0.1, Table I).
Altered ceR chain length in sc of ae patients
 We compared changes in the Ffa composition of Ae patients in both lesional and non-
lesional sites to changes in Cer composition. Of all Cer subclasses, the overall Cer chain 
length distribution was determined in non-lesional and lesional skin (Figure 4a). Chain 
lengths of all Cer subclasses showed a broad distribution mainly between 32 and 54 
carbon atoms. The only exceptions were the acyl-Cers, which showed a range between 
64 and 74 carbon atoms. This is mainly due to the additional fatty acid moiety attached 
to the Cer. In Ae patients, the level of long chain Cers (>42 carbon atoms) was reduced 
and the level of short chain Cers (<42 carbon atoms) was increased. Differences are 
most pronounced for lesional skin, but were also significantly altered in non-lesional 
skin. Among the short Cers, in particular the Cers with 34 carbon atoms (C34 Cers) 
are increased in Ae (Figure 4b). To obtain more information on which Cer subclasses 
were involved in this strong increase in C34 Cers, we also analyzed the level of all Cer 
subclasses. The relative abundance of the 12 individual Cer subclasses (see Figure 1) in 
lesional skin were combined with those in non-lesional skin previously reported37. The 
most prominent changes in lesional skin are an increase in Cer [NS] and Cer [AS], and a 
decrease in Cer [NP] (Supplementary Figure 3). The Cer chain length distribution shows a 
progressive increase in C34 Cers, predominantly in the Cer [NS] and Cer [AS] subclasses, 
and a reduction of almost 50% was observed for the long chain acyl-Cers in lesional Ae Sc 
(see Figures 4b and 4c). Together, this results in a significant reduction of the average Cer 
chain length in both in non-lesional and lesional Ae Sc, compared to controls (p<0.012, 
Figure 4d).
 A direct intra-subject comparison (paired statistics) between lesional and non-lesional 
skin from the same patient showed a lower average Cer chain length in lesional skin as 
compared to the non-lesional skin sites (Supplementary Figure 2). Since we also observed 
this trend for the Ffas, we calculated the total lipid chain length and compared lesional 
skin with non-lesional skin sites (Figure 5). From these paired observations we noticed 
for each individual a reduction in total lipid chain length at lesional skin sites compared 
to non-lesional skin sites.
 No indications were found that flg mutations have an effect on the lipid composition 
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Figure 4: Cer data on controls, non-lesional ae, and 
lesional ae (labeled as green, orange, or red bars, 
respectively). The total amount of all cers was set to 
100%. a) Bar plots showing the relative cer chain 
length distribution of all subclasses combined. There 
is a significant trend of increasing abundance of cers 
with chain lengths of 32-40 carbon atoms between 
controls, non-lesional, and lesional ae sc (p<0.001). 
There is a significant trend of decreasing abundance of 
cers with chain lengths of 46-50 carbon atoms between 
controls, non-lesional, and lesional ae sc (p<0.04). 
There is a significant trend of decreasing abundance 
of cers with chain lengths of 65-72 carbon atoms 
between controls, non-lesional, and lesional ae sc 
(p<0.05). The relative abundance of the c34 cers and 
acyl-cers are shown in b) and c), respectively. There 
is a significant trend of increasing abundance of cers 
[ns], [np], [nh], [as], [ap], and [ah] between controls, 
non-lesional, and lesional ae sc (p<0.01). There is a 
significant trend of decreasing abundance of cers [eos], 
[eop], [eoh], and total amount of acyl-cers between 
controls, non-lesional, and lesional ae sc (p<0.01). 
100% Corresponds to the amount of all 12 subclasses 
combined. Error bars represent the sd. Nd means 
not detected. The scatter dot plot in d) illustrates the 
average cer chain length. Horizontal lines indicate the 
mean value ±sd. Non-carriers and carriers of a flg 
mutation are represented by filled and open data points, 
respectively. Control subjects are indicated by / . 
Non-lesional skin and lesional skin of ae patients are 
indicated by /  and  /  , respectively.
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without a flg mutation for either lesional and non-lesional skin: neither in the level of 
acyl-Cers (P>0.1), nor in the average Cer chain length (P>0.1), nor in the total level of C34 
Cers (P>0.1).
Relationship between ffa and ceR composition
 As presented in Table II, the average Cer chain length correlated to the average Ffa 
chain length (r=0.60, P<0.001). More precisely, a high abundance of short chain Ffas 
(<23 carbon atoms) is accompanied by a high abundance of short chain Cers (<42 carbon 
atoms), whereas an increased presence of long chain Ffas (>23 carbon atoms) correlates 
to an increase in long chain Cers (>42 carbon atoms), as illustrated by the correlation 





























































Figure 5: a) Dot plots of the calculated total lipid chain length (ffas + cers) for all three groups: control, ae – non-
lesional, and ae – lesional. Non-carriers and carriers of a flg mutation are represented by filled and open data points, 
respectively. Control subjects are indicated by / . Non-lesional skin and lesional skin of ae patients are indicated by  
/  and  /  , respectively. b) Paired plot of the calculated total lipid chain length of a selected subset of patients 
from which both non-lesional and lesional skin was analyzed.
Table II: Spearman 
correlation coefficients of 
lipid composition and lipid 
organization parameters.
Correlated Parameters Correlation coefficient  
Average CER chain length versus average FFA chain length 0.596* 
Average CER chain length versus stretching peak position - 0.567* 
Average CER chain length versus scissoring bandwidth 0.517* 
Average FFA chain length versus stretching peak position - 0.683* 
Average FFA chain length versus scissoring bandwidth  0.727* 
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Altered lipid composition in ae patients corresponds to a less ordered lipid 
organization
 We investigated whether the observed changes in Sc lipid composition in Ae affect 
the lipid organization in these patients. The lateral lipid organization was assessed by 
attenuated total reflectance (ATR) FTIR spectroscopy, primarily focusing on lesional skin 
of Ae patients. Principles of ATR-FTIR measurements are explained in the materials and 
methods section. The stretching peak position in Ae patients was located at a higher 
wavenumber compared to control subjects in both non-lesional as well as lesional Ae Sc 
(P<0.001; Figure 6a). This indicates that the organization of Sc lipids in Ae patients is less 
ordered compared to control subjects. The difference in stretching peak position between 
lesional and non-lesional skin was not significant (P=0.083). 
 To obtain information about the hexagonal or orthorhombic organization of Sc lipids, 
the scissoring bandwidth was determined. Lesional Sc of Ae patients shows a scissoring 
bandwidth of 9.1±1.9 cm-1, which is significantly lower than the bandwidth in non-lesional 
skin of Ae patients (10.6±1.3 cm-1) and in control skin (11.6±0.8 cm-1; P<0.001; Figure 
6b). This indicates that the subpopulations of lipids in a highly ordered orthorhombic 
phase are less dominantly present in lesional skin in Ae compared to non-lesional skin of 



























































FTIR scissoring bandwidtha) b)
p<0.001 p=0.083
p=0.010 p=0.026
Figure 6: Scatter dot plots of a) the ftir ch2 stretching peak position and b) the ftir ch2 scissoring bandwidth for all 
three groups: control, ae – non-lesional, and ae – lesional. Non-carriers and carriers of a flg mutation are represented 
by filled and open data points, respectively. Control subjects are indicated by / . Non-lesional skin and lesional skin of 
ae patients are indicated by /  and  /  , respectively. 
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 Regarding the influence of flg mutations, a significant difference was observed for 
the scissoring bandwidth in lesional skin between Ae patients with and without a flg 
mutation: P=0.016. This was not found for the stretching peak position (P>0.05).
 Table II shows that the average Cer chain lengths correlate to a high extent with the 
change in lateral lipid ordering (|r|>0.51; P<0.001), and the correlation of Ffa chain 
length with the change in lateral lipid ordering is even stronger (|r|>0.68; P<0.001). 
Supplemental Figures 5a and b show this correlation between Ffa chain length and FTIR 
bandwidth in more detail (r=0.73; P<0.001): It becomes clear that Ffas with chain lengths 
≤20 relate to a lower FTIR bandwidth (more hexagonal lipid organization) whereas Ffas 
with chain lengths ≥24 associates with a higher FTIR bandwidth and therefore more 
orthorhombic lipid organization.
Skin barrier function shows a high affinity with lipid chain length and lipid ordering
 Supplemental Figure 6 shows that the TEWL is significantly increased in non-lesional as 
well as lesional Ae Sc compared to controls (12.2±6.5 g/m2/h, 27.6±11.6 g/m2/h, 6.5±1.7 
g/m2/h, respectively, p<0.0005). Figure 7a shows that the increase in TEWL associates very 
well with the average lipid chain length: a reduction in average chain length corresponds 
to an increase in TEWL (r=-0.80, P<<0.001). Short lipid chain Ffas and Cers (<20 and <41 
carbon atoms, respectively) correlate positively with TEWL, whereas long lipid chains (>23 
and >42 carbon atoms for Ffas and Cers, respectively) are negatively correlated (Figures 
7b and c). Also for the lipid organization a high correlation with TEWL was observed 
for both the scissoring bandwidth and the stretching peak position (Figure 7d and e): a 
decrease in lipid ordering corresponds to an increase in TEWL.
Discussion
 As there is increasing evidence that Sc lipids play a role in the impaired barrier function 
of Ae7,27, we investigated the lipid chain length distribution in Sc of Ae patients, focusing 
on Ffas. In addition, we examined the Cer composition in lesional skin in these patients. 
A clear shift to shorter Sc lipid chain lengths was observed in Ae patients for both Cers 
and Ffas. Short chain Ffas (≤20 carbon atoms) showed a negative correlation with FTIR 
bandwidth and long chain Ffas (≥24 carbon atoms) showed a positive correlation with 
FTIR bandwidth. Previous in vitro studies with lipid model systems have shown that 
the formation of the hexagonal organization is strongly enhanced by a decreased Ffa 
chain length51. This leads to the conclusion that the Ffa chain length is an important 
determinant for the lipid organization in Ae: short chain ffas enhance the formation 























































































Stretching peak position (cm-1) Scissoring bandwidth (FTIR bandwidth, cm-1)
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Figure 7: a) Correlation plot in which the lipid chain length of all individual subjects is plotted versus the tewl. The 
dashed line indicates the optimal fit through the data. b) and c) present bar plots in which each individual chain length 
of respectively ffas and cers is plotted versus their respective spearman correlation coefficients with tewl. The dashed 
line indicates the moving average (period = 3). d) and e) are correlation plots of the tewl vs either the stretching peak 
position or the scissoring bandwidth, respectively. The dashed lines indicate the optimal fit through the data. Non-
carriers and carriers of a flg mutation are represented by filled and open data points, respectively. Control subjects 
are indicated by / . Non-lesional skin and lesional skin of ae patients are indicated by /  and  /  , respectively. 
Concerning the correlation plots, spearman correlation coefficients are plotted in the upper right corner.
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orthorhombic lipid organization. Furthermore, we observed an increased level of MUFAs 
in Sc of Ae patients, which also correlated to the presence of a hexagonal lipid organization 
in in vitro studies (unpublished results).
 The reduction in Ffa chain length matches the presence of shorter Cers: Ae patients 
showed a shift from long chain Cers (≥43 carbon atoms) towards short chain Cers (≤42 
carbon atoms). It has been reported that the sphingosine base in Cers is on average about 
18-20 carbon atoms long52. Using these numbers in estimating the acyl chain length in 
the Cers, our results suggest that Cers having an approximate acyl chain length of ≥23 
carbon atoms (42 minus 18-20 carbon atoms) are decreased in Sc of Ae patients. This 
matches our observations in the decreased levels of Ffas >23 carbon atoms. In addition, 
the high levels of C34 Cers in Ae patients correspond to an acyl chain length similar to 
the 16 carbon atoms of the Ffas. The level of this particular Ffa is also highly elevated in 
these patients. These correlations between Cers and Ffas demonstrate for the first time 
that the acyl chain length in Cers correlates with the Ffa chain length, which is a strong 
argument for a common synthetic pathway42,43. 
 The reduction in long chain Ffas corresponds to a reduction in long-chain acyl-Cer 
levels in Ae. These acyl-Cers are also crucial for a proper organization of the lipids: in 
vitro studies have shown that a reduced level of acyl-Cers results in a less thermostable 
orthorhombic organization53. The decreased amount of acyl-Cers in Ae patients could 
also play an important role in the reduced skin barrier function, as permeability studies 
have shown that lower levels of acyl-Cers results in increased permeation54, or could 
even lead to neonatal death by epidermal dehydration in mice completely lacking acyl-
Cers40. Therefore, not only the changes in Ffa composition, but also reduced levels of 
acyl-Cers may contribute to the increased hexagonal organization and impaired skin 
barrier function in Ae.
 TEWL is a commonly accepted measure of skin barrier integrity. The results demonstrate 
that the increase in TEWL is strongly associated with the decreased lipid chain length. In 
other words, an increased abundance of short lipid chains contributes to an increased 
TEWL in Ae, whereas an increased presence of long chain lipids correspond to lower TEWL 
values. In addition, the increased TEWL values observed in Ae patients show a strong 
association with the altered lipid organization in Ae. This raises the question whether 
the changes in lipid chain length are causative for the changes in lipid organization and 
increased TEWL. Previous in vitro studies by Groen et al. with model lipid membranes 
demonstrate that a shorter Ffa chain length leads to an increased permeability of benzoic 
acid51.
 These findings provide new fundamental insights for possible barrier repair: the 
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presence of long-chain lipids may be crucial for the lipid organization and therefore a 
proper skin barrier function. A possible treatment to compensate for the reduced long 
chain lipids may therefore focus on topical application of long-chain lipids. Our observed 
relation between the Ffas and Cers also imply that normalization of the Ffa chain length 
distribution in Ae skin will also contribute to normalization of the Cer chain length 
distribution in these patients. As discussed below, most probably the elongase enzyme 
family will play an important role here.
 One of the challenges is to unravel the changes in the biochemical synthesis of the lipids 
that are responsible for the altered Sc lipid composition in Ae, as this may result in new 
targets for normalizing the skin barrier function. The shift to a shorter Ffa chain length 
distribution suggests that Ffa elongation is hampered to some extent. It is known that 
elongation of Ffas ≥C16 occurs by a series of elongases, ELOVL 1-755, all having a certain 
selection towards a specific Ffa chain length43. Currently, little is known about these 
elongases in the epidermis. It has been reported that ELOVL 1, 3, 4 and 6 are expressed 
in mammalian skin56. Only ELOVL4 is identified in the epidermis on a protein level and 
plays a crucial role in the elongation of Ffas ≥C2440,57. Our data on Ae shows a decrease in 
Ffas ≥C24, from which we hypothesize that the ELOVL4 protein level and/or activity may 
be decreased in Ae patients. Although no information has been reported on humans with 
respect to Ae, two studies in ELOVL4 knockout mice demonstrate a strong reduction in 
very long chain Ffas, supporting our hypothesis40,58. In addition, the loss of functional 
ELOVL4 in mice has been related to a reduced level of hydroxy-Ffas, in particular long 
chain hydroxy-Ffas40. Interestingly, in our study a reduced level of hydroxy-Ffas is also 
observed. As we also observed increased levels in Ffas with 16 and 18 carbons, ELOVL6 
and ELOVL1 – which are the major enzymes involved in elongation of respectively 
Ffas>C16 and Ffas>C18 – may also be reduced in activity in the epidermis of patients 
with Ae. Furthermore, if the elongation of these short chain Ffas is hampered, an 
alternative metabolic pathway may also become more important. This pathway involves 
the synthesis of MUFAs by stearoyl-CoA desaturases (SCDs)59. Indeed an increased level of 
MUFAs with chain lengths of 16 and 18 carbon atoms is observed in Sc of Ae patients that 
may be caused by an increased activity of SCD. Another aspect that should be considered 
is the importance of the sebaceous lipids in relationship to the Sc barrier. Previous studies 
have reported an altered level of sebaceous lipids in Ae, which may affect the Sc barrier 
function in these patients60-62.
 Eleven Ae patients had both lesional and non-lesional sites at their ventral forearms. 
We could therefore perform an intra-subject comparison of non-lesional and lesional 
skin. The shift to shorter Ffa and Cer chain lengths was more pronounced in lesional 
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skin compared to non-lesional skin. These changes in lipid composition can mainly 
be attributed to inflammation, although increased levels of cutaneous microbes (e.g. 
Staphylococcus aureus), genetic mosaicism18 or environmental factors could also play a 
role. Cytokines, which play a role in inflammation, are capable of interfering to a large 
extent with the lipid synthesis in multiple ways: they have shown to be involved in i) 
reduced levels of enzymes involved in Cer synthesis (e.g. β-glucocerebrosidase and acid 
sphingomyelinase), thereby affecting the Cer composition63; ii) peroxisome proliferator-
activated receptors (PPARs), which are closely related to the skin lipid metabolic pathway 
and show a relation to Ae64: PPAR-α and PPAR-β/δ are respectively down- and upregulated 
in Ae patients65,66. These nuclear receptors promote Sc barrier formation and are 
suggested to have anti-inflammatory properties in skin67-70; iii) TNF-α and several other 
cytokines, which downregulate filaggrin expression71-73. This may result in lower NMF 
levels thereby affecting the local pH. It has been suggested that such a pH change may 
alter the lipid synthesis in the epidermis74. This is emphasized by the importance of 
environmental factors that can also raise the pH of the  skin, of which washing the skin 
with soap and other detergents may be the most important one75,76.
 Downregulation of filaggrin expression may be a factor interfering with flg mutations 
and lipid parameters. This can explain the absence of a correlation between flg mutations 
and lipid parameters. This suggests that mutations in the flg genotype have no direct 
effect on the metabolic skin lipid pathways, but can indirectly affect these pathways via 
the filaggrin breakdown products (NMF)3737. Most enzymes involved in lipid synthesis 
are pH dependent, and changes in NMF levels caused by flg mutations may therefore 
indirectly lead to a dysfunction in lipid synthesis and skin barrier function.
 Summarizing, we analyzed the Sc lipid chain length distribution in non-lesional and 
lesional skin of Ae patients. The results demonstrate an increased presence of short chain 
Ffas and a decreased presence of long-chain Ffas in Sc of Ae patients. These changes are 
in line with the changes observed for the Cers, and lead to an altered lipid organization 
and decreased skin barrier function in Ae. The outcomes of this study do not only give 
more insights in fundamental Sc lipid knowledge, but also suggest possible new targets 
for future drug therapy for both lesional and non-lesional Ae skin.
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Supplementary data
 Quantitative analysis of ffa C16:0 and C18:0, correcting for tape strip contamination 
Recently, we developed a method that enables analysis of ffas by lc/ms, and applied 
that method on tape-stripped sc. However, endogenous C16:0, C17:0, C18:0, and C18:1 
ffas are abundantly present on control tapes (blanks), thereby interfering with the 
results. To correct for the amount of these four endogenous lipids on tape, it was not 
possible to simply subtract a certain amount of these lipids as the tape appeared to be too 
inhomogeneous for a reliable correction: We observed that the amount could vary ~100 
fold. Therefore, a more comprehensive correction method was needed that corrects for 
these 2 lipids for each individual tape strip. 
 Although the variation in absolute amounts of endogenous lipids is very high, we 
observed that the ratio of these lipids is always the same. In example, C16:0 is always 
linearly correlated to the amount of C18:0, which can be appreciated from Supplementary 
Figure 1a. We also analyzed two peaks which appear in blank tape strips but not in human 
sc, possibly exogenous lipids. Again, a very high correlation was observed between the 
amounts of the two unidentified peaks (Supplementary Figure 1b). The amount of these 
two lipid peaks also correlates very well (but not perfectly) to the amount of the four 
endogenous ffas (Supplementary Table I). Hence, by quantifying the two exogenous 
lipids on tapes that do not interfere with sc from in vivo subjects, we could calculate 
the predicted amount of endogenous lipids C16:0, C17:0, C18:0, C18:1. Indeed, we were 
able to successfully correct for the amount of contamination of these lipids. However, we 
mention that the methodological error does increase since we did not observe perfect 
correlations: Since the R2-values of the correlations are around 0.85-0.95, the expected 
increment in error is around 10%. Nevertheless, either taking into account or completely 
leaving out the C16:0 and C18:0 data did not change any of the conclusions that could be 
drawn from the data.
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R2 = 0.991 R2 = 0.986
b)
Supplementary Figure 1: Tape strips were analyzed to obtain information on the amount of endogenous lipids that 
interfere with data from sc lipids, and how to correct for this contamination. Data are presented as scatter dot plots and 
their correlations of a) endogenous ffas c16:0 versus c18:0 (r2=0.991) analyzed from control tape strips. b) Exogenous 
ions m/z 365.3 amu versus 393.3 amu. Data points include control tape strips as well as tapes from all subjects.
Supplementary Table I: Correlation coefficients (r2) between 
the endogenous lipids and the two exogenous lipids.
Correlation Coefficient
Endogenous
lipid Exogenous ion 1
(m/z = 365.3 amu)
Exogenous ion 2
(m/z = 393.3 amu)
C16:0 0.917  0.852  
C17:0 0.862  0.855  
C18:0 0.942  0.903  
C18:1 0.944  0.890  
The correlation coefficients state the accuracy in 
which the amounts of the two exogenous ions (viz. 
m/z 365.3 and 393.3 amu) are correctly predicting 
the amount of endogenous lipids related to the tape. 
In general, exogenous ion 1 was chosen to predict 
the amount of endogenous lipids, as the correlation 











































































































p<0.005 p<0.05 p=0.20 p<0.05
Supplementary Figure 2: Paired data of non-lesional and lesional ae skin for the ffa chain length, cer chain length, 
ftir stretching peak position and ftir bandwidth. P-values are calculated from the Wilcoxon signed rank test. Non-
lesional skin and lesional skin of ae patients are indicated by /  and  /  , respectively. Open and filled data points 
indicate carriers and non-carriers of flg mutations, respectively.
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Supplementary Figure 3: relative cer composition of each subclass for control (green), ae – non-lesional (orange), 
and ae – lesional (red).










































Supplementary Figure 4: Correlation map. On the horizontal axis are the individual cer chain lengths, whereas on 
the vertical axis are the individual ffa chain lengths. Strong negative or positive correlations are depicted in blue or 
red, respectively. Gray strokes indicate the tipping point of the chain length correlations; in other words, where positive 
correlations turn into negative correlations and vice versa.
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Supplementary Figure 5: a) Correlation plot in which the scissoring bandwidth of all individuals is plotted versus the 
mean ffa chain length. The gray dashed line indicates the optimal linear fit. Control subjects are indicated by / . Non-
lesional skin and lesional skin of ae patients are indicated by /  and  /  , respectively. Open and filled data points 
indicate carriers and non-carriers of flg mutations, respectively. b) Bar plots demonstrating the correlation between 
each individual ffa chain length (x-axis) versus the ftir scissoring bandwidth. Positive correlation coefficients indicate 
that these ffas contribute to a more ordered lateral lipid packing, whereas ffas with negative correlation coefficients 
contribute to a less ordered packing of the lipids. The dashed line indicates the moving average (period = 3). 































































































Supplementary Figure 6: tewl levels in control 
subjects, non-lesional sc and lesional sc of ae patients. 
Control subjects are indicated by / . Non-lesional 
skin and lesional skin of ae patients are indicated 
by /  and  /  , respectively. Open and filled 
data points indicate carriers and non-carriers of flg 
mutations, respectively. Means are indicated by gray 
horizontal lines and their corresponding values (±sd). 
Significant differences were observed between control 























FFAs <C23 FFAs >C23
CERs <C42  0.496*
CERs >C42  -0.429* -0.481*
-0.541*
Spearman correlations showing that short cers correlate positively 
with short ffas and negatively with long ffas, and vice versa for long 
cers. *:p<0.01.
Supplementary Table II: Correlations between short/long cers versus 
short/long ffas.
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Abstract
 The barrier function of the skin is primarily provided 
by the stratum corneum (SC), the outermost layer of 
the skin. Skin barrier impairment is thought to be a 
primary factor in the pathogenesis of atopic eczema 
(AE). Filaggrin is an epidermal barrier protein and 
common mutations in the filaggrin gene strongly 
predispose for AE. However, there is no strong 
evidence that filaggrin mutations are related to the 
reduced skin barrier in AE. It was recently shown 
that the SC lipid composition and organization play a 
role in the reduced skin barrier in AE.
 We determined the dry SC mass per surface area of 
controls and AE patients as well as the ratio between 
lipid and protein bands in the Raman spectra being a 
measure for the lipid/protein ratio in SC. The results 
show that the dry SC mass per skin area is altered 
only in lesional SC of AE patients compared to control 
subjects. Much more pronounced was the observed 
reduction in the lipid/protein ratio in SC of AE 
patients, both in lesional and non-lesional SC. These 
changes correlate with the barrier function and may 
indicate that the lipid/protein ratio plays a role in 
the reduced skin barrier function in AE. 
Introduction
 Atopic eczema (AE) is a chronic relapsing, in-
flammatory skin disease characterized by erythema, 
pruritus, and xerosis. AE is currently affecting over 
15% of Caucasian children and 2-10% of adults, and 
its prevalence is increasing1-4. Eczematic lesions 
have a red, flaky appearance and cause severe itching. 
There is increasing evidence that AE is related to an 
impaired skin barrier function5,6. AE is strongly 
associated to mutations in the filaggrin gene (flg), 
encoding the barrier protein filaggrin7. Filaggrin has 
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a role in the alignment of keratin filaments, facilitating the flattening of keratinocytes 
during terminal cornification8. In addition, filaggrin is metabolized into hygroscopic 
molecules, together with specific salts and sugars referred to as the natural moisturizing 
factor (NMF), which is important for SC hydration9. Despite the fact that an impaired 
barrier function has been demonstrated in adult AE patients, the precise role of filaggrin 
for the skin barrier function is not completely understood and compelling evidence that 
flg mutations are the cause of the reduced barrier function in AE is missing10-12. 
 The primary function of the skin is to reduce epidermal water loss and to prevent the 
penetration of harmful agents by acting as a permeability barrier to the environment. 
This barrier is provided by the stratum corneum (SC), the outermost layer of the skin. 
It contains nonviable corneocytes oriented parallel to the skin surface. The corneocytes 
are surrounded by a cornified cell envelope, consisting of a densely cross-linked layer of 
proteins. This envelope reduces the uptake of most substances into the corneocytes and 
therefore redirects the transport of most substances along the intercellular regions13. 
The intercellular regions are filled with highly organized lipids with a characteristic 
composition and organization. For this reason, lipid composition and organization are 
considered to be crucial for an adequate skin barrier function. The major lipid classes in 
the SC are ceramides (CERs), free fatty acids, and cholesterol. 
 In previous studies, changes have been observed in the CER composition of non-lesional 
as well as lesional SC of AE patients5,14-18. Changes in several of the CER subclasses correlate 
with a reduced skin barrier function as measured by transepidermal water loss (TEWL). 
More recently, strong evidence was observed that besides changes in CER subclasses, 
the CER chain length plays a prominent role in the impaired barrier function of AE skin: 
in non-lesional SC of AE patients both CER chain length and skin barrier function were 
significantly reduced19.
 Besides the lipid composition and organization, the lipid/protein ratio in the SC as well 
as the SC thickness may affect the skin barrier function. The aim of the present study was 
to determine the lipid/protein ratio in SC of control subjects and AE patients. In addition, 
the dry SC mass per surface area was determined, being a measure for the SC thickness. 
Subsequently, these parameters were related to the barrier function of the skin, as 
measured by TEWL. The results show that the dry SC mass per surface area is altered in 
lesional AE SC but not in non-lesional AE SC, as compared to controls. The lipid/protein 
ratio is lower in both non-lesional and lesional SC in AE compared to that in SC of control 
subjects. The lipid/protein ratio correlates strongly with TEWL values. Therefore, besides 
lipid composition and organization, the lipid/protein ratio may be an important factor in 
the impaired skin barrier function in ae patients. 
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Materials and Methods
Study population and study setup
 The study was approved by the Medical Ethics Committee of the Leiden University 
Medical Center and conducted in accordance with the Declaration of Helsinki Principles. 
All subjects gave written informed consent. Twenty-eight Caucasian AE patients 
(25.6 ± 5.6 years; 11 males) and fifteen Caucasian control subjects without (history of) 
dermatological disorders (25.0 ± 5.2 years; 5 males) were included. In the AE group, 14 
patients were carrier of at least one prevalent flg null allele. At the time of the study, 
11 out of 28 AE patients suffered from eczematic lesions on at least one of the ventral 
forearms. The subjects did not apply any dermatological products to their forearms for at 
least one week prior to the study. Measurements were performed in a temperature and 
humidity controlled room, in which the subjects were acclimatized for 45 minutes prior 
to the measurements. All measurements were performed on a single day. A dermatologist 
marked an area (~4.5 cm2) of non-lesional skin and, if applicable, an area (~4.5 cm2) of 
lesional skin on the forearm of each AE patient at the start of the study day. The Raman 
spectroscopy measurements were performed on these marked areas. After the Raman 
measurements, the same skin areas were tape stripped while TEWL was monitored after 
each two tape strips. At the end of the study day, buccal mucosa cells were collected with 
a cotton swab for flg genotyping. 
Flg mutation analysis
 All subjects were screened for any of the four most prevalent mutations found in 
the European Caucasian population (2282del4, R501X, R2447X, S3247X), as described 
previously19.
 
Skin barrier function assessment
 TEWL was monitored using a Tewameter TM 210 (Courage+Khazaka, Köln, Germany). 
The marked area on the subjects’ ventral forearm was placed in an open chamber, and 
TEWL values were recorded for a period of at least two minutes after which an average 
reading was calculated from the last 10 seconds of the measurement. Recordings were 
performed prior to tape stripping (baseline TEWL) and after each second tape strip, to 
assure proper monitoring of the changes in skin barrier function.
Confocal Raman microspectroscopy
 Confocal Raman microspectroscopy (3510 Skin Composition Analyzer, River 
Diagnostics, Rotterdam, The Netherlands) was used to determine the lipid/protein ratio 
143
of the ventral forearm. The principles of Raman spectroscopy and the procedures have 
been described elsewhere20,21. 
 Spectra were recorded in the high wavenumber spectral region (2500-4000 cm-1) using 
a 671 nm laser. The spatial resolution was 5 cm-1. Laser power on the skin was 20 mW. 
Spectra were obtained from the skin surface to a depth of 40 μm with 2 μm steps. This was 
repeated on 15 different locations within the marked area. In order to avoid interfering 
Raman signals from skin surface contamination, such as sebum, and to avoid influences 
of washout effects and desquamation near the skin surface, as well as to avoid Raman 
signals from the viable epidermis, we determined the lipid/protein ratio between depths 
of 4-10 μm in the SC. This was performed by calculating the ratio of the integrated signal 
intensity from 2866 to 2900 cm-1 (CH2 asymmetric stretching of lipids) and from 2910 
to 2966 cm-1 (CH3 symmetric stretching of proteins, the same region as taken for the 
protein band for determination of the water concentration in skin20) and taking into 
account a linear baseline between the integration boundaries. The calculated signal ratio 
between the lipid and protein bands is referred to as the lipid/protein ratio. Calculations 
were performed using SkinTools 2.0 (River Diagnostics, Rotterdam, The Netherlands).
Sc isolation and lipid extraction 
 In order to obtain Raman spectra of human SC lipids and extracted human SC, human 
SC was isolated by trypsin digestion as described elsewhere22. The SC lipids were extracted 
according to a modified Bligh and Dyer procedure23 with the addition of 0.25M KCl to 
extract polar lipids. 
Tape stripping procedure
 Multiple poly(phenylene sulfide) tape strips (Nichiban, Tokyo, Japan) were successively 
applied at the same area (4.5 cm2) on the marked area of the ventral forearm. All tapes were 
applied on the targeted skin and pressed for 5 seconds at 450 g/cm2 using a D-Squame 
pressure instrument (Cuderm Corp., Dallas, TX). Tweezers were used to remove the 
tape in a fluent stroke, using alternating directions for each subsequent tape strip. The 
Squamescan 850A (Heiland electronic, Wetzlar, Germany) was used to determine the dry 
SC mass removed by each tape strip. 
 The calibration procedure of the Squamescan was as follows: Immediately after 
measuring the absorption of the tape strip with the Squamescan, the tapes were incubated 
and shaken overnight in 1 mL 1M KOH, after which the extracts were neutralized with 79 
μl 12M HCl. The final pH of the extract was set between 7.2-7.4 with 1M HCl and/or 1M 
KOH. Subsequently, 50 μl of the extract was added to 200 μl bicinchoninic acid (BCA, Pierce 
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BCA, Protein Assay, Perbio Science BV, Etten-Leur, The Netherlands), followed by heating 
for 2 hours at 37°C and determination of the absorption at 562 nm (OD562). In this way, 
we obtained corresponding OD562 values of the tape extracts with known Squamescan 
values. Sheets of isolated human SC with known weight (between 10-1000 μg, size ~0.05-
1 cm2) were incubated overnight and treated as described above, resulting in a calibration 
curve of dry SC mass against OD562. With this curve, we converted Squamescan values of 
the tapes via their OD562 values into dry SC mass, which resulted in a calibration curve 
of Squamescan values against dry SC mass. In addition, 1/TEWL was plotted against the 
cumulative amount of tape stripped SC. Here, the intercept with the x-axis obtained by 
extrapolation is a measure for the dry SC mass per surface area24. This extrapolation was 
only performed with curves having a R2≥0.9.
Statistical analysis
 Statistical analysis was performed using SPSS Statistics version 17.0. As the data 
show a non-normal distribution, non-parametric Mann-Whitney tests were performed 
for comparison of different groups with a significance level of P<0.05. For the paired 
comparison of non-lesional and lesional SC, a Wilcoxon signed rank test was used. Bivariate 
analysis and Spearman’s ρ correlation coefficient were used to analyze correlations 
between parameters. 
Results 
 From the TEWL values and the cumulative amount of stripped SC, the dry SC mass 
per skin area was calculated. Figure 1 shows typical examples of 1/TEWL against the 
cumulative amount of tape-stripped SC of three AE patients. The abscissa intercept by 
extrapolation is indicative for the dry SC mass per cm2. In the examples in Figure 1, the 
dry SC mass varies between 1195.2 μg/cm2 and 1802.0 μg/cm2. 
 Figure 2a shows the dry SC mass per surface area in control SC (1619 ± 400 μg/cm2), non-
lesional SC of AE patients (1407 ± 340 μg/cm2), and lesional SC of AE patients (1200±168 
μg/cm2). There was neither a significant difference between controls and non-lesional 
skin of AE, nor between non-lesional and lesional AE skin (P>0.08). However, there was 
a difference between controls and lesional skin of AE (P=0.01). Open and filled circles 
indicate non-carriers and carriers of flg mutations, respectively. There was no difference 
in dry SC mass in AE patients that were carriers and non-carriers of a flg mutation (P>0.1). 
In Figure 2b, 1/TEWL values are plotted as function of the dry SC mass per surface area 
(μg/cm2). The correlation coefficient between these parameters is r = 0.67.
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Figure 1: Three examples of 1/tewl plotted against the cumulative amount of tape-stripped sc. The intercept of the 
line with the x-axis is indicative for the dry sc mass per cm2.
Figure 2: a) Dry sc mass per surface area (μg/cm2) in control subjects, non-lesional sc of ae patients, and lesional sc 
of ae patients. b) Correlation between 1/tewl and dry sc mass per cm2 in control subjects and ae patients. Green, 
orange and red data points correspond to control sc, non-lesional ae sc and lesional ae sc, respectively. Open data 
points indicate carriers of flg mutations, filled data points indicate non-carriers of flg mutations. Control subjects are 
indicated by / . Non-lesional skin and lesional skin of ae patients are indicated by /  and  /  , respectively.
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shows high wavenumber (2500-4000 cm-1) Raman spectra of SC (upper), extracted SC 
(containing no lipids, mainly protein; middle), and extracted SC lipids (lower), respectively. 
The spectrum of SC exhibits peaks at 2850 cm-1, 2880 cm-1 and 2930 cm-1. The spectrum 
of the extracted lipids contains two characteristic peaks located at 2850 cm-1 and 2880 
cm-1. In contrast, the extracted SC spectrum consists of only one peak located at 2930 cm-1. 
Figure 3b shows a typical example of a high wavenumber Raman spectrum of a control 
subject at a skin depth of 4 μm. The peaks that were used to calculate the lipid/protein 
ratio are shaded in red.
 Figure 4a shows the lipid/protein ratio as a function of depth (between 0 and 40 μm), 
with a maximum between 0 and 4 μm and a gradual decrease deeper than 8 μm. Figure 4b 
shows the average lipid/protein ratio between 4 and 10 μm in the SC in control SC, non-
lesional AE SC, and lesional AE SC. Non-lesional skin of AE patients shows a significantly 
lower lipid/protein ratio than the skin of control subjects (0.24 ± 0.05 and 0.28 ± 0.03, 
respectively, P<0.005). In lesional skin, the lipid/protein ratio is even further reduced 
(0.19 ± 0.03, P<0.001). 
 Figure 4c shows the intra-subject comparison between lesional and non-lesional skin 
from the same patient. In 9 out of 11 AE patients, the lipid/protein ratio is lower in 
lesional skin compared to non-lesional skin, which was significant (P<0.01).
 The lipid/protein ratio in AE patients showed no difference between carriers and non-
carriers of flg mutations (0.24 ± 0.04 in non-carriers and 0.23 ± 0.06 in carriers P>0.1 
for non-lesional AE SC; and 0.19 ± 0.02 in non-carriers and 0.18 ± 0.04 in carriers, P>0.1 
for lesional AE SC).
a) b)





























Figure 3: a) High wavenumber raman spectrum of sc (upper), extracted sc (middle) and extracted sc lipids (lower). 
b) raman spectrum between 2500-4000 cm-1 of control sc at a depth of 4 μm. Peaks at 2880 cm-1 and 2930 cm-1 





























































Figure 4: Lipid/protein ratio in control subjects and ae patients. a) Lipid/protein ratio in the range of 0-40 μm. The 
green, orange and red lines indicate the average (±sd) of control sc, non-lesional ae sc and lesional ae sc, respectively. 
b) Average lipid/protein ratio between 4-10 μm in the sc of the individual patients and controls. c) Paired lipid/protein 
data of non-lesional and lesional ae skin. Non-carriers and carriers of a flg mutation are represented by filled and open 
data points, respectively. Control subjects are indicated by  / . Non-lesional skin and lesional skin of ae patients are 
indicated by  /  and  /  , respectively.
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 The relationship between skin barrier properties and lipid/protein ratios is presented in 
Figure 5, showing the correlation between 1/TEWL and the lipid/protein ratio in control 
subjects and in non-lesional and lesional SC of AE patients. The correlation coefficient 
between 1/TEWL and lipid/protein ratio was 0.86 (P<0.001).
Discussion
 In this study, we determined the lipid/protein ratio in SC of control subjects and in non-
lesional as well as lesional SC of AE patients. In addition, the dry SC mass per surface area 
was determined in control subjects and in non-lesional skin of AE patients. Finally, we 
studied the correlations of these parameters with the skin barrier function as assessed by 
TEWL.
 The Raman spectra of extracted SC lipids and extracted SC demonstrate that the ratio 
between the peaks located at 2880 cm-1 and 2930 cm-1 is an excellent measure for the 
lipid/protein ratio in SC: the contribution of the lipids to the 2930 cm-1 peak as well as 
the contribution of the proteins to the 2880 cm-1 peak is negligible. The selected peak 
boundaries of the 2930 cm-1 peak were based on those used for the protein band for 
determination of the water concentration in the skin20. A change of the baseline by 
broadening the peak boundaries did not have an effect on the lipid/protein ratio (not 
shown).
 We observed that the lipid/protein ratio is significantly lower in non-lesional as well 
as lesional SC of ae patients, compared to SC of control subjects. This may be partly 
explained by changes in the SC lipid composition: previous studies have shown that the 
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Figure 5: Correlation between lipid/protein 
ratio and 1/tewl in control subjects and ae 
patients. Non-carriers and carriers of a flg 
mutation are represented by filled and open 
data points, respectively.Control subjects 
are indicated by  / . Non-lesional skin and 
lesional skin of ae patients are indicated by 
 /  and  /  , respectively.
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revealed that the level of long-chain CERs is reduced in non-lesional AE skin and the level 
of very short chain CERs (with a total chain length of 34 carbon atoms, referred to as 
C34 CERs) is increased16,19. However, the level of C34 CERs and long-chain CERs in non-
lesional AE skin are together accounting for about 10 mol% of the total CER content in 
non-lesional skin19. Assuming an equimolar CER:CHOL:ffa ratio, this is only 3 mol% of 
the total lipids, whereas the lipid/protein level has decreased by ~14% in non-lesional AE 
and ~32% in lesional AE. Hence the changes in C34 CERs, long-chain CERs and total CER 
level may not account for the complete reduction in lipid/protein ratio, which indicates 
a third, yet unknown factor. The reduced lipid/protein ratio may be partly explained by a 
delayed or incomplete lamellar body extrusion process caused by an altered peroxisome 
proliferator-activated receptor (PPAR) activation, which has been reported for AE26-28. 
PPARs can be activated by lipids, and these nuclear hormone receptors may possibly be a 
link for the observed changes in both the lipid chain length and lipid/keratin ratio29,30.
 We could perform an intra-subject comparison of non-lesional and lesional skin as 
eleven subjects had both skin types on their ventral forearms. In most cases the lipid/
protein ratio was lower in lesional compared to non-lesional skin. These differences within 
a subject may primarily be attributed to inflammation, the presence of microbes and/or 
an altered pH. These factors may affect the lipid synthesis31,32 and therefore result in a 
lower lipid/protein ratio in lesional AE skin.
 A measure of sc thickness is the total dry SC mass per surface area, which was determined 
by extrapolation of 1/TEWL versus the cumulative mass of tape-stripped SC. Between non-
lesional AE skin and control skin no significant difference in the dry SC mass per surface 
area was observed, which indicates that SC thickness was comparable for both groups. In 
lesional AE SC the total dry SC mass per surface area was lower compared to controls. In 
line with our results, Voegeli et al.33 have reported a decreased SC thickness in lesional 
AE SC. They suggested increased serine protease activity in lesional SC of AE patients as 
a possible explanation for the observed differences. We noticed that SC thickness does 
affect the TEWL values and thus the skin barrier function, as observed by the correlation 
between the total dry SC mass per surface area and TEWL. 
 An alternative method to determine SC thickness is based on the water concentration 
profile in the SC measured by confocal Raman spectroscopy34-37. The advantage of Raman 
spectroscopy is that it enables the direct monitoring in vivo without damaging the SC. 
The method determines the actual SC thickness, which includes the effects of swelling 
of the SC as a result of water uptake. In this study, we were interested in variations in 
the SC thickness as a result of changes in dry SC mass per surface area, independent of 
variations in water content of the SC. As the total amount of tape-stripped dry SC mass 
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and subsequent extrapolation does not change upon swelling, we used this method to 
determine the dry SC mass per surface area. In order to obtain a calibration curve we 
extracted small pieces of SC. During extraction of the SC, it is possible that not all proteins 
were extracted. Therefore, the amount of SC per tape-strip may be slightly overestimated.
Both SC thickness and lipid/protein ratio are factors that affect the TEWL. However, the 
correlation between lipid/protein ratio and TEWL was much stronger than the correlation 
between dry SC mass per surface area (as a measure of SC thickness) and TEWL. This 
may suggest that the level of lipids in SC plays a more prominent role in the skin barrier 
function than the dry SC mass. In the same line, our previous study shows a strong 
correlation between CER chain length and skin barrier function19.
 Flg mutations are the largest risk factor known to date for the development of AE7,38. 
However, in this study the presence of flg mutations was not associated with lipid/
protein ratio or dry SC mass per surface area in AE patients. In our previous study it was 
concluded that flg mutations do not influence CER composition and lipid organization19. 
Although flg mutations are a strong risk factor in the pathogenesis of AE, the results 
of this study indicate that in adult AE, changes in the SC lipids seem to be the dominant 
factor in the reduced skin barrier. 
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Abstract
 Netherton Syndrome (nts) is a rare genetic skin 
disease that is characterized by erythroderma, hair 
shaft defects, and severe atopic manifestations. The 
disease is caused by mutations in the serine protease 
inhibitor Kazal-type 5 (spink5) gene, which encodes 
the protease inhibitor lympho-epithelial Kazal-
type–related inhibitor (lekti). Lack of LEKTI causes 
epidermal proteases hyperactivity, which results in 
stratum corneum (SC) detachment. NTS patients 
have an impaired skin barrier function. Besides 
barrier proteins, SC lipids are also crucial for the skin 
barrier. The lipids primarily consist of ceramides 
(CERs), free fatty acids (ffas) and cholesterol. To 
date, hardly any information is available on the SC 
lipid composition and organization in SC of patients 
with NTS. Therefore, the aim of the present study is to 
determine the SC lipid composition and organization 
in NTS patients.
 We investigated the SC lipids by means of mass 
spectrometry, infrared spectroscopy and X-ray 
diffraction. We studied the lipid subclasses as well as 
the chain length distributions. A decreased ffa chain 
length and an increased level of monounsaturated 
ffas was observed in SC of NTS patients compared to 
controls. Furthermore, the level of short-chain CERs 
was increased in NTS patients, and in a subgroup 
of patients we observed a strong reduction in long-
chain CER levels. The changes in lipid composition 
modified the lipid organization: an increased 
disordering of the lipids compared to the controls. 
This study shows that there are striking changes in 
the lipid composition in NTS that may contribute to 
the skin barrier dysfunction in NTS.
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Introduction 
 Netherton syndrome (NTS) is a rare skin disorder with an occurrence of 1-3 in 200.000 
births and a fatality rate of around 20% in the first year of life by hypernatremic dehydration, 
electrolyte imbalances, perturbed thermoregulation, failure to thrive, and recurrent 
infections1-5. NTS is characterized by erythroderma, hair shaft defects (bamboo hair), 
and severe atopic manifestations6. In addition, NTS patients show a drastically reduced 
skin barrier function7-9. The skin barrier is primarily located in the outermost layer of the 
skin, the stratum corneum (SC). The SC consists of flattened corneocytes embedded in a 
highly ordered lipid matrix. The organization and composition of this lipid matrix seems 
crucial for the barrier function of the skin, but hardly any information is available on the 
SC lipids regarding NTS patients. The aim of the present study is therefore to unravel the 
composition and organization of this SC lipid matrix in NTS.
 SC lipids mainly consist of ceramides (CERs), cholesterol (CHOL) and free fatty acids 
(ffas). To date, 12 CER subclasses with a wide variation in chain length distribution have 
been identified in human SC10,11. FFAs mainly consist of saturated carbon-chains with 
lengths varying between 16 and 36 carbon atoms, of which the most abundant chain 
lengths are 24 and 26 carbon atoms12,13. In healthy SC, lipids form two lamellar phases 
with repeat distances of approximately 6 and 13 nm referred to as the short periodicity 
phase (SPP) and long periodicity phase (LPP), respectively14,15. Within the lamellae, the 
lipids form a dense (orthorhombic, highly ordered lipid chains) lateral organization, 
although lipid domains with a less dense (hexagonal, less ordered lipid chains) lipid 
organization also co-exist. Both the lipid composition and lipid organization are crucial 
for a proper SC barrier function. Recent studies show the important role of the SC lipids 
in the skin barrier function of atopic eczema (AE) patients16,17, a skin disease often 
linked to NTS because of its shared symptoms18,19. We demonstrated a modified chain 
length distribution in CERs in SC of AE patients. This change resulted in an altered SC lipid 
organization, which in turn was correlated with an impaired skin barrier function. 
 NTS is caused by mutations in the serine protease inhibitor Kazal-type 5 (SPINK5) 
gene. These mutations result in loss of function of lympho-epithelial Kazal-type–related 
inhibitor (LEKTI)20. LEKTI is described in relation to proteins involved in proliferation and 
differentiation of keratinocytes. In addition, several LEKTI-domains can efficiently inhibit 
the enzyme activity of various subtypes of kallikreins (KLKs): KLK5, KLK7 and KLK14. 
Lack of active LEKTI domains lead to increased activity of these KLKs, thereby affecting 
various biological processes that will have a detrimental effect on the skin barrier:
 i) KLKs 5 and 7 are involved in the desquamation process, that is, the degradation of 
the corneodesmosomes linking the corneocytes in the SC21-26. Reduction in the activity 
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of LEKTI, which inhibits the activity of these enzymes, causes epidermal proteases 
hyperactivity resulting in SC detachment27.
 ii) KLKs 5 and 14 induce cutaneous inflammation through proteinase-activated 
receptor 2 (PAR2) and NF-κB pathway activation in vitro28, leading to up-regulation of 
pro-Th2 cytokine thymic stromal lymphopoietin (TSLP), IL1-α, IL8, and TNF-α8,23,29,30. 
The production of these cytokines can in turn affect the SC lipid synthesis and thereby the 
skin barrier31,32. Besides, PAR2 activation can lead to abnormal lamellar body secretion 
that also results in disrupted lipid lamellae and a reduced skin barrier function7.
 iii) KLKs act as catalysts for the proteolysis of the enzymes β-glucocerebrosidase and 
acid sphingomyelinase33. Both enzymes are involved in synthesis of CERs that play an 
important role in the barrier function of the SC.
 iv) Increased activity of KLK5 (as a result of decreased inhibition by LEKTI) leads to 
hyperactivity of the epidermal protease elastase 2 (ELA2). This results in abnormal 
processing of filaggrin, a keratin filament-associated protein highly associated with atopic 
eczema34. Filaggrin breakdown products, the natural moisturizing factor (NMF), are 
suggested to be important for maintaining the acidic nature of the SC: An increase in pH 
induces premature degradation of corneodesmosomes leading to a disrupted barrier and 
cohesion of the skin35. In addition, an increase in pH can lead to altered catalytic activities 
of lipid processing enzymes that require an acidic pH for their optimal catalytic activity36. 
Besides these effects of KLKs on the different aspects of the metabolic pathways, KLKs 
may activate each other or induce self-activation, thereby exacerbating the effects30,37,38.
NTS patients show different expression of proteins like loricrin, involucrin and the 
transglutaminases. This disturbs the assembly of the cornified envelope surrounding the 
corneocytes and may also reduce the SC barrier function39-41. Altogether, this results in a 
drastically reduced barrier function in patients with NTS as measured by transepidermal 
water loss (TEWL)7-9.
 To date, little is known about the SC lipid composition in NTS. A study of Bonnart et 
al.34 with transgenic mice overexpressing ELA2 as a model for NTS reported a threefold 
increase in TEWL, demonstrating a decreased skin barrier function. For the first time, 
the lipids in total epidermis were analyzed. They observed an increased level of total 
glucosylceramides and a reduction of sphingomyelin, as well as significant decrease 
in FFA levels. In addition, it was reported that the lipids form irregular loose stacks of 
lamellae7,34,42. However, no data were reported on individual CER and FFA subclasses 
and chain length distributions of the lipids. In addition, no quantitative information 
about the lamellar phases was provided and no information is available on the lateral 
packing. Therefore, the aim of this study was to perform an in depth analysis of the lipid 
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composition and organization in SC of patients with NTS. 
 Our results show that in SC of NTS patients, there is a strong increase in short chain 
CERs and FFAs as well as an increase in unsaturated FFAs. Furthermore, the lipid chains 
are more disordered and the lamellar lipid organization is altered. A subgroup of patients 
showed no lamellar lipid profile at all, and these patients also had the most drastic changes 
in their SC lipid composition.
Materials and Methods
Study population
 The study was conducted in accordance with the Declaration of Helsinki and was 
approved by the Ethical Committee of Paris Ile de France. Eight patients with classical 
features of Netherton syndrome were included in the study. They were from different 
ethnic backgrounds and their age ranged from 8 to 39 years at the time of the study. 
Patients included four males and four females. Patients  and , as well as  and  
are siblings, respectively. Each patient presented congenital ichthyosiform erythroderma, 
trichorrhexis invaginata, and eczematous like lesions. Four of them had ichthyosis linearis 
circumflexa (patients , ,  and ). All patients had elevated immunoglobulin E in 
the serum. Each patient showed negative LEKTI immunostaining on skin biopsy. SPINK5 
mutations leading to premature termination codons were identified in each patient.
For comparison, SC from the epidermis of 5 Caucasian subjects (36.2 ± 12.2 years; 
3 males) was analyzed, which was obtained after abdominal- or mammaplasty reduction 
at the hospital. SC was isolated by trypsin digestion, a procedure that does not affect the 
lipid organization in SC43 and is described previously44.
Lipid classification and nomenclature
 FFAs are classified according to their shorthand lipid number designation in which the 
chain length and degree of unsaturation is denoted45. For example, octadecenoic acid 
(oleic acid) is denoted as C18:1. Ceramides consist of a sphingosine base linked to a fatty 
acid (acyl) chain. In human SC, both chains can vary in the number of carbon atoms. This 
results in a wide distribution in total chain length, that is, the total number of carbon 
atoms in both chains. In addition, both chains can have additional functional groups at 
specific locations. This results in 12 identified subclasses10,11 that are classified according 
to the nomenclature of Motta et al.46: CER [AdS], [AH], [AP], [AS], [EOdS], [EOH], [EOP], 
[EOS], [NdS], [NH], [NP], and [NS] (Figure 1).






























































































Figure 1: Cer nomenclature and molecular structure. Cers are composed of a sphingoid base (depicted in blue) linked 
via an amide bond to an acyl chain (gray). Both chains show a variable carbon chains length indicated by the red arrows. 
This results in a wide distribution of the total cer chain length, i.e. the chain length of the sphingoid base and acyl 
chain combined. Both chains can have additional functional groups at the carbon positions marked in red. This results 
in 4 different sphingoid bases (dihydrosphingosine [ds], sphingosine [s], phytosphingosine [p], 6-hydroxy sphingosine 
[h]) and 3 different acyl chains (non-hydroxy fatty acid [n], α-hydroxy fatty acid [a] and esterified ω-hydroxy fatty 
acid [eo]). Together, this results in the presence of 12 subclasses denoted as: [nds], [ads], [eods], [ns], [as], [eos], 
[np], [ap], [eop], [nh], [ah], [eoh]. As an example, a cer with a non-hydroxy fatty acid of 16 carbon atoms long and a 
phytosphingosine base of 18 carbon atoms will be denoted as cer [np] c34. 
Sc lipid extraction and analysis
 An enhanced procedure of the commonly used Bligh and Dyer method was performed 
to extract the lipids from the SC sheets of both NTS patients and control subjects. 
Afterwards, lipids were analyzed by liquid chromatography coupled to mass spectrometry 
(LC/MS) to profile the CERs and FFAs. A detailed protocol of the lipid extraction and lipid 
analysis is described elsewhere11,47. Briefly: a three-step sequential extraction procedure 
of chloroform/methanol/water (1:2:½; 1:1:0 and 2:1:0) was performed to extract all 
extracellular SC lipids. To enable proper analysis by LC/MS, samples were reconstituted 
in chloroform/methanol/heptane (2½:2½:95) to obtain a final concentration of 1.0 mg/
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mL. Two injections of 10 µl of each lipid sample were performed to analyze sequentially 
FFAs and CERs, using an Alliance 2695 HPLC system (Waters Milford, MA). The HPLC was 
coupled to a mass spectrometer (TSQ Quantum, Thermo Finnigan, San Jose, CA) equipped 
with an APCI ionization source. FFAs were separated using a C18 reverse phase column 
(Purospher Star LiChroCART, Merck, Darmstadt, Germany) and analyzed in negative ion 
mode, while separation of CERs was achieved using a normal phase column (PVA-Sil, YMC, 
Kyoto, Japan) while analyzing in positive ion mode. Xcalibur software version 2.0 was 
used for data acquisition. 
Small angle x-ray diffraction measurements
 SC sheets were analyzed by small angle X-ray diffraction (SAXD), performed at the 
European Synchrotron Radiation Facility (ESRF, Grenoble, France) using station BM26B. 
Sc was hydrated over a 27% NaBr solution during 24h before the measurements. SC 
sheets were oriented parallel to the primary X-ray beam in order to obtain high quality 
diffraction patterns. SAXD patterns were detected with a Frelon 2000 charge-couple 
device (CCD) detector at room temperature for a period of 10 minutes using a microfocus 
beam, similarly as described elsewhere48. The exposure time to the X-rays was kept to a 
minimum and samples showed no evidence of radiation damage. From the scattering 
angle, the scattering vector (q) was calculated by q = 4π sin θ/λ, in which λ is the wavelength 
of the X-rays at the sample position and θ the scattering angle. The repeat distance of a 
lamellar phase can be calculated from the diffraction peaks by d = n·2π/qn, in which n is 
the order of the peak. This means that a shift in peak position to higher q values results in 
a shorter repeat distance.
Conformational ordering of the lipids
 A high conformational ordering is an indication that the lipids adopt the properties of 
a crystalline phase, whereas a low conformational ordering indicate that the lipids form 
a liquid phase. To obtain information on the conformational ordering, Fourier transform 
infrared (FTIR) spectra were recorded using a Varian 670-IR spectrometer (Varian Inc., 
Santa Clara, CA) equipped with a broad band liquid nitrogen cooled mercury-cadmium-
telluride (MCT) detector and an external sample compartment containing a GladiATR 
(Pike, Madison, WI) attenuated total reflection (ATR) accessory with a single reflection 
diamond. The spectra of patients were collected in attenuated total reflectance (ATR) 
mode and transmission mode (as a control), and no difference between both methods 
was observed. SC samples were hydrated over a 27% NaBr solution during 24h. SC was 
mounted between two ZnSe windows when measured in transmission mode. Samples 
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were put under a purge of continuous dry air starting 30 minutes before data acquisition. 
Spectra were acquired as a co-addition of 256 scans at 1 cm-1 resolution during 4 minutes. 
When measuring in ATR mode, 150 spectra were acquired and averaged. The spectral 
resolution was 2 cm-1. Resolutions Pro 4.1 (Varian Inc.) was used for data acquisition.
Statistical analysis
 Statistical analysis was performed using SPSS Statistics. Non-parametric Mann-Whitney 
tests were performed when comparing 2 groups, unless explicitly noted elsewhere. 
Differences were considered either weakly significant (P<0.1), moderately significant 
(P<0.05), or highly significant (P<0.005), and are denoted throughout the manuscript as 
*, **, and ***, respectively.
Results
Decreased ffa chain length and increased degree of unsaturation in patients with 
Netherton syndrome
 Figure 2 shows data on the FFA composition of NTS patients (red) compared to the 
control subjects (green). The presence of FFAs <20 carbon atoms, being abundantly 
present in patients, were not taken into account in the present study as these FFAs are 
most probably present due to contamination of topical treatments of the NTS patients. 
It is impossible to distinguish between native FFAs and those from topical formulations. 
The relative abundance of saturated FFAs and mono-unsaturated FFAs (MUFAs) is shown 
in Figure 2a. In NTS patients, there is a lower level of saturated FFAs compared to SC 
of controls (71.3 ± 24.1% and 97.0 ± 1.1%, respectively), and a higher level of MUFAs 
compared to controls (28.7 ± 24.1% and 3.0 ± 1.1%, respectively). Figure 2b shows the 
relative chain length distribution of saturated FFAs in NTS patients (red) and in controls 
(green). The most abundant chain lengths in controls are C24:0 and C26:0. The large 
standard deviations of the NTS patients are caused by inter-subject variation and not due 
to methodological variation. 
 Compared to control subjects, lipids of SC in NTS patients show a shift to shorter FFA 
chain length: there is a significant increase in FFA C20:0 and C21:0 and a significant 
decrease in FFAs C24:0, C25:0 and C26:0. Figure 2c shows the chain length distribution 
of MUFAs. No odd chain length MUFAs were detected in SC from either NTS or control. SC 
of NTS patients show a significant level of MUFAs C20:1, C22:1, C24:1. On the contrary, 
control subjects did not show a detectable level of MUFAs ≤C24 (C20:1, C22:1, C24:1) and 
only very low levels of C26:1, C28:1, C30:1 and >C30:1. From the abundance of both the 
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Figure 2: a) Scatter dot plot showing the relative abundance of saturated ffas (left) and mufas (right). b) and (c) 
present bar graphs showing the relative abundance of respectively saturated ffas and mufas. The total abundance of 
saturated ffas and mufas together was set to 100%. d) Scatter dot plot showing the average ffa chain length. Controls 
(n=5) and nts patients (n=8) are presented as green and red bars/dots, respectively. Error bars represent sd values; 
Horizontal lines indicate averages. Nd means ‘not detected’. Individual nts patients are labeled -.
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calculated. These results are provided in Figure 2d and show that the average FFA chain 
length is significantly reduced in NTS patients versus controls (23.4 ± 0.9 and 24.5 ± 0.1 
carbon atoms, respectively).
Altered levels of acyl-ceRs and short-chain ceRs in sc of Nts patients
 The CER profiles of 5 controls and 8 NTS patients were studied. The CER profiles of two 
representative examples of controls and 4 examples of NTS patients are presented in the 
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Figure 3: 3d ion chromatograms of control sc (a and b) and nts patients (c, d, e and f). retention time (3.6-8.3 
min), mass (480-1200 amu), and relative intensity of each peak are shown on the x-, y- and ‘z’-axis, respectively. 
Chromatograms are normalized to their most abundant peak. The chromatograms of the nts patients show a decreased 
chain length of the cers. In addition, in (e) and (f) there is a decrease in acyl-cers ([eo] cers) and a narrower chain 
length distribution in all other cer subclasses. Nts patients also show an increase in short chain cers, in particular cers 
with a chain length of 34 carbon atoms (c34 cers), which are indicated in the chromatograms by red peaks. The 3d ion 
chromatograms of the other controls and nts patients are listed in Supplementary Figure 1.
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NTS patients and control subjects is provided in Supplementary Figure 1. Figures 3a and 
b show two examples of the CER profiles of control SC. As there was very little difference 
in the profile of all control subjects, these two pictures closely resemble those of all 5 
controls. There are at least 12 CER subclasses depicted, as reported before11. Within 
each CER subclass, a large number of peaks can be observed. Each peak indicates a CER 
specie with a different chain length: The difference in molecular mass of two sequential 
CER species within one subgroup is 14 mass units, representing a reduction of one CH2-
group. In all 12 CER subclasses in human SC a wide distribution in their total carbon chain 
length is observed. The CERs with higher mass values in the upper part of the 3D mass 
spectrogram belong to the CER [EO] subclasses (also noted as acyl-CERs) and show a chain 
length distribution between 63-78 carbon atoms. The α-hydroxy [A] and non-hydroxy [N] 
CER subclasses have shorter chains and therefore lower masses. The carbon chain lengths 
of these subclasses are between 34-52 and 32-56 carbon atoms, respectively. The 3D ion 
chromatograms of NTS patients are provided in Figures 3c, d, e and f. 
 In general, of all CER subclasses, CER [NP] was most significantly reduced, whereas CER 
subclasses [AS], [NS], and [AH] were least affected. Furthermore, there is a shift in the 
lipid chain length distribution of NTS patients to lower mass values compared to controls: 
increased peak intensities in the molecular range between 550 and 650 amu are observed 
in chromatograms of NTS patients (labeled as red peaks in Figure 3). 
 The chromatograms of Figures 3c and d are representative for 5 NTS patients (,,,, 
and ). In the SC of these patients, all CER subclasses are observed. There is a clear shift 
to a higher abundance of short-chain CERs. This is particularly the case for CER subclasses 
[NS], [AS] and [AH], for which a very high peak was observed corresponding to CERs with a 
very short total carbon chain length of 34 carbon atoms (referred to as C34 CERs). Figures 
3e and f show the ion chromatograms representative for the other 3 NTS patients (, 
and ). These patients show a clearly distinguishable pattern compared to the other NTS 
patients: There is a narrow chain length distribution in [A] and [N] subclasses. In addition, 
the level of acyl-CERs is drastically decreased and the C34 CERs are strongly increased. 
NTS subject  also shows a clearly distinguishable pattern in the CER subclasses, but in 
contrast to the other 3 patients, acyl-CERs were present in this subject (Supplementary 
Figure 1). 
 Quantitative results on the relative abundance of acyl-CERs and short-chain CERs are 
shown in Figures 4a and b, respectively. Control subjects show on average a relative 
abundance of 8.4 ± 1.9% acyl-CERs. This abundance was comparable for 5 out of 8 NTS 
patients, but 3 patients show a drastic reduction to ~2.5%. Regarding the abundance of 
very short chain CERs with a mass lower than 600 amu (corresponding to a total chain 









































































































































































































































































































































Figure 5: a) Mass chromatograms of a subsection (730-815 amu) of cer [np] in a representative control subject (upper 
chromatogram) and nts patient (lower chromatogram). Peak labels indicate the mass (amu) and to which cer chain 
length and degree of unsaturation it corresponds. red lines indicate the unsaturated cers observed in nts patients. 
Although [m+h]+ was the main ion observed, also the [m+h-h2o]+ is detected and shown in the chromatograms as 
dotted lines. These have a mass that is 18 amu lower than their main [m+h]+ counterpart. Figure b) shows the 3d ion 
chromatograms of Figure a). Saturated and unsaturated chromatograms are presented separately in the left and right 
column respectively. Chromatograms are normalized to their highest peak in the sample and marked by *: i.e. cer [np] 
c48:0 in the control subject and cer [np] c48:1 in nts patient.
Figure 4: Dot plots showing the relative abundance of a) acyl-cers and b) short chain cers (c32-c38). Black horizontal 
lines and the corresponding values indicate mean values (±sd). Gray dotted lines indicate averages for two different 
categories observed: 5 nts patients with normal acyl-cer levels and 3 nts patients with reduced acyl-cer levels. 
Individual nts patients are labeled -.
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length of about ≤38 carbon atoms), all NTS patients show an increase compared to control 
subjects (27.2 ± 6.0% and 8.5 ± 1.3%, respectively).
 A closer examination of the mass spectra led to the observation of unidentified peaks 
present in many CER subclasses, with a mass of exactly 2 amu lower compared to the 
identified CERs. As an example, this is illustrated in the mass chromatogram of Figure 5a, 
in which a subsection of the mass spectrum of CER [NP] is shown. These peaks correspond 
to CERs with one degree of unsaturation. The increase in unsaturated CERs in NTS is high, 
and the example of CER [NP] is illustrated in Figure 5b: The 3D ion chromatograms show 
the same subsection of CER [NP] in a control sample and a NTS patient. No unsaturated 
CERs were observed in control subjects, and the most abundant peak in this subsection 
corresponded to a saturated CER with a chain length of 48 carbon atoms. On the contrary, 
multiple peaks corresponding to unsaturated CERs of different chain length were 
observed in the NTS patient. In this subsection of CER [NP], unsaturated C48:1 was the 
most abundant peak. When comparing all the lipid profiles, it becomes apparent that NTS 
subject  does show the highest abundance of unsaturated CERs.
Altered lamellar lipid organization in Netherton syndrome
 Figure 6 shows diffraction patterns of controls and NTS patients. The positions of the 
peaks are indicative for the periodicity of the lipid lamellae: a shift to higher q-values 
in the figure is indicative for a shorter periodicity (d) of the lipid lamellae. Figure 6a 
shows diffraction patterns of control SC. In previous studies, the diffraction patterns 
were analyzed and attributed to the two lamellar phases with repeat distances of around 
13 (LPP) and 6 nm (SPP). All controls show clear peaks at scattering vector values (q) of 
1.00 ± 0.01 and 1.45 ± 0.01 nm-1. The 1.00 nm-1 diffraction peak is attributed to the 2nd 
order peak of the lpp and the 1st order peak of the SPP, whereas the 1.45 nm-1 peak is 
attributed to the 3rd order of the LPP. In addition, some controls also show the 1st order 
of the LPP as a weak shoulder at a q-value located at ~0.50 nm-1. Figures 6b and 6c show 
diffraction patterns of NTS patients. SAXD patterns of NTS patients (numbers ,,,, 
and ), who clearly showed acyl-CERs present in their 3D ion chromatograms of Figure 
3 and Supplement 1, are depicted in Figure 6b. The presence of a diffraction peak at 0.5 
nm-1, but also the presence of peak ‘2’ and ‘3’ in patients ,,, and  suggests that the 
LPP is present. The diffraction pattern of patient  is very similar to that of the controls, 
although the peak position indicated by ‘2’ is shifted to slightly higher q-values suggesting 
a reduction in the repeat distances of the lamellar phases. The other diffraction patterns 
show distinct differences. In the SAXD pattern of SC from patients , , and , the peak 
indicated as ‘3’ has a higher intensity compared that that in the controls and shifted to 
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either lower or higher q-values. The most likely explanation for this increased intensity 
and changed shape of the peak is the formation of additional phases. The diffraction 
pattern of patient  does not show any diffraction peak. Figure 6c shows the SAXD curves 
of the NTS patients (numbers ,, and ) that have a low level of acyl-CERs present in 
the 3D ion chromatograms in Figure 3. No peaks are observed in the diffraction patterns 
of these NTS patients. 
Higher degree of disordering of the lipid chains in Nts
 Figure 7 shows the CH2 symmetric stretching peak position of the SC lipids in controls 
(green) and NTS patients (red). A higher peak position indicates a higher degree of 
conformational disordering of the lipid chains. The average peak position of the NTS 
patients is 2850.0 ± 0.6 cm-1, which is significantly higher compared to the control 
samples, showing an average value of 2849.4 ± 0.1 cm-1. In addition, a larger variability 
between NTS patients compared to controls was observed when performing a non-
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Figure 6: Saxd patterns of controls a) and nts patients (b and c). The positions of the peaks (q) are indicative for the 
periodicity of the lipid lamellae. Figure b) shows nts patients with a normal level of acyl-cers, while Figure c) presents 
diffraction patterns of nts patients with a reduced level of acyl-cers. From the scattering angle, the scattering vector (q) 
was calculated by q = 4π sin θ/λ, in which λ is the wavelength of the x-rays at the sample position and θ the scattering 
angle. Individual nts patients are labeled -.
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Discussion 
 In this study, we investigated the SC lipid composition and organization in 8 NTS 
patients and compared this to control SC. Recently, Bonnart et al. studied the lipid 
composition in transgenic mice overexpressing ELA2 as a model for NTS34. They observed 
a decreased level of FFAs and an increased total level of glucosylceramide and reduction 
of sphingomyelin. Electron microscopy studies revealed the presence of unprocessed 
lipids in the intercellular space of the SC. However, no further details on lipid subclasses 
and chain length distributions were provided, which is the focus of the present study. In 
addition we analyzed the lipid organization. Both the lipid composition and organization 
in SC of NTS patients show large deviations from that in control subjects. More precisely, 
we show that in SC of NTS patients there is an increase in the levels of MUFAs and in 
short-chain FFAs. Similar changes were observed in the CER composition: increased levels 
of unsaturated CERs as well as short-chain CERs were abundantly present in SC of NTS 
patients compared to control subjects. We also observed changes in the lipid organization 
in SC of NTS patients: a higher degree in conformational disordering of the lipid chains 
as well as an altered lamellar organization. In a subgroup of NTS patients almost no acyl-
CERs were present. 
 The changes in the lipid composition correlated to changes in the lipid organization. 
NTS patients (,,, and ) with normal levels of acyl-CERs in their SC, revealed a 
diffraction pattern indicating the presence of the LPP. In contrast, NTS patients with low 
levels of acyl-CERs (,, and ) did not show any proper SC lamellar organization, as no 
diffraction peaks were observed in the corresponding SAXD profile. The exception is NTS 

































Figure 7: Ch2 symmetric stretching peak 
position in sc of controls (green dots) and nts 
patients (red dots). A higher peak position 
indicates a higher degree of conformational 
disordering of the lipid chains. Individual nts 
patients are labeled -.
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SAXD profile of this patient. However, this patient shows a clearly distinguishable profile 
in most CER subclasses and has the highest level of short chain CERs and unsaturated 
CERs. In addition, the highest level of MUFAs as well as the shortest average FFA chain 
length was observed in this patient. The abundant presence of shorter and unsaturated 
lipid chains enhances disordering of the lipid organization and may therefore explain 
the lack of regularly stacked lipid lamellae49. Finally, only one patient () showed a 
diffraction profile very similar to the controls. This patient exhibits the least deviation in 
SC lipid composition compared to the control subjects. 
 It has been reported that NTS patients show a drastic reduction in skin barrier function, 
as indicated by increased TEWL values7-9. As the lipids play a crucial role in the skin 
barrier function, an altered lipid composition and thus a change in lipid organization may 
contribute to the increased TEWL values in NTS patients: In previous studies using model 
lipid systems, we observed that both an absence of acyl-CERs as well as short chain FFAs 
results in an increased permeability49,50. Furthermore, very recently we also reported an 
excellent correlation between a reduction in chain length of CERs and an increase in TEWL 
in patients with AE, demonstrating that the lipids may play a role in the impaired skin 
barrier function17.
 NTS and AE are both inflammatory diseases with some genetic association. Patients with 
NTS show many symptoms comparable to AE patients18,19. Therefore, a comparison in lipid 
profiling between NTS and AE is also of interest. Several changes in lipid composition in 
NTS were also observed in SC of patients with AE, but in the latter less pronounced. These 
changes are: i) A reduction in the level of acyl-CERs; ii) Increased levels of CER [AS] and CER 
[NS] and a reduced level of CER [NP]; iii) Increased levels in C34 CERs; iv) A shift to shorter 
chain lengths in FFAs and CERs; v) Increased levels in MUFAs. In AE, these changes in lipid 
composition correlated very well with an increased TEWL16,17,51. Therefore, also in NTS 
these changes in lipid composition and organization may contribute to the impaired skin 
barrier. In AE we observed that changes in the SC lipids were more pronounced in lesional 
skin compared to non-lesional skin, which may indicate that either inflammation and/or 
the presence of surface bacteria may play a role in changes in the lipid composition.
 Several changes in epidermal processing may contribute to a change in the lipid 
composition in NTS. i) An increased pH in SC of NTS patients, which may be caused by an 
ELA-2 hyperactivity and lower NMF levels. This may lead to alterations in SC CER subclass 
levels in NTS33,36,52 as the activity of both sphingomyelinase and β-glucocerebrosidase are 
both highly dependent on the pH in their microenvironment. Furthermore, a pH increase 
induces high serine proteases activity that in turn degrades lipid processing enzymes33. 
Upregulation of KLK activity has also been reported to affect these enzymes33. As CER 
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[AS] and CER [NS] both have sphingomyelin as precursor, an imbalance in the activity of 
these enzymes may increase the relative levels of these ceramides. ii) Park et al. showed a 
downregulation of elongases 1, 4 and 6 (ELOVL1, 4 and 6) and a subsequent reduction in 
CER chain length in a murine atopic eczema model53, demonstrating that these enzymes 
may be involved in the reduction of CER chain length in this model. In addition, it is known 
that ELOVL-4 knockout mice show a strong reduction in long chain FFAs, especially beyond 
C24; increased presence of unsaturated FFAs; and absence of acyl-CERs54. Therefore, the 
reduction in chain length of the lipids in SC of NTS patients may be related to a decreased 
activity of ELOVLs. 
 In conclusion, this study indicates for the first time that the SC lipid composition and 
organization are both altered in NTS patients. These alterations in SC lipids may at least 
partly explain the skin barrier dysfunction in NTS. It is of interest to study the activity 
of the abovementioned enzymes in NTS patients in vivo as the SC lipid barrier is likely 
impaired due to altered epidermal enzyme activities in NTS patients.
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Abstract
 Previous results showed that our in-house human 
skin equivalents (HSEs) differ in their stratum 
corneum (SC) lipid organization compared with 
human SC. To elucidate the cause of the altered SC 
lipid organization in the HSEs, a recently developed 
liquid chromatography/mass spectrometry method 
was used to study the free fatty acid (FFA) and 
ceramide (CER) composition in detail. In addition, the 
SC lipid composition of the HSEs and human skin was 
examined quantitatively with high-performance thin 
layer chromatography. For the first time our results 
reveal that all our HSEs have an increased presence 
of mono-unsaturated FFAs compared with human 
SC. Moreover, the HSEs display the presence of CER 
species with a mono-unsaturated acyl chain, which 
are not detected in human SC. All HSEs also exhibit 
an altered expression of stearoyl-CoA desaturase, 
the enzyme that converts saturated FFAs to mono-
unsaturated FFAs. Furthermore, the HSEs show the 
presence of twelve CER subclasses, similar to native 
human SC. However, the HSEs have increased levels 
of CERs [EOS] and [EOH] and CER species with short 
total carbon chains and a reduced FFA level compared 
with human SC. The presence of unsaturated lipid 
chains in HSE offers new opportunities to mimic the 
lipid properties of human SC more closely.  
Introduction
 Human skin equivalents (HSEs) provide a valuable 
tool to predict the permeation of substances through 
the skin1-8 or to determine whether compounds 
are toxins, irritants, or sensitizers for the skin9-
12. However, to obtain a reliable in vitro – in vivo 
correlation, it is a prerequisite that HSEs have a 
comparable skin barrier function as native human 
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skin. The main barrier for compound penetration is located in the lipid matrix of the 
stratum corneum (SC). This lipid matrix is mainly composed of cholesterol, free fatty acids 
(FFAs), and ceramides (CERs)13,14. The lipid composition determines the lipid organization 
in the sc and is therefore a key factor in determining the skin barrier function15. We have 
previously investigated the SC lipid organization of four of our in-house hses, namely 
the fibroblast derived matrix model (FDM), Leiden epidermal model (LEM), full-thickness 
collagen model (FTM), and full-thickness outgrowth (FTO). The LEM is a skin equivalent 
with only an epidermal compartment. The FDM is a model wherein fibroblasts produce 
their own extracellular matrix, whereas the FTM contains a dermal compartment that 
consists of rat tail collagen populated with human fibroblasts. In the FTO, a full thickness 
explant of native human skin is placed onto rat tail collagen and is allowed to expand 
and develop an epidermis. The skin models mimic many aspects of native human skin. 
However, they display some differences in their SC lipid organization. These differences 
may have an important role in their decreased permeability barrier compared with human 
SC16,17. As the lipid organization is dictated by the lipid composition, we determined the 
SC lipid composition of each HSE in detail to unravel the cause of their altered SC lipid 
organization. For this purpose, we quantitatively assessed the SC lipid composition of our 
in-house HSEs and native human SC with high-performance thin layer chromatography 
(HPTLC). Nine CER subclasses have been identified in native human SC using HPTLC18, 
whereas twelve CER subclasses have been identified using a recently developed liquid 
chromatography/mass spectrometry (LC/MS) method19. In this study, we used LC/MS to 
determine whether all identified CER subclasses in native human SC are also present in 
the SC of our HSEs. In addition, detailed information on the chain length distribution and 
degree of saturation of each CER subclass and FFAs is provided and compared with the 
SC of native human skin. The expression pattern of several enzymes involved in the FFA 
and CER synthesis was also investigated to examine the biological cause of the altered SC 
lipid properties observed in the HSEs. This study has led to the identification of previously 
unreported targets that offer previously unreported opportunities to optimize the SC 




 Native human mammary or abdomen skin was obtained from adults undergoing 
surgery. Human skin left over from surgery was collected after written informed consent 
of the skin donors and institutional approval was obtained. The Declaration of Helsinki 
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Principles were followed when using human tissue. Normal human keratinocytes 
(NHKs) and human dermal fibroblasts were isolated as described before20. A detailed 
description of the required media is provided as supplementary information. NHKs used 
to create HSEs with only an epidermal compartment were cultured with the Dermalife 
K medium complete kit (Lifeline Cell Technology, Walkersville, MD) supplemented with 
1% penicillin/streptomycin (Sigma, Zwijndrecht, The Netherlands) until they reached a 
maximum confluency of 80%. First and second passage NHKs were used to generate hses. 
Dermal equivalents
 Collagen-type I containing dermal equivalents: Collagen-type I containing dermal 
equivalents were generated as described earlier20. Details regarding the generation of the 
dermal equivalents are provided as Supplementary Information.
 Fully human dermal equivalents: The dermal matrices for the FDMs were generated as 
decribed previously21. Details regarding the generation of the FDMs are provided as 
Supplementary Information.
Generation of Hses
 HSEs generated on collagen dermal equivalents referred to as FTM: One week after 
preparation of the collagen type I containing dermal equivalents 0.5·106 NHKs were seeded 
on top of each dermal equivalent. On the first two days, the HSEs were kept submerged 
in a medium consisting of DMEM and Ham’s F12 (Invitrogen, Leek, The Netherlands) (3:1 
v/v), 5% fetal bovine serum (FBS), 1% penicillin/streptomycin, 0.5 µM hydrocortisone, 
1 µM isoproterenol and 0.5 µg/mL insulin. The following two days the HSEs were kept 
submerged in a similar medium, except that the FBS was reduced to 1% and 0.053 µM 
selenious acid (Johnson Matthey, Maastricht, The Netherlands), 10 mM L-serine (Sigma), 
10 µM L-carnitine (Sigma), 1 µM α-tocopherol acetate (Sigma), 25 mM vitamin C and 
a lipid mixture of 3.5 µM arachidonic acid (Sigma), 30 µM linoleic acid (Sigma), 25 µM 
palmitic acid (Sigma) were added to the medium. Hereafter, the HSEs were lifted to the 
air/liquid interface and were nourished with a medium in which the FBS was omitted and 
the arachidonic acid concentration was increased to 7 µM. The medium was refreshed 
twice a week. The HSEs were harvested 16 days after seeding of the NHKs onto the dermal 
equivalents.
 HSEs generated on fully human dermal equivalents referred to as FDM: Three weeks after 
seeding fibroblasts onto filter inserts 0.5·106 NHKs were seeded onto each dermal 
equivalent. The HSEs were further cultured as described for the FTMs.  
 HSEs generated on inert filter, referred to as Leiden epidermal model (LEM): LEMs were 
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generated as described previously10 with slight modifications. 0.2·106 NHKs were seeded 
onto cell culture inserts (Corning tranwell cell culture inserts, membrane diameter 12 
mm, pore size 0.4 µm, Corning Life Sciences, Amsterdam, The Netherlands). The cells were 
kept submerged for 2-3 days in Dermalife medium until confluency. On the following 
2 days, the HSEs were kept submerged in CnT medium (CellnTec, Bern, Switzerland) 
supplemented according to the manufacturer’s protocol and 1% penicillin/streptomycin 
solution, 1 µM α-tocopherol acetate, 25 µM vitamin C, and a lipid mixture of 7 µM 
arachidonic acid, 30 µM linoleic acid, and 25 µM palmitic acid. Hereafter, the cells were 
nourished with the same medium, but were grown at the air/liquid interface. The LEMs 
were harvested 16 days after seeding the NHKs onto the inserts.  
 Full thickness cultures (FTO): Full-thickness (4 mm) fat free punch biopsies obtained 
from abdomen or mammary skin were gently pushed into freshly generated collagen type 
1 containing dermal equivalents. These hses were cultured similarly as described for the 
FTMs and FDMs, except that they were directly cultured at the air/liquid interface. The 
FTOs were grown for approximately 16 days.
Morphology and immunohistochemistry
 Harvested HSEs were fixed in 4% (w/v) paraformaldehyde (Lommerse Pharma, Oss, 
The Netherlands), dehydrated and subsequently embedded in paraffin. 5 µm sections 
were cut and used for immunohistochemical staining of human SCD1 (100× dilution; 
Sigma), serine palmitoyltransferase (SPT; 400× dilution; Cayman Chemicals, Ann Arbor, 
MI) and CER synthase 3 (CERS3; 10× dilution; Atlas Antibodies, Stockholm, Sweden). 
Immunohistochemical stainings of the samples were performed with the R.T.U. Vectastain 
Elite ABC reagent kit (Vector Laboratories, Burlingame, CA). Details of the staining 
procedure are provided as Supplementary Information. 
Sc Isolation and lipid extraction
 The SC of human abdomen or mammary skin was isolated as described previously19. 
The SC lipids were extracted according to the Bligh and Dyer procedure22 with a series of 
chloroform/methanol mixtures (1:2, 1:1 and 2:1 v/v) for 1 hour each. The extracts were 
combined and treated with 0.25M KCl and water. The organic phase was collected and 
evaporated under a stream of nitrogen at 40°C. The obtained lipids were reconstituted in a 
suitable volume of chloroform/methanol (2:1 v/v) and stored at -20°C until use. To obtain 
enough lipids for quantification, the lipid extracts of 2-4 HSEs from the same experiment 
and donor were pooled. The SC lipid composition of the full-thickness explant could not 
be determined, because there was not enough material to extract. 
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HPtLc lipid quantification
 The extracted SC lipids were quantified using HPTLC. The used solvent system to 
separate the lipids is provided elsewhere23. Co-chromatography of serial dilutions of 
standards was used to identify and quantify each lipid class. The standards consisted 
of cholesterol, palmitic acid, stearic acid, arachidic acid, tricosanoic acid, behenic acid, 
lignoceric acid, cerotic acid, and CERs [EOS], [NS], [NP], [EOH], and [AP]. CER nomenclature 
according to terminology of Motta et al.24 and Masukawa et al.25. The CERs were provided 
by Cosmoferm (The Netherlands). All other compounds were purchased from Sigma (The 
Netherlands). The lipid fractions were visualized and quantified as described before26. 
For quantification, SC lipid samples of two donors were used of each HSE type and native 
human skin. 
Lc/Ms lipid analysis
 The SC lipid species in the pooled lipid extracts of the HSEs and native human skin were 
analyzed by LC/MS according to the method described elsewhere19. Briefly: an Alliance 
2695 HPLC (Waters Corp., Milford, MA) was coupled to a TSQ Quantum MS (Thermo 
Finnigan, San Jose, CA) measuring in APCI mode. The total lipid concentration of all 
samples was around 1 mg/ml and the injection volume was set to 10 µl for the analysis 
of both CERs and fatty acids. CERs were separated using a PVA-Sil analytical column (5 
µm particle size, 100 × 2.1 mm i.d. YMC, Kyoto, Japan) using a gradient mobile phase 
from heptane to heptane/isopropanol/ethanol at a flow rate of 0.8 mL/min. The scan 
range of the MS was set between 500-1200 amu, measuring in positive ion mode. FFAs 
were analyzed by introducing some adaptations to the setup used for CER analysis as will 
be described in detail elsewhere (van Smeden et al, submitted): separation was achieved 
using a LiChroCART Purospher STAR analytical column (55 × 2 mm i.d. Merck, Darmstadt, 
Germany) under a flow rate of 0.6 ml/min using a gradient system from acetonitril/H2O 
to methanol/heptane. 1% CHCl3 and 0.2% acetic acid (HAc) were added to both mobile 
phases as ionization enhancers. The ionization mode and scan range was altered to 
negative mode and 200-600 amu, respectively.
Results
HPtLc analysis reveals that the Hses have a reduced sc ffa content compared with 
human skin 
 The SC lipids of the HSEs and human skin were extracted and quantified with HPTLC to 
determine whether the HSEs show differences in their lipid composition compared with 



























































































































HSC FDM LEM FTM FTO
Figure 1: Stratum corneum barrier lipids content. Barrier lipids of human stratum corneum (hsc), fdm, lem, ftm, 
and fto were fractionated and quantified by hptlc and photo densitometry. a) Barrier lipid composition of human sc 
and hses. b) relative level of each sc lipid class, c) ratio of acyl-cers ([eo] cers) and non-acyl-cers (non-[eo] cer), 
d) relative level of acyl-cers, e) relative level of α-hydroxy and non-hydroxy cers. The data represents the sample mean 
±sd of at least 3 analytical points. Chol = cholesterol, ffa = free fatty acids, cers = cers, * unidentified lipid. Cer 
nomenclature: a= α-hydroxy fatty acid, e = ester-linked fatty acid, n = non-hydroxy fatty acid, o = ω-hydroxy fatty acid, 
ds = dihydrosphingosine, h = 6-hydroxysphingosine, p = phytosphingosine, s = sphingosine. 
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subclasses, which are also observed in human SC. In the LEM and FTM, an additional band 
of an unidentified lipid, with an Rf-value close to that of CER [EOH], can be observed. 
This unidentified lipid, which may represent an unidentified CER, was also occasionally 
observed in the FDM and FTO.
 Figure 1b shows that human SC consists of approximately equal amounts of cholesterol, 
FFAs and CERs. All HSEs, however, show a different distribution of the SC barrier lipids 
(Figure 1b). The relative FFA content in the HSEs, especially in the FDM, LEM, and FTO, is 
much lower compared with human SC. The SC lipid quantification also indicates that the 
CER/cholesterol ratio (Supplementary Table 1) in the LEM is increased and reduced in FTO 
compared to human SC. This indicates that the relative CER and/or cholesterol levels in 
the SC of the LEM and FTO differ from the levels determined in human SC.  
Most of the Hses have an increased acyl-ceR content compared with native human sc
 In human SC twelve CER subclasses are identified. Each subclass is named according to 
its chemical structure24,25. In short, CERs with a sphingosine (S), phytosphingosine (P), 
6-hydroxysphingosine (H), or dihydrosphingosine (dS) backbone are linked via an amide 
to a fatty acid chain, which can either be an esterified ω-hydroxy (EO), α-hydroxy (A), or 
non-hydroxy (N) fatty acid. Figure 1c shows the ratio between the total acyl-CERs ([EO] 
CERs) and the other CER classes (sum of all α-hydroxy + non-hydroxy CERs) in the HSEs 
and native human skin. This figure clearly shows that the total acyl-CERs level is much 
higher in the FDM, LEM, and FTO compared with native human skin. Focusing on the 
individual acyl-CER levels, it is evident that the FDM, LEM and FTO have a higher content 
of CERs [EOS] and [EOH]* compared with human SC. The difference in EOP level between 
FDM, LEM, FTO and human SC is somewhat smaller compared with the other acyl-CERs 
(Figure 1d). FTM has a small increase in CER [EOS] and [EOH]* level compared with human 
SC, while the [EOP] level is very similar (Figure 1d).
 On the TLC plate, an unidentified lipid close to CER [EOH] is observed in the LEM and 
FTM (Figure 1a). In the LC/MS CER profiles of the HSEs, an unidentified group of lipids, 
which have a molecular weight similar to acyl-CERs, is also observed close to CER [EOH] 
(Figure 2b, indicated by **). This suggests that the lipid band on the TLC plate most 
likely represents an acyl-CER class. For this reason, the unidentified lipid was quantified 
together with CER [EOH] (the two bands together are represented as [EOH]*).
The comparison of the α-hydroxy and non-hydroxy CERs also shows some differences in 
the distribution of these CER subclasses between the HSEs and human SC (Figure 1e). 
CER [NP] is the most abundant CER in human SC. Compared with human SC, the CER 
[NP] content is reduced in the FTM and an even further reduction is observed in the FDM, 
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LEM, and FTO. In addition, the CER [AP] content in the FTM is close to the CER content 
in human SC, but reduced in the FDM, LEM and FTO. The relative content of CERs [NS] + 
[NdS], CERs [AS] + [NH], and CER [AH] are similar in the HSEs and human SC. CERs [NS] + 
[NdS], and [AS] + [NH] were grouped together for quantification, because they comigrate 
and therefore have a similar Rf-value when using HPTLC. 
All twelve ceR subclasses detected in human sc are also observed in the Hses
 LC/MS analysis of native human SC lipids shows the presence of at least twelve CER 
subclasses, as reported previously19 (Figure 2a). In addition, within one CER subclass 
a large number of peaks are observed in the multi-mass chromatogram. Each peak 
represents a CER specie that has the same head group, but a different total carbon chain 
length and therefore a different molecular weight. In descending order, each specie has 
14 mass units less, which represents a reduction in one CH2-group compared with the 
previous specie. All twelve CER subclasses in human SC show a large variation in their total 
carbon chain length distribution. In human SC the acyl-CERs have a total chain length 
varying from 63 to 78 carbon atoms. The α-hydroxy and non-hydroxy CER subclasses 
have shorter total carbon chains, which range from 34 to 50 and 34 to 56 carbon atoms, 
respectively. In addition to the twelve identified CER subclasses, human SC also shows the 
presence of some unidentified lipid classes. These unidentified lipid classes also consist 
of several species, indicated by the variation in total carbon chain length. The molecular 
structure of these lipids remains to be elucidated. The CER subclasses present in the FDM, 
including the total chain length distribution of each subclass, is provided in the multi-
mass chromatogram in Figure 2b. This figure shows that all twelve CER subclasses present 
in native human SC are also detected in FDM. The other HSEs show a very similar LC/MS 
profile as the FDM and also show the presence of all twelve CER subclasses (Supplementary 
Figure 1). Each CER subclass in the HSEs shows a wide variation in total chain length 
distribution, similar to native human SC. In the HSEs the acyl-CERs have a total carbon 
chain that varies between 64 and 78 carbon atoms, which is almost similar to the chain 
length distribution observed for native human SC. The α-hydroxy and non-hydroxy CER 
subclasses have a total carbon chain between 32 and 50 and 34 and 56 carbon atoms, 
respectively. When focusing in more detail on the LC/MS profiles of the HSEs and native 
human SC, some differences are observed. In the multi-mass chromatograms of the HSEs, 
a weak lipid band is located just below the stronger peaks of the CER species (Figure 
2c), which is observed for all CER subclasses. These additional weak lipid bands always 
have a mass of two units less than that of stronger band of the CER specie above them 
(Figure 2c and d). This specific difference of two mass units suggests that the lipid band 










































































































































































Figure 2: cer chain length distribution. Lc/ms chromatogram of cer subclasses in human sc a) and fdm b). The 
retention time, mass and intensity of each peak are shown on the x-axis, y-axis and ‘z’-axis, respectively. The total carbon 
chain length variation of each cer subclass is provided in the inset. Cers with a low total carbon chain length, which 
are present in lower quantities in human sc, are indicated by # in the chromatogram of fdm. Unidentified lipids only 
observed in the chromatogram of fdm are specified with *. The unidentified lipid quantified together with cer [eoh] 
using hptlc is indicated by **. Examples of cer species containing a mufa chain are shown in c). The masses of cer 
species with a saturated or mufa chain are shown in d). 
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represents a CER specie that contains a mono-unsaturated fatty acyl chain. The multi- 
mass chromatograms of the HSEs also show low molecular weight CER species that are 
not detected in human SC. Furthermore, some low molecular weight CER species, which 
have a mass below approximately 620 amu have a higher intensity in the multi-mass 
chromatograms of the HSEs compared with human skin. This is mainly observed for 
species of CERs [AS] and [AH], which have a total chain length of 34 carbon atoms (Figure 
2b, indicated by #). The HSEs show the presence of several unidentified lipids, of which 
some are not present in the multi mass chromatogram of native human SC (Figure 2b, 
indicated by *). 
Hses show an increased presence of mono-unsaturated ffas compared to native 
human sc
 Figure 3 depicts the FFA chain length distribution and degree of saturation in human SC 
and FDM. The other HSEs showed a similar FFA composition as the FDM (Supplementary 
Figure 1). Human SC shows a FFA chain length distribution from C16:0 to C30:0. All HSEs 
contain FFAs with chain lengths varying from C16:0 to C28:0. This indicates that the HSEs 


























































Figure 3: Fatty acid chain length distribution. Three dimensional multi-mass lc/ms chromatogram of ffas in 
native human sc a) and fdm b) are shown. The retention time is shown on the x-axis, the mass (in amu) is provided on 
the y-axis and the intensity of each peak is depicted on the ‘z’-axis. In human sc the ffa chain length distribution varies 
from c16:0 to c30:0. The fdm has a very similar ffa chain length distribution as human sc, but shows an increase in 
mufas with chain lengths varying from c16:1 to c34:1. Additionally, the odd chain length ffas show a lower intensity 
in the chromatogram of fdm compared to human sc.
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of all HSEs additionally show the presence of mono-unsaturated fatty acids (MUFAs), 
which are hardly detected in human SC. The MUFAs detected in the LC/MS profiles of the 
HSEs have a chain length varying from C16:1 up to C34:1. All HSEs also show a reduced 
level of ffas with an odd carbon chain length compared with human SC.
The Hses show an altered expression of stearoyl-coa desaturase 1  
 To investigate the biological cause of the altered SC lipid organization of the HSEs, 
the expression pattern of some enzymes involved in the FFA and CER synthesis was 
examined. Stearoyl-CoA desaturase (SCD) is the rate-limiting enzyme that catalyzes the 
synthesis of MUFAs from saturated fatty acids27,28. In native human epidermis, SCD1 is 
only expressed in the basal layer (Figure 4). In all HSEs, the expression of SCD is observed 
in the basal layer, as well as in the differentiated layers of the viable epidermis (Figure 4). 
This indicates that the expression of SCD1 is altered in the HSEs compared with human 
skin.
 The first step in CER synthesis is the coupling of serine to palmitic acid by serine 
palmitoyltransferase (SPT)29. In human skin, SPT expression is observed in the entire 
viable epidermis, showing both nucleic and cytoplasmic staining. No difference in 
expression pattern between human skin and the HSEs is observed (Figure 4). CER synthase 
3 (CERS3) is one of the key enzymes involved in de novo CER synthesis pathway. CERS3 
has a broad fatty acyl-coA preference and therefore n-acylates both long and very-long 
chain fatty acyl-CoAs to a sphingoid base. Among the six CERS members (CERS 1-6), the 
mRNA expression of CERS3 is found to be the highest in differentiated keratinocytes in 
vitro30. In addition, a recent publication by Jennemann et al.31 demonstrated that CERS3 
is responsible for the synthesis of very-long chain CERs in the skin. In human skin and in 
all HSEs, CERS3 is expressed in the entire viable epidermis (Figure 4). It should be noted 
that the expression of SCD, SPT, and CERS3 was weaker in the FTO samples compared with 
the other HSEs.
Discussion
 In previous studies, we have investigated the SC lipid organization of four in-house 
HSEs and native human skin. These studies showed that our in-house HSEs have a mainly 
hexagonal packing17, whereas human SC has the dense orthorhombic packing (a schematic 
representation of the SC lipid organization is depicted in Supplementary Figure 2). The 
presence of a hexagonal lipid organization has been correlated to a decreased skin barrier 
function as monitored by transepidermal water loss compared with the orthorhombic 
packing32. We examined the SC lipid composition of our HSEs in detail to verify the cause 
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of their altered  SC lipid properties and to determine how the latter can be optimized.
 To our knowledge, it previously unreported that the SC of HSEs contain MUFAs, which 
may be a key factor for their altered SC lipid organization. The increase in MUFA content 
in the SC of HSEs coincides with the altered expression of SCD1 in the viable epidermis of 
the HSEs compared with human epidermis. It has been demonstrated that lipid mixtures 
containing an equimolar ratio of cholesterol, FFAs, and human CERs predominantly form 
an orthorhombic packing33. However, a reduction in FFAs or the addition of MUFAs in such 











Figure 4: Expression pattern of enzymes involved in free fatty acid desaturation and de novo cer synthesis. 
Immunohistochemical staining showing the expression pattern of stearoyl-coa desaturase (scd), serine 
palmitoyltransferase (spt) and cer synthase 3 (cers3) in human skin (hs), fdm, lem, ftm and fto. The negative 
control represents sections on which only the secondary antibody was applied. The micrographs were taken at a 20x 
magnification. Scale bar represents 50 µm. 
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mixtures enhances the formation of a hexagonal lateral packing . This indicates that the 
reduction in FFA level and an increased presence of MUFAs contribute to the formation of 
the hexagonal packing in our HSEs and thus may be key factors in the observed increased 
benzocaine penetration across the SC of HSEs compared with native human skin. With 
respect to the lamellar phases, the HSEs show the predominant presence of the long 
periodicity phase (LPP)17, whereas in human SC both the LPP and short periodicity phase 
(SPP) are formed34. All HSEs have an increased relative content of CERs [EOS] and [EOH]. 
As suggested in previous studies, these high acyl-CER levels may favor the formation of 
the LPP in HSEs35, but does not make the HSEs more permeable. 
 We show that all twelve CER subclasses observed in native human SC are also present in 
the SC of all HSEs. This indicates that the keratinocytes in our HSEs retain their ability to 
synthesize all CER subclasses that are also present in human SC. This observation represents 
a big step forward in the characterization of the SC lipid properties of HSEs, considering 
that until now a maximum of nine CER subclasses were detected in HSEs, whereas in the 
commercial HSEs even those nine CER classes were not always present18,36,37. 
Masukawa et al. quantified the CER composition in native human SC using LC/MS38. The 
relative prevalence of each CER class determined in this study and the study of Masukawa 
et al. are very similar. In this study, five synthetic CERs are used for quantification of 
the SC lipids in the HSEs and native human SC. The use of several CER subclasses for 
quantification is very important, as the charring intensities of the CER subclasses differ 
considerably when equal amounts are sprayed on TLC plates (Supplementary Figure 3). 
The different composition of CER subclasses in the FDM, LEM, and FTO compared with 
human skin is indicative of an altered CER subclass synthesis in these HSEs. The reason for 
this difference remains to be elucidated. 
 Our results demonstrate that the HSEs show a similar expression of CERS3 as human 
skin. The LC/MS multi mass chromatograms indeed show that the HSEs are able to 
synthesize CERs with a large variety in total carbon chain lengths, which are very similar 
to human skin. The expression of SCD1 in the proliferating and differentiating layers of 
the epidermis of the HSEs may result in an increased activity of SCD1 in the differentiated 
epidermal layers and thus an increased intracellular content of MUFAs in the keratinocytes. 
Because of the increase in intracellular MUFA content, the CERS enzymes, including CERS3, 
n-acylate both MUFAs and saturated FFAs to the sphingoid bases. The observation that an 
increase in MUFA content in the SC is accompanied by the presence of CER species with 
a mono-unsaturated fatty acyl chain suggests that fatty acids present in the SC and the 
fatty acyl chains of CERs have a common source or synthetic pathway. 
 The results of this study indicate that the SC lipid properties of the HSEs can be improved 
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by increasing the FFA content in the SC. The culture medium used to generate the HSEs is 
supplemented with FFAs. Optimization of FFA supplementation to the culture medium 
may lead to SC FFA levels that more closely resemble the SC FFA level of native human 
skin. At present it is unclear why the HSEs show an altered expression of SCD1 compared 
to human skin. It is possible that the culture conditions or certain media components 
which are known to affect SCD expression or activity, such as insulin, glucose and fatty 
acids27,39 lead to an increased MUFA level in HSEs. However, it remains to be established 
whether increased expression of SCD1 in the suprabasal layers of the HSEs is truly 
associated with an increased activity of SCD1 compared with native human epidermis. If 
this appears to be true, the SC lipid properties can additionally be improved by reducing 
SCD1 activity and thereby the MUFA level in the SC of HSEs. SCD1 activity in the HSEs may 
therefore be reduced by using, e.g., SCD inhibitors27,40 in the culture medium. Studies 
performed by Miyazaki et al 41 have demonstrated that SCD-deficient mice show skin 
permeability barrier defects, such as an insufficient lipid deposition in the SC due to the 
presence of immature lamellar bodies with a reduced lipid content, and a reduction in 
acyl-CER content. The reduction in SCD1 activity should therefore be performed with care 
to prevent different types of SC barrier defects in HSEs that may occur by a too severe 
suppression of SCD1 activity. Optimization of the FFA content in the SC of HSEs will be the 
subject of future studies.
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Supplementary information – Materials & Methods
Cell culture
 Human dermal fibroblasts were cultured in DMEM (Invitrogen, Leek, The Netherlands) 
supplemented with 5% fetal bovine serum (FBS; Hyclone, Logan, UT) and 1% penicillin/
streptomycin (Sigma). Normal human keratinocytes were grown in medium consisting 
of DMEM and Hams’s F12 (Invitrogen, Leek , The Netherlands) (3:1 v/v), 5% FBS, 1% 
penicillin/streptomycin, 1 µM hydrocortisone (Sigma), 1 µM isoproterenol (Sigma) and 
0.5 µg/mL insulin (Sigma).
Dermal equivalents
 Collagen-type I containing dermal equivalents: a 1 mg/mL collagen, isolated form rat 
tails, solution was obtained by mixing a 4 mg/mL collagen solution in 0.1% acetic acid 
with Hank’s buffered salt solution (Invitrogen, Leek, The Netherlands), 0.1% acetic acid, 
1M NaOH and FBS (Hyclone, Logan, UT) on ice. One mL of this mixture was pipetted into 
a filter insert (Corning transwell cell culture inserts, membrane diameter 24 mm, pore 
size 3 µm, Corning Life Sciences, Amsterdam, The Netherlands) and polymerized for 15 
minutes at 37°C. Hereafter, a 2 mg/mL collagen layer was prepared as described, with the 
addition of fibroblasts to the FBS solution (final fibroblast cell density of 0.4·105 cells/mL 
collagen solution). Three mL of this fibroblast-populated collagen mixture was pipetted 
onto the previous collagen layer and polymerized as described. The dermal equivalents 
were transferred to a 6-well deep-well plate (Organogensis, Canton, MA) and cultured 
under submerged conditions in medium consisting of Dulbecco’s Modified Eagle medium 
(DMEM; Invitrogen, Leek, The Netherlands), 5% FBS, 1% penicillin/streptomycin (Sigma) 
and fresh supplementation of 45 mM vitamin C (Sigma). The medium was refreshed twice 
a week. 
 Fully human dermal equivalents: 0.4·106 fibroblasts were seeded onto filter inserts 
(Corning Transwell culture inserts, membrane diameter 24 mm, pore size 0.4 µm; 
Corning Life Sciences, Amsterdam, The Netherlands) and were nourished with a similar 
medium described for the collagen type I containing dermal equivalents. The fibroblast 
were allowed to generate their own extracellular matrix for 3 weeks. The medium was 
refreshed twice a week. 
Morphology and immunohistochemistry
 The paraffin sections were deparaffinized and rehydrated through xylene and graded 
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ethanol series and finally washed with PBS. Antigen retrieval was performed by 
immersion in sodium citrate buffer (pH 6) for 30 minutes close to the boiling point. 
After cooling the sections were blocked with normal horse serum for 20 min, followed 
by incubation with the primary antibody (diluted to the appropriate concentration in 1% 
BSA in PBS) overnight at 4°C. After washing with PBS the sections were incubated with 
the secondary antibody for 30 minutes, washed again and incubated with ABC reagent 
for 30 minutes. The sections were consecutively washed with PBS, 0.1 M sodium acetate 
buffer and incubated for 30 minutes in amino-ethylcarbazole (Sigma) dissolved in N,N-
dimethylformamide (1 g/250 mL) (Sigma) supplemented with 0.1% hydrogen peroxide 
and finally with water. Counterstaining was performed with haematoxylin. Incubation 
with normal horse serum, secondary antibody and ABC reagent were performed with the 
R.T.U. Vectastain Elite ABC reagent kit (Vector Laboratories, Burlingame, CA).
part iv chapter 10
194
2 4 6 8 10
Time (min)
2 4 6 8 10
Time (min)
















4 5 6 7 8
Time (min)
a) b)















































































Supplementary Figure 1: Ceramide and ffa chain length distribution in lem, ftm and fto. Three dimensional multi-
mass lc/ms chromatogram of ceramide subclasses in lem a), ftm b) and fto c). The retention time is shown on the 
x-axis, the mass is provided on the y-axis and the intensity of each peak is depicted on the ‘z’-axis. The total carbon chain 
length variation of each ceramide subclass is indicated in the inset. Ceramides with a low total carbon chain length which 
are present in lower quantities in human sc are indicated by #. Unidentified lipids observed in the chromatogram of the 
lem, ftm and fto which are not observed in human sc are specified with *. The unidentified lipid quantified together 
with ceramide [eoh] using hptlc is indicated by **. The ffa chain length distribution and degree of saturation of lem, 
ftm and fto are shown in d), e) and f), respectively.
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Supplementary Figure 2: Stratum corneum lipid organization. In human sc the lamellar phases refer to the stack 
of lipid layers (i.e. lipid lamellae) between the corneocytes. The distance over which one lipid layer is repeated is referred 
to as the repeat distance d). In human sc the lipid lamellae have a repeat distance of approximately 13 or 6 nm, the long 
and short periodicity phase (lpp and spp), respectively. The lateral packing discloses the density of the lipids within the 
lipid lamellae. The orthorhombic packing has the highest lipid density and the liquid packing the lowest. In human sc the 
lipids are arranged in the orthorhombic packing, although some lipid domains also form the hexagonal or liquid packing. 
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Supplementary Figure 3: charring differences of ceramide standards. Figure a) shows the charring intensities 
of the lipid standards used for the quantification of the sc lipid composition. The lipid standard contains equal weight 
amounts of each standard. The charring intensity of each spot was determined by densitometry and plotted against the 
amount sprayed to construct a calibration curve b).
 Ceramide/Cholesterol
ratio
HSC 1.3 1.3 
FDM 1.3 1.3 
LEM 1.8 1.6 
FTM 1.5 1.5 






















 Atopic eczema (AE) is one of the most common 
types of inflammatory skin diseases. It is 
characterized by eczematous lesions (lesional skin), 
whereas other areas of the body may visually appear 
normal (non-lesional skin). The diagnosis of AE 
is based on a constellation of clinical findings, as 
there is currently no biomarker characteristic for 
diagnosis of AE. The disease is often referred to as 
atopic dermatitis, neurodermatitis, and endogenous 
eczema. Because up to 60 percent of patients with 
the clinical phenotype do not have elevation of total 
or allergen-specific IgE levels in serum, there is still 
a controversy in the terminology of ‘atopic’. The 
inflammation is primarily related to penetration 
of allergens into the skin that provoke an immune 
response, resulting in clinical symptoms like 
erythema (red skin) and pruritus (itch)1-3. Also 
xerosis (dry skin) is one of the main symptoms of AE, 
indicating a dysfunction in skin hydration, regulated 
by the skin’s natural moisturizing factors (NMF)4-6. 
The NMF are breakdown products of the filaggrin 
protein. Mutations in the filaggrin gene (flg) are 
to date the single most predisposing factor for 
developing AE7, although it can only explain 20-50% of 
all occurrences8,9. This subscribes the heterogeneity 
of AE and implies the role of other genetic and 
environmental factors in the pathophysiology of 
AE. One of these is the importance of a reduced 
barrier function that facilitates the penetration of 
exogenous compounds into the skin10-15. 
 The main barrier of the skin is located in the 
outermost layer of the skin, the stratum corneum 
(SC)16-18. It consists of corneocytes embedded in 
a highly ordered lipid matrix, and prevents the 




skin19. In addition, it protects the body from excessive transepidermal water loss (tewl). 
 In AE, the SC barrier is impaired, and allergens can penetrate through the extracellular 
lipids into the lower layers of the epidermis2,11,13,20. This stresses the importance of the 
SC lipids for a proper skin barrier function. Sc lipids consist of free fatty acids (ffas), 
ceramides (CERs) and cholesterol (CHOL)21,22. Both FFAs and CERs contain respectively 
1 and 2 long carbon chains. These may differ in their molecular structure: FFAs are 
predominantly saturated, although mono-unsaturated FFAs (mufas) are present as 
well23,24. CERs consist of a sphingoid base and a fatty acid (acyl) chain. Variations in both 
carbon chains (chain length and head group structure) lead to 12 CER subclasses25,26. In 
addition to these structural variations, both FFAs and CERs show a wide distribution in 
their carbon chain lengths. The variation in carbon chain length and chemical structure is 
unique for SC lipids and results in a distinctive lipid organization: the lipid lamellae27,28. 
These stacked lipid layers have a repeat distance of approximately 6 nm and 13 nm, referred 
to as the short periodicity phase (SPP) and long periodicity phase (LPP)29-31. Besides this 
lamellar lipid organization, SC lipids are packed in a lateral lipid organization: Human 
SC lipids are mainly present in a very dense – orthorhombic – organization, although a 
subpopulation is packed in a less dense – hexagonal – organization32-36.
 Analytical methods to study the lipid composition are limited, and no methods are 
currently available to study the chain length of the SC lipids. This is one of the reasons 
that the role of the SC lipids in AE remains inconclusive: Reports on the CER composition 
give conflicting information37-45; hardly any information is available on the composition 
of the FFAs46,47; and only one study in a limited number of AE patients is present 
that studies the lipid organization, only mentioning the lateral packing48. The lack of 
knowledge about the SC barrier lipids in relation to the impaired skin barrier function of 
AE was the basis for the aims of this thesis.
Aims
 The primary aim of this thesis is to study in detail the SC lipid composition and 
organization as well as their role in the skin barrier function in eczematous patients. This 
is achieved by pursuing the following challenges:
1. Developing robust methods that enables quantitative analysis of all main SC lipid   
  classes in detail.
2. Determine the comprehensive SC lipid composition of both lesional and non-lesional  
  skin in AE patients and compare the lipid profile to healthy controls.
3. Establish how changes in the SC lipid composition of AE patients are related to changes 
  observed in the lipid organization, and how those affect the skin barrier function.
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4. Determine the relationship between SC lipid composition and organization with
  respect to other SC sources that show a reduced skin barrier function (i.e. Netherton  
  syndrome (NtS) and human skin equivalents (hses)).
Part I: Method development for detailed stratum corneum lipid analysis
 Part I addresses the first aim in which a novel method was developed that would permit 
detailed analysis on all main SC lipids (CERs, CHOL and FFAs) in a single setup. To achieve 
this, liquid chromatography coupled to mass spectrometry (LC/MS) was preferred, as it 
can analyze the SC lipid classes and subclasses as well as the chain length of each individual 
lipid. 
 The development of such a method was started with the analysis of CERs, reported 
in Chapter 3. It describes a quick and robust LC/MS method that enables quantitative 
analysis of all human SC CER subclasses using only limited sample preparation. The 
combination of normal phase LC in combination with atmospheric pressure chemical 
ionization (APCI) MS is uncommon. Nevertheless, it proved to be an excellent choice for 
the analysis of SC CERs, as all subclasses and chain lengths were adequately separated and 
could easily be identified. Human SC shows the presence of 11 known CER subclasses. 
In addition, unidentified lipid subclasses were discovered. Using high mass accuracy MS 
as well as by acquiring fragmentation data (MS/MS), one of these lipid subclasses was 
identified as the 12th (missing) CER subclass: the ester-linked ω-hydroxy acyl chain linked 
to a dihydrosphingosine base (CER [EOdS]). The method appeared successful in analyzing 
all 12 CER subclasses from both ex-vivo skin, SC obtained by tape stripping and SC from 
human skin equivalents (hses).
 The development of the second major SC lipid class, FFAs is described in Chapter 4. The 
first challenge was to develop and subsequently validate an LC/MS method for quantitative 
analysis of SC FFAs. Such a method has not been reported before for SC FFAs, as gas 
chromatography is the most common method. Besides, LC/MS of underivatized FFAs 
results usually in unstable ions or is not sensitive. Using reverse phase LC in combination 
with APCI-MS in negative ion mode as well as the addition of chloroform as an ionization 
enhancer contributed to a large extend to the formation of stable chloride adducts. A 
quantitative validation protocol demonstrated that the method is robust, reproducible, 
sensitive, fast, whereas ion suppression was negligible. This method was therefore suitable 
for analysis of human SC FFAs and could be combined with the analysis of CERs, as the 
same ionization source (APCI) was used. The second challenge was to enable quantitative 
analysis of CHOL, which was achieved by optimizing the LC-gradient for the CER method. 
The combined methods enable (semi-)quantitative analysis of all major SC lipid classes 
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in a single setup. The last part of the chapter describes the application on ex vivo human 
SC, human SC obtained from tape stripping and human skin substitutes (porcine SC and 
human skin equivalents). In conjunction with CER profiles, clear differences in FFA profiles 
were observed between these different SC sources.
 Now that the developed LC/MS methods enable the analysis of all major SC lipids, this 
method was used in several studies in which the role of the SC lipids was investigated with 
respect to the skin barrier function. These studies are described in Part II and III.
Part II: Stratum corneum lipid composition in atopic eczema and its role in the skin 
barrier function
 Using the LC/MS methods developed in part I, the second aim of the study was tackled, 
in which the SC lipid composition of AE patients was examined and compared to healthy 
subjects (controls). Part II describes 4 chapters that investigate different aspects of the 
SC lipid composition. These chapters also cover the third aim of the thesis, in which the 
relation between the lipid composition and the lipid organization was studied, as well as 
their involvement in the reduced skin barrier function of AE patients.
The first, explorative, study in AE patients is described in Chapter 5. The composition of 
the CER subclasses as well as the lamellar lipid organization of SC from six AE patients was 
compared to that of 6 control subjects. Only non-lesional skin of the ventral forearms 
was investigated. The CER composition was examined by tape stripping and successively 
analyzed by the newly developed LC/MS method. Skin biopsies were harvested in order 
to examine the lamellar lipid organization by small-angle X-ray diffraction studies. 
Regarding the CER composition, all 12 CER subclasses were observed in AE patients. 
However, a significant decrease in the level of CER [EO] subclasses (those with an ester-
linked ω-hydroxy acyl chain linked to a sphingoid base, also referred to as acyl-CERs) and 
CER subclass [NP] (CERs with a non-hydroxy acyl chain linked to a phytosphingosine base) 
was observed. Interestingly, subjects with the strongest reduction in acyl-CERs also show 
the most pronounced deviations in their SAXD-profiles. This suggests that changes in CER 
composition are related to an altered lamellar lipid organization in AE patients. 
 These findings were the starting point for a comprehensive study in 28 AE patients 
and 14 control subjects, described in Chapter 6. Both the CER composition and lipid 
organization in non-lesional SC was determined by means of LC/MS, Fourier transform 
infrared spectroscopy (FTIR) and small angle X-ray diffraction. In addition, the skin barrier 
and clinical state of the disease as well as the effect of flg mutations were examined. SC 
of AE patients showed an increased level of CERs with a very short total chain length of 34 
carbon atoms (fatty acid + sphingoid base, C34 CERs), whereas the level of very long acyl-
part v
204
cers was decreased. These changes reduced the overall cer chain length significantly, and 
induced an altered lipid organization that correlated to a decreased skin barrier function 
in these ae patients. Moreover, the changes in sc cers also correlated with disease 
severity. The cers were the first of the main lipid classes analyzed in sc of ae. Because the 
results show that the lipids seem to play an important role for the barrier function in ae, 
other main sc lipid classes were analyzed as well.
 A consecutive study in ae patients focused on the second main sc lipid class, the ffas. 
As no studies have been reported so far that studied the ffa composition and its chain 
length in sc of ae patients, Chapter 7 presents a study that focuses on the extracellular sc 
ffa composition in both lesional and non-lesional ae skin, and describes how changes in 
ffa composition are related to the observed changes in the cer composition. In addition, 
it was studied how the changes in lipid composition affect the lipid organization as well 
as the skin barrier function. An increased abundance of mufas at the expense of hydroxy-
ffas was observed in sc of ae patients. Moreover, the ffa chain length distribution is 
shifted towards shorter chain lengths. These findings were already observed in non-
lesional skin, but much more pronounced in lesional skin. The reduced ffa chain length 
matches the shorter chain length observed for the cers, which is a strong indication that 
the cers and ffas share a common synthetic pathway. The chain length of the lipids was 
strongly associated with the lateral lipid organization: An increase in lipids with shorter 
chain length results in the increased presence of a hexagonal lipid organization, while 
longer chain length lipids contribute to the orthorhombic organization. The increased 
presence of a less densely packed lipid organization also correlated to the reduced skin 
barrier function, as monitored by tewl.
 Both Chapters 6 and 7 described the effect of flg mutations on the lipid parameters. 
These mutations are a major predisposing factor for development of ae, and are therefore 
of interest to study regarding their relation to the sc lipids. Also the nmf – degradation 
products of filaggrin – are taken into account, as these play an important role in the 
hydration and establishing a pH gradient of the sc. The lipid composition and organization 
show a clear correlation with nmf levels, but not with flg mutations. This discrepancy 
illustrates that between flg genotype and filaggrin metabolites, other factors may play an 
important role (like filaggrin expression), and demonstrates the importance of studying 
filaggrin at the phenotype level in addition to profiling flg genotype.
 The studies described in the previous chapters make clear that the lipid composition 
and its organization play an important role in the reduced skin barrier function of ae 
patients. Chapter 8 describes a study in ae patients in which the importance of the lipid 
to protein level was studied.  This was achieved by determining for each ae patient and 
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control subject the dry sc mass per surface area as well as the ratio between lipid and 
protein bands in the Raman spectra, which is a measure for the relative lipid/protein ratio. 
The results demonstrate that the dry sc mass per skin area is to a minor extent changed 
in ae patients compared to control subjects. In contrast, the lipid/protein ratio is much 
more reduced in sc of ae patients, both in non-lesional skin and even more pronounced 
at lesional skin sites. These changes correlated with the skin barrier function and indicate 
that, besides lipid composition, also the lipid/protein ratio plays an important role in the 
reduced skin barrier function in ae.
 Overall, the studies described in Part II illustrate the importance of the altered lipid 
composition and organization for the impaired barrier function of the skin in ae.  The 
findings obtained in these studies formed the basis to investigate other sc sources in 
which a reduced barrier function is present, which are described in Part III.
Part III: Studies on sc lipids from other skin sources showing a barrier dysfunction
 In part II the relevance of the sc lipids for the skin barrier function and its biological 
relevance to ae has been demonstrated. In part III, we expanded the scope beyond ae to 
pursue the fourth aim of this thesis. Two additional studies were performed on the sc 
lipids from different skin sources in which a reduced skin barrier is present: patients with 
Netherton syndrome (ntS) and human skin equivalents (hses).
 Chapter 9 describes a study in 8 ntS patients. Nts is an exceptional form of dermatitis 
and share similarities with ae. NtS is caused by rare specific genetic mutations in the 
spink 5 gene, which encodes for a specific protease inhibitor (LEKTI). In ntS, lack of 
this inhibitor results in increased activity of epidermal proteases, leading to severe 
sc detachment. The aim of the study was to determine the sc lipid composition and 
organization in ntS patients, as hardly any information on these matters is currently 
available. NtS patients showed a decrease in their sc ffa chain length as well as an 
increased amount of mufas compared to controls. In addition, the level of C34 cers was 
increased in ntS patients whereas a subgroup of patients showed a strong reduction in 
long-chain cer levels. Nts patients also showed the presence of high levels of unsaturated 
cers, which had not been observed in any other sc source studied so far. These changes 
in the lipid composition increased the disordering of the lipid packing: both the lamellar 
and lateral lipid organization showed significant changes. The results demonstrated that 
acyl-cers are crucial for the long periodicity phase in the lamellar lipid organization. The 
changes in lipid composition and organization are expected to contribute to the barrier 
dysfunction in ntS.
 Chapter 10 describes a study on the sc lipids of human skin hses. These are 
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bioengineered skin models that mimic many features for native human sc, but they show 
an impaired skin barrier and a different sc lipid organization. To elucidate, in detail, the 
cause of the altered sc lipid organization, analysis by LC/MS was performed to determine 
the ffa and cer composition as well as the chain length distribution in detail. The results 
reveal that all hses i) show the presence of 12 cer subclasses (similar to native human 
sc), although cer species with short total carbon chains were significantly increased 
compared to human sc. ii) display the presence of cer species with a monounsaturated 
acyl chain, which are not detected in human sc (except for nts patients); iii) have an 
increased presence of mufas compared with human sc, whereas the total amount of ffas 
was drastically decreased; iv) exhibit an altered expression of stearoyl-CoA desaturase, the 
enzyme that converts saturated ffas to mufas.
Conclusions
 The studies described in this thesis reveal that sc lipids play a crucial role for a proper skin 
barrier function in humans. In vivo studies in ae and ntS patients reveal that changes in 
the composition of the lipids negatively affect the lamellar and lateral lipid organization. 
In particular the lipid chain length excellently correlated to the organization of the lipids: 
shorter ffa and cer chain lengths contribute to a more hexagonal lipid organization, 
while longer lipid carbon chains will results in a more densely packed, orthorhombic 
organization. From the results in ae and ntS patients, it can also be concluded that the 
acyl-cers are crucial for the long periodicity phase in the lamellar lipid organization. The 
use of LC/MS proved to be essential for these findings, as no other method to date can 
analyze the sc lipid chain lengths in all its detail. Besides, the sensitivity of MS reduced 
the amount of sample necessary for analysis, which permitted harvesting sc lipids in a 
non-invasive way by means of tape-stripping. 
 In addition, the level of sc lipids may be important for a proper skin barrier function, 
as the reduced lipid/protein ratio in ae subjects correlate to a high extent with a reduced 
skin barrier function. Chapters 5-7 report that tewl correlates with the lipid composition 
(particularly lipid chain length), whereas chapter 8 reports a strong correlation between 
tewl and the lipid/protein ratio. This raises the question whether changes in lipid 
composition correlate with the changes observed in lipid/protein ratio, in ae. Indeed, 
a high correlation is observed between the lipid chain length and the lipid/protein ratio 
(rspearman=0.79). This could indicate that the changes observed in the lipid chain length 
and lipid/protein ratio may share a common factor in lipid metabolism that is altered in 
ae (discussed below).
 The sc barrier lipids in ae, ntS and hses showed similar changes in their composition: 
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a reduced lipid chain length and increase in unsaturated lipids. Comparing sc from 
non-lesional ae with lesional ae skin and ntS reveals that more severe changes in the 
composition of the lipids result in more severe changes in the lipid organization. This may 
explain why previous studies on ntS patients show a drastic reduction in the sc barrier 
function. The relation between the composition of the ffas and cers is remarkable: the 
chain length and the degree of unsaturation of the ffas complement the composition of 
the cers. This is of fundamental relevance as it supports the hypothesis that human sc 
cers and ffas share a common synthetic pathway49,50. It is also of clinical importance, 
as it implies that normalizing the ffa chain length distribution in ae skin may also 
contribute to normalization of the cer chain length. 
 These studies give relevant information regarding possible changes in the epidermal 
lipid metabolism: i) The reduced ffa chain length observed in ae, ntS and hses suggest 
that ffa elongation is impaired51; ii) the changes in the relative abundances of the cer 
subclasses indicate that the enzymes involved in synthesis of one particular subclass may 
either be up- or downregulated. Two enzymes that are likely to be involved in the altered 
epidermal lipid metabolism are β-glucocerebrosidase and acid sphingomyelinase, which 
convert cer precursors into their final cer structure52-55. Both enzymes, however, do 
not have the same affinity to all cer precursors, and changes in the activity of one of 
these enzymes may partly explain the increase in certain cer subclasses at the expense 
of others56; iii) the correlation between lipid chain length and lipid/protein ratio may 
indicate that the changes share a common factor that is altered in ae. It goes beyond the 
current knowledge to speculate about these factors, but enzymes involved in de novo 
synthesis of the lipids are definitely a target of interest for future studies. 
 Moreover, the studies in ae patients contributed to a better understanding of the role of 
flg and nmf with respect to the sc lipids and barrier function. Filaggrin at the phenotype 
and metabolic (nmf) level seems more closely related than at the genotype level, which 
supports the hypothesis that changes in filaggrin expression may be an important factor 
in ae57,58. 
 Overall, the studies performed throughout this thesis increased the knowledge of 
the sc barrier function from both a biophysical perspective (the relation between lipid 
composition, lipid organization, and barrier function) as well as a clinical perspective (the 




 Despite the fact that the aims set at the very beginning of this thesis may have been 
accomplished, the studies have raised additional questions and may serve as a basis for 
future studies in multiple directions. The most prominent ones will be discussed below.
Exploiting the possibilities of Lc/Ms for analysis of sc lipids
 Although an adequate method was developed for qualitative and quantitative analysis 
of all major sc lipid classes, many possibilities remain unexploited. The main advantages 
of the current LC/MS method compared to other methods are that it is quick (<20 minutes 
analysis time to acquire data on all main sc lipids), robust, sensitive, and gives detailed 
information on the lipid chain length. However, the main bottleneck for high-throughput 
analysis is currently the lipid extraction protocol (taking several hours) and manual data-
processing (several hours per sample). Regarding an alternative extraction protocol, 
experiments that replace the current 3-step Bligh and Dyer extraction protocol with a 
1-step heptane/isopropanol extraction of 20 minutes provided similar results on the lipid 
composition. Future validation of such an improved extraction protocol may therefore 
significantly reduce the amount of time spend on sample preparation. With respect to 
data-processing, currently automatic data-processing results in proper quantification in 
~90% of the assigned peaks. With a number of >250 designated peaks, this needs to be 
improved for reliable automatic quantification. One way to do this is by analyzing lipids 
in mrm mode. Two additional advantages are that sensitivity is (usually) increased, and it 
may also provide more structural information, for example on the individual chains of the 
sphingoid base and acyl chain of the cers. The sensitivity may also be greatly enhanced 
when changing from the current HPLC method to UPLC. Last but not least, it is preferable 
to use only a single injection for analysis of all lipid classes at once. Currently, cers and 
CHOL are analyzed in positive ion mode and NPLC, whereas ffas are analyzed in negative 
ion mode and RPLC. Because cers are also observed when analyzing ffas in negative ion 
mode, it may be worthwhile to analyze all sc lipids in negative ion mode, using NPLC for 
adequate separation of all cer subclasses and optimize it to include proper analysis of 
ffas and CHOL.
 Another aspect for future studies concerns the identification of additional lipid peaks 
that were noticed in Chapters 3 and 4. Among these are probably the glucosyl-cers, di- 
and triglycerides, CHOL esters, and probably others which are yet unknown. In particular 
the unknown lipid species that elute in between the different cer subclasses (e.g. between 
cer [AP] and cer [AH]) may be of interest. Their mass and hydrophobicity may indicate 
that they have comparable molecular structures, but fragmentation studies (MS/MS) may 
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fully elucidate the molecular structure of these lipids. It is likely that some of these ions 
are isomers of the alpha-hydroxy fatty acid cer subclasses ([AS], [AdS], [AP], [AH]), but 
that the hydroxyl group in the acyl chain is located at the ω-position. This would slightly 
increase the polarity but not the mass, something which matches the unidentified cer 
located between cer [AP] and [AH]. These so-called ω-hydroxy fatty acid cers are already 
known to be present in the sc as bound lipids59, and it is therefore plausible that these 
could also be observed with the current method as free lipids.
Elucidating the epidermal lipid metabolism
 It was concluded from the in vivo studies performed in patients with ae and ntS, but 
also the in vitro studies with hses, that changes in the synthesis of epidermal lipids are 
the underlying cause of the altered sc lipid composition. Future studies may therefore 
focus on the enzymes that elongate the ffas (ELOVLs), as these may be a probable reason 
for the reduced lipid chain length. Since a lower level of ffas with a chain length of 24 
carbon atoms and higher was observed in ae and ntS, ELOVL4 activity may be reduced, 
as this enzyme is involved in elongation of ffas ≥24 carbon atoms. Recent murine 
studies support this hypothesis, demonstrating that sc lipids of ELOVL knockout mice 
show reduced levels of long chain ffas60-62. The increased amount of mufas suggests 
that expression of stearoyl-CoA desaturase (the enzyme that converts saturated ffas to 
mufas) may be increased in ae63. 
 In general, studying the enzymes in eczematous patients will give valuable information 
about the altered epidermal lipid pathways and may lead to more fundamental knowledge 
about epidermal lipid synthesis and the relation to ae. Also the role of inflammation on 
these epidermal lipid enzymes needs to be elucidated, as it is known that inflammatory 
cytokines affect the epidermal lipid synthesis in several ways. Studies related to the 
inflammatory aspects of ae may therefore focus on i) metabolic enzymes involved in 
cer synthesis (like β-glucocerebrosidase and acid sphingomyelinase)52-55; ii) cytokines 
like TNF-α as well as several interleukings (IL-17, IL-22, IL-25, IL-31) that are related 
to downregulation of filaggrin expression64-68; and iii) nuclear receptors (peroxisome 
proliferator-activated receptors) that are involved in sc barrier formation and have anti-
inflammatory capabilities69-75.
Sc barrier repair
 Restoring the sc barrier function has become one of the main challenges in ae. Two 
fundamentally different approaches can be pursued to achieve this: i) one can compensate 
for the reduced barrier function by application of topical formulations; ii) Another 
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approach is to restore the epidermal lipid synthesis. 
 With respect to the former approach, our studies give new insights in possible topical 
formulations which may be beneficial to the sc barrier. In particular the finding of the 
reduced lipid chain length in ae is something that offers a new perspective. An interesting 
study in ae subjects would therefore be to compensate for the reduced lipid chain 
length by topical application of a formulation containing long carbon chain cers and/
or ffas for at least several weeks, and subsequently analyze the lipid composition and 
organization of these patients and investigate whether these lipids will be incorporated 
in the native sc lipid matrix and improve the lipid organization and skin barrier function. 
One can improve such formulations even further by analyzing the sc lipid composition 
at forehand. There is a large individual variation in the cer and ffa composition of ae 
subjects, and one specific formulation may not be suitable as a treatment for all patients. 
Based on deteriorations in the lipid profile, it can be decided which formulation and dose 
should lead to an optimal barrier recovery. This approach of individual dose/formulation 
regimen is something that has increased attention for pharmaceutical companies as it 
proves to be more beneficial to the patient. 
 The second approach, to restore the epidermal lipid synthesis, may be much more difficult 
to achieve, and needs much more knowledge on the fundamentals of ae. In order to target 
the enzymes that may lead to normalization of the lipid synthesis, one need to normalize 
the metabolic processes that take place in the cytosol and endoplasmatic reticulum of 
the keratinocytes, where de novo syntheses of respectively ffas and cers primarily take 
place. A proper skin hydration, pH gradient, and keratinocyte differentiation are factors 
that should be taken into account for proper sc barrier repair using this approach.
 It should not be overlooked that ae is mainly related to the western society, and relatively 
simple, non-clinical/pharmaceutical adaptations can already significantly improve the 
barrier. For example, a proper level of the environmental humidity, or the moderate use 
of soap, preferably with a skin-neutral to acid pH, may already reduce the prevalence of ae.
Additional studies in ae may elucidate fundamental questions on the disease.
 One of the most frequently asked questions with respect to ae and the barrier function, 
is whether the inflammatory response (inside-to-outside model) or the reduced sc barrier 
function (outside-to-inside model) is the primary cause of the disease20,76-78. Although a 
definite answer cannot be given at the current time, it should be noted that future studies 
can lead to small progressions that may stepwise unravel this question. For example, 
studies in newborns with a high risk of developing ae (e.g. carriers of flg mutations; 
parents with ae) but without any clinical appearance of the disease may be monitored 
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for a longer period of time and regularly checked on markers for skin inflammation and 
sc barrier function. If the onset of ae is imminent in such a newborn, one can study 
changes in some of these biomarkers that led to the onset of ae. This will lead to a better 
understanding of the disease. However, it should be mentioned that ae is a multifactorial 
disease and that this ‘chicken-or-egg’ question may well prove to be a ‘chicken-and-egg 
question’, as discussed by Elias et al., suggesting the ‘outside-to-inside and back-to-
outside’ model11,20.
 The role of flg mutations, filaggrin protein, and filaggrin breakdown products (i.e. the 
nmf) for the sc barrier function of ae may be another aspect for future studies. Studying 
the sc lipids in patients with ichthyosis vulgaris may therefore be of interest, as these 
patients carry loss-of-function mutations in the flg gene. In addition, studies in subjects 
that carry a flg mutation and have low nmf levels but normal sc barrier properties may 
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 Een van de meest voorkomende huidziekten is 
constitutioneel eczeem (in de volksmond ook wel 
atopisch eczeem genoemd). De oorzaak van de ziekte 
is tot op heden onduidelijk, maar kenmerkend zijn 
de rode, jeukende plekken – de aangedane huid1. 
De rest van de huid ziet er op het oog normaal uit, 
en wordt de niet-aangedane huid genoemd (zie 
Figuur 1). De aangedane huid is ontstoken doordat 
allergenen de huid zijn binnengedrongen en daar 
een ontstekingsreactie in gang hebben gezet, waarbij 
sprake kan zijn van een atopie: een verhoging van 
allergeen-specifiek immunoglobuline-E (IgE)2,3. 
Echter, het gebruik van het woord ‘atopisch’ is met 
betrekking tot deze ziekte controversieel, omdat 
een groot deel (tot wel 60%) van de patiënten geen 
verhoging in IgE laat zien4.
 De vraag blijft waardoor allergenen de huid kunnen 
binnendringen. Een belangrijke eigenschap van 
deze aandoening is droge huid. Dit betekent dat het 
watergehalte in de huid verlaagd is. Dit watergehalte 
wordt gereguleerd door onder meer de natuurlijke 
nederlandstalige 
samenvatting*
Figuur 1: Een kind met constitutioneel eczeem. Herkenbaar zijn de 
rode plekken (aangedane, rode huid) naast huid dat er op het oog 
gezond uitziet (niet-aangedane huid).
* roodgedrukte woorden zijn opgenomen  
 in een verklarende woordenlijst
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hydratatiefactor van de huid, de NMF (natural moisturizing factor)5,6. Deze NMF zijn 
metabolieten van het eiwit filaggrine. Het is bekend dat mutaties in het filaggrine-gen een 
grote risicofactor vormen voor de ontwikkeling van constitutioneel eczeem7. Echter, deze 
mutaties komen bij constitutioneel eczeem maar in 20 tot 50 procent van de patiënten 
voor, en kan de ziekte daarom niet volledig verklaren8,9. Dit laat het belang zien van andere 
factoren die een rol spelen bij deze ziekte. Eén van deze factoren is de barrièrefunctie van 
de huid, welke verstoord is bij mensen met constitutioneel eczeem10-14. 
 De huidbarrière bevindt zich in de buitenste huidlaag. Dit is de hoornlaag, ook wel het 
stratum corneum genoemd15,16, verder afgekort tot SC. Deze laag bestaat voornamelijk 
uit dode huidcellen (corneocyten) die worden omsloten door lipiden. Deze lipiden 
vormen een sterk geordende structuur, en voorkomen het binnendringen van allergenen 
uit de omgeving (zie Figuur 2a-c)17. Daarnaast beschermt het SC het lichaam tegen 
overmatig transdermaal waterverlies, en dus uitdroging. In constitutioneel eczeem is 
de barrièrefunctie van het SC verminderd en kunnen allergenen via de lipiden door het 
SC penetreren en de dieper gelegen huidlagen bereiken2,10,13,18. Dit duidt erop dat de 
lipiden in het SC een belangrijke functie vervullen voor een goede huidbarrière. 
 De lipiden in het SC bestaan uit vetzuren, ceramides, en cholesterol19,20. Op moleculair 
niveau hebben vetzuren en ceramides respectievelijk één en twee lange koolstofketens, 
zoals uitgelegd in Figuur 3a. Echter, de molecuulstructuur van deze lipiden kan 
verschillen: vetzuren zijn voornamelijk verzadigd, maar onverzadigde vetzuren zijn 
ook aangetoond21,22. Ceramides bestaan uit een sfingoïde base en een vetzuurketen 
(acylketen genoemd). Beide ketens kunnen verschillen in hun chemische structuur, wat 
resulteert in ceramidesubklassen23,24. Naast deze variaties in functionele groepen hebben 
zowel vetzuren als ceramides een grote variatie in de ketenlengte. Deze variatie in zowel 
ketenlengte en functionele groepen is uniek voor lipiden in het SC en resulteert in een 
karakteristiek geordende structuur van de lipiden: lipidenlagen die geordend op elkaar 
gestapeld zijn (Figuur 2d,e)25,26. In humaan SC bevinden zich twee soorten gestapelde 
lipidenlagen (lamellaire lipidenstructuren genoemd), die zich over een afstand van 6 
of 13 nanometer herhaalt, respectievelijk de SPP (short periodicity phase) en LPP (long 
periodicity phase) genoemd27-29. Naast deze lamellaire lipidenstructuur zijn de lipiden 
in deze lipidenlagen ook geordend met een bepaalde dichtheid, bekend als de laterale 
lipidenstructuur30-34: humane SC-lipiden zijn voornamelijk zeer compact geordend –
orthorombisch genoemd. Een klein deel van de lipiden is echter geordend in een minder 
compacte – hexagonale – lipidenstructuur, of zelfs een structuur die veel minder geordend, 
en vloeibaar is. 
 Bekend is dat lipiden in het SC een cruciale rol spelen bij een goed functionerende 
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Figuur 2: Verklaring van de lipidenstructuur in de huid. a) Dwarsdoorsnede van de huid met daarin de opperhuid 
(epidermis), lederhuid (dermis), en het onderhuids vet- en bindweefsel. b) De epidermis is onderverdeeld in een 
aantal lagen waarvan het sc (hoornlaag) de buitenste is. Deze beschermt het lichaam tegen het binnendringen van 
allergenen van buitenaf, en voorkomt tevens excessievelijk transepidermaal waterverlies van binnen het lichaam. c) Het 
sc is opgebouwd als een bakstenen muur, bestaande uit corneocyten (bakstenen) omgeven door lipiden (cement). De 
corneocyten zijn veelal ondoordringbaar, en stoffen van buitenaf dringen de huid daarom binnen via de intercellullaire 
route (via de lipiden, aangegeven met de rode pijl). d) Ingezoomd op de lipiden zijn daar de lipide lamellen: gestapelde 
lipidelagen met een driedimensionale ordening, weergegeven in e). Ten eerste kunnen de lipiden onderzocht worden 
naar hun lamellaire structuur (vooraanzicht in de figuur), en inzicht worden verkregen in de lengte van de repeterende 
afstanden. Daarnaast kan ook de dichtheid van de lipiden bestudeerd worden, de laterale structuur (bovenaanzicht in de 




























Figuur 3: Molecuulstructuur van vetzuren en ceramides. a) Vetzuren bestaan uit een lange koolstofketen en 
een zuurgroep. Daarnaast kunnen vetzuren één of meerdere dubbele bindingen in de koolstofketen hebben en 
daarmee respectievelijk enkelvoudig onverzadigd of meervoudig onverzadigd zijn. Vetzuren kunnen ook een extra 
hydroxylgroep hebben op de alpha- of omegapositie in het molecuul (met rood aangegeven). Ceramides bestaan uit 
twee koolstofketens: een vetzuurketen (acylketen genoemd, aangegeven in grijs) gekoppeld aan een sfingoïde base (in 
blauw). Ook bij ceramides kan de molecuulstructuur van beide ketens variëren en kan een extra hydroxylgroep op de 
met rood gemarkeerde plaatsen voorkomen. Daarnaast kunnen zowel vetzuren als ceramides verschillen in de lengte 
van de koolstofketens (aangegeven met rode pijlen). Vetzuren in het sc kunnen een ketenlengte hebben variërend 
van ongeveer 16 tot 36 koolstofatomen. Ceramides hebben een totale ketenlengte (beide ketens samen) tussen de 
32 en 56 koolstofatomen, uitgezonderd de [eo]-subklasse (zie hieronder). b) De molecuulstructuur van de twaalfde, 
ontdekte ceramide: de ester-gebonden ω-hydroxy acylketen gekoppeld aan een dihydrosfingosine base. Deze behoort tot 
de [EO]-subklasse, waarin een extra vetzuur vastgekoppeld is (aangegeven in het groen) via een esterbinding aan de 
vetzuurketen van de ceramide. Dit maakt dat ceramides die behoren tot deze subklasse uitzonderlijk lang zijn, met een 
totale ketenlengte die ligt tussen de 62 en 78 koolstofatomen. Ook bij deze subklasse komen variaties in ketenlengte 




















huidbarrière. Onduidelijk is echter welke rol de samenstelling van de lipiden (en de 
ordening ervan) spelen in constitutioneel eczeem. Wetenschappelijke studies geven 
gebrekkige of tegenstrijdige informatie als het gaat om de samenstelling van de 
lipiden35-45. Dit komt onder meer doordat de analytische methoden om de samenstelling 
nauwkeurig te bepalen erg gelimiteerd zijn en vaak weinig gedetailleerde informatie geven. 
Ook over de mate van ordening van de lipiden is bijna geen informatie beschikbaar. Er is 
slechts één studie bekend waarin de laterale lipidenstructuur is onderzocht in relatie tot 
constitutioneel eczeem46. Het kleine aantal patiënten in die studie maakt de interpretatie 
echter beperkt, en tevens geeft dit geen inzicht in de lamellaire structuur van de lipiden. 
Het gebrek aan kennis over de lipiden in het SC belemmert de ontwikkeling van mogelijke 
behandelingen en medicatie voor mensen met constitutioneel eczeem. Het uitgangspunt 
van dit proefschrift is om meer inzicht te verkrijgen over de functie van de SC-lipiden en 




 Het hoofddoel van dit proefschrift is om in detail de samenstelling en de ordening 
van de lipiden in het SC te bepalen, en te onderzoeken wat de rol van deze lipiden is 
met betrekking tot de verminderde huidbarrière in eczeempatiënten. Om dit doel te 
verwezenlijken moest aan een viertal wetenschappelijke doelstellingen worden voldaan:
1.  Het ontwikkelen van een robuuste methode die het mogelijk maakt om in detail de   
  lipiden van het SC kwantitatief te analyseren.
2.  Het bepalen van de lipidensamenstelling in zowel aangedane als niet-aangedane 
  huid van constitutioneel eczeempatiënten, en deze vergelijken met een gezonde   
  controlegroep.
3.  Verklaren hoe veranderingen in de samenstelling van SC-lipiden in constitutioneel   
  eczeempatiënten gerelateerd zijn aan veranderingen in de ordening van de lipiden, 
  en hoe dit effect heeft op de barrièrefunctie van de huid.
4.  De relatie onderzoeken tussen de samenstelling en de ordening van de sc-lipiden in
  patiënten met Netherton syndroom en in humane huidmodellen.
Deel II: methodeontwikkeling voor het analyseren van sc-lipiden
 Deel II van het proefschrift richt zich op de eerste doelstelling waarin een nieuwe 
methode is ontwikkeld die het mogelijk maakt om alle lipiden in het SC (de ceramides, 
vetzuren, en cholesterol) tot in detail te analyseren. Dit is uitgevoerd met behulp van 
vloeistofchromatografie gekoppeld aan massaspectrometrie (LC/MS). Met deze techniek 
is het mogelijk om alle lipidenklassen en subklassen te scheiden en vervolgens te 
analyseren, evenals de ketenlengte van elk afzonderlijk lipide te bepalen.
 De ontwikkeling van deze methode staat beschreven in Hoofdstuk 3, waarin het 
analyseren van de ceramides centraal staat. In dit hoofdstuk wordt een snelle en 
robuuste LC/MS methode beschreven die het mogelijk maakt om kwantitatief alle 
ceramides te analyseren met een geringe monstervoorbewerking. De ongebruikelijke 
combinatie van normale fase LC met atmosferische druk chemische ionisatie (APCI) MS 
bleek een uitstekende keus voor de analyse van ceramides, aangezien alle subklassen en 
ketenlengtes afdoende werden gescheiden en makkelijk konden worden gedetecteerd. 
In humaan SC werden alle 11 tot dusverre bekende ceramidesubklassen gedetecteerd. 
Daarnaast werden onbekende subklassen ontdekt. Met behulp van hoge-resolutie MS 
en door middel van fragmentatie-MS (MS/MS) werd een twaalfde ceramide-subklasse 
geïndentificeerd: Ceramide [EOdS] (ester-gebonden ω-hydroxy acylketen gekoppeld aan 
een dihydrosfingosine base; zie Figuur 3b). De methode bleek niet alleen succesvol in het 
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analyseren van ex-vivohuid, maar ook voor SC verkregen door middel van tape-strippen 
en SC geïsoleerd uit humane huidmodellen.
 De methodeontwikkeling van de andere twee lipidenklassen, de vetzuren en cholesterol, 
is beschreven in Hoofdstuk 4. Hierin wordt eerst de analyse van vetzuren beschreven. 
Door gebruik te maken van omgekeerde fase LC in combinatie met APCI-MS konden 
vetzuren worden gescheiden en gedetecteerd. Toevoeging van chloroform verbeterde in 
sterke mate de ionisatie en leidde tot de formatie van stabiele chloride-adducten. Een 
kwantitatief validatieprotocol liet zien dat de methode robuust, reproduceerbaar, gevoelig 
en snel is, terwijl ionsuppressie verwaarloosbaar klein bleek. Deze methode is daarom zeer 
geschikt voor de analyse van SC-vetzuren, en kan gecombineerd worden met de methode 
voor de analyse van ceramides beschreven in Hoofdstuk 3, omdat dezelfde ionisatie-
bron (APCI) is gebruikt. Deze methode voor het analyseren van ceramides werd op enkele 
punten aangepast, waardoor cholesterol ook gedetecteerd en kwantitatief geanaliseerd 
kan worden. De gecombineerde methode maakt het nu mogelijk om alle belangrijke 
lipiden (ceramides, vetzuren, en cholesterol) in het SC gezamenlijk te analyseren. Het 
laatste onderdeel van Hoofdstuk 4 beschrijft hoe de methode gebruikt kan worden voor 
sc afkomstig van: 1) ex-vivohuid; 2) in-vivohuid verkregen met behulp van tape-strippen; 
3) humane huidmodellen, en; 4) varkenshuid. De verschillende soorten huid laten tal van 
verschillen zien in de lipidenprofielen van zowel de ceramides als de vetzuren. 
 Nadat de LC/MS-methode ontwikkeld was, is deze toegepast in een aantal studies waarin 
de rol van deze lipiden op de barrièrefunctie van de huid werd onderzocht. Deze studies 
worden beschreven in Deel III en IV.
Deel III: Samenstelling van de sc-lipiden in constitutioneel eczeem, en de rol 
van deze lipiden voor de barrièrefunctie van de huid.
 Met behulp van de ontwikkelde LC/MS-methode is de samenstelling van de lipiden 
bepaald in patiënten met constitutioneel eczeem onderzocht, en vergeleken met de 
samenstelling in gezonde vrijwilligers (controle-groep). Daarnaast is de relatie is tussen 
de samenstelling en de ordening van deze lipiden onderzocht, en hoezeer de lipiden 
betrokken zijn bij de verminderde huidbarrière in constitutioneel eczeem.
 De eerste, verkennende studie in patiënten met constitutioneel eczeem is beschreven 
in Hoofdstuk 5. Hierin is de samenstelling van de ceramideklassen bepaald in 6 patiënten 
en vergeleken met een controlegroep van 6 gezonde vrijwilligers. In dit hoofdstuk wordt 
enkel de lipidensamenstelling besproken van niet-aangedane huid. Door middel van het 
tape-strippen van de onderarmen werd SC verkregen. Daarnaast werden huidbiopten 
afgenomen om met behulp van röntgen-diffractie (SAXD) de lamellaire lipidenstructuur 
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te onderzoeken. Uit dit onderzoek blijkt dat de SC-lipiden van patiënten met 
constitutioneel eczeem een veranderde ceramidesamenstelling hebben. Evenals bij de 
gezonde controlegroep, zijn alle 12 ceramidesubklassen aanwezig. Echter, de onderlinge 
verhouding in subklassen verschilt: Percentueel gezien hebben patiënten significant 
minder ceramides die behoren tot de [EO]-subklassen. Deze worden acylceramides 
genoemd en hebben een uitzonderlijk lange koolstofketen, zoals uitgelegd in Figuur 3b. 
Daarnaast werd duidelijk dat patiënten met de grootste afname in deze acylceramides 
ook de grootste afwijkingen hadden in de lamellaire structuur van de lipiden. Hieruit 
blijkt dat er een relatie bestaat tussen de ordening en de samenstelling van de ceramides.
 De resultaten beschreven in Hoofdstuk 5 vormden het uitgangspunt voor een 
uitvoerige studie in 28 patiënten met constitutioneel eczeem en een controlegroep 
van 14 gezonde vrijwilligers, beschreven in Hoofdstuk 6. In deze studie is de 
ceramidesamenstelling bepaald en daarnaast de ordening van de SC-lipiden onderzocht: 
door gebruik te maken van SAXD werd informatie verkregen over de lamellaire structuur, 
terwijl de laterale ordening onderzocht is met behulp van Fourier transform infrarood 
spectroscopie (FTIR). Ook werd de rol van de lipiden in relatie tot huidbarrière en het 
klinisch ziektebeeld onderzocht. Omdat mutaties in het filaggrine-gen een belangrijk 
risicofactor vormen voor de ontwikkeling van constitutioneel eczeem, is ook de relatie 
tussen dit gen en de samenstelling en ordening van de SC-lipiden onderzocht. Uit de 
resultaten kwamen een aantal opvallende aspecten naar voren. Allereerst blijkt dat SC 
van patiënten met constitutioneel eczeem een verhoogd gehalte hebben aan ceramides 
met een korte ketenlengte, in het bijzonder ceramides met een ketenlengte van (slechts) 
34 koolstofatomen. Daarnaast blijkt het gehalte aan acylceramides verlaagd te zijn in 
patiënten. Deze twee veranderingen veroorzaken een verlaging van de gemiddelde 
ketenlengte van ceramides in patiënten met constitutioneel eczeem. Ook leiden deze 
veranderingen tot een andere ordening van de lipiden: Uit de laterale lipidenstructuur 
blijkt dat een groter deel van de lipiden geordend is in een minder compacte (hexagonale) 
structuur. Daarnaast laat de lamellaire ordening zien dat de afstand waarover de 
structuur zich herhaalt kleiner is. Alle bovengenoemde afwijkingen in samenstelling en 
ordening van lipiden gingen gepaard met een verminderde barrièrefunctie van de huid 
en correleerden daarnaast ook met de mate waarin de ziekte zich manifesteert in deze 
patiënten.
 Uit deze studie, waar de ceramide samenstelling en de lipidenordening in het sc centraal 
staat, blijkt dat de veranderingen in de lipiden een zeer belangrijk aspect vormen voor de 
verstoorde huidbarrière in constitutioneel eczeem. Voor het eerst werd aangetoond dat 
met name de ketenlengte van de totale ceramideklassen een rol spelen in de verminderde 
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barrièrefunctie. Naast ceramides zijn vetzuren een andere belangrijke SC-lipidenklasse. 
Bovendien zijn vetzuren essentieel voor de biosynthese van ceramides, en veranderingen 
in vetzuurketenlengte zou mogelijk ten grondslag kunnen liggen aan de verandering in 
ketenlengte van de ceramides. 
 Omdat tot dusverre de ketenlengte van de vetzuren in het SC van patiënten met 
constitutioneel eczeem niet onderzocht is, werd deze lipidenklasse ook bepaald. Hierbij 
zijn zowel verzadigde, onverzadigde, en hydroxyvetzuren geanalyseerd. Deze studie is 
beschreven in Hoofdstuk 7, waarin de lipidensamenstelling in zowel aangedane als niet-
aangedane eczeemhuid is onderzocht. Tevens werd de correlatie tussen veranderingen 
in de ketenlengte van de vetzuursamenstelling en ceramidesamenstelling bestudeerd. 
Daarnaast is onderzocht hoe veranderingen in de lipidensamenstelling kunnen bijdragen 
aan veranderingen in de ordening van de lipiden, en zo de barrièrefunctie van de huid 
kunnen verminderen. Het bleek dat in het SC van patiënten met constitutioneel eczeem 
een verhoogde hoeveelheid aanwezig is van onverzadigde vetzuren ten koste van hydroxy-
vetzuren. Daarnaast was er een verschuiving te zien in de vetzuurketenlengte: patiënten 
hadden een verhoging aan vetzuren met kortere ketens en een verlaging van vetzuren met 
lange ketens. Deze veranderingen waren al aanwezig in niet-aangedane huid, maar komen 
duidelijker naar voren in aangedane huid. De kortere vetzuurketenlengte correleert met 
een verkorte ketenlengte voor de ceramides. Dit bevestigt de hypothese dat de vetzuren 
en ceramides een gedeeltelijk gezamenlijke biosynthese hebben. De ketenlengte van 
de lipiden – zowel de vetzuren als de ceramides – blijkt sterk geassocieerd te zijn met 
de ordening van de lipiden: een verhoging in de hoeveelheid lipiden met een kortere 
ketenlengte leidt tot een minder compacte, hexagonale, lipidenstructuur. Daarentegen 
dragen langere ketenlengtes bij aan een compactere, orthorombische, ordening. Ook 
werd in dit hoofdstuk aangetoond dat een minder compacte lipidenstructuur samenvalt 
met verminderde huidbarrièrefunctie. Dit was zeer duidelijk te zien in aangedane huid, 
maar al waarneembaar in niet-aangedane huid.
 Zowel in Hoofdstuk 6 als 7 wordt het effect van mutaties in het filaggrine-gen op de 
lipiden beschreven. Ook de NMF, metabolieten van filaggrine, worden meegenomen in het 
onderzoek omdat deze een belangrijke rol spelen in de hydratatie van de huid en zorgen 
voor de juiste pH van het SC. Zowel de lipidensamenstelling als de ordening laten een 
duidelijk verband zien met de NMF: Patiënten met een sterker afwijkend lipidenprofiel 
laten ook een sterkere afname zien in de hoeveelheid NMF in het SC. Daarentegen is er 
geen enkele correlatie gevonden met mutaties in het filaggrine-gen. Deze discrepantie laat 
zien dat tussen het filaggrine-genotype en de filaggrine-metabolieten andere factoren een 
belangrijke rol spelen (zoals filaggrine-expressie), en maakt duidelijk dat onderzoek naar 
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filaggrine op fenotypisch niveau naast dat van filaggrine genotypering erg belangrijk is. 
 Uit de studies beschreven in de voorgaande hoofdstukken blijkt dat de samenstelling 
van de lipiden – en de daaruitvoortkomende ordening – een belangrijke rol spelen in de 
verminderde barrièrefunctie van het SC in patiënten met constitutioneel eczeem. Een 
laatste studie in deze patiëntengroep was gericht om het effect van de totale hoeveelheid 
aan lipiden in het SC op de barrièrefunctie te onderzoeken. Om hierin inzicht te verkrijgen 
kan men het drooggewicht van het SC vergelijken met de lipide/eiwit-ratio, verkregen 
via Ramanspectroscopie. Dit onderzoek is beschreven in Hoofdstuk 8, en laat zien dat 
het drooggewicht van het SC nauwelijks veranderd is in patiënten met constitutioneel 
eczeem ten opzichte van de gezonde controlegroep. De lipide/eiwit-ratio was daarentegen 
wel significant afgenomen in eczeempatiënten, zowel in aangedane huid als – in mindere 
mate – in niet-aangedane huid. Ook deze veranderingen correleren met een verminderde 
huidbarrière in de patiëntengroep. De resultaten impliceren dat de hoeveelheid lipiden 
binnen het SC (en niet de hoeveelheid SC) een belangrijke rol spelen bij de verstoorde 
huidbarrière in constitutioneel eczeem.
 Samenvattend: de studies beschreven in Deel III van dit proefschrift illustreren het 
belang van de lipiden voor de verstoorde huidbarrière in patiënten met constitutioneel 
eczeem. Deze conclusies vormden de basis om de lipiden van andere huidsoorten te 
onderzoeken waarin eveneens sprake is van een verminderde huidbarrière. Dit is uitvoerig 
beschreven in Deel IV.
Deel IV: Onderzoek naar sc-lipiden afkomstig van andere huidsoorten met 
een verminderde huidbarrière
 In Deel III is een sterke relatie tussen de lipidensamentelling, de lipidenstructuur, 
en een verminderde huidbarrière in patiënten met constitutioneel eczeem beschreven. 
Daarom werd besloten om ook SC te onderzoeken van patiënten met Netherton syndroom 
en humane huidmodellen. Van beide is bekend dat er sprake is van een verminderde 
barrièrefunctie van de huid, maar informatie over de SC-lipiden is er niet of nauwelijks. 
 Hoofdstuk 9 beschrijft de samenstelling en ordening van de SC-lipiden in 8 patiënten 
met Netherton syndroom, een zelfdzame en zeer ernstige huidziekte die veel 
gelijkenissen vertoont met constitutioneel eczeem. Het syndroom wordt veroorzaakt 
door mutaties in het SPINK5 gen. Dit gen codeert voor het eiwit LEKTI, een specifieke 
proteaseremmer. Bij patiënten is er geen of nauwelijks expressie van dit eiwit, wat leidt 
tot een verhoogde activiteit van epidermale proteases en daardoor extreme schilfering 
van het SC. De barrièrefunctie van de huid is dan ook ernstig verstoord bij mensen die 
lijden aan Netherton syndroom. Het doel van dit onderzoek was om te bepalen of er 
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afwijkingen zijn in de samenstelling en de ordening van de lipiden in het SC van deze 
patiënten. Er is nagenoeg geen informatie bekend over de lipideneigenschappen van het 
SC van deze patiënten. Uit het door ons uitgevoerde onderzoek blijkt dat patiënten met 
Netherton syndroom een lipidenprofiel hebben die veel overeenkomsten vertoont met 
constitutioneel eczeem: ten opzichte van de controlegroep is de ketenlengteverdeling van 
de vetzuren verschoven naar kortere ketens, en tevens is er een verhoging in het aantal 
onverzadigde vetzuren. Ook is het gehalte aan ceramides met een korte keten verhoogd 
en is er in een aantal patiënten een drastische verlaging van ceramides met een zeer lange 
keten (acylceramides). Naast deze overeenkomsten met constitutioneel eczeem zijn er in 
patiënten met Netherton syndroom hoge gehaltes aan onverzadigde ceramides gemeten. 
De veranderingen in de samenstelling van de lipiden komt overeen met een verandering 
in de ordening ervan: zowel de lamellaire als de laterale structuur lieten significante 
veranderingen zien. Het ligt voor de hand dat de bovengenoemde veranderingen in 
lipidensamenstelling en lipidenstructuur bijdragen aan de verminderde barrièrefunctie 
van de huid bij deze patiënten.
 Hoofdstuk 10 beschrijft een studie waarin de SC-lipiden van vier verschillende 
(humane) huidmodellen onderzocht is. Deze gekweekte huid afkomstig van geïsoleerde 
huidcellen lijkt in veel opzichten op de eigenschappen van menselijke huid, maar vertoont 
desalniettemin een verminderde huidbarrière en een afwijkende lipidenstructuur. Om de 
oorzaak van deze afwijkingen in huidmodellen te achterhalen, is de samenstelling van 
de vetzuren en ceramides geanalyseerd. Uit de resultaten blijkt dat in alle huidmodellen 
dezelfde 12 ceramidesubklassen aanwezig zijn als in humaan SC. Echter, ceramides met 
kortere koolstofketens zijn significant verhoogd ten opzichte van humaan SC. Daarnaast 
zijn in de huidmodellen ook onverzadigde ceramides aanwezig. Deze zijn nooit eerder 
waargenomen in humaan SC, uitgezonderd de patiënten met Netherton syndroom. Ook 
bleek de totale hoeveelheid vetzuren drastisch verlaagd, en vertonen de huidmodellen 
een verhoogde hoeveelheid onverzadigde vetzuren ten opzichte van humaan SC. Dit 
laatste kan verklaard worden door een verhoogde expressie van het enzym stearoyl-CoA 
desaturase (SCD), het enzym dat verzadigde vetzuren omzet tot onverzadigde vetzuren. 
Deel V: Conclusies
 Uit de studies beschreven in dit proefschrift blijkt dat lipiden in het SC een cruciale rol 
spelen in de barrièrefunctie van de huid. Uit studies in patiënten met constitutioneel 
eczeem en Netherton syndroom blijkt dat veranderingen in de samenstelling van de 
lipiden een negatief effect hebben op de lamellaire en laterale lipidenstructuur. In het 
bijzonder de ketenlengte van de lipiden blijkt uitstekend te correleren met de ordening 
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van de lipiden: kortere vetzuur- en ceramideketenlengtes dragen bij aan een minder 
compacte, hexagonale, lipidenordening, terwijl langere lipidenketens resulteren in een 
meer compacte, orthorombische, lipidenstructuur.
 Uit de studies blijkt ook dat acylceramides (ceramides met een zeer lange koolstofketen, 
behorende tot de [EO] subklasse) essentieel zijn voor een lange periodiciteitsfase (LPP) in 
de lamellaire lipidenstructuur. De aanwezigheid van deze LPP heeft een positieve bijdrage 
op de barrièrefunctie van de huid. Het gebruik van LC/MS als analytische methode bleek 
essentieel voor deze bevindingen, omdat geen enkele andere methode tot op heden alle 
SC-lipiden en de ketenlengtes ervan kan analyseren. Daarnaast is de gevoeligheid van 
massaspectrometrie ongeëvenaard, waardoor de hoeveelheid huidmateriaal die nodig 
is voor analyse zeer beperkt blijft. Hierdoor was het mogelijk om lipiden uit het SC te 
verkrijgen op een non-invasieve manier door middel van tape-strippen.
 Het SC van patiënten met constitutioneel eczeem, Netherton syndroom, en van 
huidmodellen laten allemaal dezelfde soort veranderingen zien in hun lipidensamenstelling: 
een verkorte ketenlengte in de lipiden en een verhoging van het gehalte aan onverzadigde 
lipiden. Een sterkere afwijking in de lipidensamenstelling – zoals aangedane huid in 
constitutioneel eczeem of huid van patiënten met Netherton syndroom – leidt tot een 
sterkere afwijking in de ordening van de lipiden en een ernstigere verstoring van de 
huidbarrière.
 Uit deze studies blijkt dat er een duidelijk verband is tussen de samenstelling van de 
vetzuren en de ceramides: zowel de ketenlengte als de hoeveelheid onverzadigde lipiden 
correleert voor beide lipidenklassen. Deze bevinding is biologisch gezien relevant, omdat 
dit de hypothese ondersteunt dat vetzuren en ceramides in het SC een overlappende 
biosynthese hebben47,48. Ook is de bevinding van klinische waarde, omdat het impliceert 
dat de ceramidesamenstelling gedeeltelijk hersteld kan worden door het normaliseren 
van de vetzuursamenstelling.
 Tevens is er meer inzicht verkregen in het epidermaal lipidenmetabolisme: Allereerst 
suggereren de kortere vetzuurketenlengtes – waargenomen in constitutioneel eczeem, 
Netherton syndroom, en de huidmodellen – dat de verlenging (elongatie) van vetzuurketens 
verstoord is49; Ten tweede laten de veranderingen in de relatieve hoeveelheid van bepaalde 
ceramidesubklassen zien dat de enzymen die betrokken zijn bij de synthese van deze 
subklassen meer- of minder actief zijn. Twee enzymen die wellicht deels ten grondslag liggen 
aan dit veranderde lipidenmetabolisme zijn β-glucocerebrosidase en sfingomyelinase. 
Beiden zijn betrokken bij de omzetting van ceramide-precursors naar hun uiteindelijke 
ceramidestructuur50-53. Beide enzymen hebben echter niet dezelfde affiniteit voor alle 
precursors, en verandering in de activiteit van één van deze enzymen kan deels verklaren 
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waarom bepaalde ceramidesubklassen verhoogd zijn ten koste van andere subklassen54.
 De studies in constitutioneel eczeempatiënten geven een beter inzicht in de rol van 
filaggrine en NMF met betrekking tot de lipiden in het SC en de barrièrefunctie van de huid. 
Filaggrine op fenotypisch en metabolisch (NMF) niveau zijn hier meer aan gerelateerd dan 
op het genotypisch (DNA) niveau. Dit ondersteund de hypothese dat veranderingen in 
filaggrine-expressie een belangrijke factor vormen in constitutioneel eczeem55,56.
 Concluderend, de studies die beschreven zijn in dit proefschrift dragen bij aan meer 
kennis omtrent de barrièrefunctie van het SC vanuit zowel een biofysisch perspectief (de 
relatie tussen lipidensamenstelling, lipidenstructuur, en barrièrefunctie van de huid), 
maar ook vanuit een klinisch perspectief, namelijk het belang van de SC-lipiden in relatie 
tot constitutioneel eczeem en Netherton syndroom. Toekomstig onderzoek zou zich 
kunnen richten op het herstellen van de huidbarrière bij mensen met (constitutioneel) 
eczeem, of meer inzicht verschaffen naar de de oorzaak en de mechanismen van de ziekte. 
Daarnaast kan men ook breder kijken door fundamenteel onderzoek te verrichten naar 
het lipidenmetabolisme van de huid, of de mogelijkheden benutten die liggen op het 
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Deze verklarende woordenlijst fungeert als supplement bij de Nederlandse 
Samenvatting, en dient in de context gelezen te worden. De termen zijn op alfabetische 
wijze vermeld.
Affiniteit: Aantrekkingskracht tussen 
het molecuul (ligand) en het enzym. 
Een ligand met een hogere affiniteit 
voor een bepaald enzym zal makkelijker 
een binding vormen met het enzym en 
vervolgens omgezet worden.
Allergeen-specifiek immunoglobuline-e 
(ige): Lichaamseigen antistof dat een rol 
speelt bij overgevoeligheid. Ige bindt aan 
de allergene stof en zet een imuunreactie 
in werking. In het geval van een allergie is 
er sprake van een overreactie.
Allergenen: Stoffen (van buitenaf) die 
een allergie kunnen veroorzaken. Het 
lichaam reageert hierop hevig met een 
overgevoelige reactie en (eventueel) de 
aanmaak van IgE. Bekende voorbeelden 
zijn pollen en huisstofmijt, maar ook 
pinda’s en koemelkeiwitten kunnen een  
IgE-gemedieerde immuunreactie in gang 
zetten.
Atmosferische druk chemische ionisatie 
(aPci): Een methode om geladen deeltjes 
(ionen) te verkrijgen via verdamping en het 
gebruik van electrische ontladingen met 
een hoog voltage (waarbij plasma ontstaat). 
Deze ionen zijn nodig om met een 
massaspectrometer te kunnen detecteren.
β-glucocerebrosidase: Enzym dat 
een suikergroep ‘losknipt’ van een 
glucosylceramide-molecuul, waardoor een 
ceramide ontstaat.
Biosynthese: Natuurlijke aanmaak van 
stoffen in het lichaam via enzymatische 
reacties.
Chloride-adducten: Een geladen deeltje 
(ion) gevormd uit de koppeling van 
het oorspronkelijke molecuul met een 
chloor-atoom. Adducten worden gebruikt 
in massaspectrometrie omdat het 
oorsponkelijke molecuul bijvoorbeeld erg 
instabiel of niet goed detecteerbaar is.
Elongatie: Natuurlijke manier om 
koolstofketens (zoals het geval bij 
vetzuren) te verlengen met behulp van 
enzymen (zogenaamde elongases).
Epidermale proteases: enzymen in de 
huid die eiwitbindingen afbreken.
Ex-vivohuid: Huid waarop onderzoek 
gedaan wordt, maar buiten het lichaam. In 
dit geval gaat het om huid dat via plastische 
chirurgie is verwijderd en vervolgens 
geprepareerd is om experimenteel werk op 
te kunnen verrichten.
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Expressie: Het proces waarin het DNA 
van een gen wordt gekopieerd en tot 
uiting komt (fenotype), vaak als een eiwit 
(in dit geval filaggrine). Of een gen ook 
daadwerkelijk tot expressie komt hangt af 
van vele factoren, waaronder de omgeving. 
Het genotype (DNA) bepaalt dus maar 
in beperkte mate de uiterlijke vorm en 
hoeveelheid van een eiwit (fenotype).
Fenotypisch: Waarneembaar/Meetbare 
resultaat van een genotype (DNA). Iets wat 
in het DNA zit hoeft niet altijd tot uiting 
te komen in een fenotype (‘zichtbaar te 
worden’), omdat ook andere factoren 
een rol spelen zoals de omgeving (zie 
‘Expressie’). In dit geval gaat het om het 
filaggrine-gen (genotype) , dat uiteindelijk 
tot uiting kan komen in het eiwit 
filaggrine (fenotype).
Filaggrine: Eiwit in de huid met twee 
belangrijke functies. Allereerst zorgt 
het voor het bij elkaar houden van 
keratinefillamenten, ‘eiwitdraden’ die 
zorgen voor de compactheid en stevigheid 
van huidcellen. Daarnaast wordt filaggrine 
afgebroken in moleculen die belangrijk 




Analytische techniek waarbij met behulp 
van infrarode straling gekeken wordt 
naar specifieke trillingen van moleculen. 
Hiermee kan de laterale structuur van 
de lipiden onderzocht worden, omdat de 
lipiden met een andere frequentie trillen 
als de ordening verandert.
Fragmentatie-Ms: 
Een massaspectrometrische techniek 
waarbij de ionen worden gefragmenteerd. 
Uit de massa van deze fragmenten kan de 
molecuulstructuur van het ion herleidt 
worden.
Genotype: De erfelijke eigenschappen 
(genen) die zich bevinden in het DNA.
Hoge-resolutie Ms: Met een 
massaspectrometer met hoge resolutie 
kan de massa van ionen bepaald worden 
tot op 5 à 6 decimalen achter de komma.
Huidbiopten: Stukjes huidweefsel dat 
is weggesneden zodat het gebruikt kan 
worden voor onderzoek.
Humane huidmodellen: gekweekte huid 
dat grote gelijkenissen vertoont met 
menselijke huid.
Hydroxy-vetzuren: Vetzuren met een 
extra hydroxyl-groep (OH-groep) in het 
molecuul. 
In-vivohuid: Huid waarop onderzoek 
verricht wordt in een levend organisme. 
In dit geval waren het de onderarmen van 
vrijwilligers waarop onderzoek gedaan is.
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Ionsuppressie: Bij massaspectrometrie 
kunnen meerdere ionen met verschillende 
massa’s tegelijkertijd gemeten worden. 
Het signaal van het ene ion kan echter wel 
het signaal van het andere ion verstoren, 
waardoor het signaal gedeeltelijk of 
zelfs geheel weg kan vallen. Dit gebeurt 
voornamelijk als de detector teveel ionen 
in een te korte tijd krijgt te verwerken.
Kwantitatief: Iets dat uit te drukken is in 
een bepaalde hoeveelheid (bijvoorbeeld 
gram, milliliter, of percentage). Dit is 
tegengesteld aan kwalitatief, wat alleen 
ingaat op de vraag OF iets aanwezig is of 
niet.
Lamellaire lipidenstructuur: Een 
structuur tussen de corneocyten dat 
bestaat uit repeterende lagen (fasen) van 
lipiden. In humaan stratum corneum 
komt een lange en korte periodiciteitsfase 
voor. Niet te verwarren met de 
molecuulstructuur, wat een weergave is 
van alle atomen in een molecuul.
Laterale lipidenstructuur: Lateraal 
betekent letterlijk zijkant. Men bekijkt 
de lipiden vanuit het vlak dat loodrecht 
op de lamelaire structuur staat. Niet te 
verwarren met de molecuulstructuur, wat 
een weergave is van alle atomen in een 
molecuul.
Lekti: Een eiwit dat staat voor Lympho-
epithelial Kazal-type-related inhibitor. 
Dit eiwit bindt zich aan specifieke 
proteases, enzymen die eiwitbindingen 
doorknippen (zie Epidermale Proteases). 
Doordat LEKTI bindt aan de proteases, 
kunnen andere eiwitten niet meer binden 
en geknipt worden. Op deze manier 
inhibeert (verhindert) LEKTI de werking 
van bepaalde proteases in de epidermis, 
waardoor de huid niet overmatig schilfert. 
Lipiden: vetachtige stoffen die slecht 
oplossen in water. Lipiden hebben in 
het menselijk lichaam velerlei functies, 
waaronder de barrièrefunctie in de huid. 
Lipiden die voorkomen in het stratum 
corneum zijn cholesterol, vetzuren en 
ceramides.
Lipide/eiwit ratio: Verhouding van 
het aantal lipiden ten opzichte van 
de hoeveelheid eiwit. Omdat het 
stratum corneum bestaat uit lipiden en 
corneocyten (dode cellen bestaande uit 
voornamelijk keratine, een eiwit), is de 
ratio een goede maat voor het aantal 
lipiden ten opzichte van het totaal aan 
stratum corneum.
Massaspectrometrie: Een analytische 
techniek waarbij moleculen eerst omgezet 
worden in ionen (geladen deeltjes), 
waarna het mogelijk is om de exacte 




afbraakproducten. Filaggrine wordt in de 
huid afgebroken tot kleinere moleculen 
– zoals de NMF – die een eigen functie 
hebben.
Monstervoorbewerking: Voordat een 
(huid)monster gemeten kan worden met 
analytische apparatuur, moeten er eerst 
een aantal stappen genomen worden om 
goede metingen te kunnen verrichten en 
vervuiling te voorkomen. Zo moeten de 
lipiden eerst uit de cellen geëxtraheerd 
worden en het lipidenextract opgezuiverd 
worden.
Mutaties: veranderingen in het DNA. In 
het geval van filaggrine kunnen mutaties 
leiden tot (onder andere) minder synthese 
van het eiwit filaggrine.
NMf: Natuurlijke hydratatiefactor van de 
huid, de zogenaamde Natural Moisturizing 
Factor. Deze is belangrijk voor een goede 
waterhuishouding in de huid, en bestaat 
uit onder meer afbraakproducten van het 
eiwit filaggrine.
Normale fase Lc: Een manier van 
vloeistofchromatografie waarbij de 
vaste fase een polaire stof is. Deze vorm 
van chromatografie is tegenwoordig 
ongebruikelijk.
Omgekeerde fase Lc: Een manier van 
vloeistofchromatografie waarbij de 
vaste fase een apolaire stof is, vaak een 
lange koolstofketen. Dit is tegenwoordig 
de meestvoorkomende vorm van 
chromatografie.
Onverzadigde vetzuren: Vetzuren 
met een dubbele binding in hun 
molecuulstructuur. Vetzuren kunnen 
enkelvoudig onverzadigd, maar 
ook meervoudig onverzadigd zijn. 
Laatstgenoemde komen nauwelijks voor in 
humaan stratum corneum.
Precursors: Uitgangsstoffen die als 
voorloper dienen voor de uiteindelijk stof.
Proteaseremmer: Een eiwit dat bindt aan 
een protease (enzym dat eiwitbindingen 
doorknipt), waardoor andere eiwitten 
niet meer geknipt kunnen worden en de 
werking van de protease dus wordt geremd 
(geïnhibeert). 
Ramanspectroscopie: Analytische 
techniek waarbij met behulp van een laser 
met monochromatisch licht (licht met 
één golflengte) gekeken wordt naar de 
Raman-verstrooiing van dit licht. Deze 
verstrooiing hang samen met specifieke 
trillingen van moleculen. Hiermee kan 
onder meer de verhouding tussen lipiden 
en eiwit in het stratum corneum bepaald 
worden omdat de lipiden met een andere 
frequentie trillen dan de eiwitten.
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Röntgen-diffractie: Analytische techniek 
waarbij Röntgenstraling wordt gebruikt 
om de lamellaire structuur van in dit 
geval lipiden in het stratum corneum te 
onderzoeken.
Sfingomyelinase: Enzym dat een 
fosfocholine ‘losknipt’ van een 
sfingomyeline-molecuul, waardoor een 
ceramide ontstaat.
SPiNk5 gen: Het gen wat codeert voor het 
eiwit LEKTI (zie LEKTI), en wat gemuteerd 
is bij mensen met Netherton syndroom. 
De naam staat voor serine peptidase 
inhibitor, Kazal type 5.
Stratum corneum: Beter bekend als de 
hoornlaag van de huid, die bestaat uit 
dode cellen met daatussen de lipiden. Deze 
dunne huidlaag fungeert als belangrijkste 
barrière tegen het binnendringen van 
stoffen van buitenaf. Daarnaast voorkomt 
het uitdroging.
Tape-strippen: methode om met behulp 
van ‘tape’ snel en op een niet belastende 
manier laagjes stratum corneum te 
verkrijgen.
Transdermaal waterverlies: De 
hoeveelheid water dat vanuit het lichaam 
via de huid wordt afgegeven aan de 
omgeving. Niet te verwarren met zweet, 
dat via zweetklieren wordt afgegeven.
Validatieprotocol: Een protocol waarin 
getest wordt of de ontwikkelde methode 
voldoet aan de eisen die vooraf gesteld 
zijn.
Vloeistofchromatografie: Een techniek 
waarbij stoffen gescheiden worden op 
basis van hun affiniteit met een vaste 
fase ten opzichte van een bewegende 
vloeistoffase: Stoffen worden meegeleid in 
een vloeistof langs een analytische kolom 
met een vaste fase. Stoffen die chemisch 
gezien meer overeenkomst vertonen 
met de vaste fase worden vertraagd en 
worden op deze manier in de mobiele 
fase gescheiden van stoffen die minder 
overeenkomst vertonen met de vaste fase. 
Ionisatie: Het proces waarbij een 
ongeladen molecuul een geladen atoom (of 
elektron) meer of minder krijgt en zo een 
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Aan het einde van dit proefschrift rest er nog 1 
belangrijke taak: het bedanken van de mensen die 
dit proefschrift tot stand hebben gebracht. Hoewel ik 
iedereen kan – en ook nadrukkelijk wil – noemen die 
mij de afgelopen vier jaar hebben bijgestaan (familie, 
(pizza-)vrienden, fysiotherapeut, en meer van 
diens), blijf ik mij hier beperken tot de mensen met 
een direct wetenschappelijk gerelateerde bijdrage 
aan dit proefschrift.
 Allereerst Michelle. We kunnen terugkijken op een 
succesvolle samenwerking tijdens de afgelopen jaren. 
Zonder jou was de planning waarschijnlijk uitgemond 
in een geordende chaos, als er al uberhaupt een 
planning was geweest. Ik denk dat er weinig PhD’s 
kunnen zeggen dat zo’n hechte samenwerking heeft 
geleidt tot zo veel mooie artikelen.
 Natuurlijk wil ik ook jou, Varsha, apart vermelden. 
Jouw bijdrage met betrekking tot de kweekhuid is van 
heel veel waarde, en waarschijnlijk meer dan je zelf 
denkt. Daarnaast zijn daar die ‘unieke’ momenten 
op bijvoorbeeld de conferenties als de Gordon. Het is 
jammer dat aan dat tijdperk een einde heeft moeten 
komen.
 Gelukkig heb je een hele lieve opvolger gekregen. 
Lolu, ik ben blij dat de huidkweek wordt doorgezet, 
en dat je kon voortborduren op dit gebied waar wij 
nu nauw samen aan verbonden zijn.
 Ook jij, Aat, mag hier natuurlijk niet ontbreken, 
aangezien je Michelle en mij zo veelvuldig hebt 
geholpen. Niet alleen voor de ontelbare keren dat er 
tape-strips gestanst moesten worden, maar ook bij 
de bca-assay, waar het woord microliterpipetteren 
een nieuwe dimensie heeft gekregen. En dan heb 
ik het niet eens over ED, excelsheets, en gewoon de 
gezelligheid op de kamer.
 Daarnaast kan ik natuurlijk ook mijn 9-maanden 
dankwoord
239
stagestudenten en de enige echte LC/MS analist niet vergeten. Walter, Edward en Hannah, 
jullie hebben eraan bijgedragen dat de vakgroep een LC/MS methode voor het analzeren 
van huidlipiden heeft die op dit moment zonder twijfel tot de meest vooraanstaande 
behoort in de wereld.
 Aansluitend wil ik ook twee andere analisten noemen: Gert en Gerwin. Als alles zou zijn 
gegaan zonder problemen, zouden jullie waarschijnlijk minder bij het project betrokken 
zijn geweest. Maar uiteraard vraagt wetenschappelijke apparatuur meer tijd, inspanning 
en onderhoud dan je zou wensen, en laten we eerlijk wezen, zonder jullie zou er de 
afgelopen vier jaar uberhaupt weinig te meten zijn geweest. En dan heb ik nog niet eens 
jullie bijdrage genoemd tijdens de nuttige conversaties.
 Lieve Connie, ook jij moet even apart genoemd worden. De afgelopen vier jaren ben jij 
als secretaresse vaak bij ons project betrokken geweest voor die kleine dingetjes die toch 
elke keer weer geregeld moesten worden. Afspraken met het LUMC, meetings tussen Joke 
en Rob, zaken voor mijn promotie, et cetera. Heel erg bedankt voor al die uren die je eraan 
hebt gespendeerd.
 Laat ik dan ook zeker Robert niet vergeten. Jij hebt mij al weer meer dan 4 jaar terug 
ingewerkt in het hele project waar dit proefschrift uit voortgekomen is. Ik ben blij dat jij 
me hebt geholpen de eerste maanden als PhD succesvol (hoop ik) door te zijn gekomen.
 Enamul en Koen, als Paranimfen ben ik blij dat jullie aan mijn zijde staan tijdens de 
verdediging van mijn proefschrift. Jullie hebben ervoor gezorgd dat ook het einde van 
mijn PhD tot een feest geworden is.
 Eveneens wil ik iedereen van de vakgroep kort vermelden. De individuele discussies, 
vragen tijdens de presentaties, of scherpe opmerkingen tijdens de koffiepauzes hebben 
mij veelvuldig aan het denken. Daar waar wetenschap soms een zwart gat lijkt en moeilijk 
te doorgronden valt, kan een simpele opmerking licht brengen en tot nieuwe inzichten 
leiden.
 En dan wil ik ook Melina noemen. Iedereen die dit proefschrift leest kan dat alleen 
maar lezen dankzij de urenlange inspanningen die jij hebt verricht om dit proefschrift tot 
zoiets moois, unieks, en bovenal waanzinnig stijlvol weten te maken. Heel, héél veel dank 
daarvoor.
 Rest mij te besluiten met de allerlaatsten, en tevens de meest dierbaren die niet mogen 
ontbreken: mijn naaste familie, in het bijzonder mijn lieve Bianca. Vaak heb ik mijn 
thuissituatie tot ’s avonds laat moeten achterlaten in dienst van de wetenschap. Los van 
het feit dat jij ook hebt bijgedragen aan de uiteindelijke versie van het proefschrift, ben ik 




AE - atopic eczema
(A)GPAT - (acyl)glycerol-3-phosphate 
ANOVA - analysis of variance
APCI - atmospheric pressure chemical   
  ionization
aSMASE - acid sphingomyelinase 
ATR - attenuated total reflectance 
AU - arbitrary units
β-GCase - β-glucocerebrosidase 
BCA - bicinchoninic acid assay
BSA - bovine serum albumin
CCD - charge-coupled detector
CER - ceramide 
CERS - ceramide synthase family (1 to 6)
CERS3 - ceramide synthase 3
CHCl3 - chloroform
CHOL - cholesterol 
DES - dihydroceramide desaturase (1 and 2)
ELA2 - protease elastase 2
ELOVL - elongation of very long chain fatty   
  acids 
ESI - electrospray ionization 
EtOH - ethanol
FAS - fatty acid synthase
FDM - fibroblast derived matrix model
FFA - free fatty acid
FLG - filaggrin gene
FT-ICR - Fourier transform ion cyclotron   
  resonance 
FTIR - Fourier transform infrared   
  spectroscopy 
FTM - full-thickness collagen model
FTO - full thickness outgrowth
FWHM - full width at half maximum 
GC - gas chromatography
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GCS - glucosylceramide synthase
GLC - gas-liquid chromatography
H2O - water
HAc - acetic acid
HPLC - high performance liquid   
  chromatography
HPTLC - high performance thin layer  
  chromatography 
hse - human skin equivalents 
IFN - interferon 
IgE - immunoglobulin E
IL - interleukin
IPA - isopropanol
IT - ion trap 
KLK - kallikrein
KSR - 3-ketosphinganine reductase
LB - lamellar body
LC/MS - liquid-chromatography-mass- 
  spectrometry
LEKTI - lympho-epithelial Kazal-  
  type–related inhibitor
LEM - Leiden epidermal model
LOD - limit of detection 
LOQ - limit of quantification 
LPP - long periodicity phase
LXR - liver X receptor
MCT - mercury-cadmium-telluride 
MeOH - methanol
MS - mass spectrometry 
mufa - monounsaturated fatty acid 
NES - Netherton syndrome
NMF - natural moisturizing factor 
NMR - nuclear magnetic resonance 
NPLC - normal phase liquid   
  chromatography 
OH-FFAs - hydroxyl-fatty acids 
PAR2 - proteinase-activated 
  receptor 2
PLA-2 - phospholipase
PPAR - peroxisome proliferator-  
  activated receptor 
PUFA - polyunsaturated fatty acid
PVA - polyvinyl alcohol
RPLC - reversed phase liquid   
  chromatography 
S/N - signal to noise ratio 
SAXD - small angle X-ray diffraction 
SC - stratum corneum 
SCD - stearoyl-CoA desaturase
SCORAD - scoring atopic dermatitis  
SD - standard deviation
SEM - standard error of the mean
SMS - sphingomyelin synthase
SPINK5 - serine protease inhibitor   
  Kazal-type 5
SPP - short periodicity phase
SPT - serine palmitoyltransferase
SULT2B1b - cholesterol sulfotransferase  
  type 2B isoform 1B 
TEWL - transepidermal water loss
TLC - thin layer chromatography
TQ - triple quad
TSLP - thymic stromal    
  lymphopoietin
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